var title_f11_36_11840="Vitrectomy";
var content_f11_36_11840=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F65234&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F65234&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Vitrectomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 365px; height: 327px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFHAW0DASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pooooAKKK5TWdWm0O7LZeaDOSjN2PuelAHV0VSstQgv7aG5tXLRSHaexU46Edjnj8azobx4L2dHkZvuk7mzjDhW/Q5oA3qKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAoopGJCkqMnHAoAjuZDFEzKMntXMeI7e31rTpCdsd5GCFz0cf3TWBqXim6tNYkguj5ZLfKG4DD0qSS5+2xGe1bbJ1khJ+8PUe9AHIaNr17oGoi2Z3+zTSrHz8xVgRhG/o34V6DrtxD/aM8YIDGNm57hkz/MVzF1p0d9aSXdu4FxENzgjiQAjg+49al8bu1p4i0+RclXijBz6HIoA9Tt5Vnt4pV+7IocfQjNSVleFZ0uPDunOhU4t41IVs4IUcVq0AFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQByPjzwnHr9r5sIAvIx8v8Atf8A168fXU77RLlrG/LxyxH5JD/L3FfR1cT8RfBcPiK0aa3Gy9QcED71AHnun+IPtBnUfLLJGUlQHGf9oe9dB40R5o9OkLc+Qv8A6HXi+pQ3mi6msFxujnR9uc/h+Vex6pctNZQFj8yRoMjsdwoA53SvFV/4X1y1wpe2liVGjPCy4JGPZvQ/hXuOi6ra6xYJd2T7o24KnhkPdWHYivIpdEj8Q6cVUK9x8waFTtL4Y4Kns3p69Kw9I8Rah4O1FftUjyO2AjlTsvIh1V/7si9M0AfQ9FQWF1HfWNtdw58qeNZUz6MMj+dT0AFFFFABRRRQAUUUUAFFFFABRUc88UCgzSKgPTJ6/Sqn9pCQf6NC8g7M3yD/AB/SgC/RWX5upysQiwIAOuCf6/0oe11KQgtehMHoijn9KANSispLXUwn/H8d2f4kUgj8qlY6miHC28jduooA0KKoG6u4gDPZgp3aJ9xH4YpYtWsZZAn2hUk/uv8AKf1oAvUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFY3iPxDZ6JEBM6tdOCY4QeW9z6Cuc03xBqGsXQQfu4cgYjHJ+tAHeUVHbqyQqrnLAVJQAUUUUAFFFFABRRRQBwPxN8BW/ieya4tUVNRj+ZT/AH8f1rjL1/Lt/Kl3KwQZ/A9K9xIyD2ry+80WHUNN1GWN8TW+7I9QDmgDgZ/FFlobedNc/Z4oGdXOMs3znAUdzU+mTat8RvFdimuRf2NoVwouFhQhXulH3dzdSzY+mM1AvwtvPGWrRzSTw29nalt7kbizkggEdzg9aWS1u/B2pLofiUu2nFs2l8n/ACxyePqpPb+RFAH0VBFHBDHDCgSKNQiKvAUAYAFPrjfCniWQ3CaTrTr9qIBt7kH5LhT057n37/XiuyoAKKKKACiiigAoorOvNR+ZobPDyA7WkxlIz6e7f7I/HFAFm8vILNA1xIFLcKo5Zj6AdTWZLd3t6zpZr5EePv8AVj+PQfhk0+10uON2ubhpXmcfO0jZZvb0Uf7IqprWuQ2I+zwqWm6LDEwBX/eP8I/WgCeO0S3JaV8t3dzub9Tn86iXXNPjJS2826kHGUGR6cnpXH3VxNdTFr6R5BnKwKdsa++O/wBTmiS6uRhI8E9gowAPXNAHZf2reTMwhjt4UHeRix/TAqVGvG5bU0H+7CvP51wPn3aOfNdQf7oPJq/a6hKeJnlOeMY/rQB2qG42n/iZKSO7QDH86VZr0ZAltJsHHKsn+Nc1HKzhtpb8WwKlimKs27cWPU560AdGL2ZP+PqzYD+9C4kH9D+lNmg03VMrKkbuQQQRtb/GsFL0wghSVJ75zUUmorIwW4jDdgT1B9Qe1AGwmkXOnf8AIJuSsf8AzxlyyAegHb8CKs2mrxsfKvcW84ODuOFJ9if61iWesXduwCP9qhHWOU/OB7N3/H862BLZawnC5cDDo64Zc9iKANeisFRd6Q+2CIzWO7LLnlB/se3t/Ktm1uIrqFZYHDIf0+tAEtFFFABRRRQAUUUUAFFFFABXLeM/FceixG1sgtxqjr8keeI89Gf29u9ZvjPxulkz2OjOkl0OJbjGUh9h/eb27VznhXQLnXZ3uZTIImfMsz8lj1P1P8qAKukaHqGu6i0l3JLLPIwaaZuw/oPQV6to2jW2lQhIFy2MFiKs2FlBYQCK2QIvc9z7mkvL6C1wsjjzD0QHk0AWqKz11FXUsMD0HWrFnLJKhaQAL/DjvQBYooooAKKKKACiiigArz3SW8jxRqli5yJpWUfRhjp+VehV5j4zYaN42s7sEqlzgnHc9P5j9aAOi8DuUn1G3YBWUo2B64Kn/wBBH51reJtBsvEWmSWd/GGUg7Xxyh/z2rLt2isvEC3qnEF6oAPYbsf+zfzrqqAPBJ7e48L3B0DxBvk0vcDbXg5aDJ4Oe6k/y7GvSvB/iCbfHpWtTRvckZtbpWyt0n1/vf561teJtAtPEOmvaXi4JB2SgAlCf5j1HevErr7T4Uu/7E8Sq72IYNBOhOYyTw6Mf89jQB9CUVxnhHxV9omj0zVpE+1MM2t0PuXadiPR/VetdnQAU2R0ijaSRlRFBZmY4AHqTVHVdWtdNCidi07/AOrhTl3+g9Pc8Vi28lxrdwPtOzy+v2ZW3JGP7zH+NvQdB+tAF8Xc+sMUs1kgsv4pm+V5R/sdwv8AtdfT1rSt7a3tERYY1QAbVCjp9BT0EdugUHqcc8ljXCeLdfe7eSzsJNtv9ySVD80h7qp7L6nvQAvivxgzSyWWiuCUyst0vO091T3/ANquU0y7CsY1+YnkknJJ9Se596WKzldNsKgKMDgAYqB3i0uRmnuIFO3k7u9AG29xBaxh5Cct+dZV3q5m5Qsq44C96yb/AFK0uFDSXERTjaynOKbG9kVUyTuSw4wDyPwoA04b8MAAqkju1Xbe8bgI3zH1rIjbTFkLFmIBwfkOK04rvSwEAlcH2jNAF034xkMe3ANXLfVATjDZ7ZqlFa2coLRTSYPGSpH9KtppGRujl3sD60ASSX8bYwSB35qNpVYDawJ6GgaRLLJkq5U+gp8mmzQxLhWxjjj9aAKhlaNiWPy55PpU8V6ZBuEzpKvKup5X/wCt7Vn3KSpFtwTnqcc1kTSOrEoWGD1oA9S8O+IftbG1vgiXP8Dg4SUe3ofb8qv3VlLA73Glsqyn7yN91q8g+3uSFkOAeM+o/wAa7Lwt4yKstjqkpLHiCdz98/3G/wBr0PegDtdM1Fb1WR0MN0n+shbqPceo96v1jajH/aFj9osXCXUf3XHXj+GsbT/GYSQRarbtGvTzowTtPoy9R9RkfSgDsqKgs7y2vYhJaTxzJ6owOPr6VPQAUUUUAI7KilnIVVGSScACvIvGXxC/tZ203w3cEWrMY5LqE5eU9NsfoP8Aa79vWvQPHlob3wdq8AYLut2Jy20EDkgn3Ax+NeLeEbiHT3hurLTUNq7LsE0eInOOgb+BseuBQB1Pgzwddai6S6lG9tZxH7hXDMe4Gf1Nes2sEVrAkNvGscSDCqowBWLp3iPTdWs0uYp2iQH54nG10cdUcdj+hrlvE3jU3QltdKYxQL8slwxwfoKAOg8R+KIrUyWlgyyXWOXz8sf4+tedvq7SSszStJcE53E8n39hWG2pL5kkaBvLzyT1Pua0vDGm3GsXwS2j3EnLNjCqPUmgDsfDrXF1PErEyFufTI/oK9ChQpGAx59ulUdD0iDSbURxZeQ/fkbqf/rVo0AFFFFABRRRQAUUUUAFcr8R9COt+Hn8gH7ZbHzYWHXjqP0/QV1VFAHmfhK9HiDQWtmK/aIsjaf4Wxg11vhTWxqMctnctjULXiRTwXXoH/x9D9RXG+NbGXwn4gh8QaYu2xnfbdRr0RuzY9D3qW7li1yeLVPD8otNbt1z5ef9YPT0P9elAHplY3ivw7Y+JtKkstQQEEHZIB80Z9R/Ud6yPCXji01d/sd/stNTRvLZM/I7+ik9D/snn61d8T6fAlrcX8rxKkY3t5rEKOeSST+lAHhKabqei6zcaBKs99axHfDPbtu8th0IYfdPpn6GvWNF1/Wn0aODUHgE6Lta4RtzsOxI6K2OvWuV8T+J2RE03RY4ZbmYkJ5SAIp9vp1J7VJounS6bYFbi4eeeU75ZGbJdj/IUAaszq0sjQnLMd0sjNlmPuT+FMufEcWg6TcXbMwJIZUQgFznAyewzVO9lSxt2muD5UMfOM4/E15/c6je+I7p/s6SRaegLF2X7yg4yfbPAHc8UAekaf4o1XW7S4julkUPt8sQQMXKY5C+7HjJIwB6mrFvps92CdOgMOwfO95G0ap7c9T9KyNJvJPDWnKzTiOQkQnexCb+uCR2GRuPrwK4H4l+KfGEl9NBbaXcwpK5HnMTJvx2RegXIz3oA9Z1NNPsoimra/BatGA0saEIqqe2cZ/GuI1fx54Q0KKSCwt7a9O7bK9wu9n98seR+NeD6za67ezg3rXVxPJnMZBB/KtvQfg34u17bNJZpp9o2MT3j7Tj2UZJoA2vFmqeDru+trvSDaWSOhMsCyZU4wc4H3SeePaubPi3T+IvtMaQ8LmOFuAD/hXpmifs5WsarJrOs3EvqttCIl/76bJ/Suv034K+BLJEMloblyf+W9yzc9umBQB87z+INJWZljklYsQfMCMCPpzTJfEmnBT5MU5ckYZWYf1r6y0vwH4SsWK2uiacpHcwbz+Gc1twaBpKuRDZW0eOjLZxjH/jtAHyJpvjtLAHbfaoPkwAZCwB+hrpNN+Jmnx+V9q1vV1HdlkwR8v09a+l20DSmcs1tCT72sf/AMTUNx4W8Ozxt9p02xdR/wA9bOPH/oNAHjehfEjSDYr5PiS7N2wIkWSdUHseR/KprnxwLi0SKDUrzc7ptkW7B5Pq3oDxiu8vfhl4HvnAbR9LLN2ERQn3+UjiuX1P9n/w3OhfThdWbt0aC63KPorf40AWYLOz0m2D6/4r1Ke4kbKrbyAovfliMHGeau2eixakDNZ+I4LhXBMRa3Hz+xIPP1FeZeJPgbrcEY/s3WluFj5jiuw0J+gPK1xyal4s8CahHDqFvdQ+RgpG4JhIB6gj5SPegD226sLxZpFnsLiJk5ZlXcje6sKzka1fdFNcQ7SACC+MfX0Nc1oHxwkjib+1LaS4kG0cEbQeOc16roWpaX4m0aa5061gY3aNuifbiXsckd6AMax8YXfh2+jsb754nbH2lpNpwR8pI7nqM1tXkiNMZI8nf82U55rir21srhWtdVtbuYBTEr7t/llTnaVxkkYzjPI6GtbSNSjnTyY5EZl4ynR1x2zyD7UAaEH2ZLxrsb4rjdkujlWB+orfs/EupWil0vY7q3A+7cJ8y/8AAhg/mDXPM4lVtwG4dD2f6+/86zpoWxJLZTmG8UcEHAPsQeMe+KAPU7HxakqBri0YJ/z0gkEi/iOCPyre0/ULfUI2e1cuFOGypGD+NeI6PBrWv25itbe3ScP5bzL8pjY9yM8cd8V6gt5aeCvCdsuqSoZIk27Yh80z/wCyOpPTmgDmfjw95/YmmxQXLW9nJcMbnaN3mBVJVcd8kdPpXnmgSvcqsd4ssEa/MbQqUEn+8p/PHSt7XPGki3Mmp6h5K3ygrbwscx2Knuf70p9O36Vx1hqOq6lunv4LmKzml8yLUJVPz9mAbGORg49qAOg1HVArTTDJIAWYJ/FF0GT6r29uK5nU9SZj5Y6rwqqevoa1bbSLl1luLW3ll0yMsjXqqdjHPQ+o9T0zWh8JPA93rNw2o6oHGnxyFYmkXBcAn7oPUe/T60AS+A/CF7rU4luUZI+rs/RR24759P5CvctI0u10m0EFnGEXjc2OWPvVi0tYLOBYbaJY4x0Vf5+5qagAooooAKKKKACiiigAooooAKKKKAIL+0gv7Oa1u41kglUq6t3FeA+J7LU/B+pS2fnAQt81rdY58s9j7jp/kV9C1m+INGs9e02Wy1CIPG4OGxyh/vD3oA8Ysb+zutENpeeR5qDzhdhQGQjli3qPY119lPt0D+0vELNc6eq7dO0+bG6RscE55Yn+EHJUGuZ8M+CDpmr6hJrU0LaNp7HLfwykDI3f7I4yO54rmvEfirT/ABpq2zVRc2SRSbdMuQ22NGHUsv8AeOOfQdKAOs0PQG0vzbu8hRLu4OSg5WNSciNR2Ufqa1ikkn7xRhgD8zccev8A9euftdZntZG/4SDzTNBF5jyL8+Yh/GuPvqfUcjvjrXA+JfHFxrqyLbO9npjHCxhvmkHYv7nsOgFAHc63NoFykba1rkVvAjfNEjZZ/bjp9e3b1qloXinwjILjS5ry5skMqyR3jEKCFPyqAv3QPQ/WvHdRMdzb+UFSOEDJfdknHr/gK5y+gQeQVZFjY4JB/r696APpS31zQxEbWzt7h/skLR2185WSKXcxbPP8We+K4bVE1qcLJqeoLexw58t94G3PUZJFeORXUaKqF1CkgDLdM06GSXf+4kcMeRtbhh70AfQnwS0m2vNb1bULhHkltIV8tJTuDMx+8OxAxivZJJZoj5UZG/JO6vkPwT461fwjqiX9okVzEQY5oPueYvccf4V9K/D7xvo3i22LaVcA3UYBkspwBLET1OP4gPUUAdQbXcsX2nzbh2PCtx+OK04rOVFAiigRcAfN/gKiMjMNjJ+8JB344UD1/wAKuxTSgYKNIo/jBGSfpQA9YZAPmdOTzhf/AK9PAAz+8Tn2/wDr0jkPIpWXZgkYI+9+dD7iQpWIg9mP9KAGAEsF86PaOw61I6syt5bRkdsjPNQyeUjfchBPHC81XMlsoOJAXHQAZx+AoAdc2jSbw0Vu4KjORycdqzG+zKzRmMxPgfcYgD6fjUt5fyKpaJdr4+8xx+lZSGV2wVZ3flnY4yaALjqViYwyGYY+aN+jD0rN1bSLC50nY8SvYXRCSW7di3GV9DV7alsoMswZzyUX09/avNvHHxX0nRUe3sp7e8v92FRGBSNgPvNjrj0H4mgDyvxBpvh/SNQurW6tYWuLa4aNtrMpYZ4Pp0x0ro/hveaLZTiPTAV1WaUpskiYQmIDcArDgNkdTXn0vijQ5Lu4vLqK9urqclnkLnkk88Hj9K2tB+KsOiWtxaW2mPNBMd21jjBxjII/lQB61emTxBOJLWxkW7dS7xLlQ+0kkBjxnuD2P41y2qWt/a3Au7IO5kXzcBCGkReC2B0ZT94fiO9chpfxW1KwuXnQXT7l2qgRf3Y9FJBP55rsLP4+wm2jin0W4SUKQZEG7r1yNo/SgDX0TVl1S3aNgEv4gDJESAGB53L6+tW1lW4fbLjzB91l43D0NceviLwDrkISa5utAvR8kbojKgHUfrn8607XUooEAuL211CEEKb20cFT6F16qentQB0kGq3Xhycarbx+cY1IdCcCZP7vsR2ryzX/ABpqWqay+o6pcM8j58lIzxGD2UeuP85r02IJOpt5D8jHK47j/Go/h34O0WP4hTSatBvcr5lnG4zGZB149ccgdOtAB8OfhhNrn2fV/FSvFZA+ZDYkn5x1DN7H9a95igihgWGKNEhUbQiqAoHpipKKAERFjQKihVHQAYApQMDiiigAooooAKKKKACiiigAooooAKKKKACiiigAooqnrF/HpmmXN7N9yFC2P7x7D8TgUAeVeOS0viL+z7e+kOl2jCR7bAC+c3OMjkgA5we7VzWr2lpdo8M8EZypLORw4HZx/wCzdR71fRZpGlubx2MkjGQ+pYnJ/r+lZ+oDzLC8B2lfuHPH1xjn2/GgDJ8MeJLP7A1hfrPqOgQtlXJxc6exyN2epX0Ycetcb418NJH4jlk0kx30QjWRSg2yNkZyU749qs+J9K1jQba3vdOLRXcR86NguQ6EfMnowII4PpXK/wBr3eo6gupQCO3nXAWNMhAADwM9P6UAZ9zBuxHsXaCFyf8AD86zdRjxHzgFTxjHQV3c0TapbNNqFpMJwu57q1XdIvrvXgSD3GG/3qpW3gd9TieawvlvrYEAzwKWRQf73dfoQDQBl/DWLSft1zca3ax3ARFjRZFyF3nG4j2HT61u+L/Bv9nbbvS1EllJyNn8Iqlf+Frrw5cLNbzi4AUklF3RzKDgrnuOMeoNdZ4V1q2awBkLPpMjeTIrnL2sh4w3sezfgeaAPKpYliDEMc8dDWr4Y8P6pqF1Hd6ZdCxdG+S4aQqdw/u45rq/FXhOOwuDKkfm27ndkNgEVv8AwulheNtNtEC31pP9qj7loz1A75U4P0NAGtpHxC8eeFSg8Q2Da/pm0Ez2wIlUD3xz+Ir0rwl8XvC/iURww3wgumHMFyBDJn0B+6fwNZs3inXVuPst9ZWt5aldpDp94+5HKnFcH4o8DaJq1095Dp89uxB3rG3zbvXIHI/DNAH0dbXsNwuYrqKQD+BuCKW7SOQESW77z/d5r558O+EvFOm2UknhfX7yPYeLO52yo30B56egqdPiX4z0G4MGu+HkutpwXtZHQk+uOR+goA92W1jXA8n7w4LN0p4McRK70GeCQcEc14g3xvDBYZvC2uGcfwIwYY+uKq3Pjzxzq8TnQdDttFtyDie9JllA+nTP4UAeyapfQWkMszMFC8GRyFVfqx4ryLxj8Z9I0lprXS2fVbojG2A4jB937/hXMy+Dr7XpTdeLPEd5qjk8ReYUiH0Uf/WrV03wrp1hGfs1miIoxkIMsP50AefarrvjXxkxM7PY2T5zFGSi49+5/GodL8A2p5vJpHJbHy8D869VFjHHyseTv6KuTz1rPntzEp2qckkZI7dqAMK18M6JYxABId47iPecj3NOjkjVSINyoCGB2gYHfgVPcrMwZHRkPDL9fT3qu6bQrHeqqwB46g9RigCxJdbYsifO04ZfLB/GptHuNMvJxFea0NPz1YwZAIrCmd40kVNxIOzkcfWtXw94dlvirPEWD/MFIwTx1J9KAOxh8G6dqwJsfEek6k7c+VNEqk/TNc/qHh6TwzqDvcaZDY3OwqkkfCsp657MPY1d1ez06KyaCGNWaJD5lzHxlsfdSoPDPi57/QodG8TlrqFk/dTyDLxHoOaAJNHK25URXC87WjQ8hT7Hup/SuoieWfbtkaK6TDxP6OOhB+tedanaf2HqDQ3pJteHRweChPJH55BrudLnZ9PhkZi00eY5D7jg/n1/GgD2fw1qq6zo1veBdkjDbKh6o44Yfn+mK1K878BX5ttbktGBEF8m9PQSoPmH4rz/AMBr0SgAooooAKKKKACiiigAooooAKKKKACiiigAooooAK4z4kXaG2tNP3EPK/nHHYL0z+JB/Cuzry/xdMbvxZeDdlLaNIFwOhxuP/of6UAYFwQroq9OuF4we39K5G6vbidka1j8yApIxkHPAbGf/Ha2NfvGhtL25OFCQuwPTBxx+pqTwZaP/Y9vBKM/ZbaEZPfdlz/MUAZ8fjhb7Sl0nWtO36eWxHdxqd8LDuB3x3FcZqnga7s9UkvdNMc9o+JJAncH+NB3HcjqK9ji0i3uYpIJU3RuckDtVnSNHXTDLbnL27nIJwdtAHlFpqmkmUR21vOIlQbhK24Mw7njg+1M1Sx0JEOowXuo6Zq0mf8ATLGEuMeksY++vqCDwK9I8efDlb+1GseGXSK9AzJEWzHNx0Po3vXj9nqL/b2s7yM2l7E2HhlG0ofWgDH0j4nQWXiiWz1yOzudNusRXU9oD5Jk6LcIhGUOOGXjOM4yK7PV4oLK+M2m2cSDZtZMbkmiI6N6gjkH8RWB4n8M+G9XST+072yt70jIuonCuP8AeHRh9fzo8FSXUVqfD93e212bNC1hewOGSWLkmJz2YdQD2yPSgDpNN1CCK0HmbptHdtmZTuezb+5If7vo3foea5/VtMuPD2pLqWj3BikB3RyKc7c+nt7VLPqQtpHktfIkfbtkQMCsqnqGHcVZj8i405DazN/ZLHYfNO57Fz/BJ6xk/db8DQBb0r4rlPKj8QaFHdTxDBltpthYeuDkfrXovhnx54d1pGW2uE0+VeXgviEJ/wB1ujV4d4h0m50ZpPtUDKsfJIGduehz3Fc5HrVkPknkjHYtjg/UUAfUv/CTaSrqG1bTXkJIVFmTJ/WtaeSO52SqY2Yjh9vUfU9a+SRq2lAFJLmMqeoA/wDrV2+ifFBrGxhtxqNjdwQALGtwTvA9Nw5IHvQB7gbQK5DSh29hioPssWTyc+vr9a8/i+MWntbor2dq0jcjZfbRn8V6Vnah8WXYKbK00yBmyC01yZPxGMetAHpwsFI3EnYDzx0/+vTxp2cscqcfKoPI9/rXnvh/4xaW5htvECQWkqkiOe1cyRfip5B9+a7uDxLotzFvg1jTnRv4vtSD+ZzQBIbGPKlowWbPNUru1RFwYwAOwpmoeL9A0yN5dQ1a0hQZxslDs30C5JrDT4geGLw7xr9nGpOQkiuhH1yKAJLiyDPu67uMelZt1EYyEWMO3Qg9q7TQjoevsUsNdsppXXKJDKrH6Feo/Ksu90W406+P22F7cLz5rnKgeo9TQBkWOhLNMjzxK8nXkfKg9WP9K1YZJb0va6WD9nzsmulH3z/cT2qvBKurgLHLLBpCnBCnEl0fb0Hqa6W3nSBBHbqiKVwiRrhVHp/nrQBnXmhQrYCMY8zGML2+n+NZdl4CRySLkKSd3K9K6XezybWJVu2K0bEbJckg46c0Acp4m8JP/wAI/cxtIJY4YWKMy9BjpUelskMMduyokiRR7wGyT8o+b8RXo91D9q0i6gcFxNE0ePqMCvF/thj8XabOwAS+01VfP9+IlW/lQB6BFc/YwlwmHktZEnHqQCA35qf1r1wEMAQcg8g14paTpIRG5ysqFDjjgjH+FereFbn7X4c06YnLGBQ3OeQMH9RQBq0UUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFeRzFprrULkFSk11MysDnI3ED9AK9bY4Un0Ga8Us5caZCzkk+UGOPcgn+dAHKePCD4fv1A+aTbGo9cvXaeG7LytI1JEkUyxSKG74Cqq4rivG0gOn28e35XurdWP1bNdJ8NdUS+1LWrcth7m4ukC5zhgeB+IAoA1LKd1kU4wp4rXWVnUgKT6e1c5HvilcYJUEhhWzp0qOFXPyDkcdPagC9Z3M+nsWiYtC/34j0NYWv+HdB1y9a51K2QsU8rfszkZ4J7/lW7JGSAyYyegFU7jMYbdjmgDyLVPgto+oXDJpxktps8MJ8o3/fVYWo/A3xPoJe90i7IaMHHO0kY7MMg59DXuDojYZRye9XLO/nsQFRiI8c87g31U8UAfF19od9pGoSWupRTW86YJVwQT7/AEq7oOp32i3y3VjMeV2Swy/NHMp6oy9wa+oPH/g6z8aadJhI4LoDMEyD/Vn0+h7ivmLU9Nn03UJ7O8BjuIHMbq3XIJoA9Y0PXtP1XTBC/mCzHyES/O9kT/A/d4SejdRwDyM1538TfAj6Ncvf6ejmzJHmRD5vJzyCD3U9jWZpd/NpeoxXdq3zKSpVhlZFOco47g+lep6Xq9tqOiYVyunL8r+YdzWDN/A396Fj0PbvyKAPBFt1QAployOo/lThEhUFV7d67fxp4Sl0W4ku7OPFoSC8Y58vPceqnsa49h82Q6sT1B7UAQmFGjyykHGP/ripltB5YXbnHqaIm3LzESoJyT61ZjHmYy/T14oAg+z7FzgKF55NMESMuCuD2yCKvmNAxIwzBRgA9WpkQcylcNjvQA2CFhyoyT/ER+gq3ZaZPqdytrbpukJyxJwEH95j2ArZ0fQ7nUjthCRRRDMs7/djH+PoOtel2Hh+w8P6ZFLqMRzKQ0VoR+9uG7NKOw9F/OgDmtM8OWuh2a3Su6FRuN2Btkdu3l91X36mux8LfFrU1u4tG8R27axp8zCNDJFvmXP97HXj8a4Pxj4le5v/ACbdlku2YLlTlIOwC+re/aur8DeG5b/xbZG2ysNk6zzzMOC3933J/lQB7nFoelS2kV3pTOiMgdYWXGxTnnB5AyKyZUVXxjqOMnk10EyRxCORUAkjXy1YcEL6fSsm5Jdvu596AKCyMiEgcevUmrttJnPGeKqEZbaB849+lOEpWQIeP0oA6/SypC7umORXiPjiIWet6S4LBIdTu7YkD+F9rAfmxr2DR5dxOck479BXlPxLC/2vaupPy6yCwH+1Ev8AhQBvW6iIQheGDHk+lep+Amb+wTCw/wBRPIg9xnd/7NXmEUZcRsPmJYgcfSvSvATH7FdIcZ8xXx6ZUf4UAdRRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAkgLIwHBIIrxG0bdp0QOATHjIHQjbXt9eJRxmK0mjAGYZJUGf9lsf0oA4zxrIyabG38MdzA5z3wRXP/DfVmsfHWtRq+GW5e8iUnuHww9+CDXQePFxoDuvVdr5B9GrzDVryTQ/H0moxDcIrjzmVf443ALD8Q1AH0Nr7iHUHaDPlSYlUjoQ3NQ2lwY5d4zsPXA6VFBPDf6NaywuJIVQbGB+/G3Kmq0b+WzjoQevtQB1cF2ssRIzuHAPWql1OWUlW5PTHUVmW90EX5eA3cn9Kvl0aMPyZSM/Qe1AFR5sMNvDA8+pq0krO4G0g55pbeAlCxwF5y2MH8BUpwcCLKJn+LvQBq2BAZU3ZQ85A4PtXj37R/hlYb6z1e1h3QSx7Z2UdCD8rH8wM16jYPltqkAZ4AJ60eOFt7rQrOO7XzImZ4Je2Udefy4P4UAfHVxmOVeQVOeD1zzzV3T9Rn0y4S5tT8+CrqeVkU9VYdwfSr3jbw5d+HNUdCvn2+SYZ+xX0PvXPiUEnBHzDp2oA+m/hFbW3iXQIbg2SPEjGJfOUSC3jU8qAepJPU9FxXoF34B0S7lG7QdGMZPy5tUyR+X8682/ZG1KNotf0iTG4FLqMH+6Rtb/ANlr6EvUKpujByvPB7UAef3Pwn8HTx4m8O2Kt1/dJs/UGsS++D/gtQVXRcEfxRSsPqPvc16hHejAAOSwwDjvVlYxPyWBZeM46GgDwu4+DHhstI8EF5CAchRIRj+dcvq/w98PabIwQXbSs4VERg7Ox6KoxyT/APrr2zxj4kg02SPTNNjN5q1x8qxxdW/wHvXn+oXp8O3my3aPVPGNwu0bOYdPU9l9/fqaAM2LT7Hwdb2/263jn1c5e10xDujtif45T/E/ueBR/wAIHqvieKS6u9Qa1uLknfN5ZLlT/CoP3V/U13HgTwOLQ/2nrjfadTm/eMZOcHtn/DtXpNrCiIcFRnjgYoA+aovguNH1GKU3q3YVgyx+XtIPq3sK9P0LR4dLsoreKMJ5Yy2PvOx6sfUn+VdpcRxG4diMAEucjqFHA+mc1zt9LvkLE5Jbk+tADJpMgqx9c5rMlkLELGOTxz/npUs05LFWOWAPeqUmAcPwSMfhQAvLOEjGUHJI/ipj/fzjGWwc1ZEZjBRQC3Qkfw+1V5cFiud3IGQOlAGvor7Acd+MdTXlfjq5a71Ndhx/xPRFkDptiX/69ep6Moi3SMRgck+wrxWyuxqK6ZcYBN5r9zOD/sqooA9OtwfskAVRu359+MV2/gHCz6knOQIc5+jf4VytnsaONNoC549T0rrPASfv9YfGB5qIPoEz/wCzUAddRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAV5BfR+RrutWjLjF4zcf3XAcf+hV6/XmnjW3Nr4zEowEvbUEerPGcED/AICy0AcD4tsDcaLcLjJ2lRxz0/8ArV494thEn9k3w+ZbuyQn/eQlCP0Fe+6rC72bbh74HIPcf1rxLxNakeHrmH5t2k3zADHHlTDIP/fQP50AdT8EtTF1pt9olw/+kWgMsAP8ULHkD6Hn8a6mdmjkDEcDKsDXhei6rPoOsWOsW2d0DZdBxvQ/eX8RXvV75V3BDfWbiSzuYw6P2IPI/EZoAIGLAdC56Z7VrQSiHJYZGcMcelc3CxhffyRnBAP8q2radZkBDYz3/pQBt284kXAUCM9MU+8h8wFgxUn+6c/pWZZymJwvAyeuetbaAPGMcCgCKBSgBVQcdwP0rn/GOpyXMIt4QcWqM7nHBOQAP1Jrr7SMlSFUY9QaoeItKW8sJUtf3Uz5JwPvHHf1zQB5lJJb6pZiG8ijlwcbXGc+30rgte+H8FwssmiSNBMvP2dzlfwPauo8mZJ5PM3BlyvHqDVqB9x3lmBHFAHK/AG9utA+KlhZ3AMEt1utXV+M7hkfqBX2ejbnwTlZF3L9e4r5b1LTbWa5stUCA3VnOkySLweCD/SvopbxL2z2wOY5DtlhfPZhkf1FAFu+hQbZFIUd8DivOfiJ42uLJBYaPE5l88QO4fG6QjJUewBGfriu8k1J54FtbFYp7xlxIC2Fjx1ZvaubsPCMVhPd30ssN5czzm4VJ1KwxMRglRySeO9AHnn2/VrK4Ft4c+xahqGooBcX0cTCSHnheTx3+X2r0XwP4Aj8P2wubwrLqMh8yWVuSGPv3P8AkVJbaPYWN4brTpjYTyEmTysOGY9WAboTV271q6sJoo7uQS27Yy7LtZfc9iKAN4JyML82Rg4J4p+oyiz0uabA3KvHrmq9jqEUvlurZRhkEEEN71na7qK3PlW8OWG8PKyjIRVOefrQAts0kWlXc08itO37pfp0Nc/O21PvAA9hzT3klkiKSt8gJIjPXrVO4ZtwU8Eds9aAK8x+clhtB5zVVdzSZY849KLp2J2gepAJ7etMidt5AJ5/M0AW2IjjCoQCepI61TmGQVBJbgYFPllAKFecHnBzS2ULz3O4qQO2fXPU0AHiq7XRvAWsXqtsMduwU/7RGB/OvHvBsDInhKAk58u4uSP944BrrPj9qyw6DZaFA2bi9lEjqD/Avt7nFZXh+DyvE5hVTs060itufXAJ/UUAeqadETLGQOjZGR06D+ldt4Ej26Xcyk5MtyzcdOAF4/KuGspGjt/MYE7FPOfb/E16R4VtWs/D9jE5y5j3t9W+b+tAGrRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVxXxStT/ZlhqaEhrC5UsR/wA83+Rv1Kn8K7WqesWEWqaVdWM/+ruIyhPpkcH8DzQB5m3NrhgCAcc9j1H9a8r8c2K2+siJ/wDj11SB7V/+ugO6Nvzx+telQM76e8U5C3EDmGXB6Oh2n9R+tc/4t0tdb8OyQRECcEPE3dXU5HP6UAfPciSIhjlUrImUdSO4r074KeIYp4p/CmouNy7ptOYt97P3ov6j8a4/xRCs91FqaI6G7ys467JlGHH4nB/GsQq0ckU1rIYruJhJFIpwVYcg0Ae938ZhaVVUL7Ec/wD6xRZvtjV1YHPXA71V8LeJLPxrpSRki38RQDFxBnAk4++nqD3HarNuot3aORcYO1lxjBoA2LS4DBmcfMBita2uAY+MgDrXPwlVKgHB57ZrVhYncQPlPUA8j60AbFhcAygBztzzntW0UjK46k8nPb6Vg2sS5D52++eKvJdFRk7m6c57UAcp4t8LmQm6sIXJfieFBuZT/fUdcGuetPDV9fRKtpCu8HDmU+WFP4/yr1GS7Ep3N98dGxgiqMk6LIWjjKv6jrQBwU/hHXLGH/jyF0P4jayB+vqtd3plrqt/ZWVrLbNp8ccSRySzHDvt7KoP6miLU54C3l/Ln7zHqfxqK41VnVn8wlgc+9AHYw3GlaNa+Raru29VU5LH1Zu5rnL/AFOS7keTHlqeMDoKwRdGVvnJx6A1KWbyQXceWCcdt1AEhuJXfkYiHfPUVtQ3lpcWUcV/bsYkyFI4fP1rCDbzvnTCD7ka8VYR2fcZiR6UAPu2sbT91pcTLERn972PpUqX8jwLE+EjVcBEG0Z9TWdOju7PHgnPcdKjyxPPBPA9qANMTbnOTzSXS5Xfn/69VUIQrzzkZpJZww5xtz3FAEZAPJxnPPuKrTMQ4WNckn8KnZ12kJ25wKrSN82wAc96AFBJbkjc3p2rdnaHQtFkvr9ljSKIyuT/AAgf403wxpiyb725UG1hOQG/jPYV5X8f/F8d2f8AhH7GQM7OJb1lP3cfdj/rQBxmmai/jHx/LrWqDFpDuuGU9I4Y+Qo9M8D6mu/8FReek15cIfMvJmuSO+D0H5AfnXH+F9NNp4eSzCbbrWCrsvdbdD/7M38q9V0m2S02KuG6Kq+v+T/KgDcitftXkWaht0zJESO2SC39fyr1YAAAAYA7Vw/gi0M2oyXTg7YF2jnqx/8ArZ/76ruKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA808a6eNK8Rfa4wFttTBD5HCzAY/8eXB+q1zs6eWSoOFkGGx6+v8AWvWPE+kR65o01m5CyHDxOf4JByp/Pr7E15ZEsssEsVwhiuIGMUqHqpH+fyNAHmXiLSdmpT2rqFg1QgRt2iuV+6fYMMg15zLaTx3M0dwnlyxsQYyv3eoPNe/+ItIi1bTZIpAQ2MBx1VgeGHuDXlfiW0nv0lunGNXskWO9A/5bJ0WYDv0w350AcYHmt7iK4s5Gguo23xyxthkI9DXpPh/4kJqPlWXiqJbe8A2pfxjCSf8AXRe31FefTxgxbgMnPzADpVWQKdu/p0GaAPoy2GCFc5U4IYchh2IPcYrVjjBcFAQ45DYIBx2rxLwb40uNEEVjfK1zpa/dXOXgz/c9vVT+GK9k0fVrfU7NLqxnSeGTOGXt7eoPtQBsJIVG18A9vQ0pkBUbT9SOtQxlZVw2OD97pUTllj2RtvzxQBZZXPKk49OuKax4++M98/zpsU2VPHI4IqCWTDggEhgccUANuC2QCc544FUZCBJx3yOauBiw5JUelNS1DSB5DhByR60AV4E4zKDsHPXrWop482UEDoq+1Rqd43MBjoMdxQ6+ZuyT5eccUAOJSQl3yFDZx0/D6U6RjK5JwFHv+lJgDYDjA4AIp+EVjjH59KADbhQMZJ6iqczY4GfWrTyIFOACR2rOllG7uW68daAHtINqszEfT1p28MvyLuBGBmqFxOxO1Vz2OaSKTooDA55AoAubXjQEfMeQOO1XdPsTd3MYbgEbnbsBUVnaTTttUHb3OcYrD+I/ju28GaabWwKS63MuFTqIgf42H8hQBN8X/iLB4c09dJ0Tb/aBXaoIz5IP8bf7R7CvCfDGmyazqjS3ryeRHm5u5Tydg5JJ9T0+prMVLzVNRM1xJJcXk7biT8zOxP8AOvTdK0NYfJ0Rcuq7ZtTkjOdzdVhB9B1NAHQ+FbBpVn1m4h8qW7A8mLHEMKjCqB645rqoVMMZLgl0XgDr/nt+NOhjLsqncoVc47Adq6Xwbpv23VGmdc2toedw+9J1C/hwT+FAHX+GrJ7DRoIpgBOw8yUejHnH4cD8K1KKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK4zxvpBikfWbRGY7Qt0iDJKjo4Hcjv7fSuzoIyMHkUAeOzhUUSq4ZWOcjp9foRXH+LNMlDxalpKqb2FiUV/uyKeGRvYjg16b4q0Y6TcGaFANLmPXtbuT90+iHt6H8K5OeJo3ban7vO1l6kGgDxHWdJijh/tLSgYrORik1u+Wa1k5+Ru+09jWDfxuYWCpnjj2NeueJNEfzXv9NRDcOpSa3b7lzH/AHWHr6Hsa4DUtMWOA3tmXexDBHR/9ZbP/ckHb2PegDnoZEkgHGGz19CK2fCPiC68Maj5sDmS2kI82EdD7j3rMMUcdx6CTv6NUE0YR1BPyk/hQB9JaBrdlrdmtzp08ciE/MAeh9COxrTDbz93v+Ir5g0u6vtHvFvNLuJIXPDBejexHQ16l4a+Kaxsia9AFxgebGvU+4oA9RSMEc44/iH+NRyjBPQrxik0rXdF1jcbDUIN+OnmAZ/A1oSQYRQQDnkMOhoAxZJMyMNvA6U1JHzuAJ7Bcda0JLM7skHHXrS+QBtypGOOlAEcW51+7hR0zVhdqLtUBcdafDblyNyj6DirH2MgtuK+3tQBn3Df3AcfqagLvg5BCj074rUuYAkeFPOeoHeqS6fJK2WJ3Y6//WoAzprjYMgH14qizebv2Abq3jo0kpy8qqOh6mpmj8N6NEH1S+i3j7weZUH+NAGBa20s8gjiiaSQ9lGSa6jTvD32MLLqjBGHSBOXP19K5rVfjJ4Z0aN4dEja5lHH+ixHB/4G39K8h8X/ABU8Q64s1vEV06ylyGEJzIw93PT8KAPSPiT8ToNID6X4aWGS/Aw8qYMdv2x/tP8AyrweSKfUL6S6nmM8rnLySHJJJ5NO062lmdIo42dnO1VXlmJ/nXaafpj6TeRW1usV1rxHyxL80dn/ALTnoWHpQAmmaZJpJhgtkLa/cL8oPP2KMjl3HZyOg7V6X4d0dNNtIoouQh5ZuSzdyfUnrVbwr4XS1jeSWRpZpDvnnb70rdyfaunaPZOiWyl5HYKioMnJ6Ae5oAs29tPczR2NkAbqY5LdkHdj7D09a9M0fToNJ06GztgdkY5Y9Wbux9yeazvCuhLo9u8k2x7+fBldegHZB7D9TzW7QAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAR3EMdzBJDOiyRSKVZWGQQa8y8R6RJok4R1aTT5DthuOuwn+CT+jV6jUdxBFcwPDcRrJE42sjjII96APEbi25IAPBHB5zn/P41zWr+HTPM9/pciQX+Nrq65juF/uOO4/UV6b4q8Py6W5ngDS6WeWIBZofZsclPfqO/rXPuu77jKQQDuJyMe/t/tCgDxTU9DW5nki0+0kt71Buk06Q5bj+KFv419uo96wRHnIIzj5Srevpz0Ne665oNtqtviYFZUO+N1OJIznqrD+dcFr+lTxyBdagMp3Ef2pbp+8x282McN9RzQBwKIoyGUpk4AY9P8adPFukjjCq5Y5xW5faJNbwpdr5NzZSfKlxG26Nvx/hPscGsyzRrZj5qZLH74OePSgCu0BydqAN6EdOtWoL3ULLi1vriPj7qysMfrVweXMqtG27dwTjr9KFtsyDaBtOec0Aadt498W2+xItWudq8fOFYH8xV2P4m+LkX5ry3lXOcSWyfTsKyfs0ax5LAsBjuKgMa4Zg2N2OAaAOps/i3r0EwN5Y2V2meQuYj/WujsvjjpaKft3h67WTHSKdWX9a8olh4JGcD19KzpfKBUuVAY0Aeual8bZJWddM8PBV6q1xN0/ACuZ1L4oeK7tCIbi0s0HaGIE/m2a4mSSMjEYaQ8DlxgUscCsoZi2484B4FAF+817XdRy93qt5IrdR5xUfkMCsyWAbg8igkclic5q5FCxdmYsBwAvce9X9N0S81GRlsbaac5PzD7i/UngUAYm9QuIiDnjGK0tC8N3msGV441W3Q/vLiQlYoh7n+ldHa6JpVhIi3sn9raj/z5WT/ALtP+uknT8q6WPTbnWoIk1PyorCM/u7C2BSFPr3c/WgDC0u2RCLXw3G5YgpLq0icn1WFe31ruPDGjWunRCKCPDE/vJCcs59WNWrG3jt4hFGuIwMDjHHoK0rFGnuks7WJ5buXOyJO3ux7L7mgCzG770s7SJpZW4VFHzOf6Cu+8K+Gk0r/AEu8YTai45b+GIHqq/496s+GNAi0a2DPslvnH72YD/x1fRf51t0AFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUABGRg9K4fxH4TeISXOiIpjAJazHHPcxnsf9nofau4ooA8eijBR8sfkJQqeNremOqn2qKW2jmby5Vyp7EYx716T4h8OW2rqZI2+zXuOJkXO72cfxD9fQ1wV1b3WnX622oxBLog+W+CUlx/dboevQ80Acre+FJbaWa40GRbS4YfvEIzDN7SR9PxFcRqdnpMkhh1e2fw7qHaWMGWxlPb3Qn/ACK9uWJsLlRGG4wTx+B7fSsbVI7eVDHcRRzKw2lWUEZ9waAPKIPBssaea1wslmRuS6sybiEg+oByv1IrRl8NqgZba6lkuQqsI3iGGVv4gwJyOvNd3pWhWWky/arK3NlJLgO0CFQwz/Ep+Xr6Yqd7TS49WN4Y4GZlAaI5jBIPUjkE/jQB41qkF3ZzmJ4mUY++nII9j2rNmmkIURFy+edw4WvbPE0UBjLaNolhdMxJlWZwgHfgjI69q87vzq9wzKPDmiRkHGIpsn8SKAOKmRy2+abBI+4uQKfaWL3ORb2kk5bGdsZauogbW2YRxQ6NZkdSkXmEY9SRWrFaeIrjzI5tdkiVWCEW0Sx849/rQBzVt4Q1Zxv+wfZ4mGd0xCAD15q2+h2Fso/tHXrC3H/PKDM0n4AcV1EHglG3SajdXl4QMlp52K/kMCtSw0PSLEI9vbwxBgSSqYJx3J7UAcnZwabC4Gk6Jc6hJjP2jUm8uM/RF61uy6VqGqKI9Uumjg6raWw8mH6EDk/jWxo9pd39qzySLZoJGTEaZc4JHJPTtXQWtpDbQrH88nP32OST6k0AYOlaJDbQgQQrn2AAFaK2CxgySsAg564FdDY6RfX8g+x2rLGf+Wsh2oPx7/gDXUaR4QtLZllv2+2TDkKy4jU+y9z7nNAHJ6PoF7rcatCn2S0Ix9okXlh/sL3+pwPrXoGg6HZaJbeVZx/O3MkzcvIfUn+nQVp0UAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVDd2sF5A0N1EksTdVYZ/wAmpqKAOD8TWcmgwG5aQTaUWWM7/wDWQFjgc/xLkgc8jPeuN1re3lrExBz2BO7HT613vxJuBNY2ejRYa4vpldl7iKNg7N+YUfVq8z8eWl5LdabBYuI5pLlRwfR1GAO/agDThmMQAFwikDOchCT/AN91XmuJnHTzD34D/rz/ADrqdf0qztdM16aOygDRW7eS+wEgj5d31yDXnfgfR4J7/VBdfMsTrBAA+35t4wR+AP5mgC55nnIwCR5OVyByPU0R6Eski7j5Y6Mg43H3PU/Sn+Fr6K91nX4l/eQ2Vz5MJclmK5PX8RXU6bb3ep6m9rpcUTNEoM1xJ/q4s9uOSx64/OgDlxYpDZ3NrGijYHCjp9OOpqqLG8mjMhWExuY5lOCATjp7dAa9NTwPdOQ0uqRRsTlvKtuT+JarNv4DtAuLu/vJh6KVjH6DP60Aeb2umBGke6vDgk4LN/Ceqke559qvWmknUDc21tDcXURdWVol3deoLngcj1r1HT/C2i2I/c2ETt/emzIfzbNbKgKoCgADoBQB59pXg2780vPHDaoxyys/mMTxzgcZ49a63T9BsbMqwj86Vejy84+g6CtWigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKjuZktreWeU7Y41LsfQAZNSVja+XuGgso1yjsHlz0IB4X8SOfYH1oAw9LtJLy4uNYvk8u9u8BUb/AJYxgZVP6n3rjZo21b4pWyW7hF0iBZRuG4GWRsAY9sg/hXqE1pKsZXeDwdzEdF5z+Zrz74b6eZr++1B3ZZr6+Dgt1McYYgjPqdo/CgCx8RruTTPBV8ocSXdxut4+xdUPXH4Max/hZEp0G3kkjYz3WqgNJg4G1c4z271H44hlmluppY1mihgCR7s5UNIxJP8AtEKeR61teGbRbPwHpCO0sbEy30jRj5gwyR+WR+VAHDeFbBbfxlr0UTFcyCR1ySNx3MOfXBr2vwNAsOgqwA3yyyO59Tuxn8gK8u8B7LvU9WvgCBdXzFc9SoUAA+nGK9R8EgjSJQeMXMuB6DdQB0FFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABTFjVXZurMc5Pbin0UAQX0TT2U8SHDPGyg5xgkVW0rSoNNs7O3g+7bpsBI5Oep/OtCigDhfGvh1pbSd7XdIZsKQe2F2KPflia09Z0ZLDw5fDTw/mrZtCvzE8H7xA7dM10xAPUA96JFDoyN0YYNAHmfgTTWg0qylZMNcAzOSOSWOf6gV3fh+IRafwu0s7MfrnH9KsafYw2NrbwQg7YYxEpPUgf/qqyAAMAAD2oAWiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Three sclerotomies are made on the outside of the eye, one that allows fluid to infuse into the eye, and two others that are used to introduce instruments into the back part of the eye. Using a light pipe and a vitreous cutter all of the central and peripheral vitreous is removed and all of the vitreoretinal traction on any of the breaks excised.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Wilkinson CP, Rice TA. Michel's Retinal Detachment, 2nd ed, Mosby-Year Book, Inc., Louis 1997. Copyright &copy; Charles P Wilkinson, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_36_11840=[""].join("\n");
var outline_f11_36_11840=null;
var title_f11_36_11841="Indirect inguinal hernia A";
var content_f11_36_11841=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F67349&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F67349&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Indirect inguinal hernia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 329px; height: 331px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFLAUkDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pooooAKKKKACiiigAooooAKKKKACiiigAooooAKK861DwNqWnanLfeGPHGr6feXk7H7LqUn260IJLskcLEFDxwVbgAjvws3jbXPC3lr480ErZZCHWdIZri2XAO6SeMqHgTpz845PPGaAPRKKq6ZqFnqthBfaZdQXdnOu6KeBw6OPUEcGrVABRRRQAV478c/EOt6X4t8E6Zo1/q9tBqSaiZ49JgjmuJWiiRo9qurdGPP+yT06j2Kqtzptjc39nfXNnbTXtnv+zXEkStJBvGH2MRldw4OMZHWgDw66+KHjfQoNH0S/0S0uvEyaQmpXyzHYZiZGXYoTCqdq5ZuVDHGK1dc+Imu32m+OntNOs4NK0K2LPMt7JHdEtbCVQm1SAQWwW3D2Br1LW/D2i675X9uaRp2peScx/bLZJth/2dwOPwp/9haR5N9D/ZVh5V8ALtPs6bbgBdoEgx83ygDnPHFAHjdh8SPEemat43uL/wCyXmkaLpFnfW9lvImzJAz8Nty2SMuWJ24yO9Ty/FvXLSG+tZdP0a81OC502OOW1nf7My3mcBjglWXHvkHOO1et/wDCP6N9uW9/snT/ALYsH2ZZ/syeYIsY8sNjO3H8PSorbwt4ftbIWdroWlQ2gmW5EEdnGqCVTkSbQMbgQMN1oA8mvvi9r2nWc9le6Tp39ux662jebC0jWvEQkD4OGLEHaFyMnnPaqmv/ABp17TtDtJ10rTY9Xispb2/09y7lESZo96uCFVW28A7mycbeMn2e58O6JdW95BdaPps0F5J51zHJaoyzyYA3uCMM2AOTk8VUm8E+FZ7e2t5/DOhyQWyskEb2ERWJW+8FBXCg9wOtAHLfDXXr3W/H3jsXE87WUQ0yS1t3cssAltFdgvpknJ9TWVbfFDUp9N1vW5m8PWGj2Ut7bR291PIbsPAGCs6qD1ZQSgGQpzk16lZaXp9hPPNY2NrbTXAQTSQwqjSBF2oGIHO1QAM9BwKpy+F9Al1G4v5dD0p764jaKa5a0jMkqMMMrNjJBHBB60AeRaV8ZtZ+yaxcavpNksGj3uni9mjLJttLosPNCFmwykKcE9G5xipR8Qtb1d9Evra2FlLqWk6pe2aGdxHsix5LyJjDEjDcjjPvXqtn4S8N2Nnd2ll4f0i3tbxBHcww2UaJOozhXULhgNxwD6n1q7Ho+mRy2ckenWSyWcJt7Z1gUGCIgAohx8q4AGBgcCgDxG3+L+u+HfAHhnWfEtvZaiuq2ExS4tc7mu1iDxRyKAApc7gQo4xxXuWlPdyaXZyalFHDfNCjTxxHKJIQNyg9wDkZrnNV+Hvh7UIdHto7KOwsdM1FdUSzsYo4YZZ1BAMiheRznjGeM5rraACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAqQS3b6hdRzWqRWkYXyZvM3GUkc/Lj5cHjvmqUkTxXba3e3F9DHBaSRPYI4khI3BvM2qu5pMLgYPQkYzV/UVvGtGGnSQR3O5SGmQsmNw3AgEHlcgc9cU9rhRdrblZN7IZN2w7QAQMFumeen1oA89fwHYatqbeJ/DjXPhnWJlWSK9sjhLxCuVFzbsAGXOMqdrcfeHZ2meOdT0PVF0r4lWNtpKyN5VlrcMubK+fBJBz/x7uQBhXPzENg8DPcxrc3MFzHdA2+ZGWJ4X+Yp2bkcH2qj4g0qK+hvFvLaXVbO7iS3l02UxmEruJL4YDnnnn+EYGRQBtKSc5GOeOetKPevLLW7l+FWp2ul6jcy3PgW7kEVne3Epkk0iVuEt5mPP2c4wkh+4flY4w1ep0AFIMgDPU0tHegAoPtRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVS1XVbDSY7d9Tu4bRLiZLaJpWCh5G4VQfU9qu15x8W9T0rUVtvA9yllcXmsRtLOLoAx2VmmTLcsf4GChhGxx+8weimgDtZ9GsJLjTbmdJGl013ktnaZ/lZ0ZCSM4bKuw+bOM8YrSrwDwT8Qf8AhEDp1p4k1C71DwNq5eTRtX1Qk3luisFH2pSoPlO3McmOAy5wDhPcQssmsmRL1xbwwmOS08obS7FWV9+M5ABGAcfNzyBQBBa2uqjWdXkvL+OTSp0iWygji2yW5CsJCX/i3EqR6YqxpNidL0ixsI55rkW0SQ+dcvukkCgDcx7sccmqi2Uy2F1a6vqdxdC7uZPKkiU27xRsxKRK0eCNo435yccmtN5WW4ijEMjK4YmQY2pjHByc854wD0OcUAc/qejadreq6zYarocktpe6fHb3F27jy7iPdJ+6ADbgy5J3YB+YYPArmfhpqs+hatJ4D1m8a8a1h87RNQcD/TrJcLtZgcGWJso3QlQrY6mu/jS5t5bSCBVltArCaWaYmRTxtxwd2ec5Ixx1rzz4m6G2n+GjrvhjTlsdW8ItLfadnaIpo2XdcpsG7IeMyLyA27BBHWgD0+is7w7rNn4h0HT9Y0yTzLK+gSeInGQGGcHHQjoR2IIrRoAKKKKACiiigArJ0bxHpOtahqllpV6l1Ppcogu/LVischGdm/G0sO4BJU8HB4rgNS1bUviT4gutC8LX8+neFtOk8vVNZtWHmXcuObW3b+EDILSDnOAMD73oGh6JYeHNBi0vw5Y21na20eyCBcqucdWPJJJ6sck8k5NAGrRVXSmvW0y1bVY7ePUDGpnS3YtGr45CkgEjPqKtUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAYvjPxDb+FPC2pa7eRSzW9jEZXjixvYZxgZIHeua0j4paRPNdQa9a3nh65gsV1PZqBjKyWrHAlR42YEAkAjgjPTrW/4/wDDn/CXeDdW0H7V9k+3wmHz/L8zy+Qc7cjPT1FcNN8IH1W01L/hJPEDX19PpA0W2mt7MW8drACGyE3sWYsASS3qBigDutS8ZeHtM+2/b9XtYPsUUU04dsFFkOIz77iMADk1hJ8WPCcviXR9EgvZZbnVFYwyCIqisHCBHDYZWLcAbe3OOK5tvg7fXd1dX+reKzdasxsJba5TTljWGW0ZijGPeQ6ndypx9fToG8D61P4m8PeILzxLBNqemNOkxXTQkc8EpTMaqJMoQEwGJfr04xQBvw+NPDk1rp9zHrNn9n1CKae1lZ9qyxwjMrAngBRySak8MeLdE8Ui4Og3wuxAEaTEbphXztYbgMg7TgjIOK830b4L3enJpNtL4pW707SbXULSyt5dMQ7Euk2ned+H2nk5GGAxgc56f4WfD6TwKNRD6w97Hd+Xsto43it7faCMojySEE55w2OBgDFAHfUU2aRIYnlmdY4kUszscBQOpJ7CuX/4WP4H/wChy8N/+DSD/wCKoA6qiuV/4WP4H/6HLw3/AODSD/4qj/hY/gf/AKHLw3/4NIP/AIqgDqqK5X/hY/gf/ocvDf8A4NIP/iqQ/EfwOP8AmcvDf/g0g/8AiqAOrrhPib8PLPxikN/aOll4kskK2t7tysiHOYJ1/wCWkDZIZDnhm7FgdH/hY/gf/ocvDf8A4NIP/iqqTePvAomnuLbxb4XW+eHy1mbUoMYGSoJ3dATnFAHiumX0+qHW9I8W7tD1iOI/8JVezoEzYB9kNnYKCf3cgKjIxkvkb2YY6/4Y+I73wT4lsfAviiaKPTtTje68OieZmubWAufLs5wRw4XgckAqUBb5QHfFWTwN4w0/T9Ts/GfhO38YaMyXWnXh1GAoZUYOI3BfmNmHf7pOeeQ3nGjeKfC/irw7qS67rEWk6fdhJvEE01xHJqmq6gCpjS3VSxFtE23YVAGFAwBvagD6qv7e4l06aCyvGtbllIjuCgkKH12ng/jUkj3IvIFjija2KsZZC5DKeNoC45zznkYwOtedfCrXtY1zR9R8LeLzPY+LtESKG9mgdT5qSAtFMjcgkqPm/wBrPAzgeg3hlnguYLG5igvAnyu8fmCMnOCVyMjjpkdKAGywQTpe2SCSAzITLJCTG2XBXcHHIbA6jkcUlw1yunx/2R5E8qvGubiVtpQOokO4Akts3Y9WxnjJq9zntWfbXCXVrDfZuLOGIyFo5lEeQMqS4PQcbh+BoA88+E9xD4d8X+LfABkkCWNx/aemRvFsH2ScK7LHgYKpK7Ln1b2wPU68h8WfaNK/aA8DeILaeBtM1rT5tFmbIOQA08eD/tNtwR6Ed69eoAKKKPpQAV5n8RNXvfEPiW2+Hvhu4ltp7mIXOtahAQHsbLptQ54lkOFHBIUlsY5HX+OvE1n4O8Japr2onMFlCXCZwZH6IgODgsxC57ZrmPg7o15o3h2O+18NceJfEUralqNzGN6qzDMce7HyqibVC5IB3beDQB0umaYnh7TtF0nwnp9jFotu5hlTzSvkxBW+ZODvcvjJY5JLEkmtS+uLiCayW3tGuEmn8uVgwXyU2Md5z1GVUY/2qW3t2gjnigSCCIsWh2L0LcsWHHO4k8daZdWct3phtJrqaOR0CvcWx8p9wxkr125x70AXOd3QYx1zS1A93bpexWjzxLdSo0kcJYB3VSoZgOpALLk+4qVO+c5z3oAdRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHzdqfi7VNb+JGhwahqcaXNl4qlto9CjiEbxQpG4jkZzy2/rk/Lzx0qlZ/Ejxlrvh7xMt7qtjaXH9iX08tmkYjurCaJSwCoPnUbQVy5zkhge1fT1FAHy/L4o8S+BdD8M6PpF9p+nW02ixakl7eRKkV5cyMSY2ZyRwu0EKQ5J3d8V2C+OPGtzpHjvWtPayuE0ORobbTUsmd5GMUb7jJuBITexxtycdRXuFFAHzrpXxL8V3WmRx22uaTeSXOuabp8N6kKStGlzvDrIiFVypQEDIbBwcdara98T/F+kaTcwXGs6cZtP1y/wBOmuhDFBPcxwxxMhjWT91uzKcrncQF25+Y19J0UAZPhK+l1PwtpF9c+d59xaRSyedB5LligJLR5Ow5/hycdMmtaiigAooooAKKKKACqtztti115lvBCuXuZJFxlFU87sgDHqc8Vaqi8aR21ymq3MU9vcSFAsyqqhXwoi9GyTjnk5xQBIj2vF8twrRTIgSTzMoQfule3ORz34ryL40WN34L1ZPiR4Zhs1utiafq7XFuZUW3Z1C3W1WUtJHgJ/ESrdgpr1yWOKP7JarZB7bO0bVXZDtGV47dABgccUl9a2t+tzZ3URkWeBopFZSVaNuCDng9elAHznfpe+HpYPHnhmO9vrfQo2Ora/qkwhfxDFIU3JGu0lkUCPy34XgBd2AT9HWGoW2oIktlIJ7eSGOeOePmKVHyVKuOG4GeOxHqK+ePDWlPZeKp/B19p83iHxV4dkB0F9RuMWltpjKFSZ1XaHMYKqylSxJUIQASvXfAfxBBY3eq+ApNcttYTSNkmk30cgYXNky8KpHDGM/KSpI5A/hNAHqVpeWGLY2DLNDeszxy24MkbEDJJdcgdOpPJ4p9+bprq0gitYZ7GYut20jYKJsOMLj5stgEehNR2E86aVaN/ZT2sjMqvaI8Z8gFsE5B2kDrxUxlks47651CeL7LGTIhCkeXGFGd3qchjn0oA8r/AGjpJdO0HwXe6eFiNj4ls3BTA2LtkXAHpyBivYK8b/aNs7CD4GX19p0ar9hubbUbJxn5JWuF+fn1Er8H+9XrmnTm60+1uCQTLEsmQCByAeh5oAsUU1N2xfMwXx8xUYGadQB458ab2fW/H3gHwJYzwlL69GpanbyDIa2gYSBW4PDFJMDuyDOK9VF3dHXXsjYSCyFsJhe712mQsQYtvXIADZ6c15N4OZfFH7RvjHU76BFk8M2VvpdkFB+7IXdnY/3s7wO21sc4yfWLWK6l0p4tbNs8z+Ysn2YMqFCzbQMknOzGeeucUAXnG5GXJGRjI6imxRmKBIw7OUULvfknA6n3qpd2FpcaULSaJ3tEVCEVmBwhBXkHJ5UfWlku7SK0TUruRbWERgmS5PlbFbHDbsYOcde9AFiQxxJ507Rr5andI2FCjvyeg4/SpSORWc1tdXd1qMGpLZTaRNEiQxBG8w5DCQSEnBB+XGAO+c8Vo0AFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFV5US5cw3FtvjQrIGkUFdwbIIHqCAQfpViqTXCaZZRtqV4pzIsYlkAXczvtRcDjOWVaAHSyXT3dobQWz2ZLi4ZnO8YHy7AAQfm4OSOKi1ISaha3dnp2ovY3ibQZ4o1doskN91wVORxyO9LeaVBcaabGJprKHerg2bmFlIcPwV6Akc+oJHerYCFpRGVEh+8VxkHHBNAHjn7RGm20EvhnXp1umtzd/2NqUNtP8AZvtVlcfejllyu1A6L95lX5myRmuR1PxBJ4f8TeBtTuNY8PPNps7Wdzpmh2bnTbKynfbJMJwMKyhYyVYgDjCgZLey/Ebw9d6/8MNc0Jbj7Tf3Fi6JI6KDLIBlcgcDJA6DjOa8TfV9P1/4fpo1z4h0nRDrWiSXFv4b8MacWUyH5wzOqkh8qVaIbc8jJ5JAPoi0sptOlsbTTVt49IijdXjfe0ueNu1icY65zntVm9dLdZ7q8uI49PigZpRIAFUDlmZj2ArkPh9qdz4+8B2Or6lJ5dlq+m+TNZxDaUky6SOsikEbh0HVcdc10yvGbttEfTrqSzFmGNxKqvA4JKGIksWL4GSCMYPXtQB5x+0a5uPgT4plRreSydLV7Vos8p50Jye3XJGO2K7z4euZPAPhp2yWbTLZjuOTzEvWvPPjtq2ma1+zx4ku9EkWSwUJAm2NowpjukRl2sARhlI6duOK774a4/4Vz4V5z/xKrTk/9cVoA6Q9OOtICSTxx/OlPtWD491KfRvAviPUrIqLqy025uYsjgOkTMP1AoA8o/Zie71HwZ4x1+JI21nVNZuZEmuC2yQhFMYYjnYGZhx717fB9oxH5wi/1Y37Cfv98Z7V55+z1A1t8FPCiQquTAZCDkDDSsxP15NegA3f9oNuFv8AYPKBByfM8zJzkdNuMd85zQBMG37TEyMmSGPXpxx+NRXUFtfQy2t3DFcQkDzIpUDK3cZB4PSks4IbRBBaQLHbkvJ8mAAzMWPHuWJqGTWLGPXYdGecDUprd7uOHa3MSMqs2cYGC6jGc8+xoAW8R76OP7DqDW/lTgyNAEfeFPzRnIOM9DjkVeFZ7Qxy/bLBLWe2hkQs1xCRGGZ87ipU7g/fOB1BzmrVpbra2kNujyusSBA0shd2AGMsx5J9zQBNRQOlFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAcn8TfGtv4B8OJrV9aTXVoLqGCbyjzEjtgydOcenc4GRmtSwvIx4eivdWv7G5tzidbxAEhdC26JxkkDgpznryKuazpllrWlXem6pbpc2N1GYpoX6Op6j1H1HI6ivG/gXe3fg/wAR6z8LPEEvmHT2a70a4lIX7TaOd21QQNxU7icE4O8dEoA9lW0jbUhqCyzFzD5IQSnyiud27b03f7XXHFNsfsNwJNQ037LK9wAGuIdp8zbkAFh1xyPbmlspb17u+S7tooreOQC1kSXcZU2KSzDA2kMWGOeAD3qrpMNrLZQ/YLa402CC5kPkCHyN5DOGJXHKsSWB78GgC+kCu0E9xHEbuNCu9RnbuxuCk84JA/IV80/C/UrPwn/anh5vGMWhadpPiG+szp8OnpLeXsQK+XK7gFl5437MEKFzwK+lYru1mvJ7eKeJ7q2C+bGrAtGGGVyO2ccfSvn7R7e+0fx38U9EfXtV0nTHvoNXjXTrPzrmQ3By7REKxGSFQ/KenbByAdT+zmI7r4bSaKjXccGgaxPZxSlTbSzBJBMDIgPy5MhVkJOQOepFeptetL5y2UXnSQTrDKrkxgZ2kkEjnCtnjr0rzD4JX7tb/EIWX268u49dmmji1QmC5ctBFsEgIyikrtUlfujpxivTNSa//s6OSze0trgPG8puAXRYwwMoyCOdu4A9M4JFAHmH7ROpm9+D/jq0NjfW4sjbR+fPEFjuN0sL7ojn5lGcE4HII7V3fwz/AOSb+FMf9Am0/wDRKVx/7S0jP8E/FPyr5Hk27JIGzuJuI+MenTn3rtPh2CPh/wCGQwAI0u1yAOB+6XpQB0Fec/tEaudF+DPiedE3tNbfYwPaZhGT+AcmvRq8T/a8V5fhKsEKs80+pW8ccaAlnY7sKAOp9qAPRPAuiXGgaHo9mNRWXTLTS7a0SAwBT5qA7pS+f4gVG3HG3OTmtq7uJbCGWd4p7wNMipHbxAuisVXnnkAksT2GfSozaQ6hZT2OpWKPaxOqBZgrLKFCsHA7Yb9Vq2JZjemLyP8AR/LDCbeOWyfl29emDn3oAYUe2aCOxtoPIaQ+cd2zYCCdwAB3EtgY46k54xUcOoebf39r9jvE+yBD5rx4jm3AnEbZ+YjGD0wSKd5aWUt3dS3E7JM6HY7blj4CgIMcA9T7kmrY3bjkDHY560AZ+l6mdR0Wz1D7DfWpuY0k+y3MQjni3dnXPykdxnitGoENyb2QOsQtAi7CCd5bnOe2OlT0AFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUV4v4F+NNz4g1vSrO+0W2jh1Nb0wmyuzPPD9myW82LYNofHykE5PH0u6x8ctFtvDmv6hp+m39zfaOkUktjMBGSrvtDF13hQD1zyDgY5oA9borgPEHxV0Pw9PYJrVnq9kl2sbCSa12CPexUBlLbsgjnAOKV/ir4fTxAuktDqm7+1P7Ga6+xt9mW74xGZOmTkYx9Tgc0Ad9RXF/DHx2vjqy1KcaRe6abK7ktsXCnbJtZlyCQPm+X5l/hyBk12lABRRRQAV4Z+0lZT+Hrzw18StItt15oN1HFess2xpLRmx5eDkYJdlyBkeZ0I6e51zHxN0BfE/w+8QaObZbmW6s5BBGxwDMF3RHPbDhT+FAGrp91/bNjpOp2M7xWk8a3PlsgzIjx5VT6Y3A8elSWN8mpwrPYuyxRzyRSCSJlLbCyMADj+IZB6EDjrXlv7PWtWNz8G9Cn1nUFS50SWSyuGupfK+zSB2RI2yQPuPGoB9QOtemn+2f+ElBB0//hHvshyMP9q+07xjn7nl7M/7W72oAn1WO8bT7j+yZLaHUGX91JcRmSMN23KpUkfQivG/FE72fxa8WWq3viS0N9pdhcB9AsftMuImnBDHY+wnBA4Gc9ex9MmhJ07W5vBNxpr6zJOVd7qV54FnUgMsgVsqQONoxg44ry7xedTPx9vIdJ/4SIyyeHIvMXRZLeNf9bKN0pn+XIz8mPmz7ZoAT4QO9j8R/iObFfEd/cyWtpc7deQQXN1KomUbcqoEZwqqSoAx6CvYYr/TjqYsLq6to9XurcTNp8k6NL5fIJCZyVzkEgYzmvKfhrBq0HxS8WpdRarBqB0e1MB1y5juJJP3kwV8w/KseRyo5znpnA9XaSC3Vrq6ign1e3tN0q2ybpSvUqg+9tLA4Hc0Aeb/ALR8s7fADxK1zaraSAwIIlcOAou4wpyB3XBx2ziu/wDAqtH4G8PKwJZdOtgc9f8AVLXnH7TRkl+Bmtyo9wou5LR/JlAHlgyxfIf7vIyc969Q8L2sll4Z0i0ni8qWCzhiePdv2FUAI3d8Y60AagIIyDketeIftG39wPE/wr0iNgkF54ihmdu4aOSNV/D96x/AV7ci7UVck4GMnvXiPx4tRffFX4PQF9mNVlnzjP8Aq2gfH47cfjQB65JqUcMd0dZjhsLYXC20MlxOm24DbQpHPBZmKhTySPcVfXeJtoRRCFGCDznPTHpiqV5HPb2N9L5b6pKCZ4LVvLU5UArGpOAPmHBY8E9cCroBmgXzUaNiAxXdyp64yKAI1lSGZLd5JJJZNzrlc4GfUDAAyBzUF5ZQ6vp9zZ6raBraRijRs+Q6g5B46ZwDipDczjV1tfsUptTAZTeb12BwwHl7c7skHOcY465qssUWsQpJqVjLAbS8Z4llfBJjZlWX5T91h8wB7EZFAFie8sWvRpc11b/bJomkW1MgEjxggMwXOdoJAz71cqhFPaXtnFq2nJBfF7cvbTRFSZUYBgFfphsL3x0qxYyyz2cMtxbtbTOgZ4WYMYz3UlSQce1AE+etFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRXB/HXVr/QvhN4h1LSLqS0vreJGimj+8hMqA4/AmvPHm8czz3aaPceLItFuPEWmw21xd2xF3HAwYXb7XT5YQdhBZdo54xQB6V4a+Gfh3w94XvtDs4Hkhvo54bi6kCC5kSUtuUyIqnA3ED04rCs/gl4eg0vVNPm1DWLqHUNPi02QyyQqY4o33Js2RqAwOOSDnHOec834rTx1p3iq5s9MuvE13JAdPTRJVQPaTpkC6a8dVCBvvfexxt21Lf3HjIa34o58UjxCtzdDRIreDOltbiFvILsR5e7PXcQ2/aOmaAOi134M6Nrl1cXOo61r0lxdQ28N1J5sObjyX3IzExcHIGQu0HHTPNbDfDTR28zNzqH7zxCviU/vE/4+V24T7n+r+Ucdf9qvI9NuPiAPCusAaj4pjuJI7Y7bjSriSWGQNiUKxXcVYdfKDBcZXGap6hffEc6NpMkdt4tRgs2bJTcF528zCOLgRbk4Bwk6gAcnOcAA988H+EbTwpNqx068v5bfULp7w21w6tHBI7Mz+XhQwBLc7i3QV0deD6lrvjq21PUdLGneJTO+v2UsFxHbGWBLFvLEieao2kA7t2Omc8c4t/Dm58ZP8UbtNZXXrvS2Ny5uLiOW1ghG7EaGJ08tuOhic+p9wD22iisLV7rxNFeFdG0jRru02jEl1qstu+e42LbyDHvu/KgDdorlft3jj/oXvDf/AIPp/wD5Do+3eOP+he8N/wDg+n/+Q6APOvghaQ2fiD4oaBq9vHcTRa79taNkWQOkvzxnaeeNoPIwCRjoa9pZrj7VGFSM25Vi7FjuDcYAGOnWvAfAl7r0Hx6+IkVloukPq0sNnJcxT6tKIkwg5jkFqSwIdMgquCOrdu6aL4j23i+fW5E8ProhsvKfS31mbYsqtnzxIbTI+XjaBjvmgD0OO1igWQWscduZJDLIY0A3sTyT6k9z1rxXxfpsmofHPU2TRNW1dYtAt1P9mat9geItLMQGPmxlw2D3IGBkc8d/p+teL9Rsbe9sdE8L3FpcRrLFLHr85V0YZBB+x9CDXh2u6trmp/GfxdbX/wAPrbxFqdnplvZtDp+syQpDbMPMYFmRTKXMqjhQRs4B5JAO7+GEB074s+K0m0vVNKVNJtG8rUr830sih5fnWTe5C8Y27jyOg6D12W2QST3tpBB/aEkPlrI4xuAyVViBnbkn8zXzz8HNS8R3PxK8ZT6b4NXTrhLe0huLTWNanLQEB2UCRoZGO4MCFAVQoGK9euJPGVxd20z6B4f821YugXxFcqpLKV+ZRZ4bgnGc4PNAHE/tWtcH4TQQlFaS41G1ilRWOw8k49xkCvZ4kCRIgVVCgAKvQewr58/aWuvEs3gjSoNX0jR7aOXWbZITaatLO7yYchSrWyDBAPOeMDg17PpN14olvkXV9H0W1syDultdWlnkBxxhGtkB5/2h+PSgDerxPxoqa3+074I06SV/L0nTZ9RKDgb2LKP1VSfYV7ZXiUgDftdRE87fDeR7fvD/AI0AevRqZLZpdNm5mmEhaYswwGAcAE8cAgAcZ5q1LDFLPC7jMkJLp8xGMgjp34J61BHNDqljFPY3ZMLOrrLCQQwV+R9Dgg/U1O7wx3EYcoJpQVTPVsckUAI1zEiTuxYLBkudp44zx68elQPqVolnbXTSN5FyUETeWx3bx8vGMj8enerbMFzkEKASW7CmLNvSF4V8yOTB3A4wpGQf5fnQBCbPy4rSGxkFnb27L+6hjXayAYCYx8o6dMdKt1Ctui3T3AaTeyhCpc7cD0XoDz1qagAooooAKKKKACiiigAooooAKKKKACiiigAooooAralYWeqWMtlqdpb3lnKAJILiMSRuM55VgQeQDXM/8LD0L+2TpW+5/tEap/ZP2fyTu83y/M34/wCee3ndXX1x8nw80ST4iP4zYXJ1V7Y2xj8wCHO3Z5mMZ37PkznGO2eaAMiL4yeFRd6rbX7X2nS6daveSi6hAJjVgpwFJIbLKNpAbkcUy5+KlhNFJHawXen3tveWNvcwanaMrKLpiEACt1IU85wOM1kTfAnQrbSL23srrULx206awtre9uESFFdw4y0cW7IdQQx3H13U3wp8JL+SXV7vxtq8t1eXt5YXSG3uBKym03FN8jRIGyW5AReB1zzQB00PxV8Py+Io9IEOqKz6lJpH2trNhbC7QkGLzOhJwcYz74rH1f4yaWth4kh0y2uo9b0rTpr9La/i2rII+DnaxI5I+U7WwelbjfDLRWjVGudRKr4gfxJ/rEGbht2U4X/V/OePvdPmrCsPgZ4dsre4gTUtaeCXTp9LVHlhxFDKwZtuIgSwI4LZPrmgCwfitp+mHVZNelRY7SLTtsNtA/mGW6jZgu5jtOdpweAADk13XhrWYtf0iHUbe3ureKUsBHcx7H4OM4BII44IJBrk7z4WaRcHVSuoapC2pR2cc2xoWG22RkQbXjZSCGJYMCMgEYxXQ+B/CmneC/DsOjaN5v2WJ3kzKwLMzMWY8AKOT0UADsKAN+iiigAoBzRRQB4Z4GGP2rviKN3XTrY4H/XO36166ItRtNOMU23V5ZJ33bwsIWF3JAxyDtUhf9rFeQ+BgB+1h8ROQSdNtjx/1zt69at9QgmaOfSg+o293eNbzvHICluUV1ckHsGj2kDuaALcFg1m1hDprW9ppdtEYjaRwAAjACBSCAgXB4AOc9sV8/XcVrqvxl+JlxZ6J4a1WeBbCA/2zeeTh/KKOIvkbkgbCcrgheuSK+gBayWFvZW2jw20VskoEqPn5YsEnZj+LOOvvXzV4ak09PEXxFW/1rwDZC48S3iNZ+J7VZpWCsNrqTKh8sljgEEAqcHk0Aei/s+6ZNpN74+t5Ims4k1solit2LiKA+Uh+RtikjDKBkZCqqkZUk+p2ssc2o3hWG5R4dsLPIpWOTjdlOxxuwT68dq8p+ANpYanoni9ZbXTJLaPxXcTRLZjdbBo1gKPFyeMqGGOhr1a7uXS1mJmtrRxII0klO9ckgLkZXkk4Az1xQB5B+0VcRW/h3wfqmv6Yr/ZvEsAeCGbfmL94eHIXBYIjdOD8ucZNe1kEqQDg+teJftfRM3whEomKSW+oQSDaMbjhlx/49n8K9l0uSSXTLSSf/WvCjPzn5iozQBZrw63nD/te3Kb+U8OhMAdDvVsH8817jXg1lNBbftc69PdNHFFD4dEjSswVUA8olmJ6YGfwoA9bjWLxTodjcIdX0pBcJcCMFrWb93J9yQddjbcFe6mta4luEubVILdZYXZhNIZNpiXaSCBj5ssAMcYzntTdQNlNp8iX7QNZXC+S4lI2SB/l2nPB3ZxjvmpovJi228RRdiDbGuBtXoOPTjFAFczXv8AbCQCzjOnGAu115/zCXcAE8vbyCCTu3dsY5zSy30I1KPTiZBcSwvMpCHAVSqn5ugOWHFTv5jwMFIilIIBI3BT2PvTow4jUSMGkAG4qMAn2GTigDBl0q2PhyDwtc6zqBuJbIwrdfatt7IqBVaXeOd2WXLere9b6KFVVBJAGMk5NVreVjZw3OoQx2s/lgyKZAwiJxld+BkZ78ZxVqgAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA8M8Crn9qr4jyKD8un2q/iYoP8K9ujaTcimEKpQsxDfdbjj36nn2rxf4Z/6Z+0X8UryLd5ccdpb7tuRuEagjPTqh4r2eaKSS2MaztHIQB5qgZB9cHIoAzX024sFhTw+bS3jlvjc3ouFeTzEcs0mz5htcsRgnKjnjpXgnwU8RC50fV9Wi8S6RpS6l4k1DUJYNQtfMVfkjY4k3oAArKS2ccgDHOfeNXv8ASdFtdc1S5ljjNtbCa9YuchFViuR24zjHWvnrwR4gg0H4OGDTvGOrxXNnokt4bCbQR5Ebsu7aHaDDLvfGS53ZzkCgDvP2ZNBgX4ReE7+aLy7qNruZPLym/wAyV13SYPznaFwT0GB2r1o/aokvJG23PJaCFQEOAo+UknBJYHnjr7VwPwR8Oiy+GHgttStZIdQsrR3jUu67PNJJ3LnBJBHBBwemK7m3axgm1GeO6UkPuut0+5YWCDggnCfLg446570AeXftK2aD4H+K7iYSmSZ7Wfy5GDCF/NhTCegwOcdy3rXongS4a88D+HblzlptOt5CfUmJT/WuM/aCtzffAnxKLKQXStbpcLJvDBkEqSEg9CNoJH4V0vwpuI7r4Y+EpYnV1OlWoyOmREoP5EEUAdVXiJAX9roYwPM8N/MPX95/9YV7dXiXxelTw58bPhh4gtrMyXF/cSaNcSchdkhRUyemQZXYDvg+nAB7BYSXk8l6uoWkUMcdxttism/zYwqkORj5Tu3DH+yD3p4eH+1GTyZPtHkgmbyjtK7j8u/GM5525z3pkFpNtvo726a4iuJGMahfLMUZUDYCvJ5BOevPtVnayeUsYHljhsk5Axxj15xQBBbXf2+weazWSJiZI0+0wshDKxXJVsHGRkeowQcEGnW63i6dCtxLA98I1EkiRlY2fA3ELkkDOcDJx6mnn7R9sXBi+y7DuBB378jGD0xjP6UrW6G7S4O/zFQxj5ztwSCfl6E8DnrQAsjxGRYJCC0ikhCM5Axn+Y/OpKginZ7yeEwSIsSqRK2Nr5zkL9Mc/UVPQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUnPelqC/uBaWNxckBhDG0hBOM4GevbpQB4l+z5atqWo/E6ee4mUzeJZMtE5VhscsBn0OQMemRXtAtIJdSj1FZJWlWFoAFmbyypYEkpnaWyo+bGRyM8mvGf2UZJJ/h7qesPCYzqWtXN1O0pIG3YvKHncAwxk4/i9OfadPNq9jA+n+V9kZA8XlABCp5BGO3NAHnv7Qt1BZ/BrxTLOixyTwC3UEqGkZnCrj165x1xXl3xZ8TE+D9d07RvHOuXkspi0yLSbrQkjEpkwpQSNAh5UMd27PHckZ7v9oizS707wlaX13cx2114ns0VrSLM8A8uXJjxklsjrg4z0PSuC1fxVJr3ifwhZ2fxCHii2u/EVlKumf2KLR4Y4nLNIZMAkAqMgjn2GaAPpYNbNeCESRm5gQN5Yf5lVsgEjPQ7TyfQ1FFY2DRXmyyt1S+ZjdKYQPPO0IS4x83yqBzngAdKZAtjc3d5c2SwC/TFrNcLEN42/MEJxkgbyQOnzH1qzLLGPJc3CohfaORhyeAPrmgDB8T6NayeEtWgW18uP+y5rNLaInyhHsICrGPl9AMD2rkP2XpvO+BvholslPtCHJJxi4kx19sV6JEltPrU1xDeSvPbx/ZpbdZyY0J2uCydA+CMHrg15J8AjNonjX4keEryRYjZan9ss7TzAQlvNudSig8DaYyQOhYZ5NAHtded/Hrwhc+M/hvf2enSyx6jZkX9oIk3NJLGrFUHcFskAg5BI6jIPolHegDlPAfjGLxh4Y0LWdPtXeDUIiZ2R1ItZFHzI2SCfmBAwPc4BrormW4h86RIRNEkRZY4z+8dxn5RnC88YyRzXkN+Zvg74zu9TW23fDzXrhZLwwrj+yLxsL5pA/5ZP8oJ7HHT5Q/rUNv5AuZrJzI11Ksx82ZmQfKqnb12jC5AHGST3NAEsc8skVq4tpE80AyJIyhogVzg4JBIOBwTUscSo7spbLnJyxI/D0qCad2umtI4pkZoTItxsBjU5xjr97vj070l1Ztd2C281zOj/KWmgcxMSCDxjoDjkehoAmuZHgtpJEhkuHRSRHHtDOfQZIGfqRUtZus3k2mpJfvhtNtraWW4jjjLzMw2ldgHXgPx6kVoROJIkkCsoZQ2GGCM9iPWgB1FFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFcx8UG2/DPxa27bjSLs59P3L109cD8e9XXRfg54tumiMwexa02g4wZyId34eZn8KAMX9mxrmH4K+Do47XfFJ9p852faYl86Zg2P4snaMf7We1emfuXS4tPs0ghiQDaI9qMCOi+v4Vwnwo0+HS/g94Y086hPaKmmw38lygCBVY+awLMCAOSDntnpXbzy3N4mm3Gj3Vm1pJIssrspkE0BQ48tlYAEkoQ3IxnjmgDyL4xSNd+Lfh7dQQ69DJBbX9/BHp1j580MqrBsMkXXaA7AqDySF71m+EL/U9S+NPhe11nW7vWrux0m7umS60X+zpbMS+WBvGTktjGMDHHXNP8b6rcax8dJtOefxTZWei6aIUuvDtv5zK9yFdvPbY4RSqDAK9VDZGK0PhDa2Nx8WfE93bav4g1WbTtJsrFpNbG2ePzGkkKY2KcAIhyRnLMcnOaAPYTcywWkL3cDGZ3WNktwZApZsZ7fKM5J7DNRQadbabpi2ul2NusMTF4rcAIgYsWJHBxySenWs7Tk+wRW/h/T9aa61GyWKa4fUD587wM7ZLEFeW2sobtjoa4D4mfEyz8NeI54PDukrqHiGMW9le6lcFo7DTI5XPl/aZh90bmzjjgn5gRggHp1xJYR3LWLTRWuoaijMBGQsshCgFge5UAc9sCvJPGK2/g34h6H8RbeKWLTLgyaDr888TBwoYJFcNxgLviUFzjI2AA7uKFv8UPG3hrXGTx9H4X+wRzxRPFYSvHNLDKVVLq33sRLEGbDAAEe3NXvFnxWsJtYbwX4P0y68b6u7yJcwlozabH3Bllk2kMil1BGAOAC2QQQD24EEAg5B70V876f8Lvi3p2nSR6Z49sdNSLL2enWyyPbxbjnyg0gLLGvRc7sAdqtN8TPGnwxvBD8XtOi1DR7qUpa6zpKrhGAJKOnHUYIBCnhsbsfKAe739pb6hY3FlewpPa3EbQzROMq6MMMpHoQSK8o8PS3Pw21Sy8IeJnkvvCV1OI9C1Wdi5t3yDHZzccEHOxicEAAYxhfVdMv7TVdPgvtNuYbqznUPFNC4ZHU9wRVXxLoWneJdDvNH1q2W60+7TZLE3GecggjkEEAgjkEA0AX42lM0oeNVjGNjBsluOcjtzTYDE80zoCJAdj5BHTp17c15/8L9a1G1/tLwX4imkuvEehKGinnfB1G0YnyZgSATgYjc4bDLySWrsotUkOo2mn3FheRXM9o1w8scZe3hYFQYzLjG/LHAxyFJ4oAmhF1aRX015Obtd7SxJFBtZExwgwTuPB54zmrcEnnQRybHj3qG2uMMuexHrVSHOm2NlbyyXd442QGZk3u5xje+0ADpknAFXqACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACvJv2qWI+BviAc8vbD/AMmI69Zrx/8AawcJ8E9XBcLvntwAf4v3qnH6Z/CgDuPAjCTwd4fsZLVntjo9sTI4BjbMYBQj1x+hqe9s7XULLUdF1nS0tdBjEMMD/aAiTrgHACkMm1gFxxnHHFU/Cs9xceCbJHS50+K3sbVo7uLy385REjsUX5jjqmGUHrgdDW/DcRaklsy2zS2c8K3CSyptAzgqCjfMGwc8jjHODQB4TLqC23xl+JtzHrOtaR5b6TDv0zTTerKxgYZlUROQB90YK5z3OK2PhGv9v+JviJqniDUlu7a51qPSrRJlNtL/AKJudVK/KcjzRxjJKsSOa4vwlq1la+O/iPdX3i/xFo+pTeIJIGi07S/tavDCzCLLfZ5cH5mAXI4HINdr+z/d2zaR4vnnR57m48WahJbLdRCOaSTYjfMpAEchAOQQuPQUAdL8W/Glz4b+HcupaTZzJ4h1IrYadbsgE5nkJVcKQdxXJYLg5wB3rh/B9nZaHYQ6Z4G8V2VxqlzvXU9C8TxvC+p3BGZZQkgWZHYDZkBkwOQSGJk+LusW0vxc0C21fV7nw9YaHpcmqf2hZ27TzCWYtFszsdEXCdWHOcDkjF+W31XXXTzbjwP48s44nhk+RYdRcFDlI2DbEYq2TkrjcegoA828dadJeaXpnw50TRbnTNW1i6WeTQb5TdR6NGG3NPaXIAUoxDFhuccsoCHIr6O+HvgnRvAfh2HSNCtwiKAZp2A8y4fu7nuf0A4GBXkP7N2lWup+M/GHiq0tp7WxgkXR7G0vbp7m4tQiq0i7mJwpJXHJ7jPGT9CUAFZniTQtN8S6Jd6TrdpHd2F0myWJ+/oQeoIOCCOQQCK06KAPnT4LanefDf4nap8K9XN5Lps8jXWiXE5HCFWcjnAKsFP3eA6vxljj6Lr5y/amistF8V/D3xhLCoew1OOO5lXJdoo3WVVx04/eH1+avoxGV0V0OVYZB9RQB5r8SAnhnxt4a8bBpUt939i6m4j3olrKSyMQBlcTCMbh/ewa9DaWcX8cItibdo2Zp94wrAgBdvU5BJz04964H9oiGeX4N+I2tE3zQJDdAY7RTxyEn2AQmu00vWLW90jSr9poYl1GON4A0g+cum8KucbjjJ47AmgCXS7KWxW6E1/dXvnXEk6m42/uVY5Ea7VHyr0Gcn1Jq7UcEbRx7XleU5J3MAD16cAdKbZ3CXdrFcRBwki7lDqVbHuDyKAJqKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK8V/a9Dn4N3Gw/KL2Dfx1GT/AFxXtVeR/tWLu+CGuHbnbLbHPp+/QZ/X9aAO38HxXsfhXRPIktzCukwKkRzgy+WuDu67ccVpvDqFxHpZa9js7iJ1lvIoEEiTjYwaMFhkLvZW3AA/KB3NYng7TIb3wp4KvZZLlZbGwhkjWOUojlrcId6DhuGJGeh6V0cf7l0a9kgM8kjRxMF2kqSWCD1OF5+lAHzx4MurjTNY8f3t14+OgaPH4pvIn02CximmaSR/lcsVZxvwdoAx8h56iuh/Z7vpIPDniZ4INQ1f7T4wu4vtQjRJdrCP/SZkcpt9WAG4Z4WsCPWbfwL8Vfiasut6VoUVze6fc/a7u3MsjJJG7yLHGvLHccZJwOuDniT4KeNrG2vfiNptjLqeryS63PfQXFhpzP5nnAgvkEoozHxvKg8HuQADoLybXtJ+Kmqw6bqmiSamvhmyjln1ljBHcziaYCTZH0H3shemQO9YHiWyuR4X1nVNT0X4ZtNHZXFx/aOj38lvcCTymBKMI9xYnIxvGehNQ+PrXXNT+M+h3dx4N0eb+2dLns7ex15YrsqbcmYvhWKoxDhRhj1Oar/GTQfsXwv8QXMnws8MaLHFDEftlvcRefGzTKuYxHCCdpIzllBBPUZBAPXfgf4Xh8JfC/QdPiRBPJbrdXDhQC8snznJ74yFBPZRXd1znw2ma4+HfheWRZFd9LtmIkbc2TEvU966OgAoGcDPWiigDxH9r+3SX4QSyt5O+K9gZS65bJJGEPY4P5A16/4fdpNB015GLO1tEWJ6k7RzXkP7X999k+DssA2f6bfQQfMATxuk49D+76jtmvXfDoI8P6WCMEWsQI/4AKAOb+NU0cHwk8XtM8UanTJ03SsVGWQqBkdySAB3JAqb4cafEfhr4KTULWNp7PS7N0EsYZoZRbqpZc/dYAsMjnBI71hftGqk/wAJtTsC6ibULi0tIY8jdKzXMXyqO7bQxwPQntXealc2Wj2b6hezNBa20e1jliqqSB90dT0GcZoAeEluLu0vILx1svJfdbiNcSlthRySNw2gNwMZ389BVmGVJ4klibcjDIPqKfRQAUUUUAFFFFABRRUc88UCBp5UjUnGXYKM/jQBJRUcFxDcAmCWOUDglGDY/KpKACioFvLZr17NbiE3aIJGgDjeqk4DFeoBIPNT0AFFFFABRRXHaR8RvD+r+I7rRbBr+S6tbma0nl+xSiCKWIEurS7dgxt7nnI9RQB2NFYt94m0u20++uoLqK+NnGJZYbSVHkCnpxuAGe2SM1U8V+N9E8L2kM2q3SiWZolS1RlM7eY4RWCZBIyeT7GgDpaKxrfxJpz2l7dXkq6fb2l29m8l5Ikas6nGQd2MHtnB9hVbwn4x0fxRoMGrafcCO2mSWQLcMqOEjkaNnIycLuQ89KAOiorPfWtKSaKJ9TsVllKrGhuEDOWGVAGecjketV28Rae02mrZyC9iv5XhjntXSSNWUEncd3sRxnmgDYoqjZavpt/dT21jqFnc3EHEsUM6u8fb5gDkfjVyR0jRnkZURRksxwAPc0AOorlJ/H+gGZoNMuJtaulO0xaTA93tPozoCif8CYVH/afjDUz/AMS7QrLR4T0m1a582Uf9sYSVP4yigDr68l/adudPk+EGv6bcalaW99KkUkMEkyrJKUlRyFUkFuFPSur/AOEQvdQJPiLxNq16p621k/2CD6Dyv3hHs0hqW48CaCvhzV9K0nTrTTTqVpNayXMEK+afMQqWZvvMee5PSgDy74M+Mri8+HHgi3/sGbU9bjjmgsri6litov3ZdCEdiXbEYAJRG4BzXfSWHjK7s2n1jWrKzSN2cQ6HYiecZYgBZZsqSAcZEQPX1wOC/ZW1ObSvA2v6Lrt9Dt0HVpLNeRiIMQMA/wB0yF8E+pr3FY/svlR2lunlPIzSYbbtzli2O5LfzoA+dfFXhEaB8XL03+saVBYavpgvYtW8R24vys1ttR0VWdEDbZA2SDgDCgc1r+DL63uviobI3cniHw34n0RYRdXtuI4ZZbTIZYF2hfKxKxKgfeYnJxk7Xx9jv9N0jRPGsGmw3d/4X1T7QAJSoNm42yAj1J8vJwSNuRxmuO+JepvDqeieIZ9bn8T+IfDF+LqeHw9ZkWtpZEjzxMwZ9rlYyPmkzjGVxlqAOr+LMEF7ceBvEmmzSarYf2u1qIo7owsxu08hWilH3AjAHHf1Fc9r/hd1+Hfi2wvfB3iWKebTpLljPrK3UReJ2aNt+/JcYD42njjmu6+MWnWHiz4SeL7j7RNJZDTvtlrLDMrxSeSnnpJH1GGPyse4HGODXnXhO00e4tYtUsPBMlvYX+nx6ff6v4Y1dryWFJIoy0bWq7nHJAOAzjG7J60Aelfs33hvvgn4XkOwFIZIcJ/sSug/HCjNelV87/so65FY3HirwOy3sTadfSXVpHfHZKLdiF2mMgFSCAx4xmToCefoigAooooA+cf2rZLXXPE/w88HyTqGv9RVrhE/1kcbukSsPY5k/FfavoyKNYokjjG1EAVR6AV8w+Hpm+KX7Uk2sJa2t74f8NJ5CTHIC7d5jbB+83mlyOMYXPYZ+nZ4Y7iGSGeNJYZFKOjqGVlIwQQeoNAHmvjuX+2fix4G0C2tlml09pNdupJCNsUKq0KEA8ljI4xjpjPqR31vd2HlXV6pjhUSNFNK42ZZGKck9eRgGvFfhn4F0TxO3iLxfa6DokNnqd2tvpVoFDQwW8DeVI67AADIyO2AODg5Oc16UPAfhkztHHp91C6gNviuriPI9NyuM/TNAHVtLtuEi8uQ7lZt4HyjBHBPqc8fQ1JXHReB9JN3PEv/AAkNvCgUq8XiC+RHJznCrMORgdu9TDwRbqB5WueJUYfxf2tM/wCjEj9KAOrorlP+EQnU/ufFfiWNfT7RE/6vGTR/wjGsIB5XjnxASOglt7Bl/HFsCfzoA6uiuV/sHxIh/d+Mbhwf+e2n27EfTaq/1pP7K8YIP3fijTGx087Ri2f97bOufwxQB1dcp8UdAs/EXgXWLW902PUZI7Waa1iaLzGE4icIyD+98xAxzzWrdX8uheGbjUNdlS6eygee5ksrZowyqCxKRl2PQdNx6fhXPH4maC9pqFxZLe30djBa3Mxt4QQEuFDR4JIH3SGOSMA80AeeeHdO1PwL4L+G93o+galBG7IfEFrp9kWuJSYCAZYwNxw+Mk9O9UNKHxA19LaHUbvxZpcTWGpzs0UJhk81bg/Z0YlDg7MYAwSBwSOvo9l8XPDl/pumXOnJqN5c6hdTWkFjBb77gvEAZeAcbVBUkgkYYdapx/F3RJHTUUnP9hnRJNXwbZ/P2pcCEnrjGTjbjPfOKAOGN18R5tMubq2tdVTU38NacZJPsYSXzvOP2gJuUAzBMnaeh6DOKf4uvPEH9iWdv4XX4hGB57k/bLyG486NhFGUUxqgkZC27azkKG35yMY9Is/ijo13a63JHY60k2krDJPazWRimeOU4SRVYj5TySSRgAk4rHT4uWerT+HH8Oxh7S/1C50+7+1IQ8DxQGXA2nB/h5BIwaAOy+HVxql14D8Pz+IFnXV3sojdiePy5PN2jduXAwc9RgV0VeX2Xxg0ZNO0EXa3V9qmp2QvhDp1q3+rLlAwV2zyQQFBZuOnSvUKACvCtI+GWv6F4l8X6vLbaVdW2pXWpXkUsN/d/aESZH2Ri3CiJmyRknJ5OCcCvdaKAPmzw58JfEWs+Bkee30rRbqXwyukwW4Ekcsjs6SM91mMFSNuNoDHJJzXQ+KfhPr+oa1q81k2hTQajcafcm6u3kFzb/ZtgaJMRkFTtJHI64I7j3KigDxWb4W65HdpfRNot9JD4m1DWUsb15Ps80NwpVd5CEiROo+UjPeuV174Va5ZeGfAWgwM39pyXF5puqXOnRu8A0+eZppNzlRtwNoAIGWJAzX0pRQB4p4x+Ds2uaz4lu4INE8q9fShYCdSWt4rY4mT7h2hlwAASDjnFTaX8KtT07X7e6t5NKhsIPEl7q8cEbOoS3mtliRAoQAMGBJAIGOhzXstFAHknwc+G+s+Ctau572fTo9MNr9ngs7dzcMjF9xYSvEjqmBjYS+ScluBXql9Z22oWslrf28NzbSYDxTIHRsHIyDweQKnooAZBFHBEsUEaRxKMKiKAAPYCn0UUAFFFFAHzvoxPgv9rHVdOexjh0vxZbCaAq4C+Yqb2cj1Mkcox1y4I68/QixkTO5kchgAEONo9xxXin7U3hm4ufDOneL9GgR9X8NXKXW4IzO0IYEj5eoVtrnOMKHOR377wPq2ja/4Rj8WRypFHrVvHJeO1y/lI6r5bIu44TawK/KBkjPJ5oA2bjS47i2udJvoZtQ02/W4Nw1zIrBQ5H7rHB24ZgMdAvXpXh2lXF3osd98PfHF/baToekWxeI2sAFx4gsAGURjGQDtGHCDzG3AArhmb6A0yxt9M061sLJGS1tolhiVnZyqKMAFmJJ4HUkmsDxp4a0fxpayaVqKzR3lpsuba8gDRzWchJ2Swy44YFM4B7DI5FAHzlrPhnxVb+GpdD8P6zceHU1GWEXnhed2mgsLe9n8iFEnKknc+5nAxw5+XKnd1fh+0sbm58OR6de3mlebA9h4b8SRoFffASj2V3GPkkBaJnXdjeBgEMMmPX9O8beE7ZofEOnX/imN/EtlrbazpcYZ5I4nQNHJbjlSFiXaFynPUY5W38SG9j8b6N4Y8N6/qc2o6ot9o7rYva21vJtiKzlpNuzbcIXPHzHnGC2ADi/EMfijw94x8R/FZ7jSrjV9C1eLTtRsLJGW3eBreOPzAzPu5LouzBKtz2r6l8GeKdJ8ZeHrbWdBuRPZzjvw8bDqjjsw9PxGQQa8os9FsvCqeH/CN9fLqGpRSTeKvEzvGXF3EFkzIwYYf9/5QUdf3YbAIzXnOn+GJpfEF5r3w/8AGTWHim8dbue1UmKCaa8Y3FpCqOgVk+z+Y7Bt2CuAOuAD65ryL46ePmsNOHg/wpH/AGn4u14SWMNvbTDfahlAaR8MChCtlScAYLE4U15rJqXxqvtU8PaMPFdgG1m5uvIubW1jObWIr/pJYR48og5TBBbcOuRj2n4Y/CvQfh+bq6sTcX+s3n/H1qd62+aTJyQD/CpbkjqTjcTgYAE+Cfw8g+G/guLSy8c+pTt599cRjh5SANqk87FAwM4zycDJFR/FzVLm4t7HwbocpXWvELmBnjdQ1rZjmeY5Bx8gZVOPvMMcgCui8aeL9K8H6al3q0kjSzN5drZ26eZcXcnaOKMcsxyPYZ5Irmvhz4euotX1HxF4sRIvGuqw5eKJ2kXT7TICW6MSVOCu5iOrE9QASAdDaaC9voUmgafI+i6baiGGwnsXXzRGgUnO9SMkhlPByCT1Oa3b8XRtJBp7QJdY+Rp1LIDnuAQeme9TKCAoJ3YHU9TTZZ4oWiWV1UytsQE/ebBOB+AJ/CgBxcCRUO7LAkcHHGO/brVfS7GHTdPt7O2MhhgQInmOXbA9WPJ/GrCKERUXoowMnPFEe/Yvmbd/fb0oAdRRRQAUUUUANljSWN45VDxuCrKwyCD1BrzSy+C3hqy8HSeHbW41RLd7+PUVuTMjzJLHgIMshVkUKAFZSMe/Nem0UAePaz8JLjTrSwk8GX0/9rW+o3V/9tvb4QyK1woEoBSB1ZTtX5SoPHDCptC+CemQeE7TTNX1G9kul0R9EnktWVEMbzidmUMpO4MMAnjHbNet0UAcB4h+Feh69Pqc13c6kkl/FaRsYpEHl/ZmLRsoKEE5PIbcD6CodJ+EmiabJbyLf6tPLDqU+qb5ZIsvNNCIXztjA27RkAY59uK9FooA8u1H4J+HdR0XSNJu77VpNN022W1jgZ4SJFDlsljEWVjnBaMoSAB2r0T+y7T/AJ5t/wB/G/xq7RQAUUUUAFFFFABRRRQAUUUUAFFFFABRRQelABRRRQBHcRJcQyQzLujkUow6ZBGCK+dfhvMnwx+Jmq/DbxJEjeG9YmN1oc1y5eLJb5YcNkZPTsd6jrvBr6OrgPjT8O7f4jeE/sQlFrqto/2iwugozHIB90nqFbjOD1CnnaBQB3RaOWUx7zviIYhWIxnOM46jrxUUk0kyg2LRMyTBJPMzgAH5gMd8dO1eU/Ar4lXWumbwh4xhns/G+kxkXKTJj7SikDzAem7BXPZs7lyCdvpupeVfeHrn7ZJd6dDLA3mOkphmhGOSGU5Vh6g0AadUDfTRaNLfXNjcLLFE8rWsQEsrbcnaoHDMccD3q47lZUURu27OWGMLj1riNa8SzancR6Z4LnL6xdqPMnkQtFp0AdgZnQ8biQwROCxGfuqTQB5fezaj4k1PUtLuM6d4p8RIlzqMoII8O6THtIgdyeWkC5aP5RmZiQBya+r3llpn2jxlBZu1/NJP4higi+SE2liwsbYKuM7XhufN3g4OOPlIx7zoPhzTtF0I6VDF59vJva5a5xI907/6x5SfvFsnOeO3AAFS22i6QlxbXFtYWiSWls1hCY4woihyuYlA4C/IvHtQBwWs+GNW8O23grVvCKprB8OWI02azcKsl5aMsSs8TEgCUeUrAE4OSM9mtnxb431dnt9B8DPp0ygk3WvXaRwqewCw72f8MDjrXa2OqW2p2t22jTQ3LWs0lq4yVVJYztZDxxgjFXyW3qAoKnOTnpQB574W8CXun36+I9d1OHxH4tdkUXlynlw2cJIEiW0a5CfJuGRgseuMmu8E7m/Nv9mlEYiEn2j5dhOSNnXOeM9Mc9alSJI41jjURovRU+UDnPajaxkYlsxlcbcdD65oASBHSPEshkbJO4gDgkkDj0GB+FV5ryCH7U94v2e3s1ErXM+FjA2klgxPAAzknGK5/wAbeOtA8F6CNX8SzPaRh3SCFk3TTOuRhFHXOOCcDBBJFeWxeGvFXxrv4NT8Ym68PeA1YNa6GjlZ75QQRJOR0BIGM8gD5QM+YwBqXXxa1bxpq8+i/B7S49RMQ23GuX4aO0ticYIGNzn73GOoyAwzXU/C/wAG+JPD93qGp+MfF11r+pXyIvlfMlvbYznYmdvPHIVeh45Ndpo+l2Wi6dBp+lWsNpYW67IoIUCqg68Y9Sc/XJq7QAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAgzjmloooAKKKKAPI/jd8JR4zNvr3hqddL8YWDCSC6U7PO28qrsOQwwNrduh46ZHw8+OkUt1N4b+JNvH4b8VWgZXe7Pk20xAyCWP+rJHPOVIwVJ3Ba9zrzP426D4d8S6XbaTqekJqniC8DQ6YkbeXNETjdL5gBKRpwzEgjoMMSAQDo/F+v3Vnd2uj6AsVx4gvY3aGGQExwoMAzykdI1J6dXOFHci14L0OLRdLbIlk1C5kM17dXGDNcy9N7EcdAMKOFXAGAK8Hsfh18TvhIxvPAOoWXie1liVLmyu4QjAqMLty4JVcnADjGT8pratfj/AKK6Lp3xM8M6v4ZuzJHKsVxBJIjBWDLJ91XGHXptPQcnkAA96hMjJmZFR8nhW3DGeOcDtUN5byTyWrR3MsAhl8x1TGJRtI2NntyDx6CuKsPip8PNVMF3D4t0hGjBKfaLn7OQCOcq+0/mK1rrxl4Uu7eSGPxdo8LEKxeHUYQ6g8g8k9R+lAGxq1o+q2N7p5nvLFZY9i3dpKElXOclDg4Ix1x3q1e3EVpaS3NzPHb28KmWWWUgKiKMsSTwBgHntXIX/wAR/AxjjLeNtEiCSBj5OoxEtjnacE8GuJ1z9orwqsyWXhOz1PxTqEobZb2Vs6AkdjuXdg+qq1AHtQIYAggg8givLfiZ8V9B8H6wunaday654xnTyIdPsRvdSeVWUj7uSc4ALc5xg5rkreH4vfFENFqZXwB4ebcf3KFryYHjYcsGHfn5OvRq9O+HPw38OfD+zeLQLVjdSjE99cMJLibnPzNgcewAHGcZ5oA5DwH8M9Q1TXR4z+Kxg1HxI4H2bT8BrbTVByFQZILD15wcnLH5q9hOeMYoooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACikCgMxGcnrkk0tABRRRQBh+LPEMWgWcQjge91S6YxWNhEcSXMuM4H91R1Zzwo5Poa/hHw9Lpr3OqaxMl54hvwpu7hRhEUfdhiB+7GuTjuSSx5NT6X4djttevdavrhr7UpyY4ZHXAtbfORDGvYcAs3VjyeAoG7QAVS1XStO1e38jVrC1voP+edzCsi/kwNXaKAPN9S+B3w41GeWa48L2qSSnLeRLLCAfZUYAfgKxb39m/wCHFwAIdMvLXDBsw3shyAOV+ctwe/f0Ir2KigDy6z+Afw1tVwvhpJGxgtLdTvn83x+Vd9oWg6RoFqLfRNNs7CEKF228KpkDpkgc/U1p0UAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAV8vR+IvsPixh4nt9RvvF0/iQ2ph/tee0ezt/MXyHghVSksO3dn1753ZH1DRQB4ZpfxW1K48Q6Xoc9xAurN4nuNNvLY2xVktFDmM8jAJAXnPPPvXGfCTx34h0/wjo9l4euovETRaJf3Vzpy2+XsJYyWh3ODuYyEkbScnsBxX1NRQB81aV8VfF82lF49Y0i7mnurCFH8lWe2aaTZIkkaEYHIwCQwwQfWtvxz4u8caJc+LIbXXrAnw3ptpfOf7MGLt3Zty4LnYuB6k+4r3qigD5/174qa3b/FOw0yxvY0spNWsdPn0+5hRW2Tqm54+rsuWJDkgcgYPU19Q+JniVPDPiDUk1y1h8SWn2g/8IydO3PaxxzbQ7N94/INxY/Kd3GMV9EUUAfOnjDx+fFuoanBpd6lxodjrWgNZSxIyFhM7mTJOCRlBWxpfxW1K48Q6Xoc9xAurN4nuNNvLY2xVktFDmM8jAJAXnPPPvXudFAHzVY/ELx7qGmafdpr1hCNS0zVLxVGmKxgNnKwGCX+YsFwSRgDtnmvevA+qz674K8P6tdqi3N/p9vdSrGMKGkjViB7ZNbdFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQB/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A patent processus vaginalis allows open communication between the peritoneal cavity and the scrotum.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from Langman, J. Urogenital system. In: Medical Embryology, 4th ed, Williams and Wilkins, Baltimore 1981. p.264.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_36_11841=[""].join("\n");
var outline_f11_36_11841=null;
var title_f11_36_11842="Carotid stenosis in NASCET and ECST";
var content_f11_36_11842=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F58353&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F58353&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 525px\">",
"   <div class=\"ttl\">",
"    Methods of measuring carotid stenosis in NASCET and ECST",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 505px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Modified from Donnan, GA, Davis, SM, Chambers, BR, Gates, PC, Lancet 1998; 351:1372. NASCET: North American Symptomatic Carotid Endarterectomy Trial; ECST: European Carotid Surgery Trial; CC: Common Carotid Method.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_36_11842=[""].join("\n");
var outline_f11_36_11842=null;
var title_f11_36_11843="Fusidic acid and hydrocortisone: Drug information";
var content_f11_36_11843=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"15\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Fusidic acid and hydrocortisone: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?29/37/30291?source=see_link\">",
"    see \"Fusidic acid and hydrocortisone: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F12887458\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Fucidin H",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F12887461\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antibiotic, Topical;",
"     </li>",
"     <li>",
"      Corticosteroid, Topical",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F12887575\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Atopic dermatitis:",
"     </b>",
"     Topical: Apply 3 times/day for &le;14 days",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F12887614\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Atopic dermatitis:",
"     </b>",
"     Topical: Children &ge;3 years: Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F12887615\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block foccan drugH1Div\" id=\"F12887619\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: Canada",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cream, topical:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Fusidin H: Fusidic acid 2% and hydrocortisone acetate 1% (5 g, 15 g, 30 g)",
"    </p>",
"   </div>",
"   <div class=\"block prod-avail drugH1Div\" id=\"F12887618\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Product Availability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Not available in U.S.",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F12887616\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     For external use only; not for use in or near the eye. Use only as directed and for the duration prescribed.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F12887462\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of mild- to moderately-severe atopic dermatitis caused by susceptible organisms",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F12887561\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dermatologic: Dermatitis exacerbation  (2%), acne rosacea, atrophy of subcutaneous tissues, burning, dryness, hypertrichosis, itching, pigmentation changes, secondary infection, skin atrophy, striae, telangiectasia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Local: Irritation (2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Miscellaneous: Hypersensitivity",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F12887466\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to fusidic acid, hydrocortisone, or any component of the formulation; fungal infections, tuberculosis of the skin, syphilitic skin infections, chicken pox, eruptions following vaccinations and viral diseases of the skin",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F12887467\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Adrenal suppression: Systemic absorption of topical corticosteroids may cause hypercorticism or suppression of hypothalamic-pituitary-adrenal (HPA) axis, particularly in younger children or in patients receiving high doses for prolonged periods. HPA axis suppression may lead to adrenal crisis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Sensitization: Topical use has been associated with local sensitization (redness, irritation); discontinue if sensitization is noted.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Systemic effects: Topical corticosteroids may be absorbed percutaneously. Absorption of topical corticosteroids may cause manifestations of Cushing's syndrome, hyperglycemia, or glycosuria. Absorption is increased by the use of occlusive dressings, application to denuded skin, or application to large surface areas.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pediatrics: Children may absorb proportionally larger amounts of corticosteroids after topical application and may be more prone to systemic effects. HPA axis suppression, intracranial hypertension, and Cushing's syndrome have been reported in children receiving topical corticosteroids. Prolonged use may affect growth velocity; growth should be routinely monitored in pediatric patients.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Dosage form specific issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Appropriate use: Avoid use with occlusive dressings. Do not use near the eye; conjunctival irritation may occur. Do not use for &gt;14 days without clinical improvement.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299372\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to individual components.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F12887564\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aldesleukin: Corticosteroids may diminish the antineoplastic effect of Aldesleukin.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Corticorelin: Corticosteroids may diminish the therapeutic effect of Corticorelin. Specifically, the plasma ACTH response to corticorelin may be blunted by recent or current corticosteroid therapy.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: Corticosteroids may enhance the adverse/toxic effect of Deferasirox. Specifically, the risk for GI ulceration/irritation or GI bleeding may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     HMG-CoA Reductase Inhibitors: Fusidic Acid may enhance the adverse/toxic effect of HMG-CoA Reductase Inhibitors. Specifically, the risk for muscle toxicities, including rhabdomyolysis may be significantly increased.  Management: Avoid concurrent use of HMG-CoA reductase inhibitors (statins) with fusidic acid if possible.  If treatment with fusidic acid is necessary, consider temporarily stopping the statin.  With any concurrent use monitor patients closely for statin toxicity.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hyaluronidase: Corticosteroids may diminish the therapeutic effect of Hyaluronidase.  Management: Patients receiving corticosteroids (particularly at larger doses) may not experience the desired clinical response to standard doses of hyaluronidase.  Larger doses of hyaluronidase may be required.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Penicillins: Fusidic Acid may diminish the therapeutic effect of Penicillins.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Protease Inhibitors: Fusidic Acid may decrease the metabolism of Protease Inhibitors. Protease Inhibitors may decrease the metabolism of Fusidic Acid.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Telaprevir: Corticosteroids may decrease the serum concentration of Telaprevir. Telaprevir may increase the serum concentration of Corticosteroids.  Management: Concurrent use of telaprevir and systemic corticosteroids is not recommended.  When possible, consider alternatives.  If used together, employ extra caution and monitor closely for excessive corticosteroid effects and diminished telaprevir effects.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F12887463\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     See individual agents.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F12887464\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Enters breast milk/use caution",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F12887465\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     See individual agents.",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F12887570\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     See individual agents.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F12887572\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     See individual agents.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16788 Version 18.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-122.72.76.133-87E6A227E7-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_36_11843=[""].join("\n");
var outline_f11_36_11843=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12887458\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12887461\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12887575\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12887614\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12887615\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12887619\">",
"      Dosage Forms: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12887618\">",
"      Product Availability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12887616\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12887462\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12887561\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12887466\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12887467\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299372\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12887564\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12887463\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12887464\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12887465\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12887570\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12887572\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/16788\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/16788|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?29/37/30291?source=related_link\">",
"      Fusidic acid and hydrocortisone: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_36_11844="Polycarbophil: Patient drug information";
var content_f11_36_11844=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Polycarbophil: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/61/29651?source=see_link\">",
"     see \"Polycarbophil: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F144790\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Equalactin&reg; [OTC];",
"     </li>",
"     <li>",
"      Fiber-Lax [OTC];",
"     </li>",
"     <li>",
"      Fiber-Tabs&trade; [OTC];",
"     </li>",
"     <li>",
"      FiberCon&reg; [OTC];",
"     </li>",
"     <li>",
"      Fibertab [OTC];",
"     </li>",
"     <li>",
"      Konsyl&reg; Fiber [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F14243029\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691793",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat hard stools (constipation).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691815",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691392",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to raise fiber in the diet.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F14243028\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3749739",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to polycarbophil or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F14243033\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697344",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have trouble swallowing, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697716",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Try to space other drugs from this one by 2 hours. This drug stops many drugs from getting into the body.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F14243034\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697891",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698108",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Gas.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698354",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly cramps.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697903",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Bloating.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F14243035\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699014",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very hard stools (constipation).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698607",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Black, tarry, or bloody stools.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F14243031\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695899",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with a full glass of water.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694818",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Drink lots of noncaffeine liquids unless told to drink less liquid by your doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F14243032\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696540",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Many times this drug is taken on an as needed basis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F14243036\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F14243037\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 83513 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-61.234.146.186-8AB89F2CF9-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_36_11844=[""].join("\n");
var outline_f11_36_11844=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F144790\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14243029\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14243028\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14243033\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14243034\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14243035\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14243031\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14243032\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14243036\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14243037\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?28/61/29651?source=related_link\">",
"      Polycarbophil: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_36_11845="Fight-bite injury";
var content_f11_36_11845=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F69232&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F69232&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Fight-bite injury",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 576px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAJAAbADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwCi6AkKVIPt2quY0Vs/d7/SrbbuAeeuBmo3VX6n3HHbpz613ngEaBwuWwVz1zgVJkKxAHB6GouVIA+bPGT/ACoDjaQCQehGelAFqJx5bc7gcg46H3FSo4DD0xxjoRVRGJHOQB0PtUgJJyRkeqnGP8+lAE4I4DY3EZ6c0pO3gj8uCfqKgikfOAAV7HuAKdlSNx4PJzigRMGwo4IGSOvSgMQ2RjAG3PrTN3chuOgHSgYAwXwo/n/WmIl8xW425BHX+tOjJZsfdI4J6iqxO1jubv34pc/KQMEDpjt+HpU7DRcYZG3ryOtNYhhkrg+maiDbSuO/OQe2B+VKckcMCvB9DmncdiVCD85HU4zmmsNvyg7h6EU0YGcOOecYpdzBfujpnrQIa2MfKvygdd3OajYjAYZXnt/PFWG5IJHJGOOhqORUbcT2OPce1AiBipBznJz14zUMZHngcbecZ7VNNwCdm5D2z3/pVHcPOOwkMTg570iuhtoQwGQOTnHXr3pVVeVAwzd81URl6sGUY24GcD/9dTq4L7AxHOAM/wBfWqRLHZIBPf7oHXFNxkgqSSMDPvSBiz8KcdyOPyqRRjG3BVep6Z9qZNhowM9QAMqexpwUBip+bjFAAA+8xw2c/wCetIqqoKux9Tnk5/oaB3GSRkAgn5wM5A5H1oYMpKkEken8/rUhLAcnJ6g+h+tJ5YJ+Vht6k560C9BmBlSRwOPUf/WqGUgrkhc9uD+fFWGG4blXg96YxP8AdAHoT0HpSKuVw6qxJAXceT0x3qzFOoXaeDwTnn/OaQeWSCyqe4A4FRG2UAlXI5zz2/xpDvcmeMB2cYyfu/X8KZygPXaf1/8Ar0BSAMnkdj1x60juu0gc8gFf8aAaFCYXBXkZIAboP8KAFQbWLgnP3sHr3+lLHsbGDkjnBPJ56U7zBzhVxuwMf/X9KAaEwisACSc9u/vTI14BC4Y8HB/rTlPzBdu0f7PNPDYBVwoGMBR0piI8EoQY8rxt7En0pojOCysFyeeM5qXblWViSegOe9HIJ5xkZ55wKQ02Q7FVgMepxnrx0o2kAgMw4wPmzj2zUxUHcGXkDoOlAHIOMHpjHpRYakyqJAT8wwCAoOPve1PILMAANuTx6VMCGbrlXOOOw9KjMYUbG3MO+Rz64p2FzdxAWw2Ny8dznH0p+91LKXyOADwfypChTccdzjAxj3oXAPJ+Y9cHoaVh3Q6SZlPzbSV9R0oDdCIxkjBI9abzjbjGemQfxp2cqQpDEHIHqaeoaMQ7CXUllPqOAPp+tBwSBvG7rimsCoyVAbuDwf0oBUsDsJI9B3ouxWQ8hmBGDjqNvXmkZynUuCBwCMYNNGTyC2Rxg9/alLNyBIc9c9T/APWouHK+g7eOhOPXI6+/+fSmrIxUFTliMjikVmzjKtwTxzmhHAB+UZGehxj2p3JsR7QWxkH6HBHtTCm1yuRgc/SpwOmefr2+tOJAOSNpHB9Kkoosu4YySPX09TUILDpksB90jkgVoOFbJyx6/nVUqvAOCBxwe5oAQYYZOSSOoOOad8uSuG+YZ6Y/HFIAQqrjnGA2OD70rKcrkZOOq85oGIDtJADYbqc8k+9SI54yQfc0zAwOMt06496UAY6ZOeeaQEyDBPGCw9aeoVmL4BHQVExZuSueMdPT/ClRim0HBXp8vY0XCzF8vgg+vAz0pAvHT5CfxzUij5Sw4yeT3/8A10OowRjj0PYikFiOMlAAFB5z9TUgf5SOAvXg8ClfHQKMg5pHQNjAzxyKBoFYZBAwRwCDipkIHKOQMcD0qqI2dT8x28dD/nFRuHjJAOR+e33ouOxoMCAVO05OOO1G0q3Axk5z16VWinyu1s5JHOetShmY4UkgZ57njtTRL0Guh3cEuuM5PJBrOmTY67cDI79z2rTbOOw44zzmq93EXD7dxwMMP60MYkLnacg+3rVhGJbIJHB5Hc+tQRZJAC8+nUf/AKqcpyHLgjA6HkD2oTE4liJjx1LDkg8VKCwOOCOpJ75qohUh1JI985qeMHAVcccHnvVXRPK0Sq2fkVcLyeKazccKcE8tSqX52kBQcnI56UhwyDb93uPfjvQDTYp4LcAD1z1pGVcfK2AT26UqjcMpt600Edh8r8emBTRMhzhWbnhQAT70xsnBOAMEYB6/j/nrT+UOWBGDkn8OlNICZDfKO+RnBoY0RFSCTweM+jf59qNpIwNoA6BfX1pxVjtJwSwx6ce1OUEyE5HPbpk0h7DCvGPlBPPHWo12jacH65PFWF4b943zDIz3qHYEJ2s4U87iRxQCGvtChggOOfmHX1P1px3MgByuBj5ufxpjY3gKMrjoaD8wYnd7/T/PakMmADIwwMHjPQ59KVQWYD5t3Jxmoeq9SG7jPapN3y8nJPIweRQAp5UMW5H8QGe/Wg5bftOf9n29KXIwQvA6jPUUYDDJOSDgmmJkY3bQUYkdzninDcASpUsOCD3pQq4ZlO3274pBglSGAUZ9jn0/pTEOxhSWxzycetINyttOMrzuPX64pI17EDawznpzmmc7mBjOT0z6f55oC5KGLYDMeuevel3fMNyZJGcr1BpCrdsjH3vT3pCqtwWxkYKgdqQxVAbJ3AJ146YpRGM78+5I9Kaqs2NuCCeOOPwp+fmYlOfp0FAIQLiPn5uOcmmtGM8kgjoKduHQttDD5SBRklRlS3HHbn/PemgbGmPB3HlgcH3qJoyQMHnP3s85qdThNzDDevrSFeOeO5/z60CuQphQeoI5xTVPyr05ycj/ABqcLxgoQP8APNJtO4bPlJ9+KCkxh64xwB0HSlU5XaRgd+eMVGRgAhsjqeadu4UE5GM8jNSA7aoO4nHFRsAM4yBjHFP98jbnrUbgMSvUkZAx+tAN2IWQqB0C9iePwpoX5+Bgnt2FS+UCD2UnBB9aR/lALHnPpQCdxuSwIKgjH4/nSkhTyecdx1ppb5Qw2kgZwfX0pgbIG/JB5B7H60guSMVJAGQCMU9FPTaAMevX29KiCfM7EEg9B2FSkZXgcnggDpSLbRLGNuCM4zg5qQZYt8pIzjr+VRR4GAuW/D/OKlAHbG3PPNMkTaBkkHsPrQXIJBJ68KelSbi24KOCeSOhp33mO5QOvUUCsRr8ylUIDHnkcmmOpUKHHy8Z9zVjjA2cLjoDTWU7uchR2HP1pobZUGd5AGOc4qVWzncoIPOSf1p4QH5hjB5Gf8e9NVQBjBK9c+tIY3cAAV6n5Tj1oMilSzbSo5IP+NPkiLKEPBzg5/rWHeypPMUDExqcbOxxWVWqqcbs3w9CVeXLEtPqFvFIQGDj0QZ/XvUX9p2wGCZUQcAuOPrxzT7WGJsDb9Aavrpsci5C8+npXB9ed9EexHKY21lqQxyiSIFGBQYwVOcVZVg6DdwB3Xr/APWNUZdKa2bzLU7Hx0/hP1FS2cizBs/JKnDR5JwfUeorro4hVdtzzsTg5YffVGgDkYGcBRn29qcxIkdQSBxj2/Cq6HC9wcZGef8AP41LHISEwcevHNdNzgaJVwxH3s4xjHT601SWO7b0PAzwKbkkKQpAxjOep/rS8kZXlyMc/SrRDeoDKgnnPU45OKUBvvAqz44ycU0tww4B+7yfakBGNuAGPtwfY0mwSHdCGAJUcEYppVgQR0znHr/nNPDAPwfmyOT/ADoxkffyzd8UDsyNTncV2hjnketLKDsbjJzxim9WIyBzjr+op4T14PQc9aBakG0Ft4D4I59vwpm0D7hbeTnHUfl/WrB+YZYg85AH8qYwBYk8kcZJwB9P8KQ7kJJBUcNg4xnFSCVUBJB3ZwP89KjVmXLryeQe+O3407dtLAY24Gc9utMaJkkRl+9weD6U7IIbawwCf8/nUOQXO4bewHGPqKVMCQHcQCAAT2GPWgGxzgAqSRjOAMdfehiMnoy9euKFIz8nTknj1prKA3l8gEbiSO3fNBIo25K5IJGVGad8gXBHzKBtprEqwzHuI9Bz/wDqqNfmPzbiBznOf50wUrFjcQeD90Z/z70gGGLcdPpUewFWII2Z/hHb1/OgNkAlj8vOMYP1pDRL8pBPyjsOMD3oIDZHzY4GAegpm47SBzj8QTzTww6gAEDHXJoATBCAgq6t0FMQnAXad7H5eeg71KCD1K5BwcnvQseXOQo45XrTQg42HJzjgHHahlG3Jbpx9aPL5ABIHUZPNDBgcH5iTwMcn6j9aA6DQMnaoB5yfWhgQxDAdeTmlZcgZzgd+mfX+VIoLfMAw/vd+PXHpQCIOhzg89u3+c0oYkcnn+VMIAIJ4HpmkZjtyMEE5UY61JTHk/JhgFznmmj2znpgGhctjK9eMmjcAvTgduuKBClehGcN7Uj/AHg3+c0ORtGOhPQfyo/hGPegVyCVQP4iSOwH61GjAk4ODjkYqztxkADOelRFQBhPxx1oGKqjeV42k5x7+lSxjgEkE5znNRIhwrZG3JBOMfhUm0v2AIIGAKVh3HgjqOxyMUeZswdpU8/r/Sl2jf0UsfSmgkgZyABz347UBdj0kXOVz747Gp1+YAKThuAc1UTPQL8x/Qe5oSdAcH5cNjB/lRsUkXsE+4xjPr701/lx1OcDIH86ajZwFDbc8027XzIdquw5Ht/KjoCtckZQf4s4PFIVyw3ZIwefb2oRTwpJz/ER0zUgHJIHI457mmIo6hO0FjKy43Y2oSe9Y9gqJs3DJxyav+ISfLgB6bifxxWUkgQ5PFeXj3rY+jySlzJs6OyIdgu0YNb9rpivbzTK7IVxtA7n3rn9BBcbz1z0rsoR5Wlb9xzI+CPoK4acbq57VaPLojHKBkwygN0xWFq9v9mlF2gwU+/x1TuK6SHD3kwI4OOfSq2qQhonRgPSqpTcZcyOTEUlOLi+pkkE/MGUkgDr1qSLcuS6ls8Z7EZ9qp2J3WcSZ+aPKkfTjP8A9erUZLAN074HpXup31PkpR5XYmJCt/eJzjHWkUHDEKpLcY70r/KwOSCQMf570KMELkbcZJxjn2rRGD3FBO4beTzwR+n6UM/zgfxDkEdaaTlvmyCR+nrTiVbaBuxgDigaRG6EMFJAPTOOaVl24GRv/X6Uu8bdoOBjqfamBv3hAILGkDEAYsCd2W67e1BJHJHPHQ9M04MCvTp2J7UrbSxGeOvXqaAQzu4yN2ePegkkfMDjnP09KXYq7W6YJP1PpRj7pXO4DGOmKYrEBKGQOMgbQBuGMH1pgKoGLPuY8Huc+3+eKnZA5xliB0OOvH86aAgH3enHTpQCIly3DE8cgdzilBO47gMEcjPHTgfWkCYX5cbQMde3rSFh0yAx5AxnPvQMnCsVcHcOmSecU5WyTuYgNwDTI2I+UsAe2P60uAXyWySDkk9vegHoOAzw4G8tyd3T2prMzA4wCp49BSxxhkXK/MvXPegsHZc7fM689DiqJHfKQGjxgnGMYpwj6ZkbIHAx3pgAJVs5U5JB/lTcnJ5OenBwakY4HKDeh2k7eOfy9qXALYLY9yM8f/rpMDJCyMFxge1HzMMYXZ14/LB/nQA44B42ltuM0EjbuIPXdz2/x/GkONuMnBORgUpHTgb/ALwJp2C4IxZ8Ky4HqKGGBgjLH5fX8aaq88k5XgjFOHOSmFB4BAwRQK40cP8AeJONoP6U7lc/LyP1FMOcZ3E84APb3pwJwOuc8etMS3KxIJwWHHXPSnSYLcHOcDP0pmeRgjp3oJIDAhQc4x0qDQY3BXZ3J96kG3O7Hf0qIuSe5Hoe9ODrhgRnoeRSESg/MrZGQcgDpSHOT/e6bsUiAEbVJYHvThg4KkYqiWheD1BxULqAB3756gVZDABSeo6KTmgnDDHBA7c/hQCK8YAyMk/QU4NhjnK4OQT2NSFGO45BA5waPKLAt2zzk96TGRo/zqc84yeeaSeUQIZJFwPXuc0rKdm1evYVj3szy3WyJcpH07jPesq1VUo8x04TDyxNTkRYM9zOGECLEp6FuTj0okt7wgHejEDoV4q7YwM9uJDKA+ceXtORWn9mktoVmuInWN/uvj5T+NeXLF1G7n0dPKqCVramPbXjIwjvEMRbABzlePf1rRQ/MxB69cUlzbCWIggMpFZ9lK8EptpXxgExue49K68NilU917nmY/LvYLnjsaRw2FPB6ZBpwz13EcgcjrUaFmG3bjuT2I+tKVBXBXtg+47V3HkGTrrGSVFGPlQkj1yetZJUsOBnHJq3rUwW+mAPACpnNVYZn8sgYIIwPYV42OfvtH1+RxtSUjrdCXFvDz1Ga6m5YpYwDnBJ7/SuW8Ptmyh7nGD6Vs6rNtijiB+Z+B7DvWcdI3O+rrMm0VPOlZz8yklvwqvqbAq2OnatLTUCW5IBwB/kVj6m/BpJWRhLVnOWrKPNXABEhNacIAwM/LjGRWJbuPNuEwc+bjP4CtqFgV3AjJAxxxXs0/gR8jiNKsvUlUYfOMjHDdce9NVEMeBzxk+9HBJxjJJJz/KnHC7R0U98cGtjl6jJB8wBDYHvSlct046dOlDY4DZUdcE0hJBCuenqcZPpQA3YSRxjPPX0prAgkHh+OfanKSQN3CnAyP6UpPz9Dx+ooFbsM5XruJDYOevtxTgwOAgDD1FIEwpCqQFOcdyKGCb/AOHnv/8AWoDXYQMW+9tY4yCP4venMwz852kD5TjqaYRhvmHXvn/PHtSqpKsXBz70ABOeeQScZDU0K5yc/MB1HSnbTjBA4GOOmajIYjnKcbhgZ/CgBcfPgdBzmmeWdyDIxj7xFODEbldSxHVsY5pWZQG2gk/eIPce9FhkYyrFXU7ev5f/AK6cuDklTuwO3T3/APrUpwMqAODwCefxocguexbAOB79aQ2DEMrMG5HYD+dKEU7guNwG3mgBmACgEg/n+NKV2k4wVbIOB2pkWBPlkPzHacHj2pWUqG29Xxg9yTSHcMDOR3H9aSNjznr6HPNBSAsMjdkL7+lNcfKFOMYPydxj9akYqzcjIIH40Yyp3nqM9OtAbiZ24yAQeACc5+tKWDAADgc5I6e9KCTkgEHPQetO2LjC9Qc/d6exoENII5BP09R60nHykcZ4P4f/AF6VhwVwAvrnoKR9uDxluxximSAJB4O0gEtx2oZmAxGcDsT60m49wQynH6UqnKngEEZYUwuUiVBwR+tKpOCMkj0FNTGMqCQPQU4ZHy8lgOvWszQUBSMgE+vNBVsZxle3tSM20nHBOSeOppyE4OXO327UwEOQQuMDOOfSnxAdRgAc4J70xWAbrjPQHsKfkbsfKQRnp39aBEiH58EHeeB6U4IuMg5ye/GKaZBnGQp9/wCtCqQvUnnOB/KmhNId8oUkKuD1waVXHGM/SmKW8vOOD1yOtSDIJAXP8zSuIg1CQxWFxJwGC9fSsXTl+79B+daWukpp79vMIXHWqumjI6ZwMVwY13tE+gySGsps6DSwRtGM5rqdZIazggPAVOg965vTOZYxj5TWxq02Zmx09zXC17rPfeslYzLWJWgyORzWFrCeVIkyjDIwP4V1FgmywZunORx1rD1lQ6OMZ4NZ0m4NSRniIqpGUWIVzngHPzDB60qluAxO3Bzk9ajsjvtIiDk7R1HenXDrHbtJgYC5HvXv76nxLVnY5LW3L6hL2O/Bx2FX9Nji+XcFKjnJNY/zyl5M8E02DT2kuRK0jY6BA3yj8K8LEVFKo2fa5dScKEUdk+sWekwxtnzCTgRR8n8aksJ57+dbm4Ty2IGEBztHpWdZadGqplehBPua6OzjACgcd+lQm5HTLlS0Nu2fZakHucisTU3Xc4BrSaURWzl88DJ4rBnkMhO4Adc1o2c1t2czFceXqNyhHSUc/UCt+0kwu7BC9QSOhrm2JFzdsAciXt9K17VBNEASckZBz3r2YaQR8jXd60vU145kk3CJwxqRipJIzjof8KpW0fkgnLdOcj+VTu56hsD0NaRuznk0thy4ywbgdP8A69JkEsGwRjIz1oztJ4yMdWPWkOdwOc54wBziqIHYTjA+UjcPXNNlwilVBHHynGfrSjIGQAc9Oe496aSQTxkEdf6UAIBvkAwM+hNO3D+HJOOvuajbLDBHtycYp287uBnBycHBzQANgnrgDODmlOCRuzxk4HekGG4JO7sD2pThmAZcdMc/5/8Ar0CG7QSo38ckEUbWx8xyD29KNoJPHAOee9IGDHqPbPQfWgewcbfmG3tgnkjvThE0i4QFi3K8fzpGyzEYx+Gc4p6TvFuIwwJ+6wxmkUl3Ipkb7pbGOvsPemuxVgGxx3xnnHenFy3MmN5yAT3pGO58nO8DoBzjpQLyFO3cAVIGce+fSngxLn5mT05pisWBBGSTjB449RSqTjLBeckdOx/lQFhVGOAw3EY5+tNYEMcnOfx+lCqNwYBCCeQOpwO9OVSFzkh+Rgn71FwsR/MCrAZfdjCj8ad5uZgMfvTzginbehBOT0PH+RTSAct0IHGOMUDsSEA4wACTnJ60hZyvJXJPI9R349egpCVKkt8ignBHb1/OnEKepLY684pksUcYwATjPPTHpRg4YISx6nHr6YpsmShyNxHJC5HHrQy9STtX09+1MTAI2FJPykYP1oAzhg5O35sD+I+lAJKhVyT6Edu9IjAHI5yccevY0CKJU7jg89eaO5IDDvtHAoIyw5wPSlC4ABOT7VJoLwxywxjnmmlWJb5Rnt2qTLE7jzx1/wA96XcTnPIzigQwof4AAccAnnPpSxq2WDHnPrzigHcwxyc8elOQBj6sBjn+lAArBvmXAJ705dq445HXOTTQu0jb36jPWnZwQSSMdh2piHt83y5OD0x1p+7chZSBzTRn5SpBNMCsMg/N2oEyhrhyYY88bWcj9KNNHyA1R12ULeuB0WID6Zq5YcKh5wRXl4l3qM+pyqPLRT7nT6XjzFxU2pyFmbH3iQPzqpprpG+9zgAYzUiP9quzIFxFGcLn19a5pPSx6y3uasqiKxjXGDXNaiflJHfpmulvj+6UHjArmNSYLET0x61DRF9GQabkWka5+XGT7VDr823T3B4Zh29KfYELZw5GV25J9eaxvEE5eZYwTtHFexOXJS5vI+Sp0/a4jk7sgtohsAHAxxWnY26kgkZFZ9oQOT2rYsyMcdO1fOt3Z9olZaGjbx8jGcdBWtCmAMcY5IrMtWAPTPua1I2KrgkkY71pEiVyHUZmKHb0xtPPc9P5VmSELDzjNWb8Bjkkk8H/ABqndnZGVxgg1pHWRM/dgc0IyZpnUjBlIIxWpZvtAYhgg659Ow9qrW0YNsWIYZc5PQHnvVpBsyBzz3Ga96C91HxFV3qSfmaauo54DEZyP8BUwOcAZJPXn9aqxSDaOwwCOP1PvUscgOAzBW7e9UZkqjPAbjocc8UEvkAY3Z5HuPSkXlV2Z6ckHjNAH3uoOPvf59qslgy92Py9wooGACd2FzkjOMUoyOQpD56A0p+8OSw78Z4oJQwqS6htwz/EvGBRwG+Y8DP0PtTwEYE4AAbIGc0jIAg7dSB2FA0M+RjtIA6c9qVio3lhjvx+lNaMNg4BAGOD1/8Ar05Q2TvwR1AFIY1wrMA2QVwfr7ilBVgUboCRzxSHjGQNvXIOMmkY5zu4K9MDOfpQAMSQNpUc9/QdKTcT97gjkY5yfXNPCBegznj6k0pyThcnB6YoGRyYLZ3Agt0VsVn3F/FG4EQklYcHZjGPTNJdXj3Fy1tZ/dXPmzf3c/wj39fSrFtYxIgUKDXJXxKhpHU9TB5c6q5qmiKP9qBHC3EEkakjj0+laNrPDco7xOHwOV7j3qX7CuwqqBlPWM9DWTcac1vIGgfa6ncjDrj0PrWEMY7+8dNXKlb929TXZhtwoHTgjg0gBGZCdx4wW9KisbwXMRJADr8rp0wfWrWY+GYbWPGQc4/yK71K+p40oOLsxGbGSdo4znbS7s4G7BzyexFNKjYDGRgdwf8APNKAchhhgTyo9BVEMdtXnacA849B3oABBK7VHTp900h2heQDj0xzTimSMk7j/n+VAmMWNhu3lnOcHBoAC53scg9l6e9OUEBGAyMZwPrTVyMJu3DtuHOe9USG5gMqx45BPf60vsEIBHORjA96eVyCeDzkEelIw4HzHnP4+1AJGWpyTz8pOakLFkGQuMde9RYHQjj2qVeikdqgsFIxyW55G6gjjAxz+lG1l3EemcdAKVNxU5Qgn0piAfKMr1I60BjtOBkHt1oYc4Kngc4pgbJIwOvc9fpQInBxnfjHGPanALtDj2yKg4DEngjoB61PGwGcEcjrnOKAsPZMMAMgjoTQNzHGRnt7UoYKnHXFNJCJncAFGeaYHKag3nandHjbv2jHtV+yu3jQJsU8Vn2KmV3kPO9y1blvApIyB614WInebaPscDHkoxT7F21865AB+T6VtxxCGERpkBTnGKoWWExt4NX1kBYt1YnqRWcTrbJbuUtHnOQRXNavLiNsGtuaTamO9cr4ik8uKYjspP6VTJMnwZrP2i1kt7iXM6OzRhzgsMnj3+lJdsst58zAgc4rhbT7U1qrW/8ArcjbjIbJPUGuysLfIVrohpVUBm9TjmuzFVLUeU8TAUlLE8/qX49i4C5GfSte0USKp3bQOfrWWkOdoUkAnPWtq1t4yijJbHHJrxz6fSxetkjaTaJFDehOP1q6DhCOTnnrS29uscQZYsjoenJ/GomysrEn5T1Hp7VrsiHqRXu5iAMbQe1Zl9JhD+taF5nAKn61j6hIqE7jgY6mtaSblY5q8uWDZPZ2+bJd6HOMkjsKVI8vuwQM/MM9Kt2u0QoATgAcD+dPeMEM+AxznOe9fQWsfDuV3cqryGC4LDt260I2FOMZHTP8VSOg3A9D9MCmlcDKq204OMgUMa1LCkHKhuScjPXp3p7KSCpP0IPJ/H86gR027ux5bv3qYlckMvA45P8AOhCY85YngkE4z3xSKwVegD8HkdaNoxtzlc4B9PWl6jAzkHI70yBoAOBnB68/ypzncM8Y9OvHahW3BM4yvJ96RR129Dzkf56UwsDdd20DaDUZT5lLHA253jjFOkycbSMDnrQQFHTcvHSkBEVIVlPAHHPcU5GYjByvOQelSNywDDIHQrxmjHqVwPlVgOlAxpZsAkrjrjpVDUrqRkMMBwxADsOPwqe6nKQqqEbn4U9wO5qrCqySALyF6n1NcuJq8q5Fuepl2E9rLnlsiWzgEcYVFCj0FaVvGW4pbeHPbjtWrYWm45bpnGPWvMaufTq0UQpATjHFRX0UQQDA3fzrob37NZQFUxI5HzAevYf1Ncxn7RKz9UQ8H1PepkuUSXNqYJj+z6spX7kw2MM9e9aJK+U3OEPA/lVPVgRc22wfN5g49asAnKsG4P3cDpXp4Rt0z5rMoqNZtdSVozwAeBgge9BAYs2OGGMBeRUasBhd36d/eptxJGBhunpXUjzRFwx+Zef5e1SJ94krhuvHf0qIsGOQM45IPBPvTlb5uv8AwL0qiXoHQA5IcDIBwaVCRkg5DcEe9IzIwYhhvByMjj059qcT8vUDuQev1oF1FAGFycAc8jrRyo9G68ev9KQ9RlQp7ZNKOcjdg45A9PWmBm5Vh8rMpHqKjIYEgnP+H0qUJwecE9SRTWBCjHr3rMsI5HVVBPTvipS5ZQRzkYxUCZRzgnafXtUhIC5GCccUxEhO75TjI9OKjYc9sY54waGICggkgcH2oBY5AO4Edv5UwHg5O3GD19elLgqq7W4z1IpAgPzNnI64qUZUEDaeOaAG/MqgAHGMAiqurSmLTZCcgldvTmrvIIwMAccjkVj+I2LxxQKCNxzzUzlaLZVOPNNLuVNNChVBIGB2ragKkA56VlabEUUA88Vpxk7l2qCD1BOOK+elK+p9tCNlZGva5IIwMnt3q2ANuAuDVOyyDnB46EVdwpH3ju7g96qLKZVuCT078c1yPi+TbYzsp/gbj8K626xsI4xiuL8VhpLOWMEbnXaPxqo6sUtI3OF0CbbdWgkj3kqcHnAOPvGuxteUxtIrOgsBpsSwbhLJJt3NjABAxW9aRiOMfT1rpx2iUTy8p15qg6MsjKQpPYVrW06gKGVQx6ZbGazyT3bPsKjV8o4XBuGwAHz93ufp2rzbH0EdTrpbsW1kocq7s3EaDBA9z6D9aqWtybxy2wAZwDn/ADz7VzEF211KYJp2xGeYw38I6jPYfrXR6OqQwbVYn5ueMfT9Kvm5iqlP2cddy1eIOufxrD1NN8bE4Psa37gbo/cGsfU1yjkgHIPFb0tJJnmYjWm0WLF5BChZOAoBYnnHfj8amhA2EKrICcYxz9agtFLWsI+9xyx4qZwWKnn6jsDX0B8PsOZdzHnBHH/66hkjZOVIOOh61NtYcbgxJ4Oaa0ZAbYRg8j296TKTIVkycMM8Y54wPWp04JCkHBzkDFVpSuApyGLZyD0+tPhHmDIAGeSR6UinqWFZlP7zoePYVICSc/wt27/lUbHILYJODwP5GlVTjgcdBz+Z+lMl6Cn5u+d3GPSkVNoByNoHIpzMSp6jPQ0hIf5sgj1xTAay5Pf1OB/Knc8kkk5yU6Z9qCWJGcZ7+1J0YggAD05yf8mgkRTgZX5wOGGaJJUihLO2FA7mowQACPlI4HHGfesq8m+1TCKLiBTluOprOrNU4uTN8PSlXmoLqRXVxJM7SfdYjavstaukwjylAPNZzW5ZQR1qe0lkgICrkV4cq15tyPsqNFU4KMTpoYyOCK04JBEvfIHA965+21lEX97CxI5GKsG/kvcIiGJf1qlUj0NOVk2ozNcMYlYk9yO1Rsi29uEAxV21t0RRkYA7HvVHVZPmbPHpStd3YOStYw7rdLeqFOCg3nP5Cp1ICblAD8HHaqkKh8zP0ZsjHYDirER+Q78kg55HT6+tevQjywSPksdV9pXk0PB3AfLkHA5p4YEgHOf6U4AkqG7dQadtGAeQo7KcVscgv38KOBg4z2pqx5zh12NxuHBP/wBbrTWXdwRgdRu5JpSMoSuNo6cdSaBCgAjCliCD0I4oXIUEnJ6hs4FBI4LHbzkEDn3pQCVBY56cHrTRLBXJGNoOOvOcH/PFDBVABLEA5B/xpR0HqM4x3pFcFeEIIO4+vSgEyptyTjp/OopJIo1PmYA/vZxUspCoWI+Veaq2tl9rfzpWRieilvuiuerWjSWp2YfCzxErLYj+3WhAy+PcgkVaRkkIeIhgwxkHP5+lacWloI+Yhjp061RvNICHzbQmGUHt0P1Fc8cam9Ud1TKpJXg7kRyjAhcc4IHakPByOD7+9RwTE7kmUo6nDD0PqPapORuyc9q7E01dHlyi4uz3JF4AxkEduP0qVQQ3oD09qhUDIUZJ/WplUFc7uc/nVEDlPBCqQR2Fc9rU27UQCSAoxz2roigBwO3OM9a5jVQf7UcjGcjJrOt/DZvhV++j6ly3PyqV+YegqzZOwkPyMef1qpbr907T74FaenoVPPuTXz59jE2LLe2CYcjGcZxVuVSISWX5t33gcjFFihdwArAAduP/ANVS3S/Iw+XHt0rRLQd9THupOOccZOa43xE6hUDHAMign05rsL/JZsYPOOK4nxiEjszNgZQhs9+tVT+NEV9KcrdiFis2pqB0X5iDWo+VizuCjPOazdCX7Q0s/JBO0E+grde2SaB4pMhXGDWmLnz1Wc+WU/Z0Yp9dSrp08dxuGDkEht3X8Ko6jq8O/wAuAbWbq/T6cnpVO7trrRbxXhbzLfJLJjPy/XvVie1h1lFubK3YrANtxOxC7CfulV6nH5VzdD3oU4xaluibwxpputQBtCFj2nfJKMrn0HrxXZWNsIIlXA3DJY+pp+k2EtnCjmVpGkUZ3fKFz/jmrWz5ifeiMbbmGIrc702Ipc7Ce2KyNS/1D544xW1MMRnIrB1I/unznAremveR5dd/u2WrQ4tY3OQoUZGDk1YU5wT36jP4VHFlVUHll4ODnHFTllA+9gt1r3z4oBgkjGMD8BSY28AgbeM05VLAfOD2wBQykL82N3YnrSArvGhlKNkA8H3pqKFbI5IGcnipAhwpmGWAyD/X60kuMgjCsD68YpFoSM8ZEvC9fzzUw3KcnGSCOvX8Kq43MvbAzx2qVGyQGABxznkY/wA9qAJmxsw3VjyB+tI3OMNhc9M44oRht3NkHp+JpwAycHngCmKxGOSzAEqT0pHIG/5Qw2jkjpzSkgrwQM5754+lRtIqQPIRtAHORjjsaZNtdCnqNyY0ESYMjcZA4FQ2cXA9etV40NxcNKQBk5xjpWraRYwSK8TF4j2srLZH1mX4NUIXl8THqhPGKesIY4qcLwOMU4J0IGDnB964/U9VIZDah3yTx0yB0rStYVVwRgYznPSoreNg7dQFqcBypC4Bxx6CrSFImacKoHGDzWDrUx24U43kKPqTWhtMY3Nyx/lWROxlvlGcCMZBAzzXVRg5ySOHGVVRpuSEUBEWMhcDjrnijK9cAnPIPSnFQBkLgLxjPQ+lI3yMV4yp/i6GvYPkE3clUKdw5X1z3FOTAI52gcj25qAOF+9gZOM/0qViVznjAxgjHPalYoeCNpcjk5+g5/lTurDON3UBj09KYJG5JTknoO9PbrtAOO7daaJYjc4LZP6fhSkjqMbucY7+lIxJXgk9M0uQ+du3d3H/ANemLcAVVdnIAxjv9fwpHJBIb36fxU4qo6gd8+9NCAKWJxnsegNAjE1mUosMan5WOT74rR0UnatY2vORNbemSK3NGA2LXl4tXkj6TKEvZS9TqVIOmtkd6rTIrQh17inSSAaft9zSwHdZHHUDNcklqerbS5zGs2+3bcJ1Q/MP7w7ioVIc7lz8wz0rWvVDAg/xVz9sSm+M5/dnGR6V3YSd7xPDzSgotVEXwGznjJ4HPWpkYDAYE46k1DGRtHQ96sb8LgjOe9dyPHY7Kk5wCO1crqLbtSfB4zXUZGCe46HsPauVmG/UWPq1ZYh2ps6cFG9eJpWYY8bc1sWkbcECqVmAqjjtW1ZRcDjPfHevFPrEadnFgAuCxPABbApLobc7gM9Ao6CpYFwMFBg+pqDUOEPTI9OlO2gJ3Zj3PU464PHvXCfEaTy9BuQo5xx+dd1ckAHA4I/WuH8YRC7uLWycZEsilvoOT/KnF21HNcysXfDduYNMt1cDd5YJ+pGTW1jpxUVrHlAe3tVvyySMetQ7t3Cn7qSXQr6nbLLp8pyN6LlR3Le1YPh65Jz5kAVkcEsF4GCO3TtXVvA5VtvBYYJ9jxXMNZXWnaxI9gGeJVUlWAwdx5A/xpSTPSw07xcD0y5iQWqO6gtIqlGByV579vas9eWJPAzmrenymbS0RypmXcWDPlh6L9RVd/vnt61pLujzndXTILo8GsDU8FSoHcfzrZu261z2rSBYwxOBuFa0FeaOPGPloyfkasODgHCYGMtzk1ZKk4CYC46YqpDKrxbmKlRtwfTP9KtJksCx7dq9w+O3FVdxAxxjv1picyAEZJBP07VKSQTwc9OOtKgGWbnn+XakFuxFk8ZGOoyT/Ooydgcr83PPGOatOuFOcDH41AyBiQ2OmeTSHqQ71GN2MY7cZ+lS5HmAKMn17VE4VowcdeDnrmmoG3g4woGD7mgomDbnCkAY6in71LDuAM8ciq6sQGyfmJ4HoKXzemVXHTjkGgCaXG0gnjtkYxgVl6w5eWO2B2kYZ8Hj2q68ixiRn+Xjk9sHnrWXYBrhpJpQd0rZ57DtXNi6vs6em7O/LMP7atd7IuW8RRQR+RFXoXQDk4I5xTFBXG8Hae47Uhh81twzXh7H1y1NGJfMA4yDVqKHHzDp0xVe0t5Y9pjkznsw4NX/ADW5SVApxjINNLuS/IeNo6Dg/wCcVDK6gcHqOtJuwDzVSd8A81oiCHUJlRTzz3zWXbKQhkfJZ23Ae3alunEs6xjnJ5PotTDaXzjCjgHHAwP/ANVelg6ejmzwM2r3apr1Jec4Ybm7cdqYGyQBkMDzznr709C6HBUnHbGMe/HvQnPXDd813HjXKz7MqcqMn8frToiNmWPKnHHcdae0YZCc5J/E/hUSBkPbd7HrQMnxjB25xzx2NN3Rkjrgdj3HenpyoaPHA3MexpgZhw/BJ6/5/GgGiT5cnaCQDk4420ivwOCQec+1Njl3OpwcqxGT0qU9Tt4x26YoJEypPIwT0P8ASkXJJboep47dzR1GTngZxinAnBPO4cY6flTEcz4hIDQeoBP61s6M48te3FYPidyJYV/2al0rUUjhAYncBjAry8S0p6n0uVL918zr7ufECxg8sf0rQsDi3I4+YflXO2BkuGMsn/AQewrbt22J83cVy813c9e1lYp3gIdh71zzkLqEg4GQCP610F4cgnrXOXfF6ATglCM10YZ/vEedmUb0H5Fy3B6rwB096u8kcrj2B5FVbePbtBH0H/16s5bGSCcjjjpXpI+ZIpJDHbs2eVBwe9czZ/vLs9cdcmtzUmKWkmGGDxWJpKnz2ZsYJxzXNjJWhY9DK4XrX7HSWak7RW3ajAHIOfbpWTYrzlcEitm1yqjmvKR9KX4QdvPA9Qaq6gdsf4dulW1I8sleoHTjn6VRvPmXB61T2BbmLeNsYDPHI/SuTmAufEBfOViXaPqa6HUnKOWJ4XNc9pIMjyTE8yOWGfSpvoWzftxgAdavKCCMfWqtsAFHrWpAo6kDnvTRK0Hwp5ncg45rQWyguYRBcopXqrD7wPbgdR7VDbAdBjk9OtX4gM5xj6cj8qtCcmjGu7O5spzLEImjxsALfMffpyO+M1ZTLJlsdK1JFyhwQV9uuf61Q24B6496mSsU6jktTJ1A4Umueu/3mxMZJbr7+ldFqWFjJrnjlrqIDH3j1rfDL30cGPdqEjTt4yFKkKRtGccAVZhlQIPuru/nUKlyoAwc9ST/AI0+Jl81kePBUZDHnOeDXsnyS0LTDcPkIUHjOeaVV5Hr7dqYxGflJOeOPWpCSCOQCBySaAQpy55+YDsKibgBgM+n+NSMPm+bgg9Rxmm5GQR8rZ4PHNA7lfYV3EZ3cj3pgLBSM4DH06etWAQwIV8dmOOlRFQAQQRxjJNIBCRliWVccZ7Y9KYQuFDLjjpj+VSyc47hTwKhuplhiZ3OFUFvrQOxm6nIX8u0H3pPmfBzha0bG32ouOn6CqGkWzzSPdSqQ8pzjrgdhXRxRBU2jv2rxsVV9pPTZH1OXYf2FLXdkSx5jwTwTgCnRWzbhhsexqysWe3P0qzDGC2VJ3dsVy2uejcdDuRMPGT/ALSniopOWLDgZq5PhUwrgjocjBqq/HOFAPfFOwXI5O5yKyr6fYCcjitC5fajEkYrmrtzNexW/wA2JDkkdgOtaU4uUrIwr1VSg5st2CkQSTEfO/57e1WDGu3anJ7k+tOCgFMcflj0xQY+CNuOzD2r3IRUYpI+Pq1JVJub6iIoGQpO3HX1NKNxBOdytzkdqVi2QQh2+uKQhf4R8x+7xkKaogjJYc9DjjA656VXbCKwJII9P51cJ5HBzjAPvUEkeHAA3FhgECgLCoWc5zuJ9fT3p2VVf4mHoBUBHXcSQB2PBNO/eYOw8McEE4wfQUBcmGGfJPcqRnv0p468YAzznt71AjknbJgZ64GOKlRiRtcjOASG4xQHSwo+ZcAHb0OOP8ikAKAMcnofYelPBLOgGRwTjp+YoweNyk4BPXGfTpTFa5xniVy15GAc8CpNLh+YEjPvUOtEPqRGckYH6Vq6UmBkjNePjHeZ9PlStRNy0AVNoz7CtNcKnvVC0UkAE1bztUj17muZM9Qr3jYB9O9c/fcXsGTjqM/hW3MwJ65rC1Bj9pgz2bNb4d++jjx6/cSNG2UqMDIA5GKsB2A5HI7iqlq+BjOen41bZgB1J5zjvXrnyhl65IFtwOG/SqGkg7RkYJ55p3iCUNIRyO1P04YwAOK8/Gy2R7WUw0lI6GzAAB5z/OteDaFAY8fWse0boRjPpmte3J7HArgPbL0QymAVYeh4NUrsbSQQykdjV+EHaVxvH+yapXwAXOeD/npVMFucZ4om8u2kIOC3AqjpSYVFB4AxxUnij97cW8S9d2fyq1p8O1F+VQfTOayNHsjSgTsM1oQL1G5vzrPjODyauwEnOVIxjoapMTiX48hQMq3bkVdgcj+EkdiprPiYZ+8V+oq5ASsZAO5e+Ov/ANetEZyRakkyM8E/TFU7hgM5PNSO23HJ6cCqVy5FKTCKM3U3BTGa59CJL5VbjapOT2rWvyCCM8e9YdnIBqsm7I+UYYGurBK8zzc1ly0bLqbsQwi+YwI7g8f/AKqsxk+u4e57etVBkg5xu6nHr6VMmMBgvJ9DkD/GvVZ80i2GwehOOMDuad8pOH69AO+ah3KRhT8qjAJFJMjlTgjjljntQJlgjaADyMce1Nb5gcgY6kntUaFs89eOcdPrS7gNpGM9uev1FAEmxW5ZQFz1Heoiu3qjYBxgfrT1kAx13DJ455pA2MKOT0x6UwK8oCrnOB8xH41l3m69vEiXmNDuY+vtU2rXOw+XAf3p4A9am0izEMe5uWPJJ71x4utyR5Vuz1MswvtZ88tkaNpD5cYA571bReCcD8+gpsS8D1qaMDucf1ryD6UmhXO3OQPQVaiXBxjJPbGQKijTaQcjgdatR84DHavbmmkBFOOmdvrx2qpMBknA2+lW5CASSAT696pXHJxzgdaGBRu2Gw5P4Vj2ADXsztyAMZx05rSvyEjYnoBVKxiCxFjw0hyfce9duChedzyM2q8tLlXUtxY2AnvnAI/lS5VQOp/Hn0poHyLs3KOdynrnrxSqMr8qn3X0FepY+duLgKpLE5A7+/enKcYB4HJznt7U1vkCgknngd/elQ5bHpxg/wCH50AICCwG05PQdqZKp52gn8envTgPnI6DgcntSP8AcDctnsemKB3KzDjcmPUd/qaUMSqjOT6k5pWChWwu3ucnpQuSVBz6Ejv70DHqSvEm0DOc44P/ANfilRRkjnGd2R0z2H1phVcFVYjbzgetG48Lhgx7nvQBKmGZlLbRnI9M04ZA5TnttP8AOo1JVmyOck5HOfanKTvwQpz37jNCEzh7li19I55O7AxW5pLkjoB9a50yAXD/ADdXIOa3NNf5xtxk142L+Nn1GWv9yjqrMNt7VZnXC9MVWsMgAk5+lW5zlMkgk1zI9Ax5zhuOuawr4l72IKedx/lW5dDOfWub1RXt7mGYHKq4JBNdGHfvo58am6Erdjatfu4wPlOPxqdwBjIIIHUVWtXBPXv+VTTvthLAryDjHavZZ8icvqMpe7A5IzyTWnp4yQSwP41izMZbxc+prcscbAET9K8jGSvUsfTZXDloJ9zatm5DfLg1rWzgDANZVnhlXclaMKLkYG2uVHomrFKdo3BvriqWoyb0bDZFXbYME+VnxwOOapaqoEbYyD34qnsJbnBXrGXVmB/5Z8fnW3aIAuABwawAQdWnDdCcV0NsrbMK5x1AIzWSZpLcmwCQv/1qtwrgNtzmqjuy/MyhvdamWTj+MkjkY6GqTGXYmyTuaranZgAnH14qnCG2/LtAIxgjk1YclEOdq5HRRkVomZtE8hDDGeD0JqjdscGpXk3ZPXn6Yqld5wTnpUsErGdcE7Dxz9a5uDMWrgNzk810lyMR5P8A+uueuz5d7btgfMSK7MG7TPMzWPNRfkbpUA7lYLgEk4+76H3zmrCMxYMRgDp3/HNRIM7cchwOnr/nFKFILbzkdiOoFeqfMWLG/kMcjnv9akBJHXnvjn9arK2cEgMBk9KmRw2A3yn2OaBkuTlS2VHTPv70E7SS3zEjJJHfvSBiSpLAqeenJ9aV2BXk/KeOKBWDPynj5uOPSqt3cCJMFyD1OKleUrw3KE8E8E4/pWbORd3WwJ8qelRVqKnHmZth6Mq81CIzT7dppzNL1xxkdq6C3j+UEYNVraMqBgEVoIhI5yR3xXhzm5u7PrqNGNKChEcue4qxEccYHNRIoPOCQDmp0Gc5IOO4qDYnTDKBjBPepz8oHQEc+9Rx4GARx79KdKdoK4xjnn+VWkQ2RyfdJ/iJqjMcDk1Zdvl4PvVC7lwh4osK5k6m+/bGp5kOOtSRqQQikMAMDI7VWjcy3TS4+ROARzz3q4OAFyAM16+Ehywv3Pl8zre0q8q2QD/a5I5wKepLKBnHSmDAC85B6cDr7+lOyAuByTyD0rqPPHBTk4GQeff/AOtQmBwfXGRSgdeCvygZPIJ9aYx2e2PlyR3pDEVdzEHpnt/XNI4BQlQvoeelPZh5YGRgDtyRTCy/KpbqcD6/1pMaIioGQN/0xUTcHIB2DjHbHcVMSfmI5HfB5/GkdASdi478elAxudyAj7vRs9qXJZT95VDDg8VEuA/ylhkYwOaezAsGxvXtu45/rQMRSynDDkcZ9vapQ53kjdg5BOOvvULH5mYA57d/xpyP+8IzuBP4UCOFuFC3MinnDVtaNG27cMtjv0xWJdg/bpMHgmun0ePEaktXk4xXkfR5W/3VvM6Sxzj5unpVmUnHAPTrTLEAr90mrU6krz+VclrHqmLcKNzZ69KxNYh8yBwBzg10F11PAFZd8N0ZOPyq4OzuKouaNmV9OcPbRORyyjn1NO1ObFsc8DrntVPSpP8ARmVskIxXpUOtTcBFOcYHXivcTukz4yS5ZuJQtoy8xZQW4wprctGAQZIHqTxWRpsgBJPTPBq6jEXaRtyCeK8Ks71Gz6/BwtRivI3IJCChCnH860YZMEbnUfQZxWfu5XIwcYq9YuvmKFG498VmdBrwTKEITOPUDBqvqjh4sjOMdanDsRtG3HsRWfeliuMluMn2qn2JW9zhJHKaxOCBnNdHaMpX5DmuYuyV11ucZrobUIy5Iwx7g1kjSe5akOCQD1PT1FSxby6jIwOaqtA2T5czZ/2uatQW8gwXmyD6DFUmwNBXAAaQgH+dPZtyARktxjgVHGixIT8ueCM85qUBnPzk7MVdySBPlBY5wDx7n2pk4+UjA6ZqeQYHGcfwiq8v3enJAoEUbsARkfKOO55rntSOJIScHD7a39RYiFscLng4zXO343woSD98E8cjmujDu00cOOjejL0NuKQEZ64GBk9KtAcgqcAevf8AziqVvjYhySrDIHvVhHCADAPqSf1r2T5QevABCkfU08Oq4OCq5HJ5/WguHI3L7Enp0pW24O0n5vfvSDYdHIGBC/ePT2qUyYbLZPfAquOcMRuB4GB/L+VSkgfvDzj9KEwaK2p3Hl2/Ukt8qgetJp8QCgd+pOOtZtxK9zqIQH5FPSt2zUIFzwOg9K8rG1eafL2Po8qw/JS53uy9HH0wP1qYEJ97cD9KI9oHoO1SZyRgDJGTXGeskKHG3OOncGpE3MRyM5xuqu0P8Scd8GrNs/UEYI6ihA0TxuCDx83cY4psrYAGeMflSM2VyOQOQR2qtKePp2qzNobI+R7YrI1a48uI/pV6V8KeawbyTz79UJ+VBuOP0rSjDnmkc2Kq+ypuZZtYmjiUH3Y/738qmGEA5xkZ2j071AuFwSxyfyxUzPuGCcORkc8j39M17aVtD5GTu22PI3YKhRkgnjpTkCkfKGKnnGeRTQB5hGwA44APU1J0O9gQerDqPpTYkC8llb88dhS5y4Xcc5A+7wc0HkbQBtHPUimNgn5ePegNhGyOQc+o9R3pFLYY4BPoD1p/Iwf4fz4pD8oVsA4Jycc5PagENbawJAOCcj2xSbcsFI3ZPTOacXXbgAkdGyPu0jZxubJyOg689Me9IdyvcD6DPTjvTeUJx0x3OeP8asvlhgBgvTnpmoChx8hPPAIPFAxrHYR8gByDtBpv3m4zyMYPGfU05lxgjBzx9T/hUTnk8cfxE+vtSuNI4uc5vWPA+aur0ZhtwByK4+YgXLljk7vSur0V8opJOO1eVi/jR9FlX8J+p1toeB1/CrMuNvOR9apWbDAwfzNXHwQTx7+tcp6aRmXYIU+9ZsuPKw3PFaN2eCB2NZxyRyelOJT2MXT2ZLq6TrzkVm6tIpnUcjFaEhMWrugPDJ0rF1B910evA717FJ3po+TxcOWvJGjpeTE3yblz2PNWv30sg2oFGcqT1FUNLZsEKOfT1rTWSRGDtExJ646V4tVWm/U+ooP93FrsjUtbdU2hvnYdye/0rVs1CSDbGD/Ksy0JkUF9wOOgFatuCWG1MnHHOKSNmaYcFQXIK+nYfjVG9B8thjk8kenpVpSOM/Mw9OAKrXS/K3f6UxI4HWF8vWIj2Y4571tWnCDBIB9s1keJgRqFsT1LAVsWeQqsMH6/1qLFT6FmMMWwMEH8Kuwk90Y49BUMIJxkfiOatxZUH+ZBoQXLUJPGFPPdqn25JDct2APFQxZLDvnrhanVcZyvy9DzgVaZJC6jDEnIHU+9VZs78nnvWg3C7iBgcge30qjMuVY9zyT/AJ/CmIx9SJ2MFOOx96xdQXZbEEbRxx6VtX56kkfKRj1rK1Nt1up+8D/KtKL99GOKV6MvQuWwb7IhQkYPT1PsafMSVOcKcg+1RaaN1ohLM2epB6e1WJl2pwScjIJ5xXtnxoschyFYBSRgH1qyoyowuCT9KxJJViuAh6kk+v8AKtKOYOifM5bIBzzipT1NGtC0qj+Hdj+EE9TUd/cGKNyCAeSOKnXO4hCMdPyrA12ckbTtyThdp6CnJ8quxU4uUlFdSTR4y5Mh/iJNdJAgwA2CPfvWTpkPlxKAOwIrYiUk8Dp0r56cuaTbPtqcFCKiuhOseMHcfUA9MelSJKpI5wW7HtUZmBBbHTrTUBk+9gHrSXkaWL6L0PX69KSUAEbflbPB9KiAKw5SRk9jyM1C9zuAV02nGMjvVEtMtiQAbh1P3lqtM+ASP59KR3+Y4JwRjmq1xIAh700ZsrXU4WIknisyzBdGkYAl23YPHFN1CXzJUgU43Hn6VLIeB228DHUelengqf22eBmte7VJEoKkEnaWzxu6H2qwGyMPjJPJ/Hv/AI1SBIwowwAwdvOKsq3yBShBPUHvXeeMTg4yGK5B7jgelSYywLEgA/wj8hUA6E5471Id2wEtuPQHGc0AOV/m5P0/CnhNz4k7D+H/AAqEElvmHA4+tS56cjjjrQSK+M8E468frRktgjkY+U47e1JhmJO04IwBmmbtqgsTg++PmoGOYrnBHz/WkJAbkfMPyIzxRIxLKpJx/ex+tLghlBXjPUevSga8hrruI5PPUH0xTXAJ+YkHAytScAAHGRxnr8tIRk7t5yp546+lICu6EE4B4UZ7YFQ5Ktw3PQZ6irZUELzuIJ98fWonDfcIJ2npSKR51OSJ3J9cGum0bAXHeuYuzieQg5G6t7RWyAWYkmvKxnxI+iyr+GzsbORRjkD8a0AwYe1ZFlg7QR1rVhHGM4Nch6pUusCspiAzZ575rZuk4rEvCUJZevpTW4bmBqTFdSRu+MfWsi9J+0t+oq9qwLtI4A+XkkH+VYZuUuXDoSSBhvrXqYaV6dj53MqbjW5u5uaPvyxXp3FdDBFuxyeuema5/QjkH8MGupsgQOM/lXmVtajPcw38KPoWYUIHAP5Yq/brgg9fYmq8R3KOpA7mrtuoX7ozn9ag3LkYUKFPBzy/fHsKrXuBkKCF6GrIHBBUDPvk1Vvc7eBz2AqgRwviVC97ZpjO581r2I+Ue35Vn6yp/ta3BHAUkVp2akMCOnpUBJ7F6EfMNuBn3qyisWwTgfzqOKPkcbscVciQBuAw9xRYLksScfeZvp3qQKQwBwpHTJ6fhTkQjqGJPGM4zT9mcjHP500JkcmCvJ5PWqF4Rj+f+FX5FweeR/d9Kzb3oeaYLUxr5gFfJxjoP/rfhWVqOTZ7l9OMir95wMk+5Pes+7YNZ4PPGOTVUn76Jrr91L0Leiuz2w8wGNgBnnjNXWOSS+VJHY9PTiqmls32QKCcY5I9auPggBQM4HX/AAr32j4lWRk3i4cDAzuB3AcD8asaYJQxVwVIJ56EfSp2ifJK7ZOgEe35UIzyTVllBBYZJIxgdv8A61ZqLuaykrBIzKhIO0jofaucuJDdavHH1CDPFbN9NsgZiuCOvbNZGgxb7tpSOSc/n0rnxlTkp27ndldH2lbm6I621QGBCRkYxkdquRkqCe1NtUAjA4BHBqR4+Mrx7Hoa8Zn1ESGQCRwy5BP61NGwB+f5T+hqEAgqcFT3+tWEcMArYYd1pIsJW9CCDyAKYHG0huM9qnYnJCDYp5xUDH+9+lWiWyORu3p6VQvJgin1qzO+3oOKx798Ak8VcVdmU3ZEOmIZrySdznsAeoArRkjDgAjLHnrUOkp5dsHK/Pj+Z6VfO1lxxuBx156V71OPLBI+MxE+erJlILh1Ktg55/wqT5txIBXHGKVoyMA556EetMw6p1yDxVGRY4+YcnvzwDTlLKCTxuJxioVOQoIG0fqP8aXIUcDjHQ85P+FAy0h7jBzx6fnSDORwp54YdP8APvUaEnIO3OcDFO2ZJCkc91NAmiRjgdMjJyM0M4Izg/TuKYp5B3Njrg9qUA437ugO49T061RKbEbljuAYYI9acpJGB1I4K+vSohlQcfdztIA/Ggk43ckMAcehPSkO5JjJBLDb0HGDT1Yc5HzAZz9e1M4ZiAPlxjOaUjaenJ7jt+FACjcRjG7PHJx9SajfO0gjg46etOVSMDJwOmR1pDkZUdO+e1IpHmN5/rXxzk1t6IuUX0rEdg0rHI5bmtnRH/elD27Zrx8Z8R9Nlf8ACfqdbaPgAqelbcIBiDDAz2Nc9aNkhl+70rdtxiMAk4IJwOv51zR1PTYy5PzEGsa9TepxWrdjaQe+cVRZcqM5zxTsHQxbmxWWPGMjGCO1eYasJND8R+VIWFnOOCea9jjjy+GBxXD/ABL0xbuyBVQJFyyn0NdFKbg7nJiKKqxsy5oJHloVIzx9DXWWvzANjbnjHoa4XwQ5k0Wz80/vNnBPXgkV3NmTt+br6+vvXPN3mzekrQivI0YU5+YnB6gdqvRqDyce/FVoiSNxAIxj8KuwNjvyfeki7k6INmBwf5fWoZl4JA5q0mAnI5/9BFQyjCnv6VQrnE66u3VUOP4TVu0bAUdc1B4iyNQi9waktDnacdKz6jfQ2YmC8DnJq5A4BHykqRjPoaoRH7p6AY/Kr0RCseNw7/40AXljXGRkEjHp+lOUBHP8S4znOMGmRnglCcEZAPT86kB3dtrdcmmIjmUlSQRisi8X5ec1syDucnnuMVmXa5HHIoGjnL5eCBmsi5yLeQdq376PjisK7BMTgE/hVQ0lcJ+9FruWtDffblckMO+OtTXN9FbyrExcE5Cnov1zWFpGoNbT4JBjfg1vXKRTxplQ8eflkGCR9K9+91dHxMlyyaZPHKMKVIIH8OcEn/8AXT9w65Kgc596iSEZIHGeuDwKhmk8ht+SqjjbjgH2pk21KOvTM8kdqmMucsR6f/XrS0C32/Nj3IrEswbu9eY9zgV12lxBcYAHFeLi6nPUsuh9Xl1D2NG73ZqwLtGRjcPXvTpBkkdOMEUqD+6Bx1B6U58EDdnHr7+xrl6Heis+eCuGFKgJOSgA6ZBpxQOC2Nw9uDSou7GJMD37UkirjGYAHpj60wqSOcrn25NWcKvzFuR/Ex/kKgkPyMSOD27kf0q0Q2UrgBM7TwOPxrBvszSJEv8AEcVrXj8dee30rKtl87UE6DbyTXRRjzTSOPF1PZ0pSZq26mOAYBHGPpUm/CsMnOCTgcUxZDuXOM8g9x+FOPzKCFZTgE7T0zXuHyAhdSDtGB9KYeDkbfXPpT3wV4DA49femttLAEHbg5P9PpSZS0GoNpAIxjJAA4H+NAAXqxweSQP0o+8xywyOuB1p0ZJJIYZBwe35HvSBDA5D7T1GSDjoatI5KZBGPy5qrIu8KMZB4ye3sKYHMZwxB+nb1xSuOxeyCxDrkAjcfb0xTWIOXHLr8x7Z7AYpocdADlugx+ppz9OxJbafWqRDQhTbggHcOpB6n3oxtUls8ZJwP0ozxk4IDcjnmkO8nPY9O1AWHJknd8vQDngfhTgQQCBxngjvTAWweRjPUkUSAIWO0fd5x2oGloSKcrguRxzz09KAAec/MTgdsD6VCeSCBg4AwD/ninHhTg5OCfrQJHmTZ2nafXHNWrOfy5km4CkYOarFQGPfHanW7Ku5CFGeQTXlYuF0pI+hyuqk3TfU7LTbkNFkHPf6V0NlcAxqWPIHQd647SJRIgHG4dQK6WwwVCkcDqa4I6M9tmm/7zHHvVGdQuSBgGr6c52jAqtcpwaskqpgSZxxWL4sg8yyI9zzWu3ySjBx1qjr2Hsz34zWnQl6M5Xw5H5dqseOhP8AOuvs3OwBuR6HtXK6bxIccA56V0tpIQcdcACsXuWbsHzEE5A9jWhAM4PbPAOKx43CbSOCOOK1rduCASCPSmhM0QMjaBk9Tj+tRSp8uP19alib5OP1pJyNuSeasybOI8Tri6iIHrUdkxCg/hU3iNibuIdjnvUNou3GeKze5fQ1ISVI5ODxVzccjAIwOcdRVSEZUgdasJJgL0x19KTKRZgYlgwLKM9jwRWgAWC5yO/H9azoZUcsAd6t36j86vw7cAZ7Y5NAMc3PIzz71WmTg5FXOAOcY6VDIu4cYI6ZqiLmBfR4U7RWDLBucrxg8iurvIzg1hyxkSZA47Uy0znb3TDGTLAvy55A4xVeyu5IGwrgEH7rDg+9dYIw0ZVh14xWdJoscnzEYY+nb2rso4lwVnqjzMXlsKz54uzIE1aN8ieJkPcryCfWotT1KGdRbwOGkb7w6fz9KbeaRNAm+Ji+OgPNUNF09/t000pLt91QR09a3q4yKg7bnFRyqftFzvQ6HRrTZEgwOe9dFaIEwD061UsogqDoDjNX4wRk446/hXk+Z9F5F2MHG4HBFOZSATjA6ECoUzuwO3enlivOSoB24PODQCRHt53be3UHFPDBVwXHPUAc/rTiOSGVCR+AP0qGVipPGQeBg9/TmhAwc88E5PPJyfxqtcyAA+vTNOYgKcHgcfKOtULiQknHYflTRLKF9Jgc9e1JpMfyNIR8z+vX8Kq37mRggzljitSAbYwAOVwMd69LBQ3keFm9XRU16kij5eBjjHNPCFlUqdpzjOKiUZJwDvJx9BUqkZBJJ7ke9ekeCDxn5gW+Xpj096jYFWKgMTjnHP5VLgA5xx69KR8eWcqNhGc0h2I1wpwNwAGTg54py4BG3J6njpQRtGOxODnnPFLgnkHqOM0rFIaQDgMuMdTmo54yQNwHTPr3qRirDcpIwO9OQktySAccnvSGU/MkjfaGDr24ORzVoSZxjIJGSf6YNNkVd3zYI45NQspViy/r/KjYfxIuxnKls84yc84PvSMoORyAQM81BDKCpB6N96nMyv8AJjg8HvT3JcbErhg4AKkc/KB1FMC5GMHgcY9aYHUlQGAG7jn+tS9MYAIzxg8/jTEMCnc7R/3c80rrnGcYPUEdPSjaRuK55ORnvSrkBtrZBGAcdTQB53exeXcyA9SfSqrfKylex7966DXrbcgmQYI6gHrXPsPlwTk1y1IXTR20KnJJTXQ2dKlKMp5G7riuw05gwHYda4TS5dyZJ4Bwcdq6/SpSEGTz2rxmrOx9bFqSujpoh3z1pk6blI6Ckt2yBg/N3yamkA2cnmqEYtwCsntnmsrWiTp7cnIrcul3KxFY2qAG1lXt1qhM5jSnLAkdQcc10tm2Tg4Oema5qxwH4JPzZ5rajcqwwetZsvqb8Mm4AjHFbFqxYcnnqcVz9m+FyOprXtJx0yeewqosTRtJLwMgL6e9V55CVIAGRSwkPgsTnpgVHOcDgfjmrMrHLa6Qb2Eeqmi2HOCKr6vIX1VQD91asW7Agc5PpWUtyrXNCHHelugVgbG7GOcdR9KSI5AGc8elWEUMNvGMenWky4uzKVlcqWgiiOwlBJs27cDOOB257VvW7ElVPI65NUHtwssRVOQ4JOOeep/z6VqogBGMfypR8yptPYnA5AAxzSGPAwBSqQWwcfh2p7cr0NaIwZRuYwRnH1rIuIBgnHBrdlwRis+4QEGqHFmOBsbGASelW0C7VLAjjk9qZIux+QM5/WnKSikHt1yKpFMqaoyJbswzk8KKz9LtdkS5B3HknFP1KQ3N0saY8uPlsdz6VcgXbxz0rKrK7sVBF6IcYAxniriYPHaqSNsOM8VbQ/Nyce/qazuXYlU4ZlOAR6+lEDA/u5MsSvGcdc9KGTzCAQA2PlPYmhedpfcCByB0P+FMRK0ZBGdqnP3QM1HIyrzwO27GTUjyYjB2sCOnOf8A9VV5Tu5fHHb/AD1pi6lWVsjjHH6Vn3LY6Enir0zAAEYHOelZV7LgE9gO/eqSJk9CnbDzb32QZrSBOR8oyCMDBFUrAfIeobrmrzZJXvj1/pXvUIckEj43GVXVqykEZJbHUHvnvmptwJGcgqMMe/8A+uolc5YDYDgYHrTiwyRjJB7elaHOPYjILMeF/KnKcnnhSNwUjpUfAPORkd+1PBIXZgFc5OOMdaBj/QY56H8aa+5chACTjNOBGwYHykYBFImVACklc8cdqQxp+QAJndz/AIUAf3RyKcyDI2nqMg01lySMkDtz+VAMFG5sL1xjrkCoplBXjkE/nTwSxPIw3tS4B4C5xgcHrQBUcMOBnJGOT/I/0pN2GwQBx0zjmp5FJ6A/3SOv6Vn3twsLeVEBJKccA5waTstWXFObsi0sir8x+6e7HANQjUbdQT5m58cBBu/GqkOnTXMm+6c887F4AratNNRFAVQPwrjqY2MdI6nqUcoqSV6jsUYtU+7iCcjqCRgfSnR6pFuImimjz/EU4/HFbK2QxnBpk9qiDnAHoaz+vPsbyyiCWkmc5eoHgZcZGPWuOkG1yDxg4rtZFbnOa5PVITFdtkjB5Arskr6njQdnYgsZPLuzxw/ODXY6XMjYwQPrXDk7ZEdedp5711OkXI+XdgD6V5OJhyyufUYCr7Skk+h2NvIeOQAKto+4cY6dKyYHzg9a0IM4PHNYo7GJcJwelYGsri1lx1210UvKD0xWHrKlrSX0C55qkI4zSzlTx36/jW/bLkDoeOaxdNUKgGD+VbtqCvOelZsbZrW6kJjtgfjVtPlA4Oep56VWt3BQHjFaFuq854+vJpxdg5rFyyOVU4/IdKW/lCRknsO9G8IpLHAA7n+dY+qyh42eQkJj5R6/hVcxm9XcwHkE9zJNnPznH0q7aMcZYAsOoHBrHuC9pbea3bnBp+g6nHdXDxBgHU5A9qzbOiFJuLkjq4wWAPAJ7GrEAww4z2ODVSB1ZsDnsatR8nKkg/TNMzsaEIwAQCc8AehqwjBhjHXrVeEYBBLZ+lTKxwM5GeeelBDLKLtAG0jHr6e9OOOcmod5I6j6kZpxYtjHSquTa5HLxnqDVSfpk45q24ABxngc1TuGycDHpVXGjNnX5jg55qnfXHkxFsndjgAdTV+YHkkYzWLdKZroKPuIc496puyuPcZaxFBk8knJJrUiBUGoYU49qtRAlsLj3rnZqkOjjJYHqCa0IgFx3GO4/Q1UXIOAB6A+9XYtwUnAOB3OOaSRTHAYPRWTrxyKkRQSCQMAHIP+NIoVWygK853dMfhSk7gWyDnr6mrSIbGT8FQMr7E5xVWQ/Kw9B/nFS3LBV4OF6DBzVRnyuR69+ppisVrhsjJz7CsXUZMkITwxxWpcvgketYN6T50Q565JrahHnmkc2LqezpSkjRgGLdSNysDwRVhDk8Z9CfamxHKx7h14/rT+CwD/AHegI6/hXunxr3FyTtGQCDj8M04Ag43gjuf6UxVXZjBAOW4Gc+9OTcDzjrnpgZ9aLjJVPGDyozketKDjrjtzngmm8leO3Xn9ach3AkfKCaQyX5SSw6EZ5pFG0EDJG3v3qMYVsrzgen+eKVeVIU8eme9Ax4VlyNw570HLFtv0+lJ5mFJIbGc4ByaPMj6Kxz9KBEaggdCxyOaG+ZjgHdjpjmlyAxAIBGevGRWdfTF5BFbscEfMf6UpSUFdmlOlKo1CO4l3dsx8q3+9nBb09qfp9kFJLDLE5JNPs7RYwAAK17aHBGBXj18RKq7LY+pwWBjh1d6yHWtsB1FXsLGqdCxPCjvT4lWOMu/AHNRWSPeXBkIKoeFx2HeubyO5rqWmDfZPMdljBOAqjk475Pasidxzyc9c1o6jMjOFBARBtUD0rFlkGCapozaVrsyjx3A4rB8QwZUSDqOtbByOck1BfxiW1ZCvbrivdex8WnZnGN8y4/WtPRJWKhGLHHcHrWe/yMVxggkVLprlLohTgHmuDFxvG57eWVLTce53ljL8i9R9a1I5hsxn+tYFjKPLABzWnBJkdQOa85Sse7a5fdtyrhjWRr52adM2e2PrWlEw5x26+9YPiicm3WPszY471d9Lk2MfTl6g9etakWA3Q561SslGAehNX0Gc4Oe/0rNi6l63kwoHTJ4+tS3mpCxg8xuM9zx/+qq9vyAMc5/Oodd0w6lZeQz4ycn0pXGrX1NfTr1dQtUkU5TPToGPrUWoAy4UEkU3Sbb7Jp8URGAFxt+nc1MQM55z14qlsS/IoXNn5qjPGPasqPQBBrRvIcLERyo7k9a6YLyAfqeKkABXcuCCOaGkaU6soKyIYYiACMg9xnp7VbiKZG9yO2QcU0KB0+vHNHy/eYLx14pbE3uXoTt+VyCDyD61ZQEgE5Kjk9qowyggAvuUjtU68Oc/ICOMHAx9KZNiyHfJBzj1HORSmTOQdwx2PpUanjgdPfofpUZ27mA+bPOcUwJN4VioOD04HT3qCTp9OmeKcoxnHQ802dgqnPPOM00IpXA+U44Gayo1zIzHOM1pzjPHPTpVXaFOM9amTLihIxz329wKtqoBGO3OR61DEMnpz3q7GO5qDRjlXGF459ehq1EgwMHAHzHcMgetQKuCD1HT1B/wqVCVYA4z25/kapIlk0bcYb5c9CKRwApIUZzyQOaQl34BB9jwaY4O3uMHGC1USQTDcvIJ7571TmwAD6cVbduu09eOtU51wDjH4HNAIozNuGSCPasO7Km6Uc4IIravCQorGlGbqPpu9K6cJ/ERwZl/Aka0QO2MZICrz6g0pZw2WQj+tKnygZKnnnIp4BGR39u3417R8nYIyTkFON2F56+9OI553D0PWkzgnOcjGTnpT+Rwv4HpSKQpzuBOTgenFP3ZAJbn+7imKT35ORyKcCCdp69OKBi8DO0gD07kUnON3p29aBgZIJBx6U9+D83KjB570AMyAFxnOTxigAMSTjNJhiQTgnpTZCPmJwB70ICG9mMUWeC33R6nNR2EOOWA3HrVdD9puN5HyLkLWxaIoIJ69q8nF1/aS5Vsj6nLMGqMOeW7JYoxmtC2TgZ6imQRZORVxQI1JI7da5kj0pSsU752Yx26kYcgHHUetXt4trUhSASNv0FZscokvXY9kJA/GquoXu7gH61cVbUjfQW5m3NnNZtzNwQKa9wSOTVG4lZzsQksxwMdacYXZlVmoxuyR2IUYzimscqRuABFQqsh6nj1zTgmc46ivXTZ8dZHK6rGIrxvc8CqcEii5Uggjoa1/EkIG1x06ZrAOY3BGMCueurxaO7Bz5akWdnYTDy1yTjHWtW0l3Nk8dgK5eykYxqd2P1zXQQuFDHdkHGDXivc+s6Gsz4Q9vf0rltVlNxeoP4E9+9bTy7129s9fWsO4wZnOMjgU0yGWLUYxkZx3q9CcbgRnPJNUYsggZznGDV+LIbbxn1pkFuEYYd26VZ3ZYgngfqaqx/dHuOvpUy4yB37AdqEUW1f5ATj6e9N74IwM0xDnjFSMOrHp6VSJY4DdgD71SIoCgdO/FMRcMMnkc4qdeCFP40rgNGc5U9OtKz4ZTnI9PQ0MGHzKnf+E1VmYlyXUq3TIFJlIsRzEE+WQFPbtVxCpPPsQe+aw4Zvu7iM88itG1nJk9cDhieBQmDRphsryADnkZ+9UfJYkNtBH3R1qIOBjvnrjtTg/AO7kk5NMRIcBeOo4xVW5k4B9Dx/jUxb159eagnUMhU9cA570DRCrgp8p/xquynJGeKsAeWvAzkZ+tCqDkddtS/MsI8Y7dOtTjjnnbj8RTUXBByD9aeSBgrn5uOeQP8ACkBIn3eMEdwD29vepAMLt4IA6Y5x9aiiVY8g4Rjzg8hvpT2cMcDCZ4yOQaaYiSRgMMTuHGP/ANdREg9Tnv64FIZZSXUhPmPLHvSIx4Ax6c8VZLQx1AU7cjjGSe1VZsEZ9atONzAnp04qCcDaQOlAIybzI9zWOQTdqc8+1at+xycd/SslOb1PTGBg966sH/EPNzR2oM24QQPkXkHpmhCS4K5Oeox0qPdlSRnrj0zUinlQc7iPpivYPlyQHDZUYPTJ6U5jgHOP8KaOcnGCSfxojIJAxyB+dAyTjaP4QeaXJKjkHg80gOTkE+tHSTaScHmkMUscYAGOx/rQoJXJ4wc9KVTt78Z/L8KYVxzgHp1pgIxIOG64xycD2qnqMu7EKPl3POOwq2zBcseQKzrRDNOZTj5j9MD0rnxNX2cPNndl+Gdaqr7Iu2lvtQY6/StO2jOajtk3YHatKGPawb0rxUfXJ2ViSLK4b86ivJXzjdgdhVmQqo4PUVn3LEkkVdyNzLurpbe4RpOjfKfpTJpY2z05qDVAXRgeuOtc/HfSW3ySZdB37ilTqa2YpRdro2bl12E4ximaTH5jvOyn5eFz39TWPc35ljCQ5LucfSuls4xBaRxg8x8Yz19a9LDxUndHhZlWcY8ncp5AXG0g96Ru5OQaavHcmnkcYA5/nXYeMZGvRrJZs3Qj0rk3QEAg13V6ge2kU9hzXNW+ha1qMAuNM0HWr20LMqzW2mzyxsVYq2GVCDhgRweorGokb0Lt6E2lkCMMOoragztXnjsfaqeneHPEUKYk8MeJFOf+gPdH/wBp1tx6VrKgZ8N+JM4/6At3/wDG68WVOV9j66NaFt195RmvoYnMcxMeAp3MpCAsSAN3TJweM5qGVRnsQxzXf/DD+1NL8Y2i3fhvXjp19myu1uNGuBGY36Ft0e0AMFJJ6DdXpPin4J+HtT3S6E8uhXROQLcb7cn3hJwB7IUrSOHco32ZhPEqMrbryPnofLg9qtRPkkjvXReJvh74q8NIzXWmnULJcn7Xp2ZQB6tHjev4BgPWuVs5o5drwyK6Z2kqc4I/kfaolCUdzSE4z2ZrRPtBz06ZqY4UHB4HeqCnaOPU/h7VdtcPKqscY5PfFQtXY1S6ixybZhGTg7d30q7G2QCKxmudusSxOPuqMMepHPatND8uQOMDmrlZbEtWLQHz5zxnGO9Sk8ZI3YqvGcsC3P171KhUkZzt5/CouA0AhSd2Rn8qrXMI25BL9uMgfhV79wo5Ckn3qrOWUhvNU9cD71Ow0ZkgjUrtXAyOh6etX7SUDAGOmM4/Ss+ZHJVmO3jA2jp65qe3+QYUdO9RsNmqHyuFyq5yff6VIp+bABPOSe+KrRHcoy2GqdCA2WbGRj600xWJGY8KRjjOAeppWOcE8+3p2pjcIuT83SljxuG7oeAtMEiM56sCCBihMgkHA4+X3pz52ndn5ehPfNRYwxJPPbHapZotSyhLrwMjPOOoFPO1gefm6ZHp71FEV6H5W6CrLKQfmUeYcYZTjP8AjQKxEy7UbYdyDoGFHVd23KHqAev4VJhQTkEEjHNAiAb92wx7n+VAXI4kZdx2/KRkAtnAp/DcKDjk4PWkZW3EYwe/FALGUliMAdBzVohgVC4Bxx6etVrjJXjp71YJ46ADNVbk8EkmmIyL3HJH4VjqCb0Y7dq1rxsZ9ayIwTf+4GeehrrwXxnmZp/BNhTwABhh1HSnqQ3UAED8/wDPpTAcgE8AAA5pwyRjCjA4/wAK9c+aHkYQAEDjOelKCNxOOvDZ/lTEyAOmeCM1IoLegPb3FIY9cnBbk9OOlOQlgc7Sc7sYxVcBkdtu0p/dxkipCQV2kEHsM8j3pASbuSBkHtz1phbPyr94fhTWyEDSHDd+e9MuJkgiZ3ZQEGeO9MCvezAKsaEkv94+g9KtWUQGMCuO0PV21PWb1pCPLRgqLjBx613empuYHFePjKnNUsuh9TltH2dFPqzStIsDt0rRRNo6c1DDHxwOTVrbhfSuZHoNlWddpz26is+4wDwfwrWnyYyzHmse7PbAJqiTKvF3qcjP0rntQs97ZAIropz8pIxWZdEEZI/GpSuwcrGTpFv/AMTGNZOVXJx6+ldQR93eCMHgds1jaSoa5kbuFxW0ozjb37969vDRUaZ8nj6jqV3foZat70/cPf2qrAp5JHHapxkZ5FanMJOBsf1xVnwn8WvFPg7QotD0qLRJLO2kmeM3NpK8n7yVpDkrMoPLkdBxiqzgbSM44rjb5dl04555xWdRXNaM3B6Hq1n8ffG1wcGHw2h/68Zz/wC162IvjH43lxtPhrP/AGD5/wD5IrwuzcpKQeMNmursHOFIHOK8ipVnF2ufT0aNOcFKx7P4M+I3jfXvFOm6bJ/wjxhnlBmMdhMrCJfmcgmcgHaCASDyRxXrPibxVofhe3WbXtTt7MP9xGJaST/cRcs34A18r6XqOsaTdTzaVqDWPnw+S8kUa+aFJyQHOdoOF6DPy8EVmyoomlmffNcynMk8rGSST/eckk/iaqOJtHXVkywl5aaI9Y8VfHieUvB4T0vylPAvNR6/VYVP6sw91NeTXd1PqmtT6vqk7XeozjEk5VUyB0G1QF4+marTKGXLLj0FQwSEEA89qynVlPc3hQjDVGyuD84xvPQGpowVkDqSMj7vr9aqROHUYJ+U9fwqdG4z/EM96yvZmqKV+n/E9hkViB5fIPfmty3cFcHmsQIz3zTsCGICgewrXiG1AfSiT1Kk7l5GYcDp2qZCMcjnPYVVRgdpBJDHrmrKuN2MkY9OcmkiSwnK9t2f4lxVS52g7iAXHPy96lJYAFhvx0weKjZ5CeQM55zzirBGfcsSgCD5++R0B60tvuVvmABHQE9KlUEsx+8wP/6qd5a7yCCc9/Q1LGSwk8kYweuamHzY3LkDnp0qENhiPQcYqRc7gc49umakCY4AHBPynOKf1OGxjsfSozJjbnG3PK1GZcSYOQcfhiqBIsybmHAGVPTuKjbLuWjGe/H+FAJdl54YZPHHFTRDnKlVkH5EUblLQYu8sSAG9Ripg6YxIpBz36UkZBIwfLcAZ9T+FJIZAiqqnGQGweo/xpD3JVKqikSHaRz7UhIZ/lGWJ69OKQlnTDLww65AOKhlc9XLKen4UCJdy9VJGem40DYF3Z3Z4OO9Vsk4JYtgZw38qTzNwOWA7ALVJktEzliT7D8M1VuW64O4Dv61LuG3IbgcCqs37xgo5AFMkz5gXYk9KxlbbfH5x1wO1dE0f3jg8frXMahuj1IsSeeeBXZgtJnl5or0jfjG/GT2yMU/A6AE/wA6rwODGhOQDyOamU+v+NesfODgcdSx54Bpw4wQM5J46Y5pgbAxx7A84oD4U9weOOMmgCQPiTrk9RRIxZNoIz13HtSbuOmDmq0ryfaQQ5CHn8aQ2TqxaLa5BJypNUmVbiXZ99U45ouZ2bdHD1zgt6VZsINgXIrixdfkXLHc9bLcJzv2k1p0JYLCFhzGoI4BAwRWzYQeWMdfeq9upGMCtODrXl+Z9Day0LsQGBTy2w5JqFSQMg/TNI7BiDnIpisNupPl5wF74PSse7YE5BHWtRuQcY+8TwKoXmGXt70xmLduATzw1ZcsnBzxirl/tAPTrWW5ILZxmnFamdTYtaKv71yOGY889q12BIBHBHX6VmaNkQMWG0HnP9a0B8pJIOe3avcpq0EfH1nepJ+ZlK2R0p2M4Pb0qDcysFwDnmpFYk5HemSTHryMj1rkNbIivH44NdaGJ5Nc34nhPmK6qPx6VM9i4fEc9FdRyXDCPduXhsjrXWaTOpVRnHFcIFuYdQDOCY3znaeFrpdLmKkYYEeleTiY+9c+mwMvc5V0O4hAZeDnI5NQSIAcA98/SorOfeo6AHqfWrsg+QYGOOfauQ7jIueCQ3rWfuAkGc56Vr3XVj3rInUqRx1OPpQgL0EhRVHRRVlZAdv93AwRWXBLj5G4IOcGrqEkcEAChiLts2W6Z5zWjEfasaCXEhHGfrWjC4ZBgE/Q0gZbTjOCQM9j/SpwQwAzgHn/AOtVZcDJA6n/ACKeAPXnuM96ALSsQpwFP41FKWOdxYH0zxVG6aWKRfLAx0JH9abDcNIoDHKg5wPX3o5irGii/KuDjuBTyOQOeR0BpgYEDaCMYxUbuwZtvBzyD3ptiJQBlSMc96eCm45ySOeKgU+Yi5GCCQealfgEA/N2oTAHkBGGIxg81A8jeYuF+VhyfeoXPYnPUDimr5wdQ+1lx98Hn61NzRI2LV98ajPBOVz29qsqM7TjlM8d8VmWcxYL04yrDt7GroLq5zuJzkKefyq0yWiyAp5c7lGAMnkU12AUgHeOpB7fiKeHK9V2k8nng1Wm2AA5Cnv3H5UwGxMQfmDE9STSSuWDMCFPuc1WkZU3tkt3OTjP0qETb+q7ccnJ61BVixuU435duuG4FAJz8uAD39PYUxACvyDk98dKeoz6Y6D39acSJCksCBjtxRzjjnPcd/WlALNuJOM4GfX1qaNQTnPTp9P/ANdWQRSL5cPP3veuS1mDIEoByMnjuDXV37fIyg5PTNZNxFucIRkFSOlbUZ8srnLiaftIOLM/R5gUdGLey1op8rA8sMelc5GzWl6ynlVbHPpW9E/yhjnBFe1F3Vz5SUXF2ZIETduJYHptHSnbQfvncO4PemZBPHJPvSM42nb1POfWmAye48npksT90etQCSTlCAZG5P8As+1LPMAy7VBk6DvirNjbEEM4yTyT6mufEV1TVluduBwbry5pfCS2NkFUfrWjHEFHT8qlt48e1T+X1I69q8eT5ndn08IKCsghTAHfFXIcccDAquihamVtp+tSWywX4x+NVXbZKpB+Rj+RpZG+maqSPlGU+mBQ2NIsySjyy3B9Rj9azbmQKhqNrkgFWJBHWs+8uF28nP40J3G1Yp3rg5z19DWbdHA2rycYqad1kBKsfz71DYRNc3/JJSP5iex9K6KMHOSSOLFVY0qbkzbsofKt1jZQc8Y96sLjaAOecfSmZZgQTgDH/wCunEAgc8Y5GO1e2lY+Qvd3MXI3A9D6Zo3YOWGR2ApGB57n1pFBGOcGpLJ45Mjnr61Q1yHzrRvUVaBI3AcjFOdFljKsOooYbanCuT0A5PFSWMipjj6U64jEd28fo2KZ5ZR9qf3uK8zE72Pocu0hc6fTbkI4zuYeldChDQ7QSO/vXGafOWdQ3B/lXS20o2YyOe9cLR6o28QBMAkHuazrjHlMfStC7f5dxPyk8d+azZz8hx06VKGMjGUDEA46mriuojUZwOmBVKNgEUAHjjjmrAGXyNtNiJ43y64xjvxV23kYMQmQvXkVnKgLEISCe4zzWlZ7UG0hsnjk1BTLatlGwSfUZ/WnxSHbkqMDuRRtUPwozjHpioJ4vkI2nkev9aBIWfEr5DlcdQOaWIMGySCW+9jjIrmpbHUrfVLWeznP2RcLLEX7f3smupgOVBOPTmk0W9EWj8ycZUDjFRGLB+YFj0yDUiEMwDLknr71KwQjuD/Km1czuNt02FVLEls4J6596sEZQk8Hrx0phJwCOQBnGOn40uQEOCdvfnOKaGQSxlmIGM/eB61GQcFVHJAx2DfjVl9rKCFByMZXtTUUMBnG4DBNJou4Wgw/mAnaRyD29RWlu2gI2CB05/TNV1A2hiAG6k9fzp+4KCPwKnB4qkrCepIDxwRj0YVBO4VGYAjA55yKUH5dobHOeecfSmPlh2Ceo44p3ArOrSNkoBgd+PzxTeCwC8AnC4UDcalaPf8AMcqp9+TUyW5ToPnxwecDNRYq4qx5U7SWGcsScZpwIKk9zwCOgAqWQA4TOcccVG8RK/Kcdh7CrM2xEIIGzPp0/OrBAUHA4FQ24CFlXk8KpqVskAZAycf/AF6pElOcbiAB044NUwu68/Cr0nLZPuapxkG9bHPFNbkSVznvE9sY5UlQdtpqHS7zeBHMRnqCa3ddjWS0LdSrZrkmtZhcGMAA9c9OK9PDV0o8snseHjsHKU+eCvc3HukiHzyjgZ4NV21CJiUj3Mc9aqxaLcynKzomevy5rW0rQltCPNbzDnOSO9XUxkIrTVmNHLaspLmVkS6dAWbfIMse9bkMQXHHFNhhCkAAVcCZIGOleVKTk7s+jp01BcqFgXipwo7cUsS49vapAvcY4rM0I8UOe3ftSk0xm5pgRmTK88VSuHOOCQRUlxIQeMcmqN1LhSRyRSHsVbxxKD8xD4rEu5JQwVgcHoe1XLmYnJ6Dpmse6uMBtxBHU5qoRuyZT5VdiTS7VAX7x4AFbemWpt4MMSGbluKytFs2nl8+UHaOgro+Bna2QOhHavZw1D2au9z5bMMY8RLljshDhnOACf1p4Xc/PDdVHbjrTcADrggYxRtwCAST/Kuk88xw2SVoH+famg+n3s0ueR3qTQVuApzzSkkA01j82ccemaSdwkTH26UNgcrIPM1NyOu41ZubcpGkgxkc1Xs8SX0rgnAz/OttohJZElRnpXlYl++fR4CNqSM2EAMj4OK2rSXAUYwKyI08uRkySB29KuW7fJ0z/SuSR6KNKZwYsdaoTZCkHGRVhjle2OpqnM7eWc49jUobJEwQF449KlVcsNvIz1qpbglcknH1rQt19cUmBPAhyCSee+KuxJhwxHvgGoIwd4CnmrYyAMBc54xUtBcnQnH4fWhwP7xHtSRFcEsM49KR1JGMn2I70CBU+XONoPXuDSKpjPHA/u9abvKna24c1IjnGcg+gxQO5Ij5Py5yPTip9+fUg8nHWqhKyP0/LrT4xtT5iD9RyPxpiLKyAgAc4P0z7U8DBK8jHG/H6Gow67cjOR2I5odlHQ5796CkOUHcVIUhuwbH5U5CQBwVbHXHFROGP3D8oHpzj1//AFU6Xa4ZQePvArxj6HuKCidC3lA8HB25HIqQHLBVOO2F5qpETvYk/eAOAcZqwFHVGYZ/hP8AjQmBKuRkDGP9qlZA3LITgcA8U4cDuB64zj3pzD5AzfUL/jTFcjVB5mQCSo79KnAz8oyccmmrnGzn3pTuzkCgQoTnecZ6AU2QAIf9kZPuamTATPPpz3qJk3dT7mqJGwLk++P1NSTHIOewoB29cccmgglTzxjj/GmJlOVe/f8AwqjB/wAfcmQMBRitGdcdOcA9KowkCWY96FuAt4hkhkXA+7+dYmoWryWS3US/vEXOB3HcV0TAZbnsKr2mPspBAwAQau5NjL0SczIHxjPSt1VDc8A1naXbiGSRB2bv6VtQxDGccVmjRIIl554xVuJcnOaaqccVOkRBHXHfFMbJCgwcdzUJXH+7Vhc5xkGmOoAJ/A0hXK0o2tjOcd6ryyADHY1Yk9qoTtg0DuVLh8dTzWTdTjdjPOau3j/L71i3UnUntQkJsr3coEfUY9DVKytG1CZT0iDVGFfULvy4/uDr7+1dNaxJAiIgAGM5B/SvUwtC3vM+fzHG8z9lD5kkUaxpsiIAXipWzw2TkdB7U3hUwAQMkAY5oKjYMkAAYP513njIfls59+1ITuOAcnPT1pDnI2kcHpS5yoD4PXGO3/16BmHk56c0owQOcEelB6cHNJkY9DUFC7cjvkGqupv5VpIc44xVpV4BPNZXiB9trt6ZND2KjuZ2ijLt7tzXTIgKYHKgZrndBU+X7kk11CYEC7Rya8as7yZ9RhlamjDv0KOcA5wCPUU+2YGMYIwetWNXj2Sh+cFaqWpzgY+71rFnUi+3CE5wD6VWuAPKIHTP6VMzHCnsOMVFJggqBz2pFEduQMA9D6dqvxSfd2E/Q1kxPtkKkgc4FaMOMcHtUyGaEUgzjDfWriOOTx71nRt0zkZ79as+bwBgH0xUXFYuISQeOD7Uu8cZOfUZxUEZwCfmx6mnb1JGCM575ouOw5tyj5RuHcMelNQgA7QF77aV4S+SM7gex60iueVKksDgjrRe4WsKBubO0q2c1bikOAx28Dr6VV8zjawxu4B71YjICbW65H4H1poRKhyeMjnPBp7ON21sAnpnIxQpBDBSMk8jGaHKtn1GOD2pggOCFBzuHGTxg/570oXKnCnZ79VPfFNCZJBHIHA65FTIAoGWwcdR3FIsVRgkMSD6EVIrkcY3EHGM9ahVlO0HBHfinjklTgMOnPWmIsq+4hRg59sVMoLKWLcA8nqcVTjBJBAPpyatI7cADgcDPf3polkyqAORz2/xpfu8dhzTQ5ALevFNY/MMHvTESZwRnPy88USKSoB4OcfWheeehx+n/wCunMcjB7DmqSJbIQcdeuSTTmOB0ppyOQfqaYzcjPqTimPcguGznGR2qjFwz84J6/nVq4zg98c4qmCRHx1zzSYyzE3ysSDyevpVPTpN8Db85DFeexzVqNh5JPAGR+dZulkglX4DsXH0JoGkbLwhGDr6dBV23IZBjoarxHcgHXBxip418tiP4e1D0Gi2g54wKsKQAVOA2cg+lV1+XkcinMQwyDge9AmTH5D1/Cq8xG3rj1oaQZPOR+oqrJIQc560BYbLJgdeBWfdSHFSzyY75Hp61kXtwccnjFAEV7MSOvB71z99I00gggHzv+g7mrl7OEjLt2FLoluQDPKo8yToD2FdWGo88rvY83MMV7GFluy1p1mlrBgff/vGroxz/eHr0NNOcEEHdjODQDwoPHbHrXrrTY+ZerHIDwMZOOlKoJ7r+NJjDLwSM43elOx1K9+5GSKAsKOXGR0OaQ8NzkHP+RQpCgktgU0uON2MfnmgZjhscdKDyc8cVHwfpSA4bJOB6VIyVck4xWB4kJCqD69K3t2e+K5fxBITcBetTN6GlNXkXNBU7OMYIxXTwLlT6L2rmtAPC54xXUWZHlnP8RzXj1fiZ9RR+BFDVFLISB2rGjYq/HTGfxrpr2PdA2PeuYnXEh5wR6VkdCL6PkbWxxyaHCsDg81BbtkgNycYzUsnHIxn2pDKM8ZNwCBke1aMAxgkgE1FgFQcYP0qeIYG7H61Mii6GUqBkA9qkBfsBn881XVmZRkAdqsR5yCRnHp2rMaJ0OFUsBnPNS7lzk4B6ZqFnx1DFTxS4OeDkdiD1qbjsPUgcAE54yO1O3DPJyc9x0qFX2nGc7v1p+VYcjJ+vNUgZKduTjHI5HarEapt6DOMc8EfjVZBgAc54+9VhCRhSOe3b86ogk8pSvDkjPGf60+MtzkgE/xNUUXEZZSRntu6VOjALnIA/MflSGSEbuM47jP8qjc7STlgD7Z5pwVRkAgdxg4qMyA5BII7nGMUxhHJwAwGD17CrCuCVxjPb6fWocIVUnGT/Een6UiFVO3cOucDpRsMuodpIHQ9fpUwC5HJ9DzwKrIx3DI+vOc/jUqNuUL+dUiGTx8je3GBSY2nBUHHzYpD06jj3wSe1KsnPzZB6kA9KskkRgTu5JPGKd17+5PTNRjBGTnjnBHrTyeCPbp6U0JkbA4GeM1HjKipZDz0PGahkOehxQNEEmC2P5VUkHyjP5VakHPUZPeq83bkYHWkxj0YGM8gntx71nW2cIyYwkjDgVbGQhB4z0PXAzUVnHtEi4xht1S2XFGxDj5SO4q0oyAT/wDqrPgOFK/3Tx7fWr6sAg9DwB609waJs4HPSkfjn8aYz4GCAcCo3k4JJAPuaZNiSRwc7gMiqUz4B5wafLLu5Oaz7iX/APXmgZFczc/oAO9Y9y+ZH/M1LczbsjkVj38+2M7efenFXdiJyUU2xsI+3agI2BMcXzN7+1b6hQgXgrjHA6VQ0i38mCMn7z/M341e7knGe+a9ujTUI2PkcTXdao5MkYjLZ6djjJppIyMZwOh7UmDkEnnP60ufl5GcHHTH5Vqc9x+AAQWI7GpM/wAWeOcD1qMoBkgk44Hek6cMSO4xQO4dvmGD2INCjJGDkjt+PShlYkgN+FIoK5zjrzx+FAIyCAehwc03B7nrQWIJJxzShgq5JP4VIxD0OcmuT1k5uyPSuuXkev1rkdZH+mHFTPY1pbmjoi/uw3U10sAZYQwbAzXN6GcQjjqea6eAAQgZBANePV3Z9RS+BEssbeX15Paue1GJkZjg9cV1EvIUDqKxNViB8zHHGfxrI2izIjfp6irSSB16A+vtVVlVoxkYPf2pLZ2LYPOeKCi+6gKW3Y/GnQAMoDKfaq8km3G7PtU1q+6MHOSevtUNDRpRMm3j/CpUCFyx49wapoqK2PUZ4p6Jk5y2R0HtUMpItBULnYxAGD0qVX25BAx64xTYRIyhsHBHWrC7yuSxPPpUWKRXkX72wgZHTsaqRSMsvzDI7elXmhIUkBsnk81XZWBJyuPyqkDLMb5IP3h6EZqzC+85UfLznHNUbTBfBAJPqKtplSBtOfTriqIsTsm6UHdnA+8eDUmQhOMgHt/9aq6zLv6YJPPb8KnUsylcgp7jg0DFY5Xg47kEcH8KTdknAJGc8HFNzjGQ3p8p5HvTmYFcHgE5weMGgEIQzYCnBHJ7cVKAAxycZHHFNQ5wUPuM9ven+5OMDp2p2GPRdu4H5vUdqspyQeMjnn+VQRtxg4JxgE96lX5Cc49jVJEMmfjqMnrj1ppJYtgnHqBTcg4yBx096egBIwevHWrRLHMSqgdWz1z1NS5AUk/U49qgON2eQeuKHfJ+UkEjpTRJJKcjOTj2quzBTgdTUhJ2jJ7daikILA5xgYpDQwkY5xUUp+YZPTtTnI564qFhkAdB1pMpIOWJx0H+NSoMSnHAPH0qGNsOw/hz/SrIH3eeak0Q8cHocdCasgkFSfuk561AvK8+nH1pC53jJIAGM0wLHnAttAwhPGaZKykHnJ9ahfHy5OF5qMyHbx16UxDZm2n5jisy9myT+XSprq4wWyeMYxWXM4PJOcjAxQIglbPOep6njiqAjM92idUQ72zVm5cKmT246cCm6SpKPIeGc8E+grswsOaVzy8yrclKy3ZqKSCnOB7VMMAc49zUEYH8QJ9qmBAyBxyOcV6p82OBx0yQegoP3Ru5Yd/aoypAZwvJ/DNSHOz5W/8ArUxEnBYAY/pnpQzZPzcZPPrTRkncSDxgijHJwvIHSkMduBJOMgdcdqNy7cHnPHXqKYuFPUZ9KMjGQDjGDQCMfg9s96djjjpTRkkkgfhS44+XrUlB2OPSuO1f/j9b6V2Zzg5HNcZrH/H6/pUVDSluaGhsPII6kHNdTZtuiGetchoD4dlz16V19hzG3ZhXk1viZ9NQd6aZoJk+nArP1BAysT06dKvJ9084NVbzmEr1zWJstzmbldjMOeBmorc4nAbB9KuXYBfkc4wapKcMhHY4oRoWbp8jg8D1pI5AjIpz852gjtUEhyGX39atW6kgELu9KTBF6NjGg3HI6jNTw3sMTZYgf1qGKLOdxJHvRLmMcIvsSKyZorGlHq9sBguv4Gp4r+CViFlQexNVNH0CXWCJZiIrXP3go3P9Pb3rrbTwlo8AUixidx/FJ8xrRU5SVzOU4x0M1CjwgE8/z+lRvaqRgdPXFbdx4XsmBe38y2bHWJ+B+B4rJurDULIltv2qMc7l4bH070Om1uEZp7FFLfazZJAJxnGRUvK4DYYZ4/8ArGiC7gmPBG4cMvQj6irRBLEIcg9j0qWiysynPDAnHHcj606NyAoJAY9e3509oc53HH04IpDHk9i3o3GRSSGSIMLgDd147fh2psgDjB78ke9NGc4XnHY/40FgeR27ensabEiMvtUHBJz+lTMWZBgkDP3hzzUSFWLHnINTbsZ2Nh89xww9PahDbHwIEXYZGY+rGrCPwc9R2/rVYLvk579yOtTYwfl5HbPerRDJEbAxjg9DT1YbarA+YnzZHHQ8U+NirZZQR1xmmhMsSOFB5HA57c03g/MT9KjzvwDnHvTjIS/GDzxTJFJ2kA4P0qNzyBkcelIWHQGomYDI5ouCGyuSeTnFMDcH1NNJJzzxUatzj+H371NzRFiMjcfUgEcdanyS3sRUcTcAn05/pTmfCg45zxSQ7knmYOMc+/ao5JsZwc+ntUEj44yOPTvUbt8uCT1596BllpjsB4x169aryz7R8zjcR0qtLcEBsYGaoS3C54JP8xTQrC3Mwc5bI/2e5+tV2y0gdjye1MBYuWwCx4BzxUVzciOMhSQQMH0qoxuyJysiG6kaeVIE6Ht6CtiNAgVVAAAwPesvRY95M5xkjC5rWxyRjqcccV7GHp8kdT5bH1/bVLLZEinGCpHB7+tPy2ScDHX6GmKo2/jUgUjgD8a3OKw4Ak5fk9/QUNkrxgZPWms2MdcHilL8AAnkYximOwuT34z+goHBzuIP86TqTgnA9aTOQBxzznHWgQ45/hxjHXHSh9wx6UAgAFSQM8gmjdknGAcZ+tAzGB5+Yml6EnnmoixycZ96fk4FSBIGzya5LXRtvG966vrXL+IU23ecdaiexrS+Ir6TJ5dwM9K7Swkwi981wEL+XKrdq7LTpSY1wccZrzMRG0rn0GClzU7djoBwhyO3Bqrc8ID1qSOcNDg9fWq9622L1yK5zrRjXA3ZC8ZPeqMowmM8g1emAYtiqMx6nqOlJGgg53ccnvWrp43RAc+wrOVTlB3Aya1bDG3g49/WkwuTdCU6fTmrGnWLX1ztIPkqfmPr7VXmfEbY6KK6zQ7b7PpsCsBu27j9TTpxu9RTlZG9YosUSJGoVFGAB2FXVOKpW33RVhD6dK6bGFi0jDBBqKQBhz0pMmkyaGNIwtd0BL2PzrfbFdLyrY4b2NctYXr+Y0MoMUqNtZT2P0r0pQCpzXC+NrAQXtveINquwjcjjnsf6Vz1YfaRtSnryssJtZRzu/Gkc7jhcHBzg9/wrPs3dQBwwPvV2I7eHzgDnNZI1eg/A2lmGR7HmmOoOSp5PPFSO2MYAz3OP50xnTgnGR270NAIAQAeMg9MdqBkBSe/H41FvwfmJIzxzingYJGQAex5poGSeZncR1B6jpTWBI2tgZPNJuGeRjHQ9waUSDftGOB69KdxEu/IBAJalbDfd4PUVGj89gOv1p3mqTwMHtmmiGPEnQ49e9JvPXjJHTpTB9zk8jmq4cvJlzjbRcSJXmIfBzUckxxg9+uKjZsnaDuJ70yTcqH5c4HWgpDxKFcHG09s1GWO4MDyeM9qrtLgDcTkjr/npSxklgOckYqWWlY0Y2AHB6D8qbI/ytjIOMH2qEMR7jtTXcDkgc89aaAXflR/e/hqGWcrkAnHrjrVe4mI6k4PWqsk5OQD9aEgJJ5wx9T1Oe1VncvznP1/lUTyADJ6eoqhd3yomBgY6Z7VpGDZEpqKuy7cXaoMEgn16VlxO19dLHGTs/ib19qz3klup9q5wa6zRrOO2hBP3yAa9Chh7ayPCxuOuuSBet4RHEiLwB/Opk7c9+9BHUDgZ79DSqOmThT7V3Hjj1Jycjn2p4YZA79TkY/Oowcdf0p549G9qLFIc0gBJxweuO1N3Afw5GP/ANRpDt29c4OeaVseuORmgW4DHHPJ6mkO7PY44xSlT978MCoy2Bn7w70xEmTjG3pTc5I3dfWgMSRjjJ6dqUgZwxGeooAxVBBBxx3p6Ec96i6JzyKeuMcHmpGP2n+9msHxKhKq47HvW929WrP1iMyWbbhzipkrocHZnIZwc10+jT5CE9QK5cnHXtWjo9zsl2k/SuCvG8bntYKdpcvc7OOTLZU8enpSXr5UEHPrVK3lG3v6detWJTmMcdOa4T1ramaHOGA65qpcHaRnqeann4ckfnVOWTzHUfgKpIbLcWSFPrgGtezXoBVK1jzjjCj1rYtVCYJGfpUsCvKA1xbQ4O6SRQR7Zrv1UBRgcVwRb/ieWWf7+T9a7+M5hX1rWmtDKo9UT25xmrakYGKqQ8EGraDitSLkgpGoPFN70mCLEP3TXP8AjODz9FuQv3lG9fqOa3FbHSqOsL5tnKuOqEfpUyV1YqLs7nDafkRoT0ccY6fT61fWQ5wTz/KoNOUiBOvAxgjipWOyQAgMvXd6Vy7HXuN80hlG5sHualIyCV59ahdcsGHfOT60qMwHzMSTxzwaVwsSOm4Er1xwcVExZY1GCCBz9RTmkJB6j8aQ5IUngU2SmIrMQpc59u2KE6ucbW7HPWmNv6LjrkYpXk+XABI7+tCBsl83G3p+FPWRWPAAOaprIBuJ/TqKatwik8kE8A4xVE2LzyIQcE59qpvJ8x6YPGBULT5fardahkk2ggnLA9etA0iV5RGeDznNKbnepx6YqscBSepJ5DVXkJOAp574qS0ibzFlk4+6D1q2jDZgZwO+KoxKE5brnkDpU7TYGMnPfHSmkDZYabCnnNVpZvlznGaryTAjaeO+Ko3MxkJGSM8nFNCJprkO55wKqT3Hl53cYqGaXbk54xwO1Zt1cscnPHvW0IXMqlVQRLd3pJwOnaqSRy3TAc8nFLZWsl7LwCF9a6zTdPS3RcgZ6816FGjY+fxWMdTRbEOl6YsCbnGDWxtwvGKRV2nIxgng+lPIAAPNdaVjzW29WIDg8nGDjFS7jgc81Hg7tzHrzT92c5wKAHgnrgEZpxYgjaMEdCO1Q7sYJP8A9anq5bgnpQMUnjqBk4JNOJbaRlSB196YX74JFIGXAyCBQIf2J2kfSms+35c8e9G7jHIzRvXHoBx9KYhcg5zyB+tIwPXH4ZpQV2duvPtQGGMAjikNGOODjP4UoHXNRjoCTShuepNIZIDn1qK4G+F1weRTw3PGRTX9QSeOlAjhrpPLmdD2JqOGTy5AwPStTxDB5c+4DAIrFb2rmkr3R30p2tJHXafcb1Ujn+lahYspJP4CsDQyPso6VtDoB6jJrzJqzsfQ05c0Uyrcjap2gYrOiO69iHGM9q0Jz8h21lBityjDqDj6U4lSOojRce1asMYCZI4HesuyUuqs2PpWorgQlc96zGzKmkA122JIyGAxXf2kmYxzzXmuoME1aBs/xCu/059yLnuK1pbGdVWsbKHpVhSccVWhGQKtqvFaGQoJpwHfvShakC4FA0MPFV7xcxkVaYVWuvuGkNHGW4ChoySDG7CnFeeSd3qKJFC310u0HLZ/Oj731+vWuWejOqL0GMGHcgdxj+VRuw+Xoc8cU92bBypz2NRlWbBHr0qChRkMdwyuMg4pzNhfc9fSkjO0AngntUdwVwCOT2waZLI2cgEJ0z+NI8m7JAwO4piHk46Um7YQTyD0NCYrDVcdiQT1pkhwvIJIpzOBlsAA9qhkbc2E+VRwwzyaq4xQwGCM8UhkGc46fzqMDnqM9hUM3mOvGOOxNBQ97pWjIVT1701G2gEcnvmq6KV3dPXkUpcL1YZ70JDZY84fMOCD1zUUlxxjPJ4yarGZCTzx3qFnznC8E96qxA93aRTjJGcmoppioHbHNMaTaOWqjcy72K849PWtYQuZVKnKgmk8wkkgKO9FjZNfybsHyB096LO2N7cLGv8AqlPze9ddaWyQoFQDCivRo0dLs8DGYpyfLEZZWccCYUAcVa29xilGcHkCnr8yn1PpXUlY83fcZkgnIHHagEbuMgfpTyAST3FMboQOvSmMeME8UoAI+93pqkk4NPUZOBjGM4PakAcDnoM04YDcc0mOO57mhSCvXHoT0oYDs/NjgnGaaTnGfXqRTgOhOPz5puSCeAc8/WkgELZOcZx19aGZQSSeB796GXHzdxSFQyjgAHmmIfhRzx/jQ2D1Ix60hXgZAxnIx2ppBxj+dAzFDkjpj604E96Z0PXmnYJOc9OKlAOz1peNuaYBwcHNOH+1VCM7XIBNaFhyRXHuf8K7i/GLV/7tcVcYEr9sVjUWp1UXpY29D2i2z3JwK3WUBQS3bFc/pJ2wRfXNbqMGPUYry6m7Po6DtBFa64AJJx2FZ5HzJ2yav3Z+XGOlVmTAXPp0qEa7s6LTAQAOx4rTJA78Ec1m6YxMCng8flVt3Ykjpxnk1mXa5ga4Qt4rDIwQa7vRJN8UZHPFcBrjZcMM5x3rsPC8260hOewrSkZ1lomdpbjgVcHSqFs/Aq6p4rU5yUGnE8VFkGlBPrQVYc3Sqtx92p92arzn5aAOS1IbdUc9NyD+dRbiy/iefWn698uowkMRkEVEpB/d45XmuepudNN6DgxKHIHp9aiwc87acWypIPy981WfIdsk4PpWRdx0r7UIPbkGoY5C2Vdev8XrTlBPPUdcUYVOc9e4OaQCfKT1xjjFRt0LMSFB7UrElRsxjPWml8qc+uKpARyEscAYHrULK6EYwOMVM8q7QADxVWSUbfutnofemhXFYbAMZIx1qMyqeAQaa75OMnA79zUAwrbhjnrVAOllYA9PoapsSzc1LIWY4AOKYVwOV5x61VgIWwvX9KiknKg44FOn5GCcVAqluW6VrFGM5kfzyH5jgdqakJml8mM/M3X2p00uCEiGXJwB610OjWItYQ0gzI3Jrso0r6s8jG4rlXLHcfY2a2kCptyRySOtaEeCeOvvUZOc9achxnAwM44rvSsjxb3dyxuGDkfj7Uq7e1RjByAT75p3YYHtQMeQCQf1FIQRmkU46UuT6HjsKQxoz15xT+OT2FIGUjI79aByBgZpAhcDBx3pXx1Hb+VKo46e4pSeffpQgYKR+VDcjBbmmqewI5pzcjoMD06UwI9+SB2704425GBj1oCgnnv1pD7duKBWFKnpkYpOfpjjim5bJOR+VPViM4HFMD//2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    When the patient with a fight-bite injury is examined with his or her fingers extended, the small skin laceration may no longer correspond to the fracture site and is frequently overlooked because of the innocuous clinical appearance (arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_36_11845=[""].join("\n");
var outline_f11_36_11845=null;
var title_f11_36_11846="Corrected sinus node recovery time";
var content_f11_36_11846=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F58763&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F58763&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 534px\">",
"   <div class=\"ttl\">",
"    Determination of the corrected sinus node recovery time (SNRT)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 514px; height: 310px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This tracing is from a 76 year-old male with paroxysmal atrial fibrillation and recurrent near syncope associated with palpitations. Surface leads represented are I, II, III, V1, and V6. Intracardiac tracings shown are the high right atrium (HRA d), the proximal His bundle electrogram (HIS p), the mid His bundle electrogram (HIS m), the distal His bundle electrogram (HIS d), and the right ventricular apex (RVa d). High right atrial pacing at 400 msec (150 beats per minute) is performed for 30 seconds. Upon termination of pacing, a sinus node recovery time of 2150 msec is observed (arrow). The basal sinus cycle length was 1200 msec, giving a corrected sinus node recovery time of 950 msec consistent with severe sinus node dysfunction. Note the significant secondary pause extending beyond the end of the tracing providing additional evidence of sinus node dysfunction.",
"    <div class=\"footnotes\">",
"     msec: milliseconds.",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Joseph J Germano, DO.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_36_11846=[""].join("\n");
var outline_f11_36_11846=null;
var title_f11_36_11847="Buruli ulcer thigh";
var content_f11_36_11847=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F77733&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F77733&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Buruli ulcer located on the thigh",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 425px; height: 371px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Undermined lesion with necrotic debris in the right thigh of a seven year-old girl.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Tjip S van der Werf, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_36_11847=[""].join("\n");
var outline_f11_36_11847=null;
var title_f11_36_11848="Evaluation of the HIV-infected patient with chronic hepatitis C virus infection";
var content_f11_36_11848=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Evaluation of the HIV-infected patient with chronic hepatitis C virus infection",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/36/11848/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/36/11848/contributors\">",
"     Barbara H McGovern, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/36/11848/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/36/11848/contributors\">",
"     David Thomas, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/36/11848/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/36/11848/contributors\">",
"     Allyson Bloom, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?11/36/11848/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 16, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;As death rates from opportunistic infections in HIV-infected patients have declined with the introduction of potent antiretroviral therapy (ART), morbidity and mortality from end-stage liver disease has increased. These clinical observations provide strong rationale for the evaluation and treatment of the HIV-infected patient with chronic hepatitis C virus (HCV) infection.",
"   </p>",
"   <p>",
"    The",
"    <span class=\"nowrap\">",
"     HIV/HCV-coinfected",
"    </span>",
"    patient benefits from a multi-disciplinary team approach and intensive support throughout treatment. The complexities of hepatitis C management in this patient population will be reviewed here. The epidemiology, natural history, diagnosis and treatment of HCV in the HIV-infected patient are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/32/30218?source=see_link\">",
"     \"Epidemiology, natural history, and diagnosis of hepatitis C in the HIV-infected patient\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/38/18026?source=see_link\">",
"     \"Treatment of hepatitis C virus infection in the HIV-infected patient\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/40/38536?source=see_link\">",
"     \"Clinical trials in treatment of chronic hepatitis C virus infection in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     INITIAL EVALUATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;HIV-infected patients who are being seen for evaluation and possible treatment of hepatitis C should undergo a complete history and physical examination.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Substance abuse",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with a history of substance abuse who are currently abstinent should be interviewed about the stability of their recovery since the use of interferon has been associated with relapse of drug use [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11848/abstract/1\">",
"     1",
"    </a>",
"    ]. Active injection drug use does not rule out the possibility of treatment; rather decisions about offering therapy should be based on the patient's ability to adhere to medications, return for follow-up, and avoid reinfection (eg, avoidance of sharing needles) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11848/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. Treatment of addiction with drugs such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/57/36761?source=see_link\">",
"     methadone",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/53/41816?source=see_link\">",
"     buprenorphine",
"    </a>",
"    can effectively facilitate HCV treatment in drug users. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/38/18026?source=see_link\">",
"     \"Treatment of hepatitis C virus infection in the HIV-infected patient\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Alcohol use should also be detailed; coinfected patients should be counseled against the use of alcohol, which has been associated with acceleration of disease progression in patients with HCV infection [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11848/abstract/4\">",
"     4",
"    </a>",
"    ]. Furthermore, CD4 counts may improve after patients stop drinking alcohol [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11848/abstract/5\">",
"     5",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/32/30218?source=see_link\">",
"     \"Epidemiology, natural history, and diagnosis of hepatitis C in the HIV-infected patient\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The patient should be interviewed about risk factors for hepatitis C acquisition in an effort to obtain information about possible duration of infection, which is helpful when interpreting liver biopsy results.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Psychiatry history",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although psychiatric health issues are common in patients with a history of substance abuse, they do not appear to negatively influence adherence or outcome [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11848/abstract/6\">",
"     6",
"    </a>",
"    ]. Prior to treatment, patients should be screened for depression (including suicidal thoughts),",
"    <span class=\"nowrap\">",
"     mania/bipolar",
"    </span>",
"    disease, and other psychiatric diagnoses since interferon can exacerbate these illnesses [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11848/abstract/1\">",
"     1",
"    </a>",
"    ]. Various screening tools are available for screening of depression; for example, the United States Preventive Services Task Force (USPSTF) clinical practice guidelines for screening for depression can be accessed through the website for the Agency for Healthcare Research and Quality at",
"    <a class=\"external\" href=\"file://www.ahrq.gov/clinic/uspstfix.htm\">",
"     www.ahrq.gov/clinic/uspstfix.htm",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    Psychiatric consultation can help facilitate HCV therapy through stabilization of active issues, such as untreated depression, prior to initiation of pegylated",
"    <span class=\"nowrap\">",
"     interferon/",
"     <a class=\"drug drug_general\" href=\"UTD.htm?26/25/27033?source=see_link\">",
"      ribavirin",
"     </a>",
"    </span>",
"    therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11848/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Other past medical history",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is important to consider whether there are any potential contraindications to HCV therapy (such as unstable coronary artery disease or uncontrolled diabetes). A full discussion of potential contraindications is found elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/45/43735?source=see_link\">",
"     \"Overview of the management of chronic hepatitis C virus infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Medication history",
"    </span>",
"    &nbsp;&mdash;&nbsp;A complete medication history is important to determine if there are any potential drug-drug interactions with HCV therapy and the patient's antiretroviral medications (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?26/25/27033?source=see_link\">",
"     ribavirin",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/38/14952?source=see_link\">",
"     didanosine",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/38/18026?source=see_link\">",
"     \"Treatment of hepatitis C virus infection in the HIV-infected patient\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients should be interviewed regarding any potential hepatotoxic drugs, such as herbal medications, or over-the-counter drugs consumed in large quantities (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"     acetaminophen",
"    </a>",
"    , non-steroidal anti-inflammatory agents, vitamin A). Opiate substitution therapy should also be noted;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/57/36761?source=see_link\">",
"     methadone",
"    </a>",
"    dosing may need modification in the setting of cirrhosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Social history",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinicians should inquire as to whether the patient may be homeless or is in a chaotic living situation, which can negatively impact on the ability to adhere to complex medication schedules. If the patient is living in a group residence, it is prudent to engage the director of the facility to determine that there will be ongoing support for medication storage.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Pregnancy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women of childbearing potential should be interviewed regarding future plans for pregnancy since the",
"    <a class=\"drug drug_general\" href=\"UTD.htm?26/25/27033?source=see_link\">",
"     ribavirin",
"    </a>",
"    component of combination HCV therapy is teratogenic.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Family history",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients should be interviewed regarding whether any of their family members have a history of cardiac disease, diabetes, or hepatoma. The presence of insulin resistance or diabetes is associated with a lower likelihood of a response to HCV therapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/38/18026?source=see_link\">",
"     \"Treatment of hepatitis C virus infection in the HIV-infected patient\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Physical examination should include evaluation for stigmata of advanced liver disease such as spider angiomata, palmar erythema, splenomegaly, jaundice, or caput medusa. Clinicians should be aware that absence of any of these findings does not rule out the possibility of underlying cirrhosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/41/23194?source=see_link\">",
"     \"Diagnostic approach to the patient with cirrhosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In patients who are being considered for interferon therapy, we also obtain a full ophthalmologic evaluation, particularly in those with diabetes and hypertension, since interferon can be associated with ischemic retinopathy and decreased color vision [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11848/abstract/7\">",
"     7",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/9/16538?source=see_link\">",
"     \"Management of the side effects of peginterferon and ribavirin being used for treatment of chronic hepatitis C virus infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Clinicians should also look for evidence of other diseases that may lead to further consideration of the inherent risks of HCV therapy, such as severe psoriasis, wasting, or thyroid disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/38/18026?source=see_link\">",
"     \"Treatment of hepatitis C virus infection in the HIV-infected patient\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Laboratory screening",
"    </span>",
"    &nbsp;&mdash;&nbsp;Laboratory screening should include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      HCV RNA and HCV genotype",
"     </li>",
"     <li>",
"      Aminotransferases",
"     </li>",
"     <li>",
"      Bilirubin and alkaline phosphatase",
"     </li>",
"     <li>",
"      Complete blood count",
"     </li>",
"     <li>",
"      Measures of synthetic function: prothrombin time and albumin",
"     </li>",
"     <li>",
"      Random glucose",
"     </li>",
"     <li>",
"      Creatinine",
"     </li>",
"     <li>",
"      Thyroid function tests",
"     </li>",
"     <li>",
"      Absolute CD4 counts and percentage and HIV RNA",
"     </li>",
"     <li>",
"      Pregnancy test for women of childbearing potential",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A baseline lipid profile is also prudent, since interferon can occasionally lead to exacerbation of hypertriglyceridemia [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11848/abstract/8\">",
"     8",
"    </a>",
"    ]. We also obtain a fasting insulin and glucose level since insulin resistance has been associated with lower treatment response rates (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/38/18026?source=see_link\">",
"     \"Treatment of hepatitis C virus infection in the HIV-infected patient\"",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Evaluation for additional causes of liver disease should also be considered. Screening for hemochromatosis is reasonable (with a serum iron and total iron binding capacity) since it is a common disorder in the general population. Screening for less common disorders (such as autoimmune hepatitis, Wilson's disease, alpha-1 antitrypsin deficiency) should be decided individually based on clinical presentation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/44/35528?source=see_link\">",
"     \"Clinical manifestations and diagnosis of autoimmune hepatitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/37/13910?source=see_link\">",
"     \"Epidemiology and pathogenesis of Wilson disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/8/6281?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and natural history of alpha-1 antitrypsin deficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients should also be screened for past exposure to or infection with hepatitis B (hepatitis B surface antigen and surface antibody) and hepatitis A (hepatitis A IgG antibody). Patients without evidence of past infection should be immunized against both HBV and HAV. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/25/37273?source=see_link\">",
"     \"Immunizations in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Screening for tuberculosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients should also be asked about prior skin testing for tuberculosis or recent exposure. If testing occurred more than one year ago, repeat testing should be performed prior to HCV therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11848/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Interpretation of aminotransferases",
"    </span>",
"    &nbsp;&mdash;&nbsp;Aminotransferases that are persistently elevated (ALT&gt;AST) are often found in patients with chronic HCV infection. A pattern of AST&gt;ALT may suggest recent alcohol ingestion or the presence of cirrhosis, particularly in association with low platelets, an elevated prothrombin time, or low albumin.",
"   </p>",
"   <p>",
"    Clinicians should be aware that persistently normal aminotransferases do not eliminate the possibility of underlying liver disease [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11848/abstract/10\">",
"     10",
"    </a>",
"    ]. Patients with persistently normal aminotransferases may still have disease requiring treatment. In a study of 326",
"    <span class=\"nowrap\">",
"     HIV/HCV-coinfected",
"    </span>",
"    patients with liver biopsies, 25 percent of the 24 patients with persistently normal liver enzymes had a fibrosis score equal to or greater than 2 [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11848/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Patients with suspected cirrhosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with cirrhosis that is suspected on clinical grounds (eg, spider angiomata",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    splenomegaly) or imaging (eg, splenomegaly) or histopathology (eg, nodular architecture) should undergo screening for hepatocellular carcinoma and esophageal varices. (See",
"    <a class=\"local\" href=\"#H5442944\">",
"     'Imaging studies'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Interferon should NOT be given to patients with decompensated cirrhosis. All cirrhotic patients should be seen by a hepatologist for further evaluation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     STAGING OF LIVER DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to the physical examination, non-invasive and invasive testing methods can assist in evaluating the stage of liver disease. Regardless of the method used, all patients should undergo staging of liver disease to determine if they have unsuspected cirrhosis, since these patients require screening for hepatocellular carcinoma and esophageal varices.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5442673\">",
"    <span class=\"h2\">",
"     Role of the liver biopsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;A liver biopsy is important for determining the stage of disease and can help guide therapeutic decision making [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11848/abstract/11-13\">",
"     11-13",
"    </a>",
"    ]. Various methods use different scoring systems to evaluate the degree of necroinflammatory activity and fibrosis severity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Advantages",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are multiple potential benefits of a liver biopsy that should be considered in the",
"    <span class=\"nowrap\">",
"     HIV/HCV-coinfected",
"    </span>",
"    patient [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11848/abstract/14\">",
"     14",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      If the histopathology demonstrates minimal disease, deferring treatment (with future reconsideration) is a reasonable option, particularly in patients who may not be ideal candidates for treatment at that time.",
"     </li>",
"     <li>",
"      Liver histology may help estimate the rate of fibrosis progression in patients in whom the duration of HCV infection is known, thereby helping to assess the urgency of treatment.",
"     </li>",
"     <li>",
"      HIV-infected patients with portal fibrosis or greater disease should be considered for early intervention since fibrosis progression rates are accelerated in this patient population. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/32/30218?source=see_link\">",
"       \"Epidemiology, natural history, and diagnosis of hepatitis C in the HIV-infected patient\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Documentation of cirrhosis (which is not always evident on physical, radiologic or laboratory assessment) may lead to adjustment in the dosages of antiretroviral medications [",
"      <a class=\"abstract\" href=\"UTD.htm?11/36/11848/abstract/15\">",
"       15",
"      </a>",
"      ] and will support the need for serial HCC screening.",
"     </li>",
"     <li>",
"      Patients with HIV are also at risk for other causes of liver injury including mitochondrial toxicity related to chronic nucleoside analog use [",
"      <a class=\"abstract\" href=\"UTD.htm?11/36/11848/abstract/16-18\">",
"       16-18",
"      </a>",
"      ], particularly the dideoxynucleosides (eg,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?14/38/14952?source=see_link\">",
"       didanosine",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/45/43734?source=see_link\">",
"       stavudine",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?11/36/11848/abstract/18\">",
"       18",
"      </a>",
"      ]. This type of liver injury may be evident through specific histopathological findings, such as microvesicular steatosis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Limitations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although histologic findings of liver disease are helpful in directing clinical decision making, the absence of findings on pathologic specimens does not ensure that the patient is free of liver disease. Multiple studies have demonstrated the lack of sensitivity of the liver biopsy, which is underscored by the estimated sampling size at",
"    <span class=\"nowrap\">",
"     1/100,000th",
"    </span>",
"    of the liver.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     When should a liver biopsy be obtained",
"    </span>",
"    &nbsp;&mdash;&nbsp;The liver biopsy is particularly important in HCV-infected patients with genotype 1 infection and high-level viremia (eg, &gt;400,000 int.",
"    <span class=\"nowrap\">",
"     unit/mL)",
"    </span>",
"    since these patients do not respond to therapy as well as those with genotype 2 or 3 infection.",
"   </p>",
"   <p>",
"    This issue is even more pertinent in HIV-infected patients with genotype 1 infection since the SVR rates in these patients are lower than historical controls with HCV alone. Knowledge of the degree of liver disease can be helpful during therapy since treatment is associated with significant side effects. For example, pretreatment documentation of early disease may prompt discontinuation of therapy if the side effects are severe. In contrast, preexisting knowledge of significant liver disease may help the patient adhere to therapy despite moderate side effects. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/38/18026?source=see_link\">",
"     \"Treatment of hepatitis C virus infection in the HIV-infected patient\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Compared to noninvasive fibrosis markers (which are best at identifying very early or advanced disease), the liver biopsy offers more detailed information about the severity of necroinflammation and fibrosis in moderate disease and can evaluate whether or not the patient has hepatic steatosis.",
"   </p>",
"   <p>",
"    Although helpful, a liver biopsy should not be a prerequisite for treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11848/abstract/14\">",
"     14",
"    </a>",
"    ]. This is particularly true of patients with genotype 2 or 3 infection, the majority of whom will attain an SVR. In addition, with the aid of serial HCV RNA measurements during therapy, lack of a treatment response can be predicted by approximately week 12, at which point a decision can be made to discontinue therapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/38/18026?source=see_link\">",
"     \"Treatment of hepatitis C virus infection in the HIV-infected patient\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The risks associated with a liver biopsy also need to be discussed. In those patients at increased risk for complications, noninvasive testing can be considered. (See",
"    <a class=\"local\" href=\"#H26\">",
"     'Noninvasive serum fibrosis markers'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/58/29608?source=see_link\">",
"     \"Percutaneous, fine-needle aspiration, and laparoscopic liver biopsy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h3\">",
"     When should a biopsy be repeated",
"    </span>",
"    &nbsp;&mdash;&nbsp;If treatment is deferred, treatment guidelines suggest a repeat biopsy in three years [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11848/abstract/19\">",
"     19",
"    </a>",
"    ]. However, in a study of 67",
"    <span class=\"nowrap\">",
"     HIV/HCV-coinfected",
"    </span>",
"    patients who had paired biopsies over a median time period of 2.8 years, more than 25 percent of those with mild histology at baseline had significant fibrosis on the subsequent biopsy [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11848/abstract/20\">",
"     20",
"    </a>",
"    ]. For this reason, we obtain repeat biopsies in patients with minimal disease within two years and offer therapy to good treatment candidates with mild liver disease.",
"   </p>",
"   <p>",
"    An alternative approach is to use noninvasive markers over time to stage liver fibrosis and its progression, as discussed below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Noninvasive serum fibrosis markers",
"    </span>",
"    &nbsp;&mdash;&nbsp;The utility of noninvasive markers is under active clinical investigation in",
"    <span class=\"nowrap\">",
"     HIV/HCV-coinfected",
"    </span>",
"    patients [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11848/abstract/21\">",
"     21",
"    </a>",
"    ]. Some of these noninvasive tests use specialized markers such as alpha 2 macroglobulin (eg, Fibrotest or Fibrosure).",
"   </p>",
"   <p>",
"    Others, such as the FIB-4 index, use easily available parameters (eg, age, ALT, AST, and platelets). The equation for the FIB-4 index is: ([age x",
"    <span class=\"nowrap\">",
"     AST]/[platelet",
"    </span>",
"    count x (ALT)(&frac12;)]). For example, a 45-year-old patient with an AST of 100",
"    <span class=\"nowrap\">",
"     U/L,",
"    </span>",
"    platelet count of 99 x",
"    <span class=\"nowrap\">",
"     10",
"     <sup>",
"      9",
"     </sup>",
"     /L,",
"    </span>",
"    and an alanine aminotransferase of 100",
"    <span class=\"nowrap\">",
"     U/L",
"    </span>",
"    would have a FIB-4 index of 5. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/59/30650?source=see_link\">",
"     \"Noninvasive assessment of hepatic fibrosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One retrospective analysis assessed whether a model using easily available demographics and common laboratory tests could predict liver histology in 832 HIV-infected patients who had a liver biopsy (ie, FIB-4 index). In the model, age, platelet count, AST, and ALT measurements accurately predicted fibrosis scores in 71 percent of patients [",
"      <a class=\"abstract\" href=\"UTD.htm?11/36/11848/abstract/22\">",
"       22",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Data from the AIDS Clinical Trial Group study protocol A5178 were used to evaluate five models of fibrosis staging in 173 patients who had undergone liver biopsy prior to treatment [",
"      <a class=\"abstract\" href=\"UTD.htm?11/36/11848/abstract/23\">",
"       23",
"      </a>",
"      ]. The FIB-4 index performed best, with 88 percent specificity for advanced fibrosis (F4) and greater than 86 percent negative predictive values for",
"      <span class=\"nowrap\">",
"       F3/F4,",
"      </span>",
"      overall noninvasive methods of fibrosis assessment had poor discriminatory capacity.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Use of the FIB-4 index is a low-cost method to help stage liver disease, although its greatest utility may be in staging mild versus advanced disease (eg, cirrhosis). Noninvasive markers may offer complementary information in patients who are undergoing a liver biopsy to see if the two methods are concordant. Whether serial measurements of FIB-4 can replace other monitoring strategies in coinfected patients is not yet known.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Transient elastography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Transient elastography (eg, FibroScan) uses ultrasound readings to measure the velocity of an elastic shear wave transmitted through the liver to estimate liver stiffness in units of kPa [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11848/abstract/24\">",
"     24",
"    </a>",
"    ]. This modality is widely used in Europe; few centers in the United States have access to this technology.",
"   </p>",
"   <p>",
"    Conflicting results have been reported regarding the diagnostic accuracy of transient elastography (TE; FibroScan), which measures \"liver stiffness\" compared to liver biopsy:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a study of 74",
"      <span class=\"nowrap\">",
"       HIV/HCV-coinfected",
"      </span>",
"      patients who agreed to undergo paired elastography and liver biopsy testing, liver stiffness significantly correlated with the histological fibrosis stage [",
"      <a class=\"abstract\" href=\"UTD.htm?11/36/11848/abstract/25\">",
"       25",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In another study of 169 coinfected patients, the diagnostic accuracy of transient elastography was high in patients with cirrhosis; however, this modality was less accurate in differentiating significant fibrosis from mild disease and misclassified 20 percent of patients [",
"      <a class=\"abstract\" href=\"UTD.htm?11/36/11848/abstract/26\">",
"       26",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a study of 192 patients, 139 (72 percent) were coinfected with",
"      <span class=\"nowrap\">",
"       HIV/HCV,",
"      </span>",
"      121 (63 percent) had insignificant fibrosis and 48 (25 percent) had cirrhosis by histology [",
"      <a class=\"abstract\" href=\"UTD.htm?11/36/11848/abstract/27\">",
"       27",
"      </a>",
"      ]. With use of cutoff values of &ge;9.3 kPa for fibrosis and &ge;12.3 kPa for cirrhosis, 79 to 83 percent of the study participants were correctly classified by liver stiffness measurements compared with histology.",
"      <br/>",
"      <br/>",
"      Although the accuracy of elastography was higher among HIV-seronegative patients than among HIV-infected patients, most of the discordance occurred when elastography suggested more advanced liver disease than did histology. However, this patient subset had additional features suggestive of more advanced liver disease, including elevated serum fibrosis markers or HIV-related immunosuppression (CD4&lt;350",
"      <span class=\"nowrap\">",
"       cells/mm3),",
"      </span>",
"      compared with persons who had milder disease by both parameters.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Combination approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some clinicians have suggested that both serum biochemical markers of fibrosis in combination with elastography may be an efficient way to stage liver disease in",
"    <span class=\"nowrap\">",
"     HIV/HCV",
"    </span>",
"    coinfection; such a strategy needs to be prospectively evaluated compared with liver biopsy alone [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11848/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5442944\">",
"    <span class=\"h1\">",
"     IMAGING STUDIES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5442987\">",
"    <span class=\"h2\">",
"     Ultrasound",
"    </span>",
"    &nbsp;&mdash;&nbsp;An ultrasound can help evaluate liver size and texture and exclude focal lesions. Ultrasound marking is also commonly performed prior to a liver biopsy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5442994\">",
"    <span class=\"h3\">",
"     Screening for hepatocellular carcinoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Imaging is particularly important in patients with cirrhosis in whom there is an increased risk of hepatocellular carcinoma. The American Association for the Study of Liver Disease (AASLD) recommends that patients with cirrhosis undergo surveillance for hepatocellular carcinoma (HCC) with a right upper quadrant ultrasound every 6 to 12 months; As a general rule, surveillance for hepatocellular carcinoma appears to be cost effective in patients with cirrhosis who have an expected annual incidence of HCC exceeding 1.5",
"    <span class=\"nowrap\">",
"     percent/year.",
"    </span>",
"    Combined use of serum alfa feto protein and ultrasonography increases detection rates, but also increases cost and false-positive rates. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/6/28778?source=see_link\">",
"     \"Prevention of hepatocellular carcinoma and recommendations for surveillance in adults with chronic liver disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    We follow similar procedures in HIV-infected patients, although there are no prospective studies evaluating best practices for this patient population. Retrospective data from the United States and Europe suggest that hepatocellular carcinoma (HCC) occurs at a younger age and is associated with shorter survival in",
"    <span class=\"nowrap\">",
"     HIV/HCV-coinfected",
"    </span>",
"    patients compared with those with HCV infection alone [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11848/abstract/29,30\">",
"     29,30",
"    </a>",
"    ]. Also in the era of potent ART, there are data suggesting that the proportion of liver-related deaths due to hepatocellular carcinoma has increased in",
"    <span class=\"nowrap\">",
"     HIV/HCV-coinfected",
"    </span>",
"    patients [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11848/abstract/31\">",
"     31",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/32/30218?source=see_link\">",
"     \"Epidemiology, natural history, and diagnosis of hepatitis C in the HIV-infected patient\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5443001\">",
"    <span class=\"h2\">",
"     CT scanning",
"    </span>",
"    &nbsp;&mdash;&nbsp;Computed tomography (CT) of the liver is often performed to evaluate an abnormality detected on ultrasound. In some centers, CT scanning is also used as a primary screening modality for HCC in patients with cirrhosis. This topic is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/10/34986?source=see_link\">",
"     \"Clinical features and diagnosis of primary hepatocellular carcinoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5443008\">",
"    <span class=\"h2\">",
"     Endoscopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;All HCV-infected patients with cirrhosis should also have endoscopy to screen for the presence of varices. We follow similar procedures in",
"    <span class=\"nowrap\">",
"     HIV/HCV-coinfected",
"    </span>",
"    patients. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/49/27418?source=see_link\">",
"     \"Primary and pre-primary prophylaxis against variceal hemorrhage in patients with cirrhosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A full history and physical examination is important in determining a patient's potential candidacy for HCV treatment. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Initial evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with a history of injection drug use who are currently abstinent should be interviewed about the stability of their recovery. Ethanol use should be strongly discouraged since alcohol can lead to increased levels of HCV RNA and contributes to liver fibrosis. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Initial evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      HIV-infected patients with cirrhosis should undergo biannual abdominal ultrasound examinations to look for hepatocellular carcinoma. (See",
"      <a class=\"local\" href=\"#H5442944\">",
"       'Imaging studies'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A liver biopsy is helpful in evaluating the extent of necroinflammatory activity and severity of steatosis, which can contribute to fibrosis progression. However, a histologic finding of mild disease does not exclude the possibility of advanced fibrosis due to problems of sampling error. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Staging of liver disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A liver biopsy is helpful in assessing the extent of disease in patients who have a lower chance of treatment success (eg, patients with genotype 1 infection and HCV RNA levels &gt;400,000 int.",
"      <span class=\"nowrap\">",
"       unit/mL).",
"      </span>",
"      However, a liver biopsy should not be used as a prerequisite for treatment.",
"     </li>",
"     <li>",
"      Non-invasive serum markers are being actively investigated for evaluation of liver disease in",
"      <span class=\"nowrap\">",
"       HIV/HCV-coinfected",
"      </span>",
"      patients. (See",
"      <a class=\"local\" href=\"#H26\">",
"       'Noninvasive serum fibrosis markers'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The use of elastography for diagnosing liver disease in",
"      <span class=\"nowrap\">",
"       HIV/HCV-coinfected",
"      </span>",
"      patients is a promising modality. This technique is widely available in Europe, but is restricted to only a few research centers in the United States. (See",
"      <a class=\"local\" href=\"#H27\">",
"       'Transient elastography'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11848/abstract/1\">",
"      Zdilar D, Franco-Bronson K, Buchler N, et al. Hepatitis C, interferon alfa, and depression. Hepatology 2000; 31:1207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11848/abstract/2\">",
"      Sylvestre D. Hepatitis C treatment in drug users: perception versus evidence. Eur J Gastroenterol Hepatol 2006; 18:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11848/abstract/3\">",
"      Taylor LE, Gholam PM, Schwartzapfel B, Rich JD. Hepatitis C treatment in an HIV-HCV-coinfected patient with drug addiction and psychiatric illness: a case report. AIDS Read 2005; 15:629.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11848/abstract/4\">",
"      Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 1997; 349:825.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11848/abstract/5\">",
"      Pol S, Artru P, Th&eacute;pot V, et al. Improvement of the CD4 cell count after alcohol withdrawal in HIV-positive alcoholic patients. AIDS 1996; 10:1293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11848/abstract/6\">",
"      Schaefer M, Heinz A, Backmund M. Treatment of chronic hepatitis C in patients with drug dependence: time to change the rules? Addiction 2004; 99:1167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11848/abstract/7\">",
"      Farel C, Suzman DL, McLaughlin M, et al. Serious ophthalmic pathology compromising vision in HCV/HIV co-infected patients treated with peginterferon alpha-2b and ribavirin. AIDS 2004; 18:1805.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11848/abstract/8\">",
"      Wong SF, Jakowatz JG, Taheri R. Management of hypertriglyceridemia in patients receiving interferon for malignant melanoma. Ann Pharmacother 2004; 38:1655.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11848/abstract/9\">",
"      P&eacute;rez-El&iacute;as MJ, Garc&iacute;a-San Miguel L, Gonz&aacute;lez Garc&iacute;a J, et al. Tuberculosis complicating hepatitis C treatment in HIV-infected patients. Clin Infect Dis 2009; 48:e82.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11848/abstract/10\">",
"      Uberti-Foppa C, De Bona A, Galli L, et al. Liver fibrosis in HIV-positive patients with hepatitis C virus: role of persistently normal alanine aminotransferase levels. J Acquir Immune Defic Syndr 2006; 41:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11848/abstract/11\">",
"      Saadeh S, Cammell G, Carey WD, et al. The role of liver biopsy in chronic hepatitis C. Hepatology 2001; 33:196.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11848/abstract/12\">",
"      Yano M, Kumada H, Kage M, et al. The long-term pathological evolution of chronic hepatitis C. Hepatology 1996; 23:1334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11848/abstract/13\">",
"      McGovern B, Fiore J, Wurcel A, et al. Delivering therapy for hepatitis C virus infection to incarcerated HIV-seropositive patients. Clin Infect Dis 2005; 41 Suppl 1:S56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11848/abstract/14\">",
"      McGovern BH. Hepatitis C in the HIV-infected patient. J Acquir Immune Defic Syndr 2007; 45 Suppl 2:S47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11848/abstract/15\">",
"      Veronese L, Rautaureau J, Sadler BM, et al. Single-dose pharmacokinetics of amprenavir, a human immunodeficiency virus type 1 protease inhibitor, in subjects with normal or impaired hepatic function. Antimicrob Agents Chemother 2000; 44:821.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11848/abstract/16\">",
"      Brinkman K, Smeitink JA, Romijn JA, Reiss P. Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy. Lancet 1999; 354:1112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11848/abstract/17\">",
"      Duong Van Huyen JP, Landau A, Piketty C, et al. Toxic effects of nucleoside reverse transcriptase inhibitors on the liver. Value of electron microscopy analysis for the diagnosis of mitochondrial cytopathy. Am J Clin Pathol 2003; 119:546.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11848/abstract/18\">",
"      McGovern BH, Ditelberg JS, Taylor LE, et al. Hepatic steatosis is associated with fibrosis, nucleoside analogue use, and hepatitis C virus genotype 3 infection in HIV-seropositive patients. Clin Infect Dis 2006; 43:365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11848/abstract/19\">",
"      Soriano V, Mir&oacute; JM, Garc&iacute;a-Samaniego J, et al. Consensus conference on chronic viral hepatitis and HIV infection: updated Spanish recommendations. J Viral Hepat 2004; 11:2.",
"     </a>",
"    </li>",
"    <li>",
"     Sulkowski, M, Mehta, S, Torbenson, M, et al. Unexpected significant liver disease among HIV/HCV coinfected patients with minimal fibrosis on initial liver biopsy. Presented at the 11th Conference on Retroviruses and Opportunistic Infections, Boston, MA, February, 2005; abstract #121.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11848/abstract/21\">",
"      Nunes D, Fleming C, Offner G, et al. HIV infection does not affect the performance of noninvasive markers of fibrosis for the diagnosis of hepatitis C virus-related liver disease. J Acquir Immune Defic Syndr 2005; 40:538.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11848/abstract/22\">",
"      Sterling RK, Lissen E, Clumeck N, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 2006; 43:1317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11848/abstract/23\">",
"      Shire NJ, Rao MB, Succop P, et al. Improving noninvasive methods of assessing liver fibrosis in patients with hepatitis C virus/human immunodeficiency virus co-infection. Clin Gastroenterol Hepatol 2009; 7:471.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11848/abstract/24\">",
"      Sandrin L, Fourquet B, Hasquenoph JM, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003; 29:1705.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11848/abstract/25\">",
"      de L&eacute;dinghen V, Douvin C, Kettaneh A, et al. Diagnosis of hepatic fibrosis and cirrhosis by transient elastography in HIV/hepatitis C virus-coinfected patients. J Acquir Immune Defic Syndr 2006; 41:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11848/abstract/26\">",
"      Vergara S, Mac&iacute;as J, Rivero A, et al. The use of transient elastometry for assessing liver fibrosis in patients with HIV and hepatitis C virus coinfection. Clin Infect Dis 2007; 45:969.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11848/abstract/27\">",
"      Kirk GD, Astemborski J, Mehta SH, et al. Assessment of liver fibrosis by transient elastography in persons with hepatitis C virus infection or HIV-hepatitis C virus coinfection. Clin Infect Dis 2009; 48:963.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11848/abstract/28\">",
"      Castera L. Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitis. J Viral Hepat 2009; 16:300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11848/abstract/29\">",
"      Puoti M, Bruno R, Soriano V, et al. Hepatocellular carcinoma in HIV-infected patients: epidemiological features, clinical presentation and outcome. AIDS 2004; 18:2285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11848/abstract/30\">",
"      Br&auml;u N, Fox RK, Xiao P, et al. Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: a U.S.-Canadian multicenter study. J Hepatol 2007; 47:527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11848/abstract/31\">",
"      Salmon-Ceron, D. J Hepatology 2009; 50:739.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3702 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-200.131.240.2-C7EAEF3114-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_36_11848=[""].join("\n");
var outline_f11_36_11848=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H29\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      INITIAL EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Substance abuse",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Psychiatry history",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Other past medical history",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Medication history",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Social history",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Pregnancy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Family history",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Laboratory screening",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Screening for tuberculosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Interpretation of aminotransferases",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Patients with suspected cirrhosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      STAGING OF LIVER DISEASE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5442673\">",
"      Role of the liver biopsy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Advantages",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Limitations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - When should a liver biopsy be obtained",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      - When should a biopsy be repeated",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Noninvasive serum fibrosis markers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Transient elastography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Combination approach",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5442944\">",
"      IMAGING STUDIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5442987\">",
"      Ultrasound",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5442994\">",
"      - Screening for hepatocellular carcinoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5443001\">",
"      CT scanning",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5443008\">",
"      Endoscopy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/10/34986?source=related_link\">",
"      Clinical features and diagnosis of primary hepatocellular carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/44/35528?source=related_link\">",
"      Clinical manifestations and diagnosis of autoimmune hepatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/8/6281?source=related_link\">",
"      Clinical manifestations, diagnosis, and natural history of alpha-1 antitrypsin deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/40/38536?source=related_link\">",
"      Clinical trials in treatment of chronic hepatitis C virus infection in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/41/23194?source=related_link\">",
"      Diagnostic approach to the patient with cirrhosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/37/13910?source=related_link\">",
"      Epidemiology and pathogenesis of Wilson disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/32/30218?source=related_link\">",
"      Epidemiology, natural history, and diagnosis of hepatitis C in the HIV-infected patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/25/37273?source=related_link\">",
"      Immunizations in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/9/16538?source=related_link\">",
"      Management of the side effects of peginterferon and ribavirin being used for treatment of chronic hepatitis C virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/59/30650?source=related_link\">",
"      Noninvasive assessment of hepatic fibrosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/45/43735?source=related_link\">",
"      Overview of the management of chronic hepatitis C virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/58/29608?source=related_link\">",
"      Percutaneous, fine-needle aspiration, and laparoscopic liver biopsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/6/28778?source=related_link\">",
"      Prevention of hepatocellular carcinoma and recommendations for surveillance in adults with chronic liver disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/49/27418?source=related_link\">",
"      Primary and pre-primary prophylaxis against variceal hemorrhage in patients with cirrhosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/38/18026?source=related_link\">",
"      Treatment of hepatitis C virus infection in the HIV-infected patient",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_36_11849="Surgical management and postoperative outcome of children with bladder exstrophy";
var content_f11_36_11849=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Surgical management and postoperative outcome of children with bladder exstrophy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/36/11849/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/36/11849/contributors\">",
"     Joseph G Borer, MD, FAAP, FACS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/36/11849/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/36/11849/contributors\">",
"     Laurence S Baskin, MD, FAAP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/36/11849/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/36/11849/contributors\">",
"     Melanie S Kim, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?11/36/11849/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 13, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bladder exstrophy is a complex congenital anomaly that is treated surgically (",
"    <a class=\"graphic graphic_picture graphicRef73750 \" href=\"UTD.htm?16/33/16914\">",
"     picture 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef53828 \" href=\"UTD.htm?22/46/23267\">",
"     figure 1",
"    </a>",
"    ). Surgery is challenging, as bladder exstrophy involves the urinary, reproductive, musculoskeletal system and, in some patents, the intestinal tract. Major goals of reconstruction are preservation of normal kidney function, development of adequate bladder storage and function (ie, urinary continence), and provision of acceptable genitalial cosmetic appearance and function.",
"   </p>",
"   <p>",
"    The surgical management and postoperative outcomes of children with bladder exstrophy are discussed here. The clinical manifestations and initial management of infants with bladder exstrophy are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/24/24966?source=see_link\">",
"     \"Clinical manifestations and initial management of infants with bladder exstrophy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     SURGICAL APPROACHES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following approaches, or variations of such, are used to manage bladder exstrophy. The first two interventions result in correction of the underlying defect.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Modern staged repair of bladder exstrophy (MSRE) involves three staged operations and was initially developed in the 1970s [",
"      <a class=\"abstract\" href=\"UTD.htm?11/36/11849/abstract/1,2\">",
"       1,2",
"      </a>",
"      ]. Subsequent modifications have been made over the past several years.",
"     </li>",
"     <li>",
"      Complete primary repair of bladder exstrophy (CPRE) was introduced in 1989 with the hope that a single operation would achieve the goals of continence and preservation of renal function [",
"      <a class=\"abstract\" href=\"UTD.htm?11/36/11849/abstract/3\">",
"       3",
"      </a>",
"      ]. However, follow-up studies demonstrate that many children still require multiple procedures following CPRE [",
"      <a class=\"abstract\" href=\"UTD.htm?11/36/11849/abstract/4\">",
"       4",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Choice of surgical approach'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Urinary diversion is the least common of the surgical options and involves creating a functional connection between the urinary and intestinal tracts. Although there are several variations, the basic approach is to divert urine away from the urinary bladder and into the bowel (large",
"      <span class=\"nowrap\">",
"       intestine/colon)",
"      </span>",
"      for temporary storage, and then intermittent passage with the stool through the rectum. When successful, passage of urine is under the control of the child. The bladder and urethra are closed but are &ldquo;dry,&rdquo; and they are not exposed to or necessary for handling the urine.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These surgical approaches are based on successful initial bladder closure either at birth or within the first two months of life. Early bladder closure, especially when coupled with epispadias repair (CPRE), is hypothesized to ensure initiation of bladder cycling in the newborn or young infant. It is thought that this will optimize bladder growth and development resulting in an increased probability of continence and adequate bladder capacity, which may reduce the need for future bladder augmentation and urinary diversions. Another view is that the initial bladder size is the best indicator of ultimate bladder capacity and function.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Modern staged repair of bladder exstrophy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The modern staged repair of bladder exstrophy (MSRE) consists of three specific components scheduled at approximate ages:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Newborn &ndash; Closure of the bladder, posterior urethra, and abdominal wall defect results in the creation of complete (penopubic) epispadias and is performed within the first two months of life [",
"      <a class=\"abstract\" href=\"UTD.htm?11/36/11849/abstract/5\">",
"       5",
"      </a>",
"      ]. Rarely, in the newborn, a small, stiff bladder \"template\" will not be amenable to closure or the infant is born prematurely, time allows for adequate growth so that closure is feasible [",
"      <a class=\"abstract\" href=\"UTD.htm?11/36/11849/abstract/6,7\">",
"       6,7",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Six months to one year of age &ndash; Epispadias repair is performed. The goal is to fashion a straight and functional penis with a glanular meatus in male patients and an acceptable cosmetic appearance.",
"     </li>",
"     <li>",
"      Four to five years of age &ndash; Bladder neck reconstruction (BNR) and bilateral ureteral reimplantation are performed when there is documented adequate bladder capacity and motivation of the patient to participate in a postoperative voiding program. The goal of this last stage is to provide urinary continence.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Complete primary repair of bladder exstrophy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complete primary repair of bladder exstrophy (CPRE) combines bladder closure and epispadias repair (and in some cases ureteral reimplantation) into a single operation (",
"    <a class=\"graphic graphic_picture graphicRef56997 \" href=\"UTD.htm?30/43/31408\">",
"     picture 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef54676 \" href=\"UTD.htm?38/38/39521\">",
"     picture 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef68809 \" href=\"UTD.htm?39/10/40100\">",
"     picture 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11849/abstract/3,8-12\">",
"     3,8-12",
"    </a>",
"    ]. This surgical approach includes wide exposure of the proximal urethra, and the transfer of the posterior urethra, prostate, and bladder neck deep into the pelvis. The goal of CPRE is to provide early and adequate bladder outlet resistance that promotes growth of the bladder. Similar to the first stage of the MSRE approach, CPRE may be performed within the first 72 hours of life, with or without pelvic bone osteotomy, or as a purposely delayed procedure at approximately two months of age.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H356708205\">",
"    <span class=\"h2\">",
"     Timing",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial reconstructive surgery may be performed within the first two to three days of life (immediate) or at approximately 6 to 12 weeks of age (delayed). Delayed closure may be preferred by the pediatric urologists based upon their clinical experience or upon the specific anatomy of the individual [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11849/abstract/13\">",
"     13",
"    </a>",
"    ]. Examples of the latter include premature infants in whom the anatomy is too small for safe repair. Another advantage of delaying CPRE is allowing infant bonding with parents before initial reconstructive surgery and the lengthy recovery period that follows. In addition, the time between birth and initial repair will allow for growth, development, and additional maturation of some organs and systems prior to the complex initial reconstructive surgery and will allow for safer anesthesia and surgery. In our center, the preferred timing for CPRE is at 6 to 12 weeks of age (ie, delayed closure).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Choice of surgical approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is unclear which surgical approach best meets the goals of preservation of normal kidney function, urinary continence, and provision of an acceptable cosmetic genitalia appearance and function. In general, the success of surgical management of bladder exstrophy is determined by the rates of urinary continence, the need for additional operation(s) (eg, bladder augmentation), and renal function.",
"   </p>",
"   <p>",
"    Data are lacking that directly compare these two approaches based upon these outcome measures partly because bladder exstrophy is an uncommon anomaly, and most tertiary centers with the surgical expertise to treat this condition typically choose one approach over the other. The latter factor potentially leads to center and publication bias. In addition, long-term follow-up of patients who undergo CPRE is limited, as this approach was only introduced in 1989.",
"   </p>",
"   <p>",
"    When CPRE was initially introduced [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11849/abstract/3\">",
"     3",
"    </a>",
"    ], it had been hoped that this approach would provide continence with a single operation, and eliminate the need for both bladder neck reconstruction (BNR) and augmentation.",
"   </p>",
"   <p>",
"    Although long-term follow-up data are limited, evidence suggests that a significant proportion of patients will require BNR following CPRE.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a review of 46 patients (31 males and 15 females) who were followed after CPRE from 1994 to 2010 at our tertiary center, BNR was performed in 12 patients who were five years old or older [",
"      <a class=\"abstract\" href=\"UTD.htm?11/36/11849/abstract/14\">",
"       14",
"      </a>",
"      ]. The need for BNR was greater in males than females (43 versus 27 percent), and the age of reconstruction was younger in males (6.3 versus 8.1 years of age). In 12 patients, six were continent 1.5 years after BNR.",
"     </li>",
"     <li>",
"      In case series of 39 children managed by CPRE from Seattle, 17 of 23 evaluable patients achieved daytime continence defined as a dry interval greater than two hours [",
"      <a class=\"abstract\" href=\"UTD.htm?11/36/11849/abstract/11\">",
"       11",
"      </a>",
"      ]. However, 12 of these patients required additional intervention to achieve continence, including BNR with or without bladder neck injection in nine patients and bladder neck injection alone in three patients.",
"     </li>",
"     <li>",
"      In another study from a tertiary center that generally does not perform CPRE, 26 of 33 patients who were referred after CPRE (performed at other institutions) underwent BNR [",
"      <a class=\"abstract\" href=\"UTD.htm?11/36/11849/abstract/15\">",
"       15",
"      </a>",
"      ]. Of the 19 patients who had complications following CPRE with bladder dehiscence and prolapse, 12 underwent BNR, but only three achieved total continence. Of the 14 patients with successful CPRE, eight were continent both day and night, four were continent only during the day, and two were incontinent.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In one series in which MSRE was performed by a single pediatric urologist, the continence rate following BNR without bladder augmentation was about 70 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11849/abstract/16\">",
"     16",
"    </a>",
"    ]. Other published rates following MSRE vary and include patients with bladder augmentation or those who required clean intermittent catheterization. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Continence'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    CPRE, although not eliminating BNR entirely, appears to reduce the number of patients who will require BNR. It has yet to be determined whether CPRE results in a similar or even higher rate of continence with a reduced rate of BNR.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Neonatal iliac osteotomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The need for iliac osteotomy as part of successful bladder closure in the first few days of life is independent of which surgical approach is selected. In general, bladder closure can be performed within the first 72 hours after birth without osteotomy if there is no extreme diastasis. This is because the pelvic ring is relatively malleable in the first two or three days of life. If the pelvis is not malleable or there is extreme diastasis, osteotomies should be performed to increase the likelihood of successful bladder closure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1135431971\">",
"    <span class=\"h3\">",
"     Pelvis immobilization",
"    </span>",
"    &nbsp;&mdash;&nbsp;Regardless of whether osteotomy is performed and which surgical approach is chosen, the pelvis is immobilized with traction following bladder closure (",
"    <a class=\"graphic graphic_picture graphicRef66430 \" href=\"UTD.htm?28/10/28833\">",
"     picture 5",
"    </a>",
"    ). A common form of traction for newborns is modified Bryant's traction (",
"    <a class=\"graphic graphic_picture graphicRef81241 \" href=\"UTD.htm?32/6/32868\">",
"     picture 6",
"    </a>",
"    ). This is typically employed for two to four weeks following the initial reconstructive surgical procedure. An alternate option is spica casting, which has been used successfully in infants undergoing bladder exstrophy repair [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11849/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complications following surgical correction of bladder exstrophy include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Bladder dehiscence &ndash; Bladder dehiscence is a relatively rare complication [",
"      <a class=\"abstract\" href=\"UTD.htm?11/36/11849/abstract/18\">",
"       18",
"      </a>",
"      ]. Some experts in the field advocate the routine use of osteotomies to prevent this complication [",
"      <a class=\"abstract\" href=\"UTD.htm?11/36/11849/abstract/19,20\">",
"       19,20",
"      </a>",
"      ]. Others, including the author, believe that bladder closure can be performed successfully, often without osteotomies, if the procedure is performed within the first 72 hours of life when the pelvic ring is malleable and if there is not extreme diastasis. Bladder dehiscence is associated with an increased risk of incontinence [",
"      <a class=\"abstract\" href=\"UTD.htm?11/36/11849/abstract/15\">",
"       15",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Urinary tract infections &ndash; Urinary tract infections (UTI) are common in patients with bladder exstrophy. UTIs may include pyelonephritis with the infection affecting either one or both kidneys. This is especially true in patients with bladder augmentation or ileal conduits who have reported incidences of UTI of 63 and 48 percent, respectively [",
"      <a class=\"abstract\" href=\"UTD.htm?11/36/11849/abstract/21\">",
"       21",
"      </a>",
"      ]. Vesicoureteral reflux is another common finding in patients with bladder exstrophy, and it increases the risk of pyelonephritis.",
"      <br/>",
"      <br/>",
"      In our series of 32 patients who underwent complete primary repair of bladder exstrophy (CPRE), nine patients (28 percent) had one to four episodes of pyelonephritis [",
"      <a class=\"abstract\" href=\"UTD.htm?11/36/11849/abstract/4\">",
"       4",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Bladder stone (calculus) &ndash; Formation of a bladder stone may occur due to urinary stasis",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      recurrent UTI. Because of increased mucus production and bacterial colonization, stone formation is more common in patients with bladder augmentation with a reported incidence that ranges from 24 to 72 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?11/36/11849/abstract/22,23\">",
"       22,23",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Bladder perforations &ndash; Bladder perforations rarely occur. Patients are at increased risk for this complication following procedures that increase bladder outlet resistance such as bladder neck reconstruction. This complication may also occur in a patient that has had bladder augmentation [",
"      <a class=\"abstract\" href=\"UTD.htm?11/36/11849/abstract/22\">",
"       22",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Fistulas &ndash; Urethrocutaneous or vesicocutaneous fistulas (abnormal connection of the urethra or bladder to the skin) are the most commonly reported complications after initial bladder closure [",
"      <a class=\"abstract\" href=\"UTD.htm?11/36/11849/abstract/24\">",
"       24",
"      </a>",
"      ]. The reported fistula rate is about 9 percent in patients managed by CPRE [",
"      <a class=\"abstract\" href=\"UTD.htm?11/36/11849/abstract/20,25\">",
"       20,25",
"      </a>",
"      ], and between 4 and 16 percent in those managed by MSRE [",
"      <a class=\"abstract\" href=\"UTD.htm?11/36/11849/abstract/26,27\">",
"       26,27",
"      </a>",
"      ]. It should be noted that in one of the MSRE series, all of the patients had spontaneous resolution of their fistulae [",
"      <a class=\"abstract\" href=\"UTD.htm?11/36/11849/abstract/26\">",
"       26",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Hypospadias &ndash; Hypospadias appears to be a more common result at the initial closure in patients with CPRE versus those with MSRE [",
"      <a class=\"abstract\" href=\"UTD.htm?11/36/11849/abstract/25,28\">",
"       25,28",
"      </a>",
"      ]. In our initial series of patients managed with CPRE, the rate of hypospadias was 43 percent. However, with modification of the procedure (interrupted suture closure of the urethra at epispadias repair), the rate of hypospadias has been reduced to 5 percent. Of note, repair of hypospadias after CPRE with a Thiersch-Duplay urethroplasty (a relatively simple urethral tubularization technique) resulted in a high rate of urethrocutaneous fistula, and thus, we do not recommend this technique for hypospadias repair following CPRE [",
"      <a class=\"abstract\" href=\"UTD.htm?11/36/11849/abstract/25\">",
"       25",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Penile injury &ndash; Ischemic penile injury may occur after exstrophy closure combined with&nbsp;epispadias&nbsp;repair (CPRE), particularly when osteotomy is not performed. Compression of the pudendal vessels after pubic apposition",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      direct injury to the pudendal vessels may play an important role in the pathogenesis of this complication [",
"      <a class=\"abstract\" href=\"UTD.htm?11/36/11849/abstract/29\">",
"       29",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Long-term complications",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Epididymitis &ndash; Epididymitis is an infrequent long-term complication with a reported incidence of 19 to 33 percent in adult male patients [",
"      <a class=\"abstract\" href=\"UTD.htm?11/36/11849/abstract/30-32\">",
"       30-32",
"      </a>",
"      ]. In some cases, orchiectomies, vasectomies, or an epididymectomy is required for treatment and pain relief.",
"     </li>",
"     <li>",
"      Vaginal and rectal prolapse &ndash; Vaginal and rectal prolapse are also long-term complications that occur in about 20 percent of female patients at a mean age of 16 years [",
"      <a class=\"abstract\" href=\"UTD.htm?11/36/11849/abstract/33\">",
"       33",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Malignancy &ndash; The risk of malignancy appears to be higher in patients with exstrophy than the general population, especially in a high risk group of patients with bladder augmentation using intestinal components to create a colorectal reservoir (eg, ureterosigmoidostomies) [",
"      <a class=\"abstract\" href=\"UTD.htm?11/36/11849/abstract/34,35\">",
"       34,35",
"      </a>",
"      ]. This was illustrated in a large case series of 103 patients with bladder exstrophy [",
"      <a class=\"abstract\" href=\"UTD.htm?11/36/11849/abstract/34\">",
"       34",
"      </a>",
"      ]. In the high risk group of 28 patients, there were seven cases of malignancies (colonic carcinoma [n = 3], bladder cancer [n = 3], and carcinoma in situ of the colon [n = 1]). In the low risk group of 33 patients, one patient had bladder cancer, and one had renal cell carcinoma.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     OUTCOME",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Continence",
"    </span>",
"    &nbsp;&mdash;&nbsp;As discussed previously, urinary continence is one of the goals of successful surgical management of bladder exstrophy. The published rates of continence vary from 37 to 90 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11849/abstract/16,22,36-38\">",
"     16,22,36-38",
"    </a>",
"    ], but it is difficult to compare findings from different studies because of the following issues:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      There is no standard definition used for continence in the bladder exstrophy literature. The most commonly used definition is maintenance of dry periods of three or more hours during the day without stress incontinence, although others have used two or more hours [",
"      <a class=\"abstract\" href=\"UTD.htm?11/36/11849/abstract/11,39\">",
"       11,39",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Confounding factors, including the age at bladder closure, type of bladder closure performed, the number and type of procedures required to establish continence, and ongoing surgical management changes.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    For example, prior to the mid-1990s and the advent of routine neonatal bladder closure, a higher proportion of patients required bladder augmentation or urinary diversion (eg, ureterosigmoidostomies), urinary continent diversions, and the need for clean intermittent catheterization (CIC) in order to empty the bladder [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11849/abstract/40,41\">",
"     40,41",
"    </a>",
"    ]. In some studies, patients who required these interventions were defined as achieving continence.",
"   </p>",
"   <p>",
"    Case series that use a modern staged repair of exstrophy (MSRE) with bladder neck reconstruction (BNR) report continence rates of about 70 percent without bladder augmentation and CIC [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11849/abstract/16,38\">",
"     16,38",
"    </a>",
"    ]. Another center reported a higher rate of continence of 90 percent, but bladder augmentation and clear intermittent catheterization were required in 70 and 67 percent of patients, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11849/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Successful initial bladder closure is an important factor for achieving continence [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11849/abstract/15,42,43\">",
"     15,42,43",
"    </a>",
"    ]. There appears to be a higher continence rate in female versus male patients [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11849/abstract/23,40\">",
"     23,40",
"    </a>",
"    ]. Data are not consistent regarding whether bladder capacity before BNR and the initial use of pelvic osteotomies are important factors associated with continence [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11849/abstract/22,34,35,38,44\">",
"     22,34,35,38,44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    As discussed above, data on continence achievement in patients treated with complete primary repair of bladder exstrophy (CPRE) are limited and suggest that a significant number of these patients will require BNR to achieve continence [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11849/abstract/4,20,45\">",
"     4,20,45",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Choice of surgical approach'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Renal function",
"    </span>",
"    &nbsp;&mdash;&nbsp;Early series reported poor renal outcome, particularly in patients who required bladder augmentation or ileal loop conduits, with 10 percent of deaths attributed to renal failure [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11849/abstract/21\">",
"     21",
"    </a>",
"    ]. The loss of renal function was felt to be due to recurrent pyelonephritis resulting in significant renal scarring and loss of renal parenchyma.",
"   </p>",
"   <p>",
"    It is unknown what impact the newer surgical approaches that include early bladder closure will have on renal function [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11849/abstract/4,16\">",
"     4,16",
"    </a>",
"    ]. In our series of 32 patients with complete primary repair, renal scan demonstrated cortical defects in six patients, which were bilateral in three patients [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11849/abstract/4\">",
"     4",
"    </a>",
"    ]. Seven patients had evidence of mild to moderate hydronephrosis on follow-up renal ultrasonography.",
"   </p>",
"   <p>",
"    Prospective evaluation that includes serial renal nuclear scans and ultrasounds, and renal functional studies (eg, creatinine clearance) are needed to determine the long-term renal outcome of patients with bladder exstrophy who are managed with either modern staged or complete primary repair. This information will be helpful to determine the optimal surgical approach in the care of patients with bladder exstrophy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Psychological outcome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although the major early focus has been on surgical techniques, surgical outcomes, and bladder function, follow-up studies have shown that these patients must deal with psychological ramifications of their disorder, including issues of body image and the impact of multiple and complex surgical procedures. As a result, it is important that these patients undergo psychological evaluation and, if needed, psychological support and therapy.",
"   </p>",
"   <p>",
"    Although several studies over the last 10 to 20 years have examined the physiological outcomes of bladder exstrophy, they are flawed by faulty or inadequate methodology because of self-selection bias and the lack of normal controls. Nevertheless, studies of children and young adults with bladder exstrophy demonstrate that these patients are at risk for developing a poor body image, anxiety, depression, and adjustment disorder.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Genitalia and body image",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several studies based upon patient surveys and interviews report that adolescents and young adults with bladder exstrophy are dissatisfied with their genital and body appearance [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11849/abstract/18,33,46-49\">",
"     18,33,46-49",
"    </a>",
"    ]. Their poor body image results in avoidance of undressing or showering in front of others, low rates of masturbation and genital touching, anxiety in establishing a close sexual relationship, and restricting sexual activity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Anxiety and depression",
"    </span>",
"    &nbsp;&mdash;&nbsp;Studies that used validated survey tools for psychological evaluation report that patients with bladder exstrophy are at risk for anxiety, depression, and adjustment disorder [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11849/abstract/50\">",
"     50",
"    </a>",
"    ]. Results also suggest that incontinence was associated with increased psychological dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11849/abstract/18\">",
"     18",
"    </a>",
"    ]. Other reports based on patient interviews or study-designed surveys also demonstrated increased anxiety and need for psychological support [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11849/abstract/47,51\">",
"     47,51",
"    </a>",
"    ]. One retrospective study reported that 15 percent of their 121 patients expressed suicidal ideation; however, a control group was not available for comparison [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11849/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Sexual function",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although patients with bladder exstrophy are generally dissatisfied with their genitalia and body image, they appear to have adequate sexual function.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Male patients &ndash; Several studies in postadolescent males report erection rates between 94 and 100 percent, and ejaculation rates between 82 and 88 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?11/36/11849/abstract/18,30,31,47\">",
"       18,30,31,47",
"      </a>",
"      ]. However, ejaculatory abnormalities (including retrograde ejaculation) occur in some cases, which may be a potential cause of infertility. Despite these concerns, about 60 percent of postpubertal males experienced satisfactory intercourse [",
"      <a class=\"abstract\" href=\"UTD.htm?11/36/11849/abstract/53\">",
"       53",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Female patients &ndash; The data are more limited regarding sexual function in postpubertal females. In one case series of 42 females with bladder exstrophy, 34 engaged in sexual activity. However 28 required a modified episiotomy, and two required vaginoplasty to allow for intercourse [",
"      <a class=\"abstract\" href=\"UTD.htm?11/36/11849/abstract/54\">",
"       54",
"      </a>",
"      ]. In one study that surveyed 16 female patients greater than 18 years of age, all patients reported appropriate sexual desire, and 10 were sexually active at a mean age of 19.9 years [",
"      <a class=\"abstract\" href=\"UTD.htm?11/36/11849/abstract/33\">",
"       33",
"      </a>",
"      ]. Three patients reported dyspareunia (genital pain with intercourse) with all sexual activity, and two with occasional dyspareunia. Seven patients reported having orgasms.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Fertility",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H369378913\">",
"    <span class=\"h3\">",
"     Male patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;Case reports and small case series suggest that male patients with bladder exstrophy have decreased fertility due to oligospermia, azoospermia, asthenospermia, decreased sperm motility, and low ejaculate volumes [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11849/abstract/30,32,53,55,56\">",
"     30,32,53,55,56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In one case series, semen analyses from 8 of 25 men with bladder exstrophy showed low ejaculate volume in six specimens, normal sperm count in five, and oligospermia in three [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11849/abstract/31\">",
"     31",
"    </a>",
"    ]. Normal sperm motility and viability were maintained in half of the specimens. In a long-term follow up study of 53 male patients, 5 have fathered children.",
"   </p>",
"   <p>",
"    Further prospective studies are needed to determine whether or not there is a significant impact on fertility in male patients with bladder exstrophy. If there is a decrease in male fertility, possible causes include semen abnormalities, failure of proper ejaculatory function, or a combination of both. With advances in assisted reproductive technology, conception remains a viable possibility for male patients who have fertility problems. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/33/3610?source=see_link\">",
"     \"Treatment of male infertility\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H369378920\">",
"    <span class=\"h3\">",
"     Female patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bladder exstrophy appears to also have an impact on female infertility and",
"    <span class=\"nowrap\">",
"     fetal/neonatal",
"    </span>",
"    outcome. Case reports and series have described successful pregnancies and delivery in women with bladder exstrophy [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11849/abstract/33,54\">",
"     33,54",
"    </a>",
"    ]. However, impaired fertility, poor",
"    <span class=\"nowrap\">",
"     fetal/neonatal",
"    </span>",
"    outcome, and a risk of significant maternal complications at delivery were reported in a case series of 52 women (mean age 33 years) with classic bladder exstrophy as follows [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11849/abstract/57\">",
"     57",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Of the women who had tried to become pregnant, about two-thirds (19 of 28 patients) were able to conceive.",
"     </li>",
"     <li>",
"      For the 19 women who had conceived, there were a total of 57 pregnancies including three sets of twins. Outcomes of these pregnancies were 34 live births (56 percent), 21 miscarriages (35 percent), 4 still births or neonatal deaths, and 1 termination.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    There were four major maternal delivery room complications including two women with postpartum hemorrhage, and one patient with transection of the ureter and one with fistula formation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H198880338\">",
"    <span class=\"h2\">",
"     Orthopedic outcome",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is one retrospective survey study that suggests that adult patients with bladder exstrophy may be at risk for back and hip pain, which may limit the degree of physical activity. In a questionnaire-based survey without physical exam with only a 52 percent response rate (n = 33 respondents), patients with bladder exstrophy were more likely to complain about back pain and an inability to run continuously than those with epispadias [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11849/abstract/58\">",
"     58",
"    </a>",
"    ]. Among patients with bladder exstrophy, those who underwent pelvic osteotomy appeared to experience more hip pain than patients without pelvic osteotomy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Professional, educational, and social outcome",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H487508133\">",
"    <span class=\"h3\">",
"     Patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;Limited data demonstrate that patients with bladder exstrophy are capable of achieving a high educational level and satisfactory employment.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one long-term follow up study of males with bladder exstrophy, all had attended high school, about half had a college education, and those who were not attending school had a full-time job [",
"      <a class=\"abstract\" href=\"UTD.htm?11/36/11849/abstract/31\">",
"       31",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a series of 100 patients with a mean age of 14.5 years, only two patients attended schools for special needs children, while the remaining 98 patients attended normal primary and secondary schools and, in some cases, college [",
"      <a class=\"abstract\" href=\"UTD.htm?11/36/11849/abstract/47\">",
"       47",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a long-term follow-up study, 25 of an original cohort of 42 patients with bladder exstrophy born between 1937 and 1968 were evaluated. These patients were treated with ureterosigmoidostomy [",
"      <a class=\"abstract\" href=\"UTD.htm?11/36/11849/abstract/59\">",
"       59",
"      </a>",
"      ]. Of these 25 evaluable patients (mean age 50 years), 21 were married or lived in a stable relationship. Eight were parents (six by normal conception and two by artificial reproductive technology). Nine patients reported no sexual activity or were unable to engage in intercourse. All but two patients were professionally and socially successful.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H487508140\">",
"    <span class=\"h3\">",
"     Parents",
"    </span>",
"    &nbsp;&mdash;&nbsp;Data are limited on the effect of bladder exstrophy on parents. A survey of 20 parents showed that parents of children diagnosed experienced a significant amount of stress [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11849/abstract/60\">",
"     60",
"    </a>",
"    ]. Answers to standardized questionnaires revealed parents used adaptive means of coping with routine care (ie, plan-based problem solving, seeking social support, positive reappraisal), and non-adaptive means (ie,",
"    <span class=\"nowrap\">",
"     escape/avoidance",
"    </span>",
"    and distancing) during times of increased stress. These findings have highlighted the need for specific parental evaluation and interventions that have now become a component of the routine comprehensive care at our institution.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28491673\">",
"    <span class=\"h2\">",
"     Health-related quality of life",
"    </span>",
"    &nbsp;&mdash;&nbsp;Despite the number of long-term sequelae associated with bladder exstrophy, limited data suggest that adolescent patients adapt to the challenges of their disorder. This was illustrated in a study that surveyed adolescents with bladder exstrophy and epispadias using a validated quality of health questionnaire [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11849/abstract/61\">",
"     61",
"    </a>",
"    ]. Although, the majority of patients reported incontinence and a median nine surgical procedures, patients with",
"    <span class=\"nowrap\">",
"     exstrophy/epispadias",
"    </span>",
"    had similar scores in nearly all domains compared with those of normal reference control population.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     LONG-TERM MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Life-long care is required for patients with bladder exstrophy because of the risk of long-term complications and the complexity of psychological issues that face these patients. Care is a shared responsibility between the patient and an experienced",
"    <span class=\"nowrap\">",
"     medical/surgical",
"    </span>",
"    team of health care professionals.",
"   </p>",
"   <p>",
"    Care includes periodic assessment of the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Bladder function and continence",
"     </li>",
"     <li>",
"      Renal function with serial renal scans, ultrasonography, and",
"      <span class=\"nowrap\">",
"       plasma/serum",
"      </span>",
"      creatinine",
"     </li>",
"     <li>",
"      Psychological problems, including poor body image, anxiety and screening, and if needed, appropriate referral for counseling",
"     </li>",
"     <li>",
"      Postpubertal sexual function and fertility, and if appropriate, referral for artificial reproductive technology",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bladder exstrophy is a complex congenital anomaly that is treated surgically. Care for the individual with bladder exstrophy requires life-long care by an experienced and dedicated team of health care professionals.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Major goals of surgical correction are preservation of normal kidney function, development of adequate bladder storage and function, and provision of acceptable appearance and function of genitalia.",
"     </li>",
"     <li>",
"      Two surgical approaches are currently used to correct bladder exstrophy: modern staged repair of bladder exstrophy (MSRE), and complete primary repair of bladder exstrophy (CPRE). Although it is unknown which approach best achieves the goals of surgical outcome, bladder closure in the neonatal period is a major feature of both. In our center, we manage infants with bladder exstrophy with CPRE. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Surgical approaches'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In all infants with exstrophy, we suggest early closure of the bladder (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). This allows initiation of early bladder cycling that optimizes bladder growth and development. In our center, most infants undergo bladder closure within the first 72 hours of life. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Surgical approaches'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We do not suggest routine iliac osteotomy if the pelvis is malleable (before 72 hours of life) and there is no extreme diastasis (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Osteotomy is performed in patients with extreme diastasis or poorly malleable pelvis. All infants require immobilization with traction following bladder closure (",
"      <a class=\"graphic graphic_picture graphicRef73750 \" href=\"UTD.htm?16/33/16914\">",
"       picture 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_figure graphicRef53828 \" href=\"UTD.htm?22/46/23267\">",
"       figure 1",
"      </a>",
"      ) regardless of whether an osteotomy is performed. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Neonatal iliac osteotomy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Complications following surgical correction include bladder dehiscence, urinary tract infections, bladder stones and perforations, fistulas, and hypospadias. Long-term complications include epididymitis in adult males, vaginal and rectal prolapse in female patients, and an increased risk of malignancy, especially in patients with bladder augmentation using intestinal components. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Complications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Bladder continence continues to be one of the major outcome goals following surgery. Reasonable continence levels appear to be achievable following bladder neck reconstruction (BNR) in patients managed by MSRE. It appears that a significant number of patients with CPRE will also require BNR to achieve continence. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Continence'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Because postpubertal patients with bladder exstrophy often have psychological problems that include poor body image, dissatisfaction of their genitalia appearance, anxiety, depression, and adjustment disorder, management should include psychological evaluation and, if needed, psychological support and referral. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Psychological outcome'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Sexual function appears to be adequate in both postpubertal male and female patients with bladder exstrophy. Although data are limited, it does not appear that fertility is an issue for affected females. But, decreased fertility may be a concern in male patients. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Sexual function'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H16\">",
"       'Fertility'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with bladder exstrophy are capable of achieving satisfactory professional, educational, and social outcomes. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Professional, educational, and social outcome'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Long-term management includes periodic assessment of bladder and renal function, psychological state, and postpubertal sexual function and fertility. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Long-term management'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11849/abstract/1\">",
"      Gearhart JP, Jeffs RD. State-of-the-art reconstructive surgery for bladder exstrophy at the Johns Hopkins Hospital. Am J Dis Child 1989; 143:1475.",
"     </a>",
"    </li>",
"    <li>",
"     Jeffs RD, Charrios R, Mnay M, et al. Primary closure of the exstrophied bladder. In: Current Controversies in Urologic Management, WB Saunders, Philadelphia 1972. p.235.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11849/abstract/3\">",
"      Grady RW, Mitchell ME. Newborn exstrophy closure and epispadias repair. World J Urol 1998; 16:200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11849/abstract/4\">",
"      Gargollo PC, Borer JG, Diamond DA, et al. Prospective followup in patients after complete primary repair of bladder exstrophy. J Urol 2008; 180:1665.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11849/abstract/5\">",
"      Ansell JS. Surgical treatment of exstrophy of the bladder with emphasis on neonatal primary closure: personal experience with 28 consecutive cases treated at the University of Washington hospitals from 1962 to 1977: techniques and results. J Urol 1979; 121:650.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11849/abstract/6\">",
"      Dodson JL, Surer I, Baker LA, et al. The newborn exstrophy bladder inadequate for primary closure: evaluation, management and outcome. J Urol 2001; 165:1656.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11849/abstract/7\">",
"      Baradaran N, Stec AA, Schaeffer AJ, et al. Delayed primary closure of bladder exstrophy: immediate postoperative management leading to successful outcomes. Urology 2012; 79:415.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11849/abstract/8\">",
"      Mitchell ME, B&auml;gli DJ. Complete penile disassembly for epispadias repair: the Mitchell technique. J Urol 1996; 155:300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11849/abstract/9\">",
"      Grady RW, Carr MC, Mitchell ME. Complete primary closure of bladder exstrophy. Epispadias and bladder exstrophy repair. Urol Clin North Am 1999; 26:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11849/abstract/10\">",
"      Grady RW, Mitchell ME. Complete primary repair of exstrophy. Surgical technique. Urol Clin North Am 2000; 27:569.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11849/abstract/11\">",
"      Shnorhavorian M, Grady RW, Andersen A, et al. Long-term followup of complete primary repair of exstrophy: the Seattle experience. J Urol 2008; 180:1615.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11849/abstract/12\">",
"      Braga LH, Lorenzo AJ, Jrearz R, et al. Bilateral ureteral reimplantation at primary bladder exstrophy closure. J Urol 2010; 183:2337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11849/abstract/13\">",
"      Baradaran N, Cervellione RM, Stec AA, Gearhart JP. Delayed primary repair of bladder exstrophy: ultimate effect on growth. J Urol 2012; 188:2336.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11849/abstract/14\">",
"      Gargollo P, Hendren WH, Diamond DA, et al. Bladder neck reconstruction is often necessary after complete primary repair of exstrophy. J Urol 2011; 185:2563.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11849/abstract/15\">",
"      Gearhart JP, Baird A, Nelson CP. Results of bladder neck reconstruction after newborn complete primary repair of exstrophy. J Urol 2007; 178:1619.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11849/abstract/16\">",
"      Baird AD, Nelson CP, Gearhart JP. Modern staged repair of bladder exstrophy: a contemporary series. J Pediatr Urol 2007; 3:311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11849/abstract/17\">",
"      Shnorhavorian M, Song K, Zamilpa I, et al. Spica casting compared to Bryant's traction after complete primary repair of exstrophy: safe and effective in a longitudinal cohort study. J Urol 2010; 184:669.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11849/abstract/18\">",
"      Diseth TH, Bjordal R, Schultz A, et al. Somatic function, mental health and psychosocial functioning in 22 adolescents with bladder exstrophy and epispadias. J Urol 1998; 159:1684.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11849/abstract/19\">",
"      Baker LA, Gearhart JP. The staged approach to bladder exstrophy closure and the role of osteotomies. World J Urol 1998; 16:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11849/abstract/20\">",
"      Hammouda HM, Kotb H. Complete primary repair of bladder exstrophy: initial experience with 33 cases. J Urol 2004; 172:1441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11849/abstract/21\">",
"      Mesrobian HG, Kelalis PP, Kramer SA. Long-term followup of 103 patients with bladder exstrophy. J Urol 1988; 139:719.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11849/abstract/22\">",
"      Shaw MB, Rink RC, Kaefer M, et al. Continence and classic bladder exstrophy treated with staged repair. J Urol 2004; 172:1450.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11849/abstract/23\">",
"      Mouriquand PD, Bubanj T, Feyaerts A, et al. Long-term results of bladder neck reconstruction for incontinence in children with classical bladder exstrophy or incontinent epispadias. BJU Int 2003; 92:997.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11849/abstract/24\">",
"      Lepor H, Shapiro E, Jeffs RD. Urethral reconstruction in boys with classical bladder exstrophy. J Urol 1984; 131:512.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11849/abstract/25\">",
"      Borer JG, Gargollo PC, Hendren WH, et al. Early outcome following complete primary repair of bladder exstrophy in the newborn. J Urol 2005; 174:1674.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11849/abstract/26\">",
"      Baird AD, Mathews RI, Gearhart JP. The use of combined bladder and epispadias repair in boys with classic bladder exstrophy: outcomes, complications and consequences. J Urol 2005; 174:1421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11849/abstract/27\">",
"      Surer I, Baker LA, Jeffs RD, Gearhart JP. Modified Young-Dees-Leadbetter bladder neck reconstruction in patients with successful primary bladder closure elsewhere: a single institution experience. J Urol 2001; 165:2438.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11849/abstract/28\">",
"      Hafez AT, El-Sherbiny MT, Shorrab AA, El-Mowafi H. Complete primary repair of bladder exstrophy in children presenting late and those with failed initial closure: single center experience. J Urol 2005; 174:1549.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11849/abstract/29\">",
"      Cervellione RM, Husmann DA, Bivalacqua TJ, et al. Penile ischemic injury in the exstrophy/epispadias spectrum: new insights and possible mechanisms. J Pediatr Urol 2010; 6:450.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11849/abstract/30\">",
"      Stein R, St&ouml;ckle M, Fisch M, et al. The fate of the adult exstrophy patient. J Urol 1994; 152:1413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11849/abstract/31\">",
"      Avolio L, Koo HP, Bescript AC, et al. The long-term outcome in men with exstrophy/epispadias: sexual function and social integration. J Urol 1996; 156:822.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11849/abstract/32\">",
"      Ben-Chaim J, Jeffs RD, Reiner WG, Gearhart JP. The outcome of patients with classic bladder exstrophy in adult life. J Urol 1996; 155:1251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11849/abstract/33\">",
"      Mathews RI, Gan M, Gearhart JP. Urogynaecological and obstetric issues in women with the exstrophy-epispadias complex. BJU Int 2003; 91:845.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11849/abstract/34\">",
"      Smeulders N, Woodhouse CR. Neoplasia in adult exstrophy patients. BJU Int 2001; 87:623.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11849/abstract/35\">",
"      Eraklis AJ, Folkman MJ. Adenocarcinoma at the site of ureterosigmoidostomies for exstrophy of the bladder. J Pediatr Surg 1978; 13:730.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11849/abstract/36\">",
"      Hollowell JG, Ransley PG. Surgical management of incontinence in bladder exstrophy. Br J Urol 1991; 68:543.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11849/abstract/37\">",
"      Lottmann HB, Melin Y, Cendron M, et al. Bladder exstrophy: evaluation of factors leading to continence with spontaneous voiding after staged reconstruction. J Urol 1997; 158:1041.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11849/abstract/38\">",
"      Surer I, Baker LA, Jeffs RD, Gearhart JP. Combined bladder neck reconstruction and epispadias repair for exstrophy-epispadias complex. J Urol 2001; 165:2425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11849/abstract/39\">",
"      Lloyd JC, Spano SM, Ross SS, et al. How dry is dry? A review of definitions of continence in the contemporary exstrophy/epispadias literature. J Urol 2012; 188:1900.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11849/abstract/40\">",
"      Capolicchio G, McLorie GA, Farhat W, et al. A population based analysis of continence outcomes and bladder exstrophy. J Urol 2001; 165:2418.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11849/abstract/41\">",
"      McMahon DR, Cain MP, Husmann DA, Kramer SA. Vesical neck reconstruction in patients with the exstrophy-epispadias complex. J Urol 1996; 155:1411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11849/abstract/42\">",
"      Chan DY, Jeffs RD, Gearhart JP. Determinants of continence in the bladder exstrophy population: predictors of success? Urology 2001; 57:774.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11849/abstract/43\">",
"      Gearhart JP, Ben-Chaim J, Sciortino C, et al. The multiple reoperative bladder exstrophy closure: what affects the potential of the bladder? Urology 1996; 47:240.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11849/abstract/44\">",
"      Mathews R, Sponseller PD, Jeffs RD, Gearhart JP. Bladder neck reconstruction in classic bladder exstrophy: the role of osteotomy in the development of continence. BJU Int 2000; 85:498.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11849/abstract/45\">",
"      Casale P, Grady RW, Waldhausen JH, et al. Cloacal exstrophy variants. Can blighted conjoined twinning play a role? J Urol 2004; 172:1103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11849/abstract/46\">",
"      Reiner WG, Gearhart JP, Jeffs R. Psychosexual dysfunction in males with genital anomalies: late adolescence, Tanner stages IV to VI. J Am Acad Child Adolesc Psychiatry 1999; 38:865.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11849/abstract/47\">",
"      Ebert A, Scheuering S, Schott G, Roesch WH. Psychosocial and psychosexual development in childhood and adolescence within the exstrophy-epispadias complex. J Urol 2005; 174:1094.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11849/abstract/48\">",
"      Koo HP, Avolio L, Duckett JW Jr. Long-term results of ureterosigmoidostomy in children with bladder exstrophy. J Urol 1996; 156:2037.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11849/abstract/49\">",
"      Mathews R, Hubbard JS, Gearhart JP. Ureteral reimplantation before bladder neck plasty in the reconstruction of bladder exstrophy: indications and outcomes. Urology 2003; 61:820.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11849/abstract/50\">",
"      Diseth TH, Emblem R, Schultz A. Mental health, psychosocial functioning, and quality of life in patients with bladder exstrophy and epispadias - an overview. World J Urol 1999; 17:239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11849/abstract/51\">",
"      Reiner WG, Gearhart JP. Anxiety disorders in children with epispadias-exstrophy. Urology 2006; 68:172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11849/abstract/52\">",
"      Reiner WG, Gearhart JP, Kropp B. Suicide and suicidal ideation in classic exstrophy. J Urol 2008; 180:1661.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11849/abstract/53\">",
"      Mesrobian HG, Kelalis PP, Kramer SA. Long-term followup of cosmetic appearance and genital function in boys with exstrophy: review of 53 patients. J Urol 1986; 136:256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11849/abstract/54\">",
"      Woodhouse CR, Hinsch R. The anatomy and reconstruction of the adult female genitalia in classical exstrophy. Br J Urol 1997; 79:618.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11849/abstract/55\">",
"      Lattimer JK, MacFarlane MT, Puchner PJ. Male exstrophy patients: a preliminary report on the reproductive capability. Trans Am Assoc Genitourin Surg 1978; 70:42.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11849/abstract/56\">",
"      Hanna MK, Williams DI. Genital function in males with vesical exstrophy and epispadias. Br J Urol 1972; 44:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11849/abstract/57\">",
"      Deans R, Banks F, Liao LM, et al. Reproductive outcomes in women with classic bladder exstrophy: an observational cross-sectional study. Am J Obstet Gynecol 2012; 206:496.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11849/abstract/58\">",
"      Suominen JS, Helenius I, Taskinen S. Long-term orthopedic outcomes in patients with epispadias and bladder exstrophy. J Pediatr Surg 2012; 47:1821.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11849/abstract/59\">",
"      Gobet R, Weber D, Horst M, et al. Long-term followup (37 to 69 years) in patients with bladder exstrophy treated with ureterosigmoidostomy: psychosocial and psychosexual outcomes. J Urol 2009; 182:1819.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11849/abstract/60\">",
"      Mednick L, Gargollo P, Oliva M, et al. Stress and coping of parents of young children diagnosed with bladder exstrophy. J Urol 2009; 181:1312.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11849/abstract/61\">",
"      Schaeffer AJ, Yenokyan G, Alcorn K, et al. Health related quality of life in adolescents with bladder exstrophy-epispadias as measured by the Child Health Questionnaire-Child Form 87. J Urol 2012; 188:1924.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6582 Version 12.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.39.66.147-42E0F5FCD1-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_36_11849=[""].join("\n");
var outline_f11_36_11849=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H19\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      SURGICAL APPROACHES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Modern staged repair of bladder exstrophy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Complete primary repair of bladder exstrophy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H356708205\">",
"      Timing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Choice of surgical approach",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Neonatal iliac osteotomy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1135431971\">",
"      - Pelvis immobilization",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Long-term complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      OUTCOME",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Continence",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Renal function",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Psychological outcome",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Genitalia and body image",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Anxiety and depression",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Sexual function",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Fertility",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H369378913\">",
"      - Male patients",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H369378920\">",
"      - Female patients",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H198880338\">",
"      Orthopedic outcome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Professional, educational, and social outcome",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H487508133\">",
"      - Patients",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H487508140\">",
"      - Parents",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28491673\">",
"      Health-related quality of life",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      LONG-TERM MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/6582\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6582|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?22/46/23267\" title=\"figure 1\">",
"      Bladder exstrophy male",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6582|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?16/33/16914\" title=\"picture 1\">",
"      Bladder exstrophy female",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?30/43/31408\" title=\"picture 2\">",
"      Intraop bladder exstrophy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?38/38/39521\" title=\"picture 3\">",
"      Postop prim close exstrophy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?39/10/40100\" title=\"picture 4\">",
"      Pre post exstrophy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?28/10/28833\" title=\"picture 5\">",
"      Postop sled exstrophy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?32/6/32868\" title=\"picture 6\">",
"      Exstrophy Bryants traction",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/24/24966?source=related_link\">",
"      Clinical manifestations and initial management of infants with bladder exstrophy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/33/3610?source=related_link\">",
"      Treatment of male infertility",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_36_11850="Clinical features, diagnosis, and staging of gastric cancer";
var content_f11_36_11850=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"0\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical features, diagnosis, and staging of gastric cancer",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/36/11850/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/36/11850/contributors\">",
"     Paul F Mansfield, MD, FACS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/36/11850/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/36/11850/contributors\">",
"     Kenneth K Tanabe, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/36/11850/contributors\">",
"     Deputy Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/36/11850/contributors\">",
"     Diane MF Savarese, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/36/11850/contributors\">",
"     Shilpa Grover, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?11/36/11850/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 11, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients with gastric cancer in the United States are symptomatic and already have advanced incurable disease at the time of presentation. At diagnosis, approximately 50 percent have disease that extends beyond locoregional confines, and only one-half of those who appear to have locoregional tumor involvement can undergo a potentially curative resection. Surgically curable early gastric cancers are usually asymptomatic and only infrequently detected outside the realm of a screening program. Screening is not widely performed, except in countries which have a very high incidence, such as Japan, Venezuela, and Chile. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/52/6983?source=see_link\">",
"     \"Screening and prevention of gastric cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The common presenting symptoms and diagnostic approaches to gastric cancer will be reviewed here. Epidemiology, issues related to screening for high-risk patients, and the treatment of gastric cancer are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/35/4661?source=see_link\">",
"     \"Epidemiology of gastric cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/52/6983?source=see_link\">",
"     \"Screening and prevention of gastric cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/38/11882?source=see_link\">",
"     \"Adjuvant and neoadjuvant treatment of gastric cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/15/33018?source=see_link\">",
"     \"Invasive gastric cancer: Surgery and prognosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/10/44202?source=see_link\">",
"     \"Chemotherapy for locally advanced unresectable and metastatic esophageal and gastric cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Weight loss and persistent abdominal pain are the most common symptoms at initial diagnosis (",
"    <a class=\"graphic graphic_table graphicRef67702 \" href=\"UTD.htm?9/31/9723\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11850/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Weight loss usually results from insufficient caloric intake rather than increased catabolism and may be attributable to anorexia, nausea, abdominal pain, early satiety,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      dysphagia.",
"     </li>",
"     <li>",
"      When present, abdominal pain tends to be epigastric, vague and mild early in the disease but more severe and constant as the disease progresses.",
"     </li>",
"     <li>",
"      Dysphagia is a common presenting symptom in patients with cancers arising in the proximal stomach (",
"      <a class=\"graphic graphic_figure graphicRef79793 \" href=\"UTD.htm?4/45/4817\">",
"       figure 1",
"      </a>",
"      ) or at the esophagogastric junction.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Patients may also present with nausea or early satiety from the tumor mass or in cases of an aggressive form of diffuse-type gastric cancer called linitis plastica, from poor distensibility of the stomach. They may also present with a gastric outlet obstruction from an advanced distal tumor.",
"   </p>",
"   <p>",
"    Occult gastrointestinal bleeding with or without iron deficiency anemia is not uncommon, while overt bleeding (ie, melena or hematemesis) is seen in less than 20 percent of cases. The presence of a palpable abdominal mass is the most common physical finding and generally indicates long-standing, advanced disease [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11850/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A pseudoachalasia syndrome may occur as the result of involvement of Auerbach's plexus due to local extension or to malignant obstruction near the gastroesophageal junction. For this reason, gastric cancer needs to be considered in the differential diagnosis for older patients presenting with achalasia [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11850/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Approximately 25 percent of patients have a history of gastric ulcer. All gastric ulcers should be followed to complete healing, and those that do not heal should undergo resection [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11850/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Need for follow-up endoscopy for gastric ulcers'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Signs of tumor extension or spread",
"    </span>",
"    &nbsp;&mdash;&nbsp;The signs and symptoms described above are those most commonly seen at initial presentation of gastric cancer. More unusual presentations, related to the propensity of gastric cancer to spread by direct extension through the gastric wall, can also alert the clinician to the diagnosis. As an example, feculent emesis or passage of recently ingested material in the stool can be seen with malignant gastrocolic fistula, although this is quite rare. More commonly, colonic obstruction may occur.",
"   </p>",
"   <p>",
"    Patients may also present with signs or symptoms of distant metastatic disease. The most common metastatic distribution is to the liver, peritoneal surfaces, and nonregional or distant lymph nodes. Less commonly, ovaries, central nervous system, bone, pulmonary or soft tissue metastases occur.",
"   </p>",
"   <p>",
"    Since gastric cancer can spread via lymphatics, the physical examination may reveal a left supraclavicular adenopathy (a Virchow's node [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11850/abstract/3\">",
"     3",
"    </a>",
"    ]) which is the most common physical examination finding of metastatic disease, a periumbilical nodule (Sister Mary Joseph's node [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11850/abstract/4\">",
"     4",
"    </a>",
"    ]), or a left axillary node (Irish node).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Peritoneal spread can present with an enlarged ovary (Krukenberg's tumor [",
"      <a class=\"abstract\" href=\"UTD.htm?11/36/11850/abstract/5\">",
"       5",
"      </a>",
"      ]) or a mass in the cul-de-sac on rectal examination (Blumer's shelf [",
"      <a class=\"abstract\" href=\"UTD.htm?11/36/11850/abstract/6\">",
"       6",
"      </a>",
"      ]). However, there are patients with ovarian metastasis without other peritoneal disease.",
"     </li>",
"     <li>",
"      Ascites can also be the first indication of peritoneal carcinomatosis.",
"     </li>",
"     <li>",
"      A palpable liver mass can indicate metastases, although metastatic disease to the liver is often multifocal or diffuse. Liver involvement is often, but not always, associated with an elevation in the serum alkaline phosphatase concentration. Jaundice or clinical evidence of liver failure is seen in the preterminal stages of metastatic disease [",
"      <a class=\"abstract\" href=\"UTD.htm?11/36/11850/abstract/7\">",
"       7",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Paraneoplastic manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Systemic manifestations of gastric cancer related to paraneoplastic phenomena are rarely seen at initial presentation. Dermatologic findings may include the sudden appearance of diffuse seborrheic keratoses (sign of Leser-Trelat) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11850/abstract/8\">",
"     8",
"    </a>",
"    ] or acanthosis nigricans [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11850/abstract/9\">",
"     9",
"    </a>",
"    ], which is characterized by velvety and darkly pigmented patches on skin folds. Neither finding is specific for gastric cancer.",
"   </p>",
"   <p>",
"    Other paraneoplastic abnormalities that can occur in gastric cancer include a microangiopathic hemolytic anemia [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11850/abstract/10\">",
"     10",
"    </a>",
"    ], membranous nephropathy [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11850/abstract/11\">",
"     11",
"    </a>",
"    ], and hypercoagulable states (Trousseau's syndrome) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11850/abstract/12\">",
"     12",
"    </a>",
"    ]. Polyarteritis nodosa has been reported as the single manifestation of an early and surgically curable gastric cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11850/abstract/13\">",
"     13",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/54/19306?source=see_link\">",
"     \"Causes and diagnosis of membranous nephropathy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/43/35514?source=see_link\">",
"     \"Hypercoagulable disorders associated with malignancy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/26/9641?source=see_link\">",
"     \"Clinical manifestations and diagnosis of polyarteritis nodosa\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Even though a delay in diagnosis has not been associated with a poorer prognosis, a prompt diagnostic evaluation should be commenced when gastric cancer is suspected.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Endoscopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tissue diagnosis and anatomic localization of the primary tumor are best obtained by upper gastrointestinal endoscopy (",
"    <a class=\"graphic graphic_picture graphicRef58136 graphicRef71672 \" href=\"UTD.htm?20/11/20664\">",
"     picture 1A-B",
"    </a>",
"    ). Although more invasive and more costly, upper endoscopy is also more sensitive and specific for diagnosing a variety of gastric, esophageal and duodenal lesions than alternative diagnostic strategies (such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/17/12564?source=see_link\">",
"     barium",
"    </a>",
"    studies, see below). The early use of upper endoscopy in patients presenting with gastrointestinal complaints may be associated with a higher rate of detection of early gastric cancers. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/15/33018?source=see_link&amp;anchor=H2#H2\">",
"     \"Invasive gastric cancer: Surgery and prognosis\", section on 'Early diagnosis of gastric cancer'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The ability to perform biopsy during endoscopy adds to its clinical utility. Since up to 5 percent of malignant ulcers appear benign grossly, it is imperative that all such lesions be evaluated by biopsy and histologic assessment [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11850/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Endoscopic techniques",
"    </span>",
"    &nbsp;&mdash;&nbsp;During endoscopy, any suspicious-appearing gastric ulceration should be biopsied. A single biopsy has a 70 percent sensitivity for diagnosing an existing gastric cancer, while performing seven biopsies from the ulcer margin and base increases the sensitivity to greater than 98 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11850/abstract/14\">",
"     14",
"    </a>",
"    ]. While it is clear that any suspicious-appearing lesion requires biopsy, it may be even more important to take numerous biopsies from smaller, benign-appearing gastric ulcers, since the diagnosis of early gastric cancer offers the greatest opportunity for surgical cure and long-term survival. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/10/37033?source=see_link\">",
"     \"Early gastric cancer: Epidemiology, clinical manifestations, diagnosis, and staging\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The diagnosis of a particularly aggressive form of diffuse-type gastric cancer, so called \"linitis plastica\", can be difficult endoscopically. Because these tumors tend to infiltrate the submucosa and muscularis propria, superficial mucosal biopsies may be falsely negative. For this reason, the combination of strip and bite biopsy techniques should be used when there is a suspicion of a diffuse type of gastric cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11850/abstract/15\">",
"     15",
"    </a>",
"    ]. Poor distensibility of the stomach or the classic appearance on",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/17/12564?source=see_link\">",
"     barium",
"    </a>",
"    swallow (described as a leather-flask appearance) may suggest the presence of this disease. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Barium studies'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Brush cytology increases the sensitivity of single biopsies [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11850/abstract/16\">",
"     16",
"    </a>",
"    ], but the extent to which it enhances diagnostic yield when seven biopsies are obtained remains unknown. If bleeding with biopsy is of concern to the endoscopist, it is reasonable to brush the ulcer base, since the risk of bleeding from this technique is negligible.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Need for follow-up endoscopy for gastric ulcers",
"    </span>",
"    &nbsp;&mdash;&nbsp;The indications for a follow-up endoscopy in patients with an established gastric ulcer is discussed in detail, separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/21/24919?source=see_link&amp;anchor=H6#H6\">",
"     \"Diagnosis of peptic ulcer disease\", section on 'Follow-up endoscopy to exclude malignant GU'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Barium studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/17/12564?source=see_link\">",
"     Barium",
"    </a>",
"    studies can identify both malignant gastric ulcers and infiltrating lesions (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef62708 graphicRef64355 graphicRef62794 graphicRef51673 graphicRef51893 graphicRef63601 \" href=\"UTD.htm?43/12/44234\">",
"     image 1A-F",
"    </a>",
"    ), and some early gastric cancers also may be seen (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef61767 \" href=\"UTD.htm?12/7/12400\">",
"     image 2",
"    </a>",
"    ). However, false-negative barium studies can occur in as many as 50 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11850/abstract/17\">",
"     17",
"    </a>",
"    ]. This is a particular problem in early gastric cancer where the sensitivity of barium meals may be as low as 14 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11850/abstract/18\">",
"     18",
"    </a>",
"    ]. Thus, in most settings, upper endoscopy is the preferred initial diagnostic test for patients in whom gastric cancer is suspected. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/10/37033?source=see_link\">",
"     \"Early gastric cancer: Epidemiology, clinical manifestations, diagnosis, and staging\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The one scenario in which a",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/17/12564?source=see_link\">",
"     barium",
"    </a>",
"    study may be superior to upper endoscopy is in patients with linitis plastica. The decreased distensibility of the stiff, \"leather-flask\" appearing stomach is more obvious on the radiographic study, and the endoscopic appearance may be relatively normal (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef79963 \" href=\"UTD.htm?4/39/4723\">",
"     image 3",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     STAGING AND PREOPERATIVE EVALUATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Staging systems",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are two major classification systems currently in use for gastric cancer. The most elaborate, the Japanese classification, is based upon refined anatomic location, particularly of the lymph node stations [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11850/abstract/19\">",
"     19",
"    </a>",
"    ]. The other and more widely used staging system, developed jointly by the American Joint Committee on Cancer (AJCC) and the International Union Against Cancer (UICC), is the classification most often used in the Western hemisphere and now commonly in Asian countries as well.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     TNM staging criteria",
"    </span>",
"    &nbsp;&mdash;&nbsp;The staging schema of the",
"    <span class=\"nowrap\">",
"     AJCC/UICC",
"    </span>",
"    is based upon tumor (T), node (N), and metastasis (M) classifications, and is outlined in the table (",
"    <a class=\"graphic graphic_table graphicRef57916 \" href=\"UTD.htm?11/6/11374\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11850/abstract/20\">",
"     20",
"    </a>",
"    ]. T stage is dependent on depth of tumor invasion and not size. Nodal stage is based upon the number of positive lymph nodes rather than the proximity of the nodes to the primary tumor (as in the TNM classifications used prior to 1997).",
"   </p>",
"   <p>",
"    Regional nodes for tumors located along the greater curvature include greater curvature, greater omental, gastroduodenal, gastroepiploic, pre-pyloric antrum, and pancreaticoduodenal nodes; for tumors along the lesser curvature, they include lesser curvature, lesser omental, left gastric, cardioesophageal, common hepatic, celiac and hepatoduodenal nodes; for both sites, nodes in the pancreatic and splenic area (pancreaticolienal, peripancreatic, splenic) are considered regional nodes. Involvement of other intraabdominal nodal groups (ie, hepatoduodenal, retropancreatic, portal, mesenteric, and paraaortic) is classified as distant metastases.",
"   </p>",
"   <p>",
"    The 2010 edition contains numerous changes compared to the 2002 classification, including the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Tumors arising at the esophagogastric junction (EGJ), or in the cardia of the stomach within 5 cm of the EGJ that extend into the EGJ or esophagus (the so-called Siewert III EGJ tumors [",
"      <a class=\"abstract\" href=\"UTD.htm?11/36/11850/abstract/21\">",
"       21",
"      </a>",
"      ]) are staged using the TNM system for esophageal rather than stomach cancer. Tumors that are within 5 cm of the EGJ that do not extend into the esophagus are staged as gastric cancers. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/45/7898?source=see_link&amp;anchor=H6#H6\">",
"       \"Diagnosis and staging of esophageal cancer\", section on 'TNM staging criteria'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/51/39738?source=see_link&amp;anchor=H497521#H497521\">",
"       \"Multimodality approaches to potentially resectable esophagogastric junction and gastric cardia adenocarcinomas\", section on 'AJCC classification'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/51/39738?source=see_link&amp;anchor=H12477151#H12477151\">",
"       \"Multimodality approaches to potentially resectable esophagogastric junction and gastric cardia adenocarcinomas\", section on 'Siewert classification'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The T categories were modified to correspond to the T categories of esophageal and bowel cancers.",
"     </li>",
"     <li>",
"      N categories were modified with N1 = one to two positive nodes (compared to one to six in the 2002 criteria); N2 = three to six positive nodes (compared to 7 to 15 in 2002), and N3 = seven or more positive nodes (compared to &gt;15 in 2002).",
"     </li>",
"     <li>",
"      Positive peritoneal cytology is classified as M1 disease.",
"     </li>",
"     <li>",
"      Stage groupings have been changed.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    An example of stage-stratified overall survival using the 2010 modification of the TNM staging system and outcomes data derived from the SEER database is provided in the figure (",
"    <a class=\"graphic graphic_figure graphicRef69815 \" href=\"UTD.htm?17/0/17409\">",
"     figure 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11850/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Whether the prominent changes in the classification of stomach and EGJ cancers have improved the prognostic stratification of the TNM staging system is unclear; the available data are conflicting [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11850/abstract/22-25\">",
"     22-25",
"    </a>",
"    ]. Some suggest little difference in stage-stratified survival when survival curves are compared using the sixth (2002) and seventh (2010) edition staging systems in the same population of patients, despite the staging reclassification of as many of 60 percent of patients from one system to the other [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11850/abstract/23\">",
"     23",
"    </a>",
"    ]. This stage migration phenomenon has obvious implications for interpretation and comparison of outcomes from trials and retrospective series that use the 2002 versus the 2010 staging criteria.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Clinical staging and the selection of treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although staging is most accurately determined through surgical pathology, clinical staging directs the initial approach to therapy:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients who appear to have locoregional disease (stage I to III) after preoperative testing are potentially curable; all patients with a primary tumor that is considered to invade through the submucosa (T2 or higher) or with a high suspicion of nodal involvement on pretreatment staging studies should be referred for multidisciplinary evaluation to identify the best treatment strategy. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/38/11882?source=see_link\">",
"       \"Adjuvant and neoadjuvant treatment of gastric cancer\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/15/33018?source=see_link&amp;anchor=H16#H16\">",
"       \"Invasive gastric cancer: Surgery and prognosis\", section on 'Adjuvant and neoadjuvant therapy'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/51/39738?source=see_link&amp;anchor=H12480581#H12480581\">",
"       \"Multimodality approaches to potentially resectable esophagogastric junction and gastric cardia adenocarcinomas\", section on 'Multimodality approaches'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Patients with advanced stage IV disease are usually referred for palliative therapy depending on their symptoms and functional status. Multiple studies indicate both longer survival and better quality of life with systemic treatment. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/10/44202?source=see_link\">",
"       \"Chemotherapy for locally advanced unresectable and metastatic esophageal and gastric cancer\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Preoperative evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The purpose of the preoperative evaluation is to initially stratify patients into two clinical groups: those with locoregional, potentially resectable (stage I to III, (",
"    <a class=\"graphic graphic_table graphicRef57916 \" href=\"UTD.htm?11/6/11374\">",
"     table 2",
"    </a>",
"    )) disease and those with systemic (stage IV) involvement.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1207371\">",
"    <span class=\"h3\">",
"     Indicators of unresectability",
"    </span>",
"    &nbsp;&mdash;&nbsp;The only widely accepted criteria of unresectability for gastric cancer are the presence of distant metastases and invasion of a major vascular structure, such as the aorta, or disease encasement or occlusion of the hepatic artery or celiac",
"    <span class=\"nowrap\">",
"     axis/proximal",
"    </span>",
"    splenic artery. Distal splenic artery involvement is not an indicator of unresectability; the vessel can be resected en bloc with a left upper quadrant exenteration: stomach, spleen and distal pancreas. &nbsp;(See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/15/33018?source=see_link&amp;anchor=H7006444#H7006444\">",
"     \"Invasive gastric cancer: Surgery and prognosis\", section on 'Indicators of unresectability'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The lymphatics around the stomach are rich, and the presence of locoregional lymph node metastases that are located geographically distant from the tumor (eg, celiac nodes with a primary tumor on the greater curvature of the stomach) should not necessarily be considered an indicator of unresectability. However:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients who have bulky adenopathy fixed to the pancreatic head that might indicate the need for a Whipple procedure are at a high risk for occult metastatic disease. In these cases, it is probably best to consider staging laparoscopy or upfront chemotherapy or combined modality therapy rather than surgery initially. Performance of a Whipple for gastric cancer is an extremely rare occurrence. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/15/33018?source=see_link&amp;anchor=H4#H4\">",
"       \"Invasive gastric cancer: Surgery and prognosis\", section on 'Staging laparoscopy'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/15/33018?source=see_link&amp;anchor=H18#H18\">",
"       \"Invasive gastric cancer: Surgery and prognosis\", section on 'Neoadjuvant chemotherapy and chemoradiotherapy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Lymph nodes behind or inferior to the pancreas, aorto-caval region, into the mediastinum, or in the porta hepatis are typically considered outside of the surgical field and thus evidence of unresectability. &nbsp;These nodes would fall into areas that would be defined as third or fourth echelon nodes in the Japanese nomenclature.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In about 5 percent of primary gastric cancers, a broad region of the gastric wall or even the entire stomach is extensively infiltrated by malignancy, resulting in a rigid thickened stomach, termed linitis plastica. Linitis plastica has an extremely poor prognosis, and many surgeons consider the presence of linitis plastica to be a contraindication to potentially curative resection. &nbsp;(See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/15/33018?source=see_link&amp;anchor=H7006295#H7006295\">",
"     \"Invasive gastric cancer: Surgery and prognosis\", section on 'Linitis plastica'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Abdominopelvic CT scan",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dynamic computerized tomography (CT) scan imaging is usually performed early in the preoperative evaluation after a diagnosis of gastric cancer is made. CT is widely available and noninvasive. It is best suited to evaluating widely metastatic disease, especially hepatic or adnexal metastases, ascites, or distant nodal spread. Patients who have CT-defined visceral metastatic disease can avoid unnecessary surgery, although biopsy confirmation is recommended because of the risk of false-positive findings.",
"   </p>",
"   <p>",
"    Peritoneal metastases and hematogenous metastases smaller than 5 mm are frequently missed by CT, even using modern CT techniques [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11850/abstract/26\">",
"     26",
"    </a>",
"    ]. In 20 to 30 percent of patients with a negative CT, intraperitoneal disease will be found at either staging laparoscopy or at open exploration [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11850/abstract/27-29\">",
"     27-29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Another limitation of CT is its inability to accurately assess the depth of primary tumor invasion (particularly with small tumors) and the presence of lymph node involvement. CT accurately assesses the T stage of the primary tumor in only about 50 to 70 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11850/abstract/30-36\">",
"     30-36",
"    </a>",
"    ]. The tumor is more often understaged because the depth of invasion is underestimated; however, overstaging also occurs.",
"   </p>",
"   <p>",
"    The classification of nodal status is usually based on lymph node size, and sensitivity of CT for detecting regional nodal metastases is limited for involved nodes that are smaller than 0.8 cm [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11850/abstract/30,35\">",
"     30,35",
"    </a>",
"    ]. Furthermore, false-positive findings may be attributed to inflammatory lymphadenopathy. In series of patients undergoing staging CT for gastric cancer or gastric and esophageal cancer, sensitivity and specificity rates for regional nodal metastases range from 65 to 97, and 49 to 90 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11850/abstract/37-41\">",
"     37-41",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Endoscopic ultrasonography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endoscopic ultrasonography (EUS) is thought to be the most reliable nonsurgical method available for evaluating the depth of invasion of primary gastric cancers, particularly for early (T1) lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11850/abstract/42\">",
"     42",
"    </a>",
"    ]. The accuracy of EUS for differentiation of individual tumor stages (T1 to T4) ranges from 77 to 93 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11850/abstract/43-47\">",
"     43-47",
"    </a>",
"    ], with the experience of the operator markedly influencing these rates.",
"   </p>",
"   <p>",
"    In comparative studies, EUS generally provides a more accurate prediction of T stage than does CT [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11850/abstract/48-51\">",
"     48-51",
"    </a>",
"    ], although newer CT techniques (such as three-dimensional multidetector row CT) and MRI may achieve similar results in terms of diagnostic accuracy in T staging [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11850/abstract/41,52,53\">",
"     41,52,53",
"    </a>",
"    ]. In contrast, accuracy for nodal staging (65 to 90 percent) is only slightly greater with EUS as compared to CT [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11850/abstract/43-45,48,54-56\">",
"     43-45,48,54-56",
"    </a>",
"    ]. EUS-guided fine needle aspiration of suspicious nodes and regional areas adds to the accuracy of nodal staging [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11850/abstract/57\">",
"     57",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/30/3561?source=see_link\">",
"     \"Endoscopic ultrasound-guided fine-needle aspiration biopsy in the gastrointestinal tract\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Most errors in staging with EUS are due to understaging nodal involvement and the depth of primary tumor invasion; however, overstaging can also occur that is attributed to inflammation around the tumor or in lymph nodes [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11850/abstract/56\">",
"     56",
"    </a>",
"    ]. Distinguishing T2 from T3 lesions (",
"    <a class=\"graphic graphic_table graphicRef57916 \" href=\"UTD.htm?11/6/11374\">",
"     table 2",
"    </a>",
"    ) is especially difficult because of this problem.",
"   </p>",
"   <p>",
"    EUS is a relatively low-risk procedure, although it is more invasive than CT. One review quoted a risk of serious complications of 0.3 percent, most of which occurred in the setting of obstructing esophageal tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11850/abstract/58\">",
"     58",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/36/27208?source=see_link\">",
"     \"Endoscopic ultrasound in esophageal carcinoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The routine use of staging EUS can sometimes alter the therapeutic plan because of the finding of otherwise occult distant metastases (eg, left lobe hepatic lesions, ascites) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11850/abstract/59\">",
"     59",
"    </a>",
"    ]. However, due to the limited field of vision with the echoendoscope, the utility of EGD as a screen for metastatic disease is questionable.",
"   </p>",
"   <p>",
"    Perhaps more importantly, an accurate assessment of T and N stage has become important for selecting the therapeutic approach:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Neoadjuvant chemotherapy or chemoradiotherapy may be recommended for patients with a primary tumor that is considered to invade into the muscularis propria (T2 or higher) or with a high suspicion of nodal involvement on pretreatment staging studies. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/38/11882?source=see_link&amp;anchor=H14#H14\">",
"       \"Adjuvant and neoadjuvant treatment of gastric cancer\", section on 'Neoadjuvant chemoradiotherapy'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/38/11882?source=see_link&amp;anchor=H15#H15\">",
"       \"Adjuvant and neoadjuvant treatment of gastric cancer\", section on 'Initially locally unresectable nonmetastatic disease'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/51/39738?source=see_link&amp;anchor=H12480581#H12480581\">",
"       \"Multimodality approaches to potentially resectable esophagogastric junction and gastric cardia adenocarcinomas\", section on 'Multimodality approaches'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      EUS is also of value for patients with early gastric cancer because accurate assessment of submucosal invasion is essential before considering the option of endoscopic mucosal resection. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/10/37033?source=see_link\">",
"       \"Early gastric cancer: Epidemiology, clinical manifestations, diagnosis, and staging\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In light of these considerations, EUS is now recommended for pretreatment evaluation of gastric cancer in patients who have no evidence of metastatic (M1) disease in guidelines from the",
"    <a class=\"external\" href=\"file://www.nccn.org/professionals/physician_gls/f_guidelines.asp\">",
"     National Comprehensive Cancer Network (NCCN)",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     PET scan",
"    </span>",
"    &nbsp;&mdash;&nbsp;The role of positron emission tomography (PET) using 18-fluorodeoxyglucose (FDG) in the preoperative staging of gastric adenocarcinoma is evolving. From the standpoint of locoregional staging, integrated",
"    <span class=\"nowrap\">",
"     PET/CT",
"    </span>",
"    imaging can be useful to confirm malignant involvement of CT-detected lymphadenopathy [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11850/abstract/60\">",
"     60",
"    </a>",
"    ]. However, this usually does not impact the decision to proceed to surgery. Furthermore, a negative PET is not helpful since even large tumors with a diameter of several centimeters can be falsely negative if the tumor cells have a fairly low metabolic activity. Furthermore, most diffuse type gastric cancers (signet ring carcinomas) are not FDG avid [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11850/abstract/61-65\">",
"     61-65",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The main benefit of PET is that it is more sensitive than CT for the detection of distant metastases [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11850/abstract/65-68\">",
"     65-68",
"    </a>",
"    ]. In one prospective study, integrated",
"    <span class=\"nowrap\">",
"     PET/CT",
"    </span>",
"    identified otherwise radiographically occult metastatic lesions in approximately 10 percent of patients with locally advanced gastric cancer (&ge;T3 or &ge;N1 disease, (",
"    <a class=\"graphic graphic_table graphicRef57916 \" href=\"UTD.htm?11/6/11374\">",
"     table 2",
"    </a>",
"    )) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11850/abstract/68\">",
"     68",
"    </a>",
"    ]. An important caveat is that the sensitivity of PET scanning for peritoneal carcinomatosis is only approximately 50 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11850/abstract/69\">",
"     69",
"    </a>",
"    ]. Thus, PET is not an adequate replacement for staging laparoscopy.",
"   </p>",
"   <p>",
"    <a class=\"external\" href=\"file://www.nccn.org/professionals/physician_gls/f_guidelines.asp\">",
"     NCCN guidelines",
"    </a>",
"    for preoperative evaluation of gastric cancer suggest integrated",
"    <span class=\"nowrap\">",
"     PET/CT.",
"    </span>",
"    However, gastric cancer is not a reimbursable diagnosis for PET scanning in the US Medicare program.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Chest imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;A preoperative chest x-ray is recommended in patients with gastric cancer. However, the sensitivity for metastases is limited, and a chest CT scan is preferred (particularly for patients with a proximal gastric cancer) if the detection of intrathoracic disease would alter the treatment plan.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Serologic markers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serum levels of carcinoembryonic antigen (CEA), the glycoprotein CA 125 antigen (CA 125), CA 19 9, and CA 72 4 may be elevated in patients with gastric cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11850/abstract/70-74\">",
"     70-74",
"    </a>",
"    ]. However, low rates of sensitivity and specificity prevent the use of any of these serologic markers as diagnostic tests for gastric cancer.",
"   </p>",
"   <p>",
"    In a minority of patients, a drop in an elevated level of CEA",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    CA 125 may correlate with response to preoperative therapy, but clinical decisions are almost never made based upon tumor marker changes alone. Likewise, in many [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11850/abstract/75-85\">",
"     75-85",
"    </a>",
"    ] but not all studies [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11850/abstract/73,86\">",
"     73,86",
"    </a>",
"    ], preoperative elevations in serum tumor markers are an independent indicator of adverse prognosis. However, no serologic finding should be used to exclude a patient from surgical consideration. Recommendations for preoperative evaluation and staging of gastric cancer from the",
"    <a class=\"external\" href=\"file://www.nccn.org/professionals/physician_gls/f_guidelines.asp\">",
"     NCCN",
"    </a>",
"    do not include assay of any tumor marker.",
"   </p>",
"   <p>",
"    Some gastric cancers are associated with elevated serum levels of alpha-fetoprotein (AFP); they are referred to as alpha-fetoprotein producing gastric cancers [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11850/abstract/87-90\">",
"     87-90",
"    </a>",
"    ]. A subset, hepatoid adenocarcinomas of the stomach, has a histologic appearance that is similar to that of hepatocellular cancer (HCC). Regardless of morphology, AFP-producing gastric cancers are aggressive and associated with a poor prognosis.",
"   </p>",
"   <p>",
"    Increases in serum pepsinogen II or decreases in the pepsinogen I:pepsinogen II ratio has been used in population screening programs to identify patients at increased risk for gastric cancer but are insufficiently sensitive or specific for establishing a diagnosis in an individual patient. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/30/31205?source=see_link\">",
"     \"Classification and diagnosis of gastritis and gastropathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     STAGING LAPAROSCOPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Laparoscopy, while more invasive than CT or EUS, has the advantage of directly visualizing the liver surface, the peritoneum, and local lymph nodes. Between 20 and 30 percent of patients who have disease that is beyond T1 stage on EUS will be found to have peritoneal metastases despite having a negative CT scan [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11850/abstract/27-29,91,92\">",
"     27-29,91,92",
"    </a>",
"    ]. Particularly among patients with advanced (T3 or 4) primary tumors, performance of a diagnostic laparoscopy may alter management (typically by avoiding an unnecessary laparotomy) in up to one-half [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11850/abstract/93\">",
"     93",
"    </a>",
"    ]. As noted previously, the sensitivity of PET scans for the detection of peritoneal carcinomatosis is only about 50 percent. (See",
"    <a class=\"local\" href=\"#H17\">",
"     'PET scan'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Another advantage to laparoscopy is the opportunity to perform peritoneal cytology in patients who have no visible evidence of peritoneal spread. In most (but not all [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11850/abstract/94\">",
"     94",
"    </a>",
"    ]) series this is a poor prognostic sign, even in the absence of overt peritoneal dissemination, and predicts for early peritoneal relapse [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11850/abstract/95-97\">",
"     95-97",
"    </a>",
"    ]. The majority of patients who are found to have peritoneal disease on laparoscopy will never require a laparotomy or resection. However, at some institutions (including our own) positive peritoneal cytology in the absence of other evidence of intraabdominal disease is an indication for neoadjuvant therapy.",
"   </p>",
"   <p>",
"    At our institution, we routinely obtain peritoneal washings during laparoscopy in patients who lack visible peritoneal disease, and refer patients with positive cytology in the absence of other evidence of metastatic disease for neoadjuvant approaches. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/15/33018?source=see_link&amp;anchor=H18#H18\">",
"     \"Invasive gastric cancer: Surgery and prognosis\", section on 'Neoadjuvant chemotherapy and chemoradiotherapy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Some experts suggest restricting staging laparoscopy for patients with EUS stage",
"    <span class=\"nowrap\">",
"     T3/4",
"    </span>",
"    disease [",
"    <a class=\"abstract\" href=\"UTD.htm?11/36/11850/abstract/29\">",
"     29",
"    </a>",
"    ]. Guidelines from the",
"    <a class=\"external\" href=\"file://www.nccn.org/professionals/physician_gls/f_guidelines.asp\">",
"     NCCN",
"    </a>",
"    suggest only that laparoscopy be \"considered\" for patients who appear to have locoregional disease (other than stage IV, Tis or T1a stage) after conventional radiographic and EUS staging. However, we believe it can sometimes be difficult to differentiate T2 and T3 lesions on EUS; our practice is to use preoperative staging laparoscopy for any medically fit patient who appears to have more than a T1 lesion on EUS, no histologic confirmation of stage IV disease, and who would not otherwise require a palliative gastrectomy because of symptoms. Diagnostic laparoscopy should also be undertaken in patients who are being considered for neoadjuvant therapy trials. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/38/11882?source=see_link\">",
"     \"Adjuvant and neoadjuvant treatment of gastric cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, \"The Basics\" and \"Beyond the Basics.\" The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on \"patient info\" and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?31/28/32195?source=see_link\">",
"       \"Patient information: Stomach cancer (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?32/41/33426?source=see_link\">",
"       \"Patient information: Upper endoscopy (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?21/0/21506?source=see_link\">",
"       \"Patient information: Upper endoscopy (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For patients presenting with symptoms suggestive of a gastric cancer, diagnostic upper endoscopy is generally preferred over",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/17/12564?source=see_link\">",
"       barium",
"      </a>",
"      studies. The one setting where a barium swallow may be superior to upper endoscopy is in a patient with linitis plastica. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with documented gastric cancer should undergo a staging evaluation in order to guide therapy and more reliably predict outcome. Careful staging allows the clinician to select the most appropriate therapy, minimizes unnecessary surgery, and maximizes the likelihood of benefit from the selected treatment. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Staging and preoperative evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The most commonly used staging schema is that of the",
"      <span class=\"nowrap\">",
"       AJCC/UICC,",
"      </span>",
"      which is based upon tumor (T), node (N), and metastasis (M) classifications (",
"      <a class=\"graphic graphic_table graphicRef57916 \" href=\"UTD.htm?11/6/11374\">",
"       table 2",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?11/36/11850/abstract/20\">",
"       20",
"      </a>",
"      ]. The most recent 2010 edition of the TNM staging criteria contains many changes from the 2002 edition. This has obvious implications for interpretation and comparison of outcomes of studies that use the newer versus the older criteria to assign stage. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'TNM staging criteria'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The ultimate choice of staging modalities is dependent upon the clinical scenario and local expertise. We recommend the following approach, which is consistent with guidelines from the",
"      <a class=\"external\" href=\"file://www.nccn.org/professionals/physician_gls/f_guidelines.asp\">",
"       National Comprehensive Cancer Network (NCCN)",
"      </a>",
"      :",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Abdominopelvic CT scan is indicated to look for metastatic disease (M stage); it should not be relied upon for assessing tumor depth or lymph node involvement (T or N staging, respectively) or the presence of peritoneal metastases. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Abdominopelvic CT scan'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Suspicious visceral lesions require biopsy confirmation. Paracentesis should be performed when ascites is detected, and the fluid sent for cytology and standard chemical analysis.",
"     </li>",
"     <li>",
"      A preoperative chest x-ray is recommended; chest CT scan is preferred (particularly for patients with a proximal gastric cancer) if the detection of intrathoracic disease would alter the treatment plan.",
"     </li>",
"     <li>",
"      Endoscopic ultrasound (EUS) is better than CT at assessing tumor depth (T stage) and perhaps lymph node involvement (N stage), particularly if fine-needle aspiration is also performed. An accurate assessment of T and N stage is important for treatment selection, particularly in selecting patients for neoadjuvant chemotherapy or chemoradiotherapy rather than initial surgery. In keeping with guidelines from the",
"      <a class=\"external\" href=\"file://www.nccn.org/professionals/physician_gls/f_guidelines.asp\">",
"       NCCN",
"      </a>",
"      , we perform EUS for patients who have no evidence of metastatic (M1) disease. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Endoscopic ultrasonography'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      If the radiographic staging evaluation is otherwise negative for metastatic disease, integrated",
"      <span class=\"nowrap\">",
"       PET/CT",
"      </span>",
"      is a reasonable addition to the preoperative staging evaluation for patients with &ge;T2N0 disease, mainly to screen for distant metastases. As with CT, suspicious visceral lesions warrant biopsy. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'PET scan'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Serum tumor markers (including CEA and CA 125) are of limited utility, and we do not routinely assay for them, unless a patient is undergoing neoadjuvant therapy. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Serologic markers'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In our view, staging laparoscopy is indicated in all medically fit patients who appear to have more than a T1 (",
"      <a class=\"graphic graphic_table graphicRef57916 \" href=\"UTD.htm?11/6/11374\">",
"       table 2",
"      </a>",
"      ) lesion on EUS, no histologic confirmation of stage IV disease, and who would not otherwise require a palliative gastrectomy because of symptoms. Diagnostic laparoscopy should also be undertaken in patients who are being considered for neoadjuvant therapy. We routinely obtain peritoneal washings during laparoscopy in the absence of visible peritoneal disease. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Staging laparoscopy'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/1\">",
"      Wanebo HJ, Kennedy BJ, Chmiel J, et al. Cancer of the stomach. A patient care study by the American College of Surgeons. Ann Surg 1993; 218:583.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/2\">",
"      Kahrilas PJ, Kishk SM, Helm JF, et al. Comparison of pseudoachalasia and achalasia. Am J Med 1987; 82:439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/3\">",
"      Morgenstern L. The Virchow-Troisier node: a historical note. Am J Surg 1979; 138:703.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/4\">",
"      Pieslor PC, Hefter LG. Umbilical metastasis from prostatic carcinoma--Sister Joseph nodule. Urology 1986; 27:558.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/5\">",
"      Gilliland R, Gill PJ. Incidence and prognosis of Krukenberg tumour in Northern Ireland. Br J Surg 1992; 79:1364.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/6\">",
"      Winne BURCHARD BE. Blumer's shelf tumor with primary carcinoma of the lung. A case report. J Int Coll Surg 1965; 44:477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/7\">",
"      Fuchs CS, Mayer RJ. Gastric carcinoma. N Engl J Med 1995; 333:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/8\">",
"      Dantzig PI. Sign of Leser-Tr&eacute;lat. Arch Dermatol 1973; 108:700.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/9\">",
"      Brown J, Winkelmann RK. Acanthosis nigricans: a study of 90 cases. Medicine (Baltimore) 1968; 47:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/10\">",
"      Antman KH, Skarin AT, Mayer RJ, et al. Microangiopathic hemolytic anemia and cancer: a review. Medicine (Baltimore) 1979; 58:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/11\">",
"      Wakashin M, Wakashin Y, Iesato K, et al. Association of gastric cancer and nephrotic syndrome. An immunologic study in three patients. Gastroenterology 1980; 78:749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/12\">",
"      Sack GH Jr, Levin J, Bell WR. Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: clinical, pathophysiologic, and therapeutic features. Medicine (Baltimore) 1977; 56:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/13\">",
"      Poveda F, Gonz&aacute;lez-Garc&iacute;a J, Picazo ML, et al. Systemic polyarteritis nodosa as the initial manifestation of a gastric adenocarcinoma. J Intern Med 1994; 236:679.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/14\">",
"      Graham DY, Schwartz JT, Cain GD, Gyorkey F. Prospective evaluation of biopsy number in the diagnosis of esophageal and gastric carcinoma. Gastroenterology 1982; 82:228.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/15\">",
"      Karita M, Tada M. Endoscopic and histologic diagnosis of submucosal tumors of the gastrointestinal tract using combined strip biopsy and bite biopsy. Gastrointest Endosc 1994; 40:749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/16\">",
"      Wang HH, Jonasson JG, Ducatman BS. Brushing cytology of the upper gastrointestinal tract. Obsolete or not? Acta Cytol 1991; 35:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/17\">",
"      Dooley CP, Larson AW, Stace NH, et al. Double-contrast barium meal and upper gastrointestinal endoscopy. A comparative study. Ann Intern Med 1984; 101:538.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/18\">",
"      Longo WE, Zucker KA, Zdon MJ, Modlin IM. Detection of early gastric cancer in an aggressive endoscopy unit. Am Surg 1989; 55:100.",
"     </a>",
"    </li>",
"    <li>",
"     The General Rules for the Gastric Cancer Study in Surgery and Pathology, 12th, Japanese Research Society for Gastric Cancer (Ed), Kanahara Shuppan, Tokyo 1993.",
"    </li>",
"    <li>",
"     American Joint Committee on Cancer Staging Manual, 7th, Edge SB, Byrd DR, Compton CC, et al (Eds), Springer, New York 2010. p.117.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/21\">",
"      R&uuml;diger Siewert J, Feith M, Werner M, Stein HJ. Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients. Ann Surg 2000; 232:353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/22\">",
"      Deng J, Liang H, Sun D, et al. Suitability of 7th UICC N stage for predicting the overall survival of gastric cancer patients after curative resection in China. Ann Surg Oncol 2010; 17:1259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/23\">",
"      Warneke VS, Behrens HM, Hartmann JT, et al. Cohort study based on the seventh edition of the TNM classification for gastric cancer: proposal of a new staging system. J Clin Oncol 2011; 29:2364.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/24\">",
"      Kim DH, Oh CA, Oh SJ, et al. Validation of seventh edition AJCC gastric cancer staging modifications. J Surg Oncol 2012; 105:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/25\">",
"      Reim D, Loos M, Vogl F, et al. Prognostic implications of the seventh edition of the international union against cancer classification for patients with gastric cancer: the Western experience of patients treated in a single-center European institution. J Clin Oncol 2013; 31:263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/26\">",
"      Kim SJ, Kim HH, Kim YH, et al. Peritoneal metastasis: detection with 16- or 64-detector row CT in patients undergoing surgery for gastric cancer. Radiology 2009; 253:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/27\">",
"      Lowy AM, Mansfield PF, Leach SD, Ajani J. Laparoscopic staging for gastric cancer. Surgery 1996; 119:611.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/28\">",
"      Feussner H, Omote K, Fink U, et al. Pretherapeutic laparoscopic staging in advanced gastric carcinoma. Endoscopy 1999; 31:342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/29\">",
"      Power DG, Schattner MA, Gerdes H, et al. Endoscopic ultrasound can improve the selection for laparoscopy in patients with localized gastric cancer. J Am Coll Surg 2009; 208:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/30\">",
"      Davies J, Chalmers AG, Sue-Ling HM, et al. Spiral computed tomography and operative staging of gastric carcinoma: a comparison with histopathological staging. Gut 1997; 41:314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/31\">",
"      Sussman SK, Halvorsen RA Jr, Illescas FF, et al. Gastric adenocarcinoma: CT versus surgical staging. Radiology 1988; 167:335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/32\">",
"      Abdalla EK, Pisters PW. Staging and preoperative evaluation of upper gastrointestinal malignancies. Semin Oncol 2004; 31:513.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/33\">",
"      Minami M, Kawauchi N, Itai Y, et al. Gastric tumors: radiologic-pathologic correlation and accuracy of T staging with dynamic CT. Radiology 1992; 185:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/34\">",
"      Rossi M, Broglia L, Maccioni F, et al. Hydro-CT in patients with gastric cancer: preoperative radiologic staging. Eur Radiol 1997; 7:659.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/35\">",
"      D&uuml;x M, Richter GM, Hansmann J, et al. Helical hydro-CT for diagnosis and staging of gastric carcinoma. J Comput Assist Tomogr 1999; 23:913.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/36\">",
"      Lee IJ, Lee JM, Kim SH, et al. Diagnostic performance of 64-channel multidetector CT in the evaluation of gastric cancer: differentiation of mucosal cancer (T1a) from submucosal involvement (T1b and T2). Radiology 2010; 255:805.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/37\">",
"      D'Elia F, Zingarelli A, Palli D, Grani M. Hydro-dynamic CT preoperative staging of gastric cancer: correlation with pathological findings. A prospective study of 107 cases. Eur Radiol 2000; 10:1877.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/38\">",
"      Sohn KM, Lee JM, Lee SY, et al. Comparing MR imaging and CT in the staging of gastric carcinoma. AJR Am J Roentgenol 2000; 174:1551.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/39\">",
"      Kienle P, Buhl K, Kuntz C, et al. Prospective comparison of endoscopy, endosonography and computed tomography for staging of tumours of the oesophagus and gastric cardia. Digestion 2002; 66:230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/40\">",
"      Wakelin SJ, Deans C, Crofts TJ, et al. A comparison of computerised tomography, laparoscopic ultrasound and endoscopic ultrasound in the preoperative staging of oesophago-gastric carcinoma. Eur J Radiol 2002; 41:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/41\">",
"      Yan C, Zhu ZG, Yan M, et al. Value of multidetector-row computed tomography in the preoperative T and N staging of gastric carcinoma: a large-scale Chinese study. J Surg Oncol 2009; 100:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/42\">",
"      Yoshida S, Tanaka S, Kunihiro K, et al. Diagnostic ability of high-frequency ultrasound probe sonography in staging early gastric cancer, especially for submucosal invasion. Abdom Imaging 2005; 30:518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/43\">",
"      Pollack BJ, Chak A, Sivak MV Jr. Endoscopic ultrasonography. Semin Oncol 1996; 23:336.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/44\">",
"      Kelly S, Harris KM, Berry E, et al. A systematic review of the staging performance of endoscopic ultrasound in gastro-oesophageal carcinoma. Gut 2001; 49:534.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/45\">",
"      Botet JF, Lightdale CJ, Zauber AG, et al. Preoperative staging of gastric cancer: comparison of endoscopic US and dynamic CT. Radiology 1991; 181:426.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/46\">",
"      Byrne MF, Jowell PS. Gastrointestinal imaging: endoscopic ultrasound. Gastroenterology 2002; 122:1631.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/47\">",
"      Ganpathi IS, So JB, Ho KY. Endoscopic ultrasonography for gastric cancer: does it influence treatment? Surg Endosc 2006; 20:559.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/48\">",
"      Willis S, Truong S, Gribnitz S, et al. Endoscopic ultrasonography in the preoperative staging of gastric cancer: accuracy and impact on surgical therapy. Surg Endosc 2000; 14:951.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/49\">",
"      Meining A, Dittler HJ, Wolf A, et al. You get what you expect? A critical appraisal of imaging methodology in endosonographic cancer staging. Gut 2002; 50:599.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/50\">",
"      Yeung HW, Macapinlac H, Karpeh M, et al. Accuracy of FDG-PET in Gastric Cancer. Preliminary Experience. Clin Positron Imaging 1998; 1:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/51\">",
"      Harris KM, Kelly S, Berry E, et al. Systematic review of endoscopic ultrasound in gastro-oesophageal cancer. Health Technol Assess 1998; 2:i.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/52\">",
"      Bhandari S, Shim CS, Kim JH, et al. Usefulness of three-dimensional, multidetector row CT (virtual gastroscopy and multiplanar reconstruction) in the evaluation of gastric cancer: a comparison with conventional endoscopy, EUS, and histopathology. Gastrointest Endosc 2004; 59:619.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/53\">",
"      Kwee RM, Kwee TC. Imaging in local staging of gastric cancer: a systematic review. J Clin Oncol 2007; 25:2107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/54\">",
"      Fukuya T, Honda H, Hayashi T, et al. Lymph-node metastases: efficacy for detection with helical CT in patients with gastric cancer. Radiology 1995; 197:705.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/55\">",
"      de Manzoni G, Pedrazzani C, Di Leo A, et al. Experience of endoscopic ultrasound in staging adenocarcinoma of the cardia. Eur J Surg Oncol 1999; 25:595.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/56\">",
"      Tsendsuren T, Jun SM, Mian XH. Usefulness of endoscopic ultrasonography in preoperative TNM staging of gastric cancer. World J Gastroenterol 2006; 12:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/57\">",
"      Chang KJ, Katz KD, Durbin TE, et al. Endoscopic ultrasound-guided fine-needle aspiration. Gastrointest Endosc 1994; 40:694.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/58\">",
"      Nickl NJ, Bhutani MS, Catalano M, et al. Clinical implications of endoscopic ultrasound: the American Endosonography Club Study. Gastrointest Endosc 1996; 44:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/59\">",
"      McGrath K, Brody D, Luketich J, Khalid A. Detection of unsuspected left hepatic lobe metastases during EUS staging of cancer of the esophagus and cardia. Am J Gastroenterol 2006; 101:1742.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/60\">",
"      Yun M, Lim JS, Noh SH, et al. Lymph node staging of gastric cancer using (18)F-FDG PET: a comparison study with CT. J Nucl Med 2005; 46:1582.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/61\">",
"      De Potter T, Flamen P, Van Cutsem E, et al. Whole-body PET with FDG for the diagnosis of recurrent gastric cancer. Eur J Nucl Med Mol Imaging 2002; 29:525.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/62\">",
"      Stahl A, Ott K, Weber WA, et al. FDG PET imaging of locally advanced gastric carcinomas: correlation with endoscopic and histopathological findings. Eur J Nucl Med Mol Imaging 2003; 30:288.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/63\">",
"      Kim SK, Kang KW, Lee JS, et al. Assessment of lymph node metastases using 18F-FDG PET in patients with advanced gastric cancer. Eur J Nucl Med Mol Imaging 2006; 33:148.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/64\">",
"      Mukai K, Ishida Y, Okajima K, et al. Usefulness of preoperative FDG-PET for detection of gastric cancer. Gastric Cancer 2006; 9:192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/65\">",
"      Chen J, Cheong JH, Yun MJ, et al. Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography. Cancer 2005; 103:2383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/66\">",
"      McAteer D, Wallis F, Couper G, et al. Evaluation of 18F-FDG positron emission tomography in gastric and oesophageal carcinoma. Br J Radiol 1999; 72:525.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/67\">",
"      Kinkel K, Lu Y, Both M, et al. Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis. Radiology 2002; 224:748.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/68\">",
"      Smyth E, Sch&ouml;der H, Strong VE, et al. A prospective evaluation of the utility of 2-deoxy-2-[(18) F]fluoro-D-glucose positron emission tomography and computed tomography in staging locally advanced gastric cancer. Cancer 2012; 118:5481.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/69\">",
"      Yoshioka T, Yamaguchi K, Kubota K, et al. Evaluation of 18F-FDG PET in patients with advanced, metastatic, or recurrent gastric cancer. J Nucl Med 2003; 44:690.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/70\">",
"      Horie Y, Miura K, Matsui K, et al. Marked elevation of plasma carcinoembryonic antigen and stomach carcinoma. Cancer 1996; 77:1991.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/71\">",
"      Kodama I, Koufuji K, Kawabata S, et al. The clinical efficacy of CA 72-4 as serum marker for gastric cancer in comparison with CA19-9 and CEA. Int Surg 1995; 80:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/72\">",
"      Carpelan-Holmstr&ouml;m M, Louhimo J, Stenman UH, et al. CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers. Anticancer Res 2002; 22:2311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/73\">",
"      Lai IR, Lee WJ, Huang MT, Lin HH. Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence. Hepatogastroenterology 2002; 49:1157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/74\">",
"      Marrelli D, Pinto E, De Stefano A, et al. Clinical utility of CEA, CA 19-9, and CA 72-4 in the follow-up of patients with resectable gastric cancer. Am J Surg 2001; 181:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/75\">",
"      Mihmanli M, Dilege E, Demir U, et al. The use of tumor markers as predictors of prognosis in gastric cancer. Hepatogastroenterology 2004; 51:1544.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/76\">",
"      Marrelli D, Pinto E, De Stefano A, et al. Preoperative positivity of serum tumor markers is a strong predictor of hematogenous recurrence of gastric cancer. J Surg Oncol 2001; 78:253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/77\">",
"      Kochi M, Fujii M, Kanamori N, et al. Evaluation of serum CEA and CA19-9 levels as prognostic factors in patients with gastric cancer. Gastric Cancer 2000; 3:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/78\">",
"      Bold RJ, Ota DM, Ajani JA, Mansfield PF. Peritoneal and serum tumor markers predict recurrence and survival of patients with resectable gastric cancer. Gastric Cancer 1999; 2:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/79\">",
"      Ishigami S, Natsugoe S, Hokita S, et al. Clinical importance of preoperative carcinoembryonic antigen and carbohydrate antigen 19-9 levels in gastric cancer. J Clin Gastroenterol 2001; 32:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/80\">",
"      Kim DY, Kim HR, Shim JH, et al. Significance of serum and tissue carcinoembryonic antigen for the prognosis of gastric carcinoma patients. J Surg Oncol 2000; 74:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/81\">",
"      Marrelli D, Roviello F, De Stefano A, et al. Prognostic significance of CEA, CA 19-9 and CA 72-4 preoperative serum levels in gastric carcinoma. Oncology 1999; 57:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/82\">",
"      Nakata B, Hirakawa-YS Chung K, Kato Y, et al. Serum CA 125 level as a predictor of peritoneal dissemination in patients with gastric carcinoma. Cancer 1998; 83:2488.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/83\">",
"      Tocchi A, Costa G, Lepre L, et al. The role of serum and gastric juice levels of carcinoembryonic antigen, CA19.9 and CA72.4 in patients with gastric cancer. J Cancer Res Clin Oncol 1998; 124:450.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/84\">",
"      Sakamoto J, Nakazato H, Teramukai S, et al. Association between preoperative plasma CEA levels and the prognosis of gastric cancer following curative resection. Tumor Marker Committee, Japanese Foundation for Multidisciplinary Treatment of Cancer, Tokyo, Japan. Surg Oncol 1996; 5:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/85\">",
"      Takahashi Y, Takeuchi T, Sakamoto J, et al. The usefulness of CEA and/or CA19-9 in monitoring for recurrence in gastric cancer patients: a prospective clinical study. Gastric Cancer 2003; 6:142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/86\">",
"      Duraker N, Celik AN. The prognostic significance of preoperative serum CA 19-9 in patients with resectable gastric carcinoma: comparison with CEA. J Surg Oncol 2001; 76:266.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/87\">",
"      Liu X, Cheng Y, Sheng W, et al. Clinicopathologic features and prognostic factors in alpha-fetoprotein-producing gastric cancers: analysis of 104 cases. J Surg Oncol 2010; 102:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/88\">",
"      Kono K, Amemiya H, Sekikawa T, et al. Clinicopathologic features of gastric cancers producing alpha-fetoprotein. Dig Surg 2002; 19:359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/89\">",
"      Chang YC, Nagasue N, Kohno H, et al. Clinicopathologic features and long-term results of alpha-fetoprotein-producing gastric cancer. Am J Gastroenterol 1990; 85:1480.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/90\">",
"      Ushiku T, Uozaki H, Shinozaki A, et al. Glypican 3-expressing gastric carcinoma: distinct subgroup unifying hepatoid, clear-cell, and alpha-fetoprotein-producing gastric carcinomas. Cancer Sci 2009; 100:626.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/91\">",
"      Watt I, Stewart I, Anderson D, et al. Laparoscopy, ultrasound and computed tomography in cancer of the oesophagus and gastric cardia: a prospective comparison for detecting intra-abdominal metastases. Br J Surg 1989; 76:1036.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/92\">",
"      Sarela AI, Lefkowitz R, Brennan MF, Karpeh MS. Selection of patients with gastric adenocarcinoma for laparoscopic staging. Am J Surg 2006; 191:134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/93\">",
"      Leake PA, Cardoso R, Seevaratnam R, et al. A systematic review of the accuracy and indications for diagnostic laparoscopy prior to curative-intent resection of gastric cancer. Gastric Cancer 2012; 15 Suppl 1:S38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/94\">",
"      Abe S, Yoshimura H, Tabara H, et al. Curative resection of gastric cancer: limitation of peritoneal lavage cytology in predicting the outcome. J Surg Oncol 1995; 59:226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/95\">",
"      Bando E, Yonemura Y, Endou Y, et al. Immunohistochemical study of MT-MMP tissue status in gastric carcinoma and correlation with survival analyzed by univariate and multivariate analysis. Oncol Rep 1998; 5:1483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/96\">",
"      Burke EC, Karpeh MS Jr, Conlon KC, Brennan MF. Peritoneal lavage cytology in gastric cancer: an independent predictor of outcome. Ann Surg Oncol 1998; 5:411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/36/11850/abstract/97\">",
"      Leake PA, Cardoso R, Seevaratnam R, et al. A systematic review of the accuracy and utility of peritoneal cytology in patients with gastric cancer. Gastric Cancer 2012; 15 Suppl 1:S27.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2513 Version 24.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-58.240.98.179-1360C6F796-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_36_11850=[""].join("\n");
var outline_f11_36_11850=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H21\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Signs of tumor extension or spread",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Paraneoplastic manifestations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Endoscopy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Endoscopic techniques",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Need for follow-up endoscopy for gastric ulcers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Barium studies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      STAGING AND PREOPERATIVE EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Staging systems",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - TNM staging criteria",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Clinical staging and the selection of treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Preoperative evaluation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1207371\">",
"      - Indicators of unresectability",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Abdominopelvic CT scan",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Endoscopic ultrasonography",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - PET scan",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Chest imaging",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Serologic markers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      STAGING LAPAROSCOPY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ONC/2513\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/2513|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?31/9/31894\" title=\"diagnostic image 1A\">",
"      Malignant gastric ulcer UGI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?8/0/8195\" title=\"diagnostic image 1B\">",
"      Malignant antral ulcer UGI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?18/60/19396\" title=\"diagnostic image 1C\">",
"      Infiltrating gastric cancer UGI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?19/42/20132\" title=\"diagnostic image 1D\">",
"      Gastric cancer UGI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?12/27/12722\" title=\"diagnostic image 1E\">",
"      Leiomyoma gastric UGI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?43/16/44291\" title=\"diagnostic image 1F\">",
"      Leiomyosarcoma gastric UGI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?12/7/12400\" title=\"diagnostic image 2\">",
"      Early gastric cancer UGI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?4/39/4723\" title=\"diagnostic image 3\">",
"      Linitis plastica UGI",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/2513|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?4/45/4817\" title=\"figure 1\">",
"      Parts of the stomach",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?17/0/17409\" title=\"figure 2\">",
"      SEER survival gast CA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/2513|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?4/46/4835\" title=\"picture 1A\">",
"      Malignant gastric ulcer Endosc",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?29/47/30451\" title=\"picture 1B\">",
"      Gastric cancer Endosc",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/2513|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?9/31/9723\" title=\"table 1\">",
"      Presenting symptoms gastric CA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?11/6/11374\" title=\"table 2\">",
"      2010 TNM staging stomach CA",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/38/11882?source=related_link\">",
"      Adjuvant and neoadjuvant treatment of gastric cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/54/19306?source=related_link\">",
"      Causes and diagnosis of membranous nephropathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/10/44202?source=related_link\">",
"      Chemotherapy for locally advanced unresectable and metastatic esophageal and gastric cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/30/31205?source=related_link\">",
"      Classification and diagnosis of gastritis and gastropathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/26/9641?source=related_link\">",
"      Clinical manifestations and diagnosis of polyarteritis nodosa",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/45/7898?source=related_link\">",
"      Diagnosis and staging of esophageal cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/21/24919?source=related_link\">",
"      Diagnosis of peptic ulcer disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/10/37033?source=related_link\">",
"      Early gastric cancer: Epidemiology, clinical manifestations, diagnosis, and staging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/36/27208?source=related_link\">",
"      Endoscopic ultrasound in esophageal carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/30/3561?source=related_link\">",
"      Endoscopic ultrasound-guided fine-needle aspiration biopsy in the gastrointestinal tract",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/35/4661?source=related_link\">",
"      Epidemiology of gastric cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/43/35514?source=related_link\">",
"      Hypercoagulable disorders associated with malignancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/15/33018?source=related_link\">",
"      Invasive gastric cancer: Surgery and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/51/39738?source=related_link\">",
"      Multimodality approaches to potentially resectable esophagogastric junction and gastric cardia adenocarcinomas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?31/28/32195?source=related_link\">",
"      Patient information: Stomach cancer (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?21/0/21506?source=related_link\">",
"      Patient information: Upper endoscopy (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?32/41/33426?source=related_link\">",
"      Patient information: Upper endoscopy (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/52/6983?source=related_link\">",
"      Screening and prevention of gastric cancer",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_36_11851="Diagnostic criteria VWD";
var content_f11_36_11851=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F75092&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F75092&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Diagnostic test levels for von Willebrand disease (VWD)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Assay",
"      </td>",
"      <td class=\"subtitle1\">",
"       VWD",
"      </td>",
"      <td class=\"subtitle1\">",
"       \"Low\" VWD",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       von Willebrand factor: Ristocetin cofactor activity (VWF:RCo)",
"      </td>",
"      <td>",
"       &lt;30 IU/dL*",
"      </td>",
"      <td>",
"       30-50 IU/dL",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       von Willebrand factor Antigen (VWF:Ag)",
"      </td>",
"      <td>",
"       &lt;30 IU/dL*",
"      </td>",
"      <td>",
"       30-50 IU/dL",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Factor VIII",
"      </td>",
"      <td>",
"       Decreased or normal*",
"      </td>",
"      <td>",
"       Decreased or normal",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     VWD: von Willebrand disease; IU: International units",
"     <br>",
"      * In type 2N VWD, VWF:RCo and VWF:Ag levels are usually 30-200 IU/dL and factor VIII levels are &lt;10-15 IU/dL.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: The National Heart, Lung, and Blood Institute. The Diagnosis, Evaluation, and Management of Von Willebrand Disease. Bethesda, MD: National Institutes of Health Publication 08-5832, December 2007.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_36_11851=[""].join("\n");
var outline_f11_36_11851=null;
var title_f11_36_11852="Diagnostic criteria for periodic limb movement disorder";
var content_f11_36_11852=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F86839&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F86839&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Diagnostic criteria for periodic limb movement disorder (PLMD)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Polysomnography shows repetitive, highly stereotyped limb movements that are:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        0.5 to 10 seconds in duration,",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Minimum amplitude of 8 mV above resting EMG,",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        In a sequence of four or more movements, and",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Separated by an interval of more than 5 seconds (from limb movement onset to limb movement onset) and less than 90 seconds",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        The PLMS index is &ge;5/hour in pediatric cases and &ge;15/hour in adult cases",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        There is clinical sleep disturbance (difficulty with sleep initiation, sleep maintenance, and/or unrefreshing sleep) or a complaint of daytime fatigue*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        The PLMS are not better explained by another current sleep disorder,",
"        <sup>",
"         &bull;",
"        </sup>",
"        medical or neurologic disorder, mental disorder, medication use, or substance use disorder (eg, exclude from PLMS counts the movements at the termination of cyclically occurring apneas)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     PLMD: periodic limb movement disorder; EMG: electromyogram; PLMS: periodic limb movements of sleep; RLS: restless legs syndrome.",
"     <br/>",
"     * If PLMS are present without clinical sleep disturbance, the PLMS can be noted as a polysomnographic ���������nding, but criteria are not met for a diagnosis of PLMD.",
"     <br/>",
"     <span class=\"bullet\">",
"      &bull;",
"     </span>",
"     A diagnosis of RLS supersedes a diagnosis of PLMD. Thus, a patient can have RLS with PLMS, but not RLS and PLMD.",
"    </div>",
"    <div class=\"reference\">",
"     Modified from:",
"     <br/>",
"     <ol>",
"      <li>",
"       Allen RP, Picchietti D, Hening WA, et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003; 4:101.",
"      </li>",
"      <li>",
"       Berry RB, Brooks R, Gamaldo CE, Harding SM, Marcus CL, Vaughn BV. The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications, Version 2.0. Darien, IL: American Academy of Sleep Medicine; 2012. Available at: www.aasmnet.org.",
"      </li>",
"     </ol>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_36_11852=[""].join("\n");
var outline_f11_36_11852=null;
var title_f11_36_11853="Effect of inhaled vasodilators";
var content_f11_36_11853=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F56760&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F56760&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Effect of inhaled vasodilators on blood flow",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 450px; height: 203px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Inhaled vasodilators (green circles) preferentially dilate the pulmonary vessels (red lines) that perfuse functioning alveoli (white circles), recruiting blood flow away from poorly ventilated units (black circles). The net effect is improved ventilation/perfusion matching.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_36_11853=[""].join("\n");
var outline_f11_36_11853=null;
var title_f11_36_11854="Salmonella Shigella agglut";
var content_f11_36_11854=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F71759&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F71759&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Serologic grouping by agglutination with antisera",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 343px; height: 240px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCADwAVcDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5aoooxSEFFGKXFACUd6XFGKAEopcUmKACilxRigBKO1O2ml2E0DsMpaeI2ro/C/grWvE0dw+j2yziDG/Mir19Mms6tWFGLnUdkurNKdKdR8sFdnM0V2uqfDTxNptrNcXVigiiXe5E6HaPXGa48wuD0qaOIpV1zUpKS8ncqrhqtG3tItXIaWpFhkb7qk0eU/8AdrYysyOjFP8ALf8Aump7WynuriOCCMvLKwRFHUk8AUm7asai3oiriiu0b4aeLlIDaHcg/Vf8awdc0DUtDuxbaraSW05UOEfGSD34rCniqFV8tOab8mmazw1WC5pRaXoZNFP8t/7po8p/7proMbEdLT/Kf+6fyoMT/wB00CsMop4hkPRG/KtPRvDmr6z5n9ladc3fl/f8mMtt+uKmc4wXNJ2Rcacpu0VcyaSunbwL4mH/ADA9Q64/1DcVz9xazQTPFNEySISrKRggjtUU61Op8Ek/RjnQqU/ji18iDFFP8tv7ppPLb+6fyrUzsNop21v7ppMH0NArCUdqXB9KTBoAKKXFFABSUUtACUUUUAFFFFAC0UdqKYwooooEFBopaBhQKKWgBAKcBQBTgKBigU4DigClFBSFFfRf7Otvs8LXs2OZJyM/QCvnVetfUPwHt/K+H8D/APPWV2/8ex/SvnuJ58uBa7tf5nq5Sv3zfl/kM+J9tNZaDr16826GW3WJI/7pJ6/rXzMetfTfx5lMfgaYKcB5EU/99CvmiMKHw44bio4ZblhHJ97fckdOdVHOdNPt+tv0Go7RSAx9QaQqfmI6d6GVlOGGCKA3Unqa+iPEv0EBG4HH1FdB4Etzc+MtGiXq13Hj/vqsBSF2sOWB5Brq/he+PiBoLn/n7WsMS3GjNrs/yNsN/Fj6o+tpBhiSBxXzF8c5zceO5FPSK3jXH4Z/rX1DdALvYngjNfJnxcnE/wAQNWdTldyKPwRa+G4WjfGSfaL/ADR7uYy/2b1aOMIwaKWkxX6AfNhSjrSUopgOGQeOte//ALNiAaJrEuBnz1BP/Aa8AFfQ37OcCx+FNRnLHMl3tx9FH+NeBxJK2Al6r8z08rV6r9P8j0tkAaVgO5NfH/itSviTVB6XMn/oRr7GkXEchr438Tv5niHUmPU3Eh/8eNeRwjdyqv0/U7s4d6cfUys0tJRX2x8+IRmmMtPzSGglkDDFNqVhTKZLG0UtJQIKSl7UlAgooooAQiilooAKSiigApaSlpiCiiikMBTgKQU8CgYAU/FIKUUDQqkDqM04EgEDuKZThQUOXrX1l8HIgnw30gf3gzf+Pmvk8DBH619a/CgBfh3ouO8WT+Zr5biz/dIr+8vyZ6+Ur35PyOf/AGg2x4MjA7zrXzimGTb/AB5yK+hP2iJdvhq1j/vTD9M187gjIBHeujhqNsCvVjzZ2qx/w/qy7ex3Qit7mcB4nXaj9jjt9RVFlbYHx8pOM+9O3nYVyxjz0z3qP27V7yVjypNMdgkL+VdL4HkFt4y0NgeUu4wf++q5uEqsilhuUHketbOlp9j1rTZcjaZY5Bg5/iFZ1lzQce6ZthtJqXmj7KuMea2fSvk74uRCP4iaugOAZFIz2yi19XyuGVMdwK+U/jI2fiNrOOzoP/HFr4fhW/1uf+H9Ue1mX+7r1X6nFUHrRSgZI5wK+9PnRMUuMdaGG1iMg47igUDFFfSf7P8ACP8AhBGcg5N3IR78KP6V82ivqH4IJ5Pw3szj78sjf+PV85xRK2CS7yX6nrZSv3kn5fqjsdSYpY3LA4wjH9K+LrxjJcSuTksxJ/OvsjxBJ5ei37k4CwOf/HTXxnJy5rj4SjanVfmv1Nc4ekF6/oMNJxQaSvsDxBDSUGkoJA0win0hpiIiKKcaaaCRKKKKBCUtFFACGiiigAooooAKKKKBBSgUU4UFABTgKBS0DCloooGLThTRSigZIuSea+uPhYMfD7Q/+uP9TXyOvWvr34ZKB8P9D45+zivluK/91j/i/Rnr5T8cvQ4H9o6TGmabH3MhP6V4EATk+le7/tJD9xpLe7CvDIlVkly20gZAPf2rt4f0wEPn+Ys11rpeSIsnn0PaiiivbPKJ7O2lupTHAu5wN2M+lS25Md1GSSrK4yP7pBqqNyEHkZHFSIx37icnOal6mlNpNH2vF80MLgk5RSfyr5W+L3/JRdb/AOuq/wDoC19S6dI0um2DKMq9sj5/4CK+Vviq/mfEHXG/6eCPyAFfD8Mxti6np+qPezR3oL1/zORoopa+5PnRKcKTtSgUDQ5RX1L8HgF+HGl+5f8A9CNfLoBr6n+Falfh5oowASGP6mvmOKn/ALJH/F+jPbyhay+Rf8dTeV4P1mTPItZf/QTXyC/U19cfENc+CNbB720n8q+RmPUVPCqth5+v6E5x8UV5DaQ0UGvqjxRp9qSlpDz1oEHNJRk0CmIQimGppnEjlgioP7q5wPzqEigTQlJS0lAgooooAKKSigQUUUUAFFFLQACnikFPA4oGhKUUUUDClpKcOozQNBSig+1KKBj0619gfDIZ+HuhHr/o618fp1r6/wDha274c6F/17gfqa+W4r/3WP8Ai/Rnq5U/ffoee/tJqRY6Se29v5V4dLYyRQJNJgLJ93nk17r+0nxpmlf9dG/lXgbSuyqpY4Xp7V18PXeAh8/zY80t7ZX7IYBk0p6nFOKEsNuTn2pMHGfwr3Dy7CAnAzzVhX3IoEaAKMEjqfenypbxoNrGRmRWBHAVu4PrTIJSqSIVBDgdRyCD1FLfYuKs9T7E8ImSXwpospIKtYQ8Y5zsFfK/xDlE3jfW5Acg3cg/I4r6t8Hrt8E6FjtYwn/xwV8f69KZ9ZvpWOS87sfxY18hw7H/AGqvJdP83/ke1mMr0UvP/Mz8YNJThRjmvsDwhUQnpT9pB5p9uwQ5p7FW6Dmlc1jFWuIzsUVTjC9OK+qfhcob4daIw7Ien1NfKpGK+qfgu3m/DPS/VWdfyY18xxSv9li/736M9bLZWcvkHxODL4B1pv8Ap3YfnXyU3U19e/FBM+ANazn/AI9mPFfIT9TVcLf7tL/F+iMs2d5x9P1GVcilsxp0scttIbwsDHMsuFA7hlxz9ciqlNNfTNXPJTsGDjOOKbTqSmSNooNFMQU0inUbGKlgpIHU46UBa5EaSnGm0EhRRRQIKKQ0UAFFFAoAKdTaeKAQqinUgpxxxxzSKEoooHv0pgApe9A5PXFKRgkZB+lAwpRSCnCgY9Mg8V9gfC1Svw50Hj/lgP5mvj9DyM19g/DHH/CudBOeluDj8TXy3Ff+6R/xfoz1cr/iP0PPP2lGAs9HT1dz+leCHrXtf7SFwWu9IiPQK7Y/KvGEgkkjkkRGZExuI52/Wu3h9cuX0/n+bFmv8e3ZL/MaZGZUVjwowPakqRI1aIlWO8dVx29c0m1fK3bvnzjbjt617J51mNUZ4q/dRywiOCeDyZIlw2RgnJyCfzqvZRyzXEUMCh5XYBVPc9hzUt000k7zyps3uwwBwCOoH0yKT3saQWlz7B8MN/xb3RpACMadGf8AyGK+N7hi8zseSWJr668PzbfhJp0xP3dJz+UdfIR618xw7G1XEP8Avf5no49/u4fP9BtKOtLRX1B5dhRUgqMVItBURx6V9S/A4gfDCxZuglk5/wCBGvlojivqT4LJu+FlioUNl5Dgnqdxr5vif/dI/wCJfkz1Mv8Ajd/61L3xMYP4B1vHINq+MfSvkF+pr68+IUez4f6yG4b7I5PPQ4r5DfqajhX/AHef+L9ETmySnGwykpabX1J5AY4zxSUvekoEJSUtHemISneY4QoGIU9RTaSgabWw1hTTTzTTQQNoo70UCEooNFABRRRQAop4FNFSLQNBRS4pDSKFGMHOc9qSkpaBCiikpaYxRTh0popRQMkXqK+t/hVIX+G2iEdoSv5MRXyQvavq34NSb/hlpRwPl8xf/IjV8xxUr4SL/vL8merlP8Vry/U87/aQJ/tPRh/0xf8AmK8dV2TcEZhuGGA7ivY/2jwP7R0Y/wDTJ/5ivGu9d2Rf7hT+f5snM9MQ/RfkiW2Enm7YSdzAjjuD1qSG3aaRk3RoQeS7BQOcVXVcg8jirD2kyWkdyY2+zyMUWTHBYYyP1FeqzhREylHKkjIOMg5p7BgoJJK5IFOaEKiMGDBhnjsc9KJgFKgenIouWo2R9W6OrL8HLRAfmOjkgj3jNfJrjBr6v8LSq/wo09mG5RpeCPXCEf0r5Qc8183kF1UxC/vf5npZgrU4fP8AQQc0rIyMVcEEdQaRaly0r7nYsx6k8mvpDy0rjEUk1bihJxT4Ic9q0YoMYOMVEp2OmnS6szJ4Sor6Z+BTAfDWzH/TaTP/AH1XzrdwkITX0F8B2z8Ooxn7tzIP1r57iT3sGv8AEvyZ34OKVR+n6o2/iS4HgjW+Mj7K/B+lfH75ya+vPiN83gjXf+vV/wCVfIjfe5qeFf8Ad5/4v0RlmytKPoR0hpT1NJX1J44lJS0lAhKKU0UwG0UtBoENbpTDUhqM0CY2ig9aKBCUUGigQUUUUAOFSLUYqRaCkOpCKWigobRQetFAheMZzz6UUUCgBaUUduwoHSgY9etfUfwXcf8ACsbDdjAklH/j5r5cTrX058HQf+FYWOw4PnSYPb75r5vij/c1/iX6nrZOr17eX6o4r9olw17ooH/PJz+orx7P869X/aCAj1nSYgqqRbMxCnI5avKCDnB6125IrYGmvX82Tmr/ANqlby/JCj9K0RqdwNM/s/eGtQ28KwztJ649Kpkq6JhSJBkE8AEcY/HrVkabdhJZDaziOI4kfyzhD7ntXpS5X8RxRUvsldevPSlBzJuJHH96rEIh2kSbsnpgVHfRLDcMikkdQSMZovrYvlsrn074JG74TWSkkbrF/wBQ1fLUmNxwP1r6n+Hg874VabjBzaOv5FhXy06kSEEcg96+eyN/v8Sv736s9LMNaVP+uwiLk1cgiyRxUcKevStewtwxHHFe/OVkcFOHVk1pbcDIrRWDjpVm0tcqDxV4W+F6c1xyqanXGLZz15D+6bI9a9r+AZ/4oSUdlvH/AJLXkt/DtjYYr1j4Cf8AIj3gH8N6/wD6CteRnrvgn6r9TowitUfp+qN74g4/4QnXtw4+ySd/Y18iv1r62+I748B66fW1YGvkl+tHCq/2ef8Ai/RGOb/HH0Iz0pKU0lfUnjCUUvHekoASiiigQUnelNJTAQ0xqfTGoJY00lKaSgQUUh6UUCDtQKKKAHCnimCnigaHUUlLSKCk70tJTBi0UlLQAtKKSloGPWvqP4FbZPhtaqSRtmlGQcEfNmvlxa+nvgDGZfh9Gobbi5kOfxFfOcUK+C/7eX6np5VpW+R57+0WR/wltkoAAFoDx7s1eUjk16l+0SwPjuJOmy0Qf+PNXlyjmu7J1bBUvQzzB3xEvl+SJkR/m+TlRk54IrWtRdXix2djLcu75LQlsKTjnHPfHfrUvhGXTk1u3HiASHTndfOdFDMBkc5PP1xXTfETWtL1O78jw3pYtIElA89F2NOAoC4Xt3PvxXRUqyVRQUfn0QqUFyt3ORuorOO5C2xm2Kg8zz1CESY+YDGe/TNZsz7znaAfXPWtW5jieWNt0H7yNWYR5+Ujgg57nGT9arahZGBBJGd8R/iHY+hrWElpcUou2h9I/A+dbr4c2kZI/dPLEf8Avon/ANmr5z8TWv2LxJqVtziK4dBk9gxr3T9nCff4W1KFjkx3eQM9ig/wryX4qQC3+IuuRgcefv8A++lB/rXz2Wfu8zxFPvr+P/BO/Evmw0H6fkYNouccE10mmQ/IrYPNZGjZWZSpKuDlSK7bSbQSfM3fnpXs158u5hTjdJElpF8g+Wrog4q/bWoAAA5x0qdrfjgV5kqt2dihZHK6rBhCcda9H+AOD4S1ZO63p4+qLXF6umIzgdOea634BPjSdejzwLhW/NR/hXHm75sBL1X5lUlapp/WqNv4p/J8PNdY/wDPIAc+rAV8mue1fV3xbP8AxbjWiP7iD6/OtfKLda24VX+ySf8Aef5I5M2f7xegw02n9vam19QeSJQaD7UlAgJyBgUlLSUCA0lKaSmAhppp9MNAmMNIaU9aSgliGiiikIKKKKYhRTxTBTxQUhwNFJ3pRzSGLSGijimMKWkFLQAopR0pF5PXFKKBj1r6j/Z/jaPwLaN/DJLKeno1fLa19V/BZvs3w50fCje5lbJ9N7f4V87xN/uiX95fkz1MqTdVpdmeM/HK6+0/EW/x0iRIx+Az/WuG372BYKMDHAxmtPxpfHUPFurXJO7fcvg+wOB/KsleCK9bBUvZYanDsl+Rz4ufNXnba5taNCL+QafGyLNcECJpJFSMNn+Ikfh1HWp9Tmu2uYrPWJVVbKIxKq44AyQuV6nPGeaopJDtikSP58fPn5QpH90g9x611OmSaPN4eaIwTrfu7RqoQS5JU/MOPUAY6jOQetKq+R81r/1uXTXMrXOMVl8rbsPmZzu3cY9MVPBcsYJ4HyyOufoRyDUQhYOEbh920qTyDTJVOMnOf6V0aMwV0e3/ALNEw8jXoSTw0Lj/AMf/AMK4f41RiP4mamR0cRN/5DWuh/ZxvBFrer2w/wCWtujgf7rY/wDZqw/joCvxEuHPG+CJh+WP6V87Ri4Z1U84/wDyJ6U9cFF+f6s5vTQQykcGuy0qWfao3cD0Fcz4bWKdhuYcdRmvRNLghjC4Ax9RmvRxU+XRozo69Se0LZBPX1rUiKOmD1psSLtwVHFMkBjO5OQK8qTUmdq0KGtW+LeWTbwo5rb+A4Qafr/PzGZOP+A1ialqkaWF3FON3mRlV9Vbsau/AS5Vk15ODl0P6GsMxjL6hUv0a/NFUmpVUl2Og+NU6xfDa/A6yNGn1+cH+lfK7da+iv2g78ReEbK0XjzrnJz6KD/jXzqx5r0OGqfJgU+7b/T9Dzszd61uww0lLR9K+hPNG0lObtTaBBSUuaSgQo689KaRS0UANNMNPNMNMTGmkoNFBIhooNFIQUUUUwFFOFMFPFAIdRmilB5pFBRQeOtFMAoPXijPNHegCa3naBmZBGSylTvRXGD7EHn3qMdKSlHFFir9B69RX1f4QI0b4a6fJJ8ot7MyNnjBILH+dfK+mQm51G2gUZMkqoB9SBX0R8XdVbTPh4beNlV52S3GOu3HP6CvAzyDrulh19p/1+Z7OUWhz1nsl/wf0PnaWUyTvI3VmLH6mnoy9yRxxVUmlBr3rHj8zvc0rdwWMjthVxnaRk/QV2Nx4jgumtHsrCLS0S4I3Whw7ptA57ZAzk98159mnK64IIPtz0rGpRjOzfQ2hWcdEdRe3YuTOEW0aCLEqRxKV2k43Bc88HqOlYtzNGZGEbNt/h3Y6VVhnlifdC7IR0KnBFRk8g44qo01HQUqrkesfAq2MPi0SiWORZrNzhTkqQ6jB9D/AI1mfHacP4+lA6x28SH64J/rVz4Eg2+sanqR/wBRbW+3k92I/oprlfiPqP8AbXivUdShVjayS+XG/Y7QB/SvHp03LNJVOijb5/8ADHp1XbARst2YdvMUIIYg+xrZs7+dWQ+fIdvTLE4rmg2DVuO4VcYz05z617EoXPNp1Etz2Xwz4mt7yKO3vZBHc4PzkgA10nl5bsQe9eCw3yqBnPHSun07x3dWNnFbxxo4QEbnyT1ryq+Abd6Z6EMSlvqdV4ttGS1d0ByBzV79npWNvrcx6GRFB9xn/GuF1Tx5Pe2ckUltErsMBlJ4r0f9n9UXwneSEjdJdHP4KK4c0hOll8oz6tfmdOCnGpiLx6JmP+0Xc5h0aAklt0r9f90V4gTXovxx1db/AMXfZY2ylmnln/ePJ/pXnJr1sppOjg6cH2v9+p5mYVFPESa/qwZooxkEgHjqaTPBHavROMTNLtOCw5ApvWigCRIndJHQZVBlj6VHQDRQGgox3pDQaQnigQjdKjantTDTJY00GjvRQSIaKDRSASloopiCnAim0ooGSAr70o2+9RinUFDvl96XK+9MooAk+X1NGE55P5UyjvQFx/y/3jR8vqabQKBl3Tb17C6S4hCM69N65A9/rWj4g8SX2upbx302YrcYRffuTWFRUOnFyUmtUaKrNRcE9GO/GgfWm0tWQPXk9QPrTwmf41z9ahopAWFjX+KVRTXUA/KwNRUZosO5o2Gp32nRzpZXUkKTpskVW4Ye9UsHvTKM0lFJ3G5NqzH7W9KMMuMgimZNLk+tMkkVyKf5vFV80ZNFh3aJXctXtfwV1rTbTw5cWNxdJHeyTM6xPwWGAOPXpXiAYjoamW8uFEW2aQeV/q8Mfl+npXJjcJHF0vZSdup14LFPC1PaWv0LniS5a817UJ2bcXnc5/His3mlMjHqc/Wk3n8K6orlSSOWT5m2NzxRTt3sKTd7CmSNp8sryvukbc2AM/SguMAbRQGH92gYzNKKeHUNnZn2oZkLZC4HpTAaqls7QTjrimmpopmi3+WzLuG047j0qM7Cec4pIHYhY03vUkm3cduce9RmmQxtLRQaCRDRQaKQCUtJRTELRSUtMBRThTacKRSClpKWgYUtJS0AFLSUCgBaUUlFAxaKSloAWikooAKWkooAWiikoGOopM0UAFFFFAC0UlFIBaSig0AFFJRQIWkFFFMYUUUUCCmtTqYaAYhpppTSUEiUtJS0CENFBopAJRRRTEFLSUtAAKcKbS0DHUUgpaBi0UUUAFLSUtAwpaSigBaKKKBi0UlFABRRRQAtAooFABRRRSAKKSloAKKKKACiiigBKKKKYBQKKBQAUCjvRmgANMNKTTTQJiGkpaSgkKKKWgBDRQaKQCUtJRTEFLSUUALRSUUDHClBpopQaAHUtNFLQMWlptLQMWikpRQAUtJRQAtFJRSAWikpaYwooopAFLSUUAFFFFABRRRQAUUUUAFFFJTAWikooAKQmgmkzQJgaaaKKBBSUUUCCiiigANFIaKQj//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Isolates of Salmonella and Shigella can be presumptively identified by agglutination with appropriate antisera. A positive agglutination is on the left, a negative agglutination on the right.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Harriet Provine.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_36_11854=[""].join("\n");
var outline_f11_36_11854=null;
var title_f11_36_11855="Barcelona Rx algorithm HCC";
var content_f11_36_11855=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F69566&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F69566&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 608px\">",
"   <div class=\"ttl\">",
"    Barcelona clinic liver cancer staging classification and treatment algorithm",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 588px; height: 475px; background-image: url(data:image/gif;base64,R0lGODlhTALbAcQAAP///wAAAIiIiERERLu7uyIiIt3d3WZmZjMzM5mZmREREe7u7szMzFVVVXd3d6qqqp+fn0BAQN/f38/PzxAQEGBgYH9/f+/v77+/vwAAAAAAAAAAAAAAAAAAAAAAAAAAACH5BAAAAAAALAAAAABMAtsBAAX/ICCOZGmeaKqubOu+cCzPdG3feK7vfO//wKBwSCwaj8ikcslsOp/QqHRKrVqv2Kx2y+16v+CweEwum8/otHrNbrvf8Lh8Tq/b7/i8fs/v+/+AgYKDhIWGh4iJiouMjY5eAZGSk5SVlpSPmZqbiQE/npyhoqN4oD2mpKmqq2aoO66ssbKzVLA5trS5urtCuDe+vMHCwzDANcbEycrJrgIFIwUCAAsNkg7T1ZHXJMjL3t+zzc8i0QAICAsABAjm6Ors3ODy87ri0AIMAekj+fsn3fQCClzUjJIAAuNGIFQBcKDDh4HskcMXwACJfBZRNITIseMdiQDKnbO4rh1JeCM2/3pcybINyHIGBkRScC3mzG0pW+rcSUelC588gwrNApRF0aFIkzo5ylCp06dEP0GdShUK0xRXq2rdWkwq169gT3kNS7bsjKz/zKpda/SS27eY2MqdKwMt3bt4AdjNy3ft3r6Aw/4NTFjr4MKInx5OzHjo4saQdT6OTLnj5MqYB17OzFne5s6glX0OTTrY6NKoaZ1OzXrV6tawRb2OTTvT7NqE4Orezbu379/AgwsfTry48ePIkytfzrx5b9O4TdyeOz1Pdb/RpUPPnpN7913X1YYXv937eLPne3oXkZ5sezcSJrAXMUEC7fjzAdSvjV8vffusXBBABBAEAEEEAVxAm/+ABBqIoIILDljggQnKUgElFeB24SQZaojhLBNQIl9tIU4yIoki0oJgJBFkt+KA3L3YIi0FRgJBdjUayF2ON+ZCQQAUePdjkEICuYsFAVjgHZJKLpnkLhIEAGB2UU5JpZS8YLAeAFpu2eWWYHbm3Jhk/mZbmWimWUksarbpGw/vfREnF3PSyeYef9Vp5yN6atEnGX/2AucmgVpRqKF36pEnobZpcigYj/qwqKONVuoanoNSyqemlyqaKREMIBAJAgkAMIA0Nwgwqj9DRCrFYwkoEMkADBBgl6gZlZBAAaMSMJYqexEgawANqDOADQZIUkCpr3w6BALbCHCAqajWkA//A+bg1KqlPCwQwAPYJGBrDsIiUO0IDwTA7AHnNsvKXgpIE6qxyAbgq6rg6jApEQgcO0ICkuwaSQHYqjqrOryqS4IA8AjgLxGuRrGYt+cmXECyqwKQTQDSGExwCQc0sKsJDWgLRMR75qDAtNBEIoDHFh0giUUOuExCsr4CELK7+hrBgMwB0EptCQU4kA+4DgOgQKkPKLCwv84YgfITsMoUwAELjHvztwIoYNGpDCiArQPFjrCAAg+cTQDGFQ3ArKDv7rCOzQQ8LMKpwlp0MUIGnI2tCDiLkHTPPB9xADunTgP01SMD4DDbkeTKsOB2w+3IZgtAqzUDVqt7AMunAqws/wmiR8LyCA2cHsTUfvpwbd0iCMxxAv5eXLq9IwQOANmF43AaqSIccOwA1wCcDgIHXKvxsUufoDy0UnMrt9CZH6SPzux4m4AzCywQTdh/l0C8CLaymi6q7P6ail0GIICtrbXCs6zGAjxQwAIGeG0/q4DjrmrOt3CWEGo2KouILgGiCkABpgW0AhwLIQMrgcHcUQTWNWExBthYsTKnQGEpUF0cVGDHJHG6ZIWvHAsb1gAAKEBS2IUakpCG9zjmMWnIRAFe293McqestwWwd1VIHaI2JQXv+fAKFsTCdZLFv+gBMQpWQ0CuppDEJaRHEpVDYqKSkLB2HWFfRLwcp4CFqf8nEkR6jKjiEK3TQiUMToJ205oN5EgDNSahG4lrAe7iYMdasAB2LEiA6lrXO4MRaxpWi9fiDqYQWX0MBbJDAAHeqA5PUJKO7BkYC1OAyRLgqilhHEHXItGAdOTRKJs8gblOEKtIHFEhkpCiDk1nSEncLIGvJOAj0xK3EujSV4BcgSBVADRZmoBt/rJaAQiwyIooZIoiyMYg/VPIZxggGg6AB+1Sksp47Q4lJUjXul6WRcfFERYK61oLOtnIVWJFeuIEQPuKdcoV7BEFtuLYCRxQKnWewFZfa0DTLBKqjNQzmsVKF/8agK0GlI2XnRLlxw6ggKyV0wTDZAH0jmmv/L3/7H6OQ9VCSoAQrJFAisqLRzWjeYBsQlMvm+xHJVFQMgkWgFfoGFfSIBgJ6ZQKIzCpSPskQQBbiUpsIBNZQiDaCFfUVAT9SNzhrimNZBlgqJFYWyybeNBwOu2fznRG01LZVbSxJ5Ui4J1GtigCdypNXMfK5gLSt00GJGxaViunEU8QOOJ1LXzkW+rCilYCbwGWmoSTKADCloC5ygp4ZyUpKAB6ArfZtG9L0ynzpDEuoE1LYQd4RlAzCA972cpXA1Dd2dKmALTmR4wkQKE82yat2lW1Ig3w1z2TlS8S5NGzuStAbyXbN+Q57qjV6uoePWe6Rr70O2SM7dvwdip/0XV4/8U7ndp0FQBwbm1tzSOg+wKrgpuSQIglAKPjSMjdfdwTqtdjp8YGObhladaqM03vwLA12vnBVGufI90kpgndNJbgqYvVxwBwmJH+MstenAuYCboK1ebhc6sXMevQSqDh98Zul0xdnyerldlI/O26IfHVMA2JVgRvrbnnLdtITeAMbQkvxL+w6XlRFSv3dlMa2RSBN9GlT52RkxzisuRm1+tT305LVRksVj6KCooAj2B8lUzHkAt8RgGXap6mckBov/Zk3ErZXoebhsLE50XHgXjLlZScScOWs646FAAKFR8FhdyuPlJRgkilaNZIdbHdMfBYqxQzflt7XmwhIKFf7f8fANNnKhkLFmEmFUHmCIzYHypWoprkpgk8+LGw8W+UQZtk7ZJsTgCITlRNhmV3K2LXD1I5eCUMwAnxUdH0ohHVpRxaaGs1Klrj1LSOXDP5Rke0SSTA1CSgLPkSWOQN39KVJYAcrXut0oiO4Jf0coYBwtbdB44KrwHAIQvFS7Nz6c7VCTPmjJ+Z7Un0uY07cECbl4CRGOhbO6G0wr+ZMPBuR3cJxlSCet2Qz2rnOOAG7iUbzagIPzsR4qOweFco3gk0dtnbH8E3ESipAgpf0OMzoHA9ST4Dll/84ClPZTB19soYDGbhP5hbdwt20QnvmwQO6LlYMN4CQzYgJudK2sr/K9fwhKvA5ZpW4AkMucyzsJUFBvPmCqU78wMcEWiMNgoKYNhd1+LYBp/JH+juB3Wf2zNoL4+4vz8Wk7q1eenErXTRe86wsA/2bg/dOMifzmhmmkrmdvM6yOIaaVBOWJYvewHOezC5EaAtabti5qo1FsOQ7JfGQhf5IYCi4Ssn8MnDGyEjYWkRZwAM1wizpTNwyr9oWPnv5vi542G+Arfe7ahfK+qxSvd1c3vPV3SV8KzB6S2z7953RLgxNLbnNllKf1nitnZITNbqCqLcntAcgLkNoHSK3OtYCUtycb1e5WnRZKbiPpsPyyesBYjuGVTX/TslzgL/Xlka6bNCdbNa/zSnFz11Yw4gWsgnAASoeLhTdf3zXGLHcTpQeUL2AKOUL9cnSKDDgIszTW03dLAVAxb2f7NFfqnXOCTXdPbXfvilWUhGAot0RFGTYMP1E1enAr53eCF1eHWTLMHzdZ9XdewChAUIClsXdc63f4kVBMmydgvAMABzL88gLNtzP94jAMZjDiAYehRYCECRgL5Sd4ljVeWnPLmVd8t2VcblTarSff5HgMelYwm2hGcnGy/QNcCEV/diQ8JnWOZQfCfVWOYCiMCDhCw0AJCnfwYHfUSgc+OFeepyTd21NBykANGAVQukX5EDMd+3Ah+IdCdYfjozKkznTFeWbsZ1f0oWg/+xE2kmtDD2ZnX8xwIEpHV96IPHMkGC+C+jonrzg4gksABRZIdchnaMQnRYUIMnV4tVIFzq83CfaAiPknXGaDm8JwVA44V1JHqIoHGeOI1jFHJfSI3iCIY5WAeTV3HnmBvpqB7liI7K+I3vOAfr2HHzOHr1KAf3SI/5aI7OqI5w4iYESSZnUpAIqRxskpAMaUsCuR7gCBERuUbcMZEOYZF+BJFggpF/ppFbwpGv8pEbWR4VOZK8AJLzgJIpSZLZoZKewZLR4ZLgIJPNaB4mCR6y0ZA6uZM82ZNrMnE4GQo0iY0Z5ykniYfZKJRGGZScMJSrM3jwyJTJKGJJaY8w+Y//I+hCS1kPSEmVXkmOUjmOXamVQMmVSlmVUwmWZtmUUMmWZZkLThmPckeWpXCVWVmUaMlHdtlUbZmWdhCXdzSWePmVf5kL/QEK+8EIh/kfm7CY+mEljuCYiQkHkgmZpMAgE/IgjYCZDlIhmsCZFAIhmQCamhkHpOmZrLAhktAhjaCakcCamuCaAQCbmSCbtPkGtgkiKeIIJSIJJ6IJvRkJv5kJwRkAw/kGxXmcqiAjmsCcouCcoQCdcyCdscAjmmCdooCdoaCdc8CdsjAknACepCCeo0CedWCes8AknKCepMCeo+CedQCfs1AlnECfpGCfo4CfdaCftPAlm+CfowCg/6IgoHRAoGFyoJDhkwrqFhqxoA7qCg8aoW+SEhKqoP9QoVRzl8fojo34lYApeB3akTX5cb7GjiE6mJ3mjyWqRUuhoa+loi8Kcx8qeXcoMRnKlzUqCBAqC6gwozgIcCw6oiYKpDCaoh46lxtqoy3qBPL1LASWN0R6ordwjTwgV/+UQyBqpEtgck9gpaOGpQbXECHoO1RaA/ZzWIADjSsqpUXApeOBCs13D0PQpP9QppAED1jFLCyHCxtxO5wmai4wpi2QP7lSM28jqGuaolZTcx6mA4nTqHQ6ddy4AoRaSZ3XfWFqAt5yaYh6DGbXqSugpqEyMJzFbcfoCglzqTZnjP9ueqOowzLlM6cb0agyoKZ3lmfeAk18CgONo0dUCqop0FJmowDiZzao+KNcZnK0igNcGqmghwPCGmeO81W5uqaw0HebBKx18amTqgIIBDgrIzhlA1mnClZt+nNv6lXpsDPZkFP2oi69ZoHydHqliG3VtUwVgTuxClUJlDozYzEFg0Wxp2yztQ8dljM7uKsv0KuztSqnpS5olkzaQkC6RkKlMy1YhTvtyipq6mpec6w7aE+JOjRGlW4/MzMegy3qskADkDAtm26t93kbIw0dtVUWw3ndxSoUmw+mc7HzSlQ4u2chkS+UpVa5Z60mYHssY0gDEIvlA7B6gUs/SyxYhbH/1LZuksCzjMNeGesrGyuD0eJdaRV4WmoLWsNTpbKywuOyvJJDpjVrgSZhrbqkJIA2asMwx2M9qDI//jdf8oRUwYM4stRZDKQ68uphRXM0rdY8TRNtCbFc4zSyMSpMA8ZDD2ArqFKzV3WsetFbJGc8DVBak+QOvnes43NKlIask5s4p2Uqn+Ur4LM7xXJIpjJ8D8hrY9MA2feoAMRbWoO3R5sSnls5oCu6wFu6GdFwV7MPqfuirkB/FTVlrZZafgsN16BPUZOGLPW3DKC97/UtokS8+hC6Z3W852JZjkNg2xSiZgsKjOs0tFusUxgSNEtlqKU6aTa3Qiq7I7NIByBH/w5jP80WMKj2DHk0LnnDuRnUXWnrK3NlsePwOJSQKzN2sMFzbzmKUUsVYa4kR7hzKmJmU8s7OAj0rw/GTJWbEhkBOQnRvBOYrJzVfjDlapPwDHvEukiohTVsZbzLweoCYCksOLyCNSRMbdd0wv7LDcnrTN6zDS7coyDjbCr4QB/bNx84wyPjf6m6sic8WCPsLyUcOf6FZkFsKnp6aa5WObbQvg07Mzccw3dTvwD2ZMNiwOjqqvzQXR2zZ3J0NjuIXrMFLgm4YVqjiGSrWOC7hciDhsxTc0yEUHh2PcG7oX26VGmmPR4MTAUAuCawNJVHWOkSZXUIvEmbL5UnhyH7fP+wgMOwB76xC6isTC2v7GbdUw5olj0/fD2kjAKeLD/XEMp3NmW7HFtEy8QolLAGJ4cMw8jk4EA0fDyvC2/L86oxVocn0Mvk8MtmNspCOwLRmj9lIwBlY7STq6VaU4IzTLI5/F8uCL6DrL9MYAufhLO5DHSmCjhGrEx2vGwikC7ZKmFAo4kMNDAPdLPEjM/Ypma6ulYLO2CkVs+RZQ6VczarQm7sMjDGZmv07EPRKls7U6002oiLOsf1Sn7s9cb5lTiGhDVHZctFlWyEKHUb8zYUnbMW7TEZzSteK2HevA3KG2wgDV2oECs8dLLlFju4I9BYbE39mrHjdmwAVNPocNP/GP3UGj3TpIMSkIgq5FrObDywNlxncDw0bwt7+qx9kosEV8GlMaCtNPWnsSO24RulSboD23UD/ZYClYoC2rqje5DXKLDXkkqkFgfYKNCxX8o/axwVdDsDeYYD+XODMRBFEnhSTwqmlEwEQVYDDceIXkpSmK1HaR0HnW2L3Uw+od1pdlTaK3CmfIXYXs3Y+1ukdR0Ro32W5SyPt43HVuSiWsqhtZ2WPiradC2i8ezbFkmry8rQwR0EzsoCKseIv3IbbE2RzY0Drn2lL5Wu5IKK0md0MUtKlY0quoSmX8TcQJdFzFgOZBcA19De3Id1qrqtdZqliyF104CJ5jo42hrd/7193Xcz35W1b3iXKt1qczn63P0HLpCDE3vK25zt3XFFdyuUgNhSd1PnzBrTUId83ji2ep9Gv+2QDiVxDiQu1y7w2PQtHWXq16eQyPgtWZgqA/6tcGw6YdMCPyVH4NJt3HWt4N6Kp860DmUT1Lnt4TggbTdWeheoAg6wMi9FzjgLv3c1KmZkCyy33hTBKjLFVwl0DQ4DZTQmWLOmMFhVE1f7ejoTzRs7qrRbYPddrP3yDBsIUCSkdPR65tEUQ2oeYIkDtWp7MjcuPizjyaOisrLjSotTKniniM3F3miz6LOkazslK83j6FfTjVHaShxjMT7btUHLKt+Mil2OzI09R/+UcCycqxeVzSvPBaUSlSv6NGbvJo2Sm+UGMW8IkwLB3FrOkEoYs0nY+wy9TgDeSwB9/rrmK6+NeN9dYz9RU+etOL3jV+y7q8NmXTHX2+GFsxHUCzDKc2Px2y75m3TDM35Rw4zY07lz7U09VqzShuBRimX55YvUYLyke77Mgl8R/cQQTgNK3sgcVnPfBuWkA2Jrzg3nF9GOWNxZnhDfw7mGLV13Q30pYNi4k8XM4jZjjOwyTMYktMBdnaL3LUg0ROerBoPTe1tHXPE8jO0JfyoP3FzL7Wm/jQKdkwCNsxAoPa0R1OgsrzbAU8Bu9sX8TlsnSIuJOje0ojVhXBEdn8T/V7bvpC7J/n7qEZ4RCFh1dSeG8pSENpVMp519kTU4NZ+lx/jwcjoS72ASbY86Z6ZqE+Yr6QJYGU/scR/Mb8uGyj72ZL7bdfRsFZXuVVhic7jyJ6j3k4SF0QBQ7YNXOgzNM6y9InjzlXU6zHzDNeHO+zzXZehMoVVRvLU7S+XJS9Y1xMjyStPjsX0CqROroLzNwnzaOrMNL2hcbYXBsz0DAR88IV+vVzPebdyJqZhuM2z2dsqEIzsJU6TlX38Tz59u2qLnuG4zCi/Nel5rooJaqsjmBMzTcP4Jh2pNOGX4N516J6jnl1gON2Rcp6LUuON3zuLthnvo6XxAZw30SZ8s/6gCAkMQFMWijMgiDACBKgkwCIARGIyyAL3/AwGBoBAoIjEWCJJgVMAxnk8CoDEKyHwJRO92rfUWOOCQaD6j00U1u+1+w+O/cpAuv+Pzefta7//DPbQAks0RHiICOYC58fU4wjGMoRU8oLHUJcJBanZ6EnFyfo4m8omSoqYW+pyquspBtp4RfKk9FDCYvRhkvq76AuuFBhPHmRYjd9rJJifHNpsxf0pDFw9XY7P+ZnM3GnZjP4NTK4NzX5s7b6ezfz+2q/d2k2vKLliNOLxhatLut9CAFe0PmCMKqPyhlYJXAhQBBki6MgJhjyMH7hxDpjAAAl4OrhyIKJGigSVYmv8tY9OkQY8CYB6capJFZg+YaI4EqMHAJIIEByQ+BGIzyIIjKtiIm4dMFoKjBLjAOxPQ2MA8AgoM8uEAqh9avAY0EGPp3sysPq4uMKDAElV3xLzOaPBAAa+dvADw+9GAJUweS92eEaAgBgCXM0Zc4tjy5JGbF2nt1If34iOKPhoHMTBgwQLDapKe+4tGkl8fT5AISVDgAIHTAjANMHmxZD68p5uOsPRzRJYe/q4+Oar1CgMWCa6ornHj7hl0cRwoOMDcRwPK1EcoEHJ6N1cgcNHmDJKXuuSpm9YB+17poHizPdZWjvdOzVXBncH4C1yCgKCTLk4NQFkMCLgXXxD5nYH/ACNogJYNPaWk0doZBegTAEsAKMAIbC14tRcAOhBwlQE31HCAWQd091sBBpzQmxBs4QUQGIYtl4ZzbzwxXQ/HrfiDiKyUuOINlvnglRIXJWCRX+NVVJB1b2RUjJEIXCTAEhmeVWAACPlnDWBmoBWdZwgSUd8BDRyXBZlBBAjAcTnsBhErRPpGx2m9WdlGLEDx2aeffwIaKGJejjZJGLsFcNGWNhgKm3I4FJDFAAnwsygmgjnxw2+DROrjEwesIGNLj+ooD3puQCedeAX8cMCTlg6y6IFXCBcGApIxWUV5C3rzpS8b1fohfDEGMayshM6XxlV4jYBfTCsGkJ1/axqB/xwQKM5JBLU+oFiajaQ8mA5THbnQUwA8UCkEQlj24CijBngoSYixUsHCDZY4wGqRQ/DTabGUAlRelYZWZaocV7VQkkfZndVjfJVS0YBZcPkmpxJg5IqWWjBCeeorFE/GA4jtFuhhX/L1cYm+Tzjrg7yeVlHDtHS8fNmTPfVgYrazElHSk5+BG5WeamiGnQO0kaAoQi806+5ySOsDMbFHlKApv5z2dkIKobrJm0JLlOpxuOIBcI8TRBqkLrFqs7cvc/BeceHa1SaKkceugPxULSRnZpKLxKREn77H1YCTDEwuy4oMhs9d0ZMfLbTzD4z/cNwV+n47ytjjCC2awcgI4v/g3Z2H4+sdCNDZBurmbN4r6c29HsyNsWs+Ou2ep3x77bvrbnrv9RT8ezm+Cw9M4MUPPw3yuS+PyOzN+xEl9LITP71AvAvfuvXBV7+968l678rx4e8RNPLak68NKOmX3z37hIz//nnY/44++8/LD7T7+QuzP//+48F+1RAg+fD3P+4R8ICmSqD1GLi+8wkqghKcIAUraEE+ReOCGtwgBzt4BTJ4MIQiHKEH50DCE6KQg+ZTICoc+D4X/g+G/JMh61iYChqGD4cvtCH8ZsjDFf5wfkFs3xAD6MMiAg+J31Nix5jYFvnpkIdRbKATn1jFoeVviizUIvS46D0vbg+MKLv/IhHJ+EAz6g+NmYOiGsvYRvC98XNxVB8b5yjEOYpxenns4hHtuMQ37rF5gVzeII3nxybasZDFU2T2+njINOLxkQC8IiPFJ0mkHLKSvdOk7jjZwktCMo6epN0oY1dK5YGSQZlM5SlJ18rkpfKMkQTlK4VWSwjFknuAZCUvs5hLXbbxlvAQZjuI2cNfylGNxhRXL+uIzEkWcZk1pKUjn8m8YDZTktKMnjWhOcRtKoWavuwmHHcpzkuC043PTOcYV3nOHZJTCCmcJz3riUEmsrN04yRnPjvXT1g+8p93tKZAh+nEguLufvG8JkEPmk2FxhOh7JDoMdFZzXUulI5IpCj1//bZTY5yDp8PTR9IkyGBCcxnAhJ45klTutJvjrSA1rxAACIAgQBAIAIBuMAzaWpTnOqUpzB9J0SfWQGgVKCbR5VIUqMZ0xx2cwJAQak1pSoRqg7Voh5Fpk5HEIF4drWmSizpK8gKzFjedAQQiGdacTrWp34xnhQIAAUyOte6vpWoJI2nBQJggYz29a951aozrSmBALw0nodNrFP1KtN4YiCjPYisSB0LVclitrKEhSca7emn13k2tCUM52aLakYvStOsoRwgXMOITUu60oalVO0NL1pF1IJWtiEt7V6VWdbcbnG32rStQ2HrT92SdrhbpeRvY5uIXDUOJcINKHE1+/8DBxQocYWpgdlq090ASEajUeGD1jgSNpUUKLpyMEjqBspay8bVtyDMLuYM0xQePAUA9y2X7ZILhFvdAbrQVcnqtNIdu/nXnYUlIyQyVl8BkOYHET4rM4nQGRcBhyM8OMJmmDWCFtAIB5hoDW8AALkA5EJTVlCVXn7WhBEwYACnkXG0dDTb1lJRvkDIGFAEICFNYU6W4yXCT9wjohah5WIvw0SIDYAJwszlRUSuGxB4NJ2azaAFx6GCZ8T7Xt4+trNloq9pIEwwSZyXoRUmQnV8hDVXtesAquFbk+0FFCd/ylsuWLGOtOumIAckP+YpJzRo+8nl3nbMqyqzfsmV36b/8CK/3kxoAi6EALmtLVJJdokkciGxGQzMyS0gzL/AhDqFmZhhPcByoMswaDUnVMGcPW0drjAd7dLIIPooWrTCS+iJAmEnkctSSxb3YR5wh0MpEDGHTmMChwQLURPpbgGI9GIUt7pJ/e0omC8rZuPaErmhga9rdVxb5yrwxuTO8bdVkVpxi27denytu4Gb7unK2rQMbu5xg5tgPxp60jHkd7j9Pe5ux7fd5+73vf+dyOoOduEFb/jBlbtgSopWIqDNOMcriG+AQxzHuQy4e0GO6F+SPNZBTLknWM5yX7yc2xsVOR8jitmYr9bkF09lS9egUptbl7onv6RPb5rTnQI9/+JC33kql3qFpvKzuAgv9zOtegWsflTqFp81V6/w1YXinAg9L8PP4zj2HpQ9zM9s61rBXsSiAxXpcYT70YWq9mfeVbJhJ4LTRwD1OPY9AH/3tjUDq3ckWn0EWH9j4gOw+IQbFrGHR2JYv+7HyjM9l5TN6N6JwPZHfp7rmcWoEvMuSdOLfvQoZ6LhJdn61E+047KfPVA6ycTFXhL3mZ9mQ2/XeTNsXpLB17dBs+571SOf4EM2PimdQfvna1B80BdU8RlO+uarfOb1/njFl9977CMr0dt3eLytT4gB+0IArIHEtrT1IHYW8vdrPDT59Wn+a2Na0fpPRrXXtKVNRYgptP+Xl5mfIe3b+HUf961Zu7CKAXTZ/u1Yev0Kq2xL+/FMyU0c4NAaApbfAnofA/ZAdTANYdAATiSK5dTNeNDCEuBCaqwGiZ3EiTFAQzSLzhSGDGDBC95JztTACqLG/13NDLDAamCND7YgEF5JihFgBsqcGbxaCw2gEEocEPmBA4aHnrTXLb0bzOhAQ9RAQxQFuTDJcXDNvngaS1jIe8hAlAUAjAxAeNlgp6QhhqxhdogBfqFYFaAhAQBgbPBCHCYAZOihutACFbSJwElXrOGfZvAKFN6EzEShgRwLFk2hsHHE36gBdrVBQEwiInJg9bULSNSIEDAi37iJSTCb1YDgonj/ga1dRaIsgN5ABCCqTSuOgJNdSH4sCxBODRgAoi6yCi8CAJx5YvaBm4m1oGYQwBOCSxQyYzREoipxIIBNBhw0QCPaSBaC4gfaxg9giX1MRZ4Uhj7AhKipon4pjRoSAalVwQEsywvg4Lq4CAKwRX6kCy+6SzfCoz0qTX4Q4xJyowH6wLBchmzYgEG+IkeYhCWMoAwgzUXQ2EM8AV0Igd+4AAwsDiQiCqs4GwMgypAcxkPEIkdEixL+GkARiHdgpBDKGKIkAAo6mRMwgA8qQC5wokUWI/0xoZ81pBQKS6K8WI6oIK3wgqzA4LNtDdUwgBUiAGEYZUeqGrAUJR8G4VQw/2UMSCUhlsE/nuQ2CuQj6MgAKBu8zEZNigiJDOOofeEOtJlaxJiWLYphhIdgYMhaFgUkdoG/tESFcEmImMDFFCKobVtFrVqc5AKWgKEftgoXBIQO5IIDNEBgtgkn1gBd5iQVemU/eJED+FoTopsGeuPfBMRynAZvSI2d3QWkSESS9KCr4aVXTAIOcCIVdGHZIEo6qgsxqp8//gwXiQKKjKJsYoxDsEpAoCAJ8KYULgrIwNqXMWEnWCDk2RtoakW12cAALCOptBmxqc2TVSZbPkm2KScV5Etd4sUOzObIdA26KApbbMmm+dhW9uYx4kxamic4Pgq+FKdO1OS+5AxE4v9leV4m/WRmLMFfO91mKT4NKppjd3LISiKNcP6Htl0OFfTkbJog0qzGMN7ionDYSP7nYAICH5yYo63kVFDNfobiCKxfiHLi2Yho+AXkyNmeMWaVTnYg7z0njR6fja7cMdqfBxYozemoZyodgTpnkQ6pvAkpzG3gFAapkhZT1PWojAYdkhbako7D9HGpZ73O2QFA2inflaJS/SXp9c1UTRldUBmp9kHpmZopk0pS4A0ekB5pmSZgnE5dKjXe47lblwIqoEhfoN4TsCUdOWFe8ikqnn4fOYXeokKq87idXdFVpFrqIcgfo3bT611qpxrRoZKT7nnqqFpRo0IWqaIqBvL/aKqyaqdmasvBAqF+1h7IaqC06qRSqapmqTpJ6a2uKvMhkgJS4pT6KrCa6rDqqTRqabEunbEia54Gq6EyKzK9KkA9a46WapNO657KaYySwqtpTymB67ZSK64CgQTYncEcASaiwrimAbrCThCATfTQSXRq24CS64+Cqg9IVQX4qSM847fyiiz0678eiAIoCHTKgrvmK5E2KxB0lU2hR6sloYdh2xA+ZNewqJs4RA3gw1HgwxUC5A9EbNt52ZnMGcc2Cw2Gx4dWAXaoSyuqgLO9rIbVrMh2ZcOKkrkCQVvRlQW8FMC2piGGxLEoZlv2546cyxuexVEoyI8wLBr4LAUA/y0cncADnIAhhhfTMiBnPK3DqE0XtKEuOu1r9EjU6uzDrlMFRZbQTugwyhmgzchqboGtyaJHSoSrUAa4blDbVlnelstDzOQSzCJlqB9XbkmMIYc/5i0xom3a6pyz+sDUVi3ziKersBoYbOdeAkA5Uoc71gp8bhvlBq0RSAYtlMbmVgd8/khlYIsYBOK54EXo/uUDNifkKtyx+kDJrsO6Jue1xRgYRGhMkoBsyuTNJoASRIvtMgPvusUNKKFLKKVShmSHpc3/ocATJC8LIq/yKgDz4u7W6W6YCp7BausPFKyQnW/45i6a/gC8UtiuogH8qm+vsm/7lmu2Yquu7u/94v/v6ulvlAZwsvqvm0puzgkw/3IndRYwvR3w/BFw/LqZTzppA5tTrkYrtP4RmEjgJ1owc+0rJq2vCAfGFchIUcAsDMqAS5oYcahwC8OYsn7wkz4wg9RqoSKYGSyZjKDuQNbhYkqZOrIhx8TrDNPw+MJbEKSsu3xEhtiiiBGnbSSKSNziK4KKDBux+GHwjQZBp1WBqKwaDrDjvSBjaLJjaGJxFpMpABvwlHEED4OEC9BsipaXChxlHeuZt6pxyHXr7vXvHuvrFgcysQLyGv8qF49wIVNcDS+ytCpyYwnyDxFTtT7y7XLrwM1oJRscIx/QJGsyJHMyJi/rJ8PeIa/cDf//CSkPMhLnryq77yuHsis/XAizsiznGyzXsi3PciTnsi7vLC3jsi9Hbi87rDAfcTC3sjGLLzKzsTKrbTIDszM7MDH3sTQbsoHenDU/czMXECqLljbXKC+zGx+Ds/1icynfXTnvKDcT3tCpcyJf8vk08juP8jJLpx/TswafM/Ghcz7r8yOBqZguT0Az1vYQtD87ci7RHZtOz0LLXfg4dLoi9D8/Ep16j0WzD0ZPtLBKUp96j0ezD0hvdATPUaJ6j0mzD0qP9B+D0qNuj0unD0yvNJzmEuqFj02/D07PNE3HEqd6j0+zD1DvdCJ2k6iGj1G/D1IPNVF30/CFj1O/D1Qv/7WPTnVVIx8l1xr0nYMKdRJXW/WbtvGYttMGFyBZf3USgXCbWqlZZzIJnzWWgnIFJ/C1ljVdv7WkHqBaM7ACJ3QG3zUupfVXyi+zXIjt6nG8bUUYm6QE/zU35bXAHjb2CAZhGDa+GuB96FdnMnZj82obr8SoEMLjokx97IBhvBgCmGQ+0cEL5EtaGCTLggFWF6tsA8Zky0Bl34Fo406YHACn5aEN5iwhc2jElGWMdSZt3ypywxFpY/Zp2+QQJiRutCGHlphuh9+yvJgApOyPBbcj50dpYsHddjdn57AWd62YmFku6IxinmV4APcwMubAVlzisIwXf9rIgmJ+bG6Ljf83eQ8wF2P3yuqLhIQjvRALppAABfc3AiYO4XgYalu2XL/t8FKvJfv3f68yfeeEfYPxaQ4AGZende+1X9e1W1/4iB5xg89lCjy3KcJKSFaNiOs1BE8nX584ice1WFN1EYMfht+4jW+yhA82kHN0Gv/4pwa2kDM1kZN0hF+4clu4tTrfBm2SVx95/zy2kvd1P1/5H0B5IC0TzkF5w375WsPzOHc5Wpu3lp/5vKU5rDLY9H2mO785louzm4tyneP1nddcnus5YVJzI3XynwN2LC/SPBO6nRu6oPt5oit6oNcPojt6eUP6Jkn6pPt4PB/6oGO6YyPTQU8PqB81VZFdQXf/+ruSOtqZ+iNFtPW0Ovm8+qmzQaw3HVJdtK1nNK7LehtodCyJ9PT8evgE+66jwbCDkkpPD7KHj7IT+xkw+yXJNPREu/dMe7N73hWYLDLptPVsO/l0u7WbwbeDklBPD7mHj7mDexCge+5JXvootbu3e7qrwbtrnvxIdfrcu7wHQb7re7+nrTd/kI0AvD0FUKDO9MDXXjjHacxtDiON+Zqbcz3PeJQLEpLvuDYLk2onMsNbvJnTc8ZbesRTPCF1/Ij7M8grPEVzPKWbfD6jfJUuPKdfzyNODjY+OkK/fI//B4zmQX7Ya/1Gdhuk7L2O9bOKAeYMGjPKSici8MffwUbg/6wutI7GW41HHFgc/LyRBz0bDD1L07iVtE3SYyPTs7U6j813qNosTH3Iu80gZqwMZizSNICz+QPU2EZw6Jks0FDX00BDtAsXfOxI0gK7ojjLu4TjGmRAdORHeuix0eRiP7zWvQFcQOZBbixs0+zM6/xGfHg72kBNTncIFvd9v60/xMtBHNkZ3+7ey22L0KGVoEt82jygRyvqvsCGsUSnDRqFhO17/qWCSOZ8rvTZ5+09FDfXvi3Lz7lXNAQvgDel5Nnz66XPD4G/TEq//I3efwLfV+YA3AJ1s2jW3/wSSVtGPgJrLsBt9j4B6GaLwu3W2zLx80Jn5Mtq3q34b7YHUv++Cuw3CACikjSHKDYDSgQL0AJNAzABIaxAkaBi4AuigMKi8YhKFHwDAcAQKDgFiJcohsxqf1sjUbRQPERUQBPwCBiaCRcAcQqMATdBYbGQYg8n37cLGCg4SFhoeIiYyEXYYgCQJ2BSZNJiRfinmBmI2SgyMGCAEDDKoDBaFTqqlhrQsCBaEMPqAJAjwhOEWaSrCdCmmuMEcKBg1aCagNUrxNv1l6CAAsUwAGwmwFpwcjAKRWA2OrCw1ze0fI6err6u2KzVourKqlYdxfAaVejOrrnPr+WPzr+BggIeMfgPIcGFDBsOVOjQT8R+E7cEhFjxHEaJGRd1/AgypDORSDb/kjRJ8CLJlIZQalwJM+ZHlwxpzpQpMItNnDpbgtzJM6jQkkOBVjSaTiU/Ww4F9GDm8+bQqVQTIWV31WHWZUpRMO31FUlYH0zHGnmAwAQCRxwv/awKN+4mgljM9pTrEWZXMjrA9hX7l2zgLVB4udyqD6/ixW35KRuEeGHkTHsLBzgQTI2qKi1EKbhXL9oAUZdrreA2qsfoUQcsH/h12bUtAqZImCF9Aq2KtbmidpzMODg/TA5UMTigA1cA0j2Wp4ZRu0dmVVJABWAAwwWBAs8bx1UFPrz48eTLmycPMEjZWD6gPGjxbcCBSigG0LDBIOwBBGZWNBrbxgJlraCAE9As//BJdmw5tUtL5z0IYYTACUchOpjIgQJytzQ3RTQBdAhAgb4UY8c3da0gnwwn2PZANN5VWJR6OjBFDTLkAFCciGfQkYAtApiSzxlQGMBUAqSpMeCQP6zhhJJEwQhllCJhYsdlC2i4Q3Mmaralk0jqcCJ0Q1rWzYtSykQlf6aJsN8jASRDBB8o2MAkGl+6h+MSQiKpZgG0pEGkmraI+COCTapx15mKLspSESTYAZ2WedLxjQNLEEoimG4wVUABOtjWIKM4YVLKZUzRFsWb5MBTWj0frllPp9c8oUapmI3CnQG2zhbdrE4eJGqwwnLlQxinLGAAdwjYRt03zUIXgG1M4f9TnQhtfAMDd/mYOexv6OyIZrfijltQQdj+cO46E5I71zngxrQuu/JShdENfqSrTrzzJtqtvvv+C2+MAEfk70kDHzxswYcojHBO4jLccMSSCSxxQuRCXHHG+VKs8cbjYtxxyJRxLDKxH5eMMr2GCGAcam9eM0ABrJQDWcoaSYhzzjrvjJ7NPodLiA34DsPfaI5IYsBnif3MdNNOG0yIEmQBqacw2nZX89Nab821xUHbS+sYls6qolVdn4122guvbFysVYswD1tZq0133XZzuxLId+/Nt5R6t9t34ILb/DcghQ+OeOI8HW6R4o4/DjDj6UFOeeUJk2x55ppTKDm/m386Dvp3mIdOeunw8ox66qavznrrrr8Oe+yyz0577bbfjnvuuu/Oe+++/w588MIPT3zxxh+PfPLKL79QCAA7);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     HCC: hepatocellular carcinoma; N: nodules; M: metastases; PST: performance status test.",
"     <br/>",
"     * Cadaveric liver transplantation or living donor liver transplantation.",
"    </div>",
"    <div class=\"reference\">",
"     Modified with permission from: Llovet JM, Di Bisceglie AM, Bruix J, et al. Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma. J Natl Cancer Inst 2008; 100:698. Copyright &copy; 2008 Oxford University Press.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_36_11855=[""].join("\n");
var outline_f11_36_11855=null;
